AGE|AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|BEHAVIOR|COUNT|POPULATION|SEX|SITE|YEAR
0-19|~|~|~|Benign/Borderline|~|39865121|Female|All other|2004
0-19|~|~|~|Malignant|~|39865121|Female|All other|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|All other|2005
0-19|~|~|~|Malignant|~|39998876|Female|All other|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|All other|2006
0-19|~|~|~|Malignant|~|40165421|Female|All other|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|All other|2007
0-19|~|~|~|Malignant|~|40382360|Female|All other|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|All other|2008
0-19|~|~|~|Malignant|~|40576293|Female|All other|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|All other|2009
0-19|~|~|~|Malignant|~|40670476|Female|All other|2009
0-19|~|~|~|Benign/Borderline|~|40649165|Female|All other|2010
0-19|~|~|~|Malignant|~|40649165|Female|All other|2010
0-19|~|~|~|Benign/Borderline|~|40540942|Female|All other|2011
0-19|~|~|~|Malignant|~|40540942|Female|All other|2011
0-19|~|~|~|Benign/Borderline|~|40450188|Female|All other|2012
0-19|~|~|~|Malignant|~|40450188|Female|All other|2012
0-19|~|~|~|Benign/Borderline|~|40416682|Female|All other|2013
0-19|~|~|~|Malignant|~|40416682|Female|All other|2013
0-19|~|~|~|Benign/Borderline|~|40420522|Female|All other|2014
0-19|~|~|~|Malignant|~|40420522|Female|All other|2014
0-19|~|~|~|Benign/Borderline|~|40478360|Female|All other|2015
0-19|~|~|~|Malignant|~|40478360|Female|All other|2015
0-19|~|~|~|Benign/Borderline|~|40566497|Female|All other|2016
0-19|~|~|~|Malignant|~|40566497|Female|All other|2016
0-19|~|~|~|Benign/Borderline|~|40607151|Female|All other|2017
0-19|~|~|~|Malignant|~|40607151|Female|All other|2017
0-19|0.1|0.1|0.1|Benign/Borderline|128|197530982|Female|All other|2017-2021
0-19|0.3|0.3|0.3|Malignant|582|197530982|Female|All other|2017-2021
0-19|0.0|0.1|0.1|Benign/Borderline|22|40600164|Female|All other|2018
0-19|0.3|0.4|0.3|Malignant|126|40600164|Female|All other|2018
0-19|0.1|0.1|0.1|Benign/Borderline|37|40536667|Female|All other|2019
0-19|0.3|0.5|0.4|Malignant|162|40536667|Female|All other|2019
0-19|0.1|0.1|0.1|Benign/Borderline|34|39443036|Female|All other|2020
0-19|0.3|0.4|0.4|Malignant|146|39443036|Female|All other|2020
0-19|0.1|0.1|0.1|Benign/Borderline|30|38944115|Female|All other|2021
0-19|0.3|0.5|0.4|Malignant|151|38944115|Female|All other|2021
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Anaplastic astrocytoma|2004
0-19|0.1|0.2|0.1|Malignant|46|39865121|Female|Anaplastic astrocytoma|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Anaplastic astrocytoma|2005
0-19|0.0|0.1|0.1|Malignant|25|39998876|Female|Anaplastic astrocytoma|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Anaplastic astrocytoma|2006
0-19|0.1|0.1|0.1|Malignant|31|40165421|Female|Anaplastic astrocytoma|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Anaplastic astrocytoma|2007
0-19|0.1|0.1|0.1|Malignant|31|40382360|Female|Anaplastic astrocytoma|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Anaplastic astrocytoma|2008
0-19|0.1|0.1|0.1|Malignant|32|40576293|Female|Anaplastic astrocytoma|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Anaplastic astrocytoma|2009
0-19|0.1|0.1|0.1|Malignant|30|40670476|Female|Anaplastic astrocytoma|2009
0-19|~|~|~|Benign/Borderline|~|40649165|Female|Anaplastic astrocytoma|2010
0-19|0.1|0.1|0.1|Malignant|40|40649165|Female|Anaplastic astrocytoma|2010
0-19|~|~|~|Benign/Borderline|~|40540942|Female|Anaplastic astrocytoma|2011
0-19|0.1|0.1|0.1|Malignant|39|40540942|Female|Anaplastic astrocytoma|2011
0-19|~|~|~|Benign/Borderline|~|40450188|Female|Anaplastic astrocytoma|2012
0-19|0.0|0.1|0.1|Malignant|24|40450188|Female|Anaplastic astrocytoma|2012
0-19|~|~|~|Benign/Borderline|~|40416682|Female|Anaplastic astrocytoma|2013
0-19|0.1|0.2|0.1|Malignant|51|40416682|Female|Anaplastic astrocytoma|2013
0-19|~|~|~|Benign/Borderline|~|40420522|Female|Anaplastic astrocytoma|2014
0-19|0.1|0.1|0.1|Malignant|40|40420522|Female|Anaplastic astrocytoma|2014
0-19|~|~|~|Benign/Borderline|~|40478360|Female|Anaplastic astrocytoma|2015
0-19|0.1|0.1|0.1|Malignant|35|40478360|Female|Anaplastic astrocytoma|2015
0-19|~|~|~|Benign/Borderline|~|40566497|Female|Anaplastic astrocytoma|2016
0-19|0.0|0.1|0.1|Malignant|30|40566497|Female|Anaplastic astrocytoma|2016
0-19|~|~|~|Benign/Borderline|~|40607151|Female|Anaplastic astrocytoma|2017
0-19|0.0|0.1|0.1|Malignant|27|40607151|Female|Anaplastic astrocytoma|2017
0-19|~|~|~|Benign/Borderline|~|197530982|Female|Anaplastic astrocytoma|2017-2021
0-19|0.0|0.1|0.1|Malignant|107|197530982|Female|Anaplastic astrocytoma|2017-2021
0-19|~|~|~|Benign/Borderline|~|40600164|Female|Anaplastic astrocytoma|2018
0-19|0.0|0.1|0.1|Malignant|24|40600164|Female|Anaplastic astrocytoma|2018
0-19|~|~|~|Benign/Borderline|~|40536667|Female|Anaplastic astrocytoma|2019
0-19|0.0|0.1|0.1|Malignant|29|40536667|Female|Anaplastic astrocytoma|2019
0-19|~|~|~|Benign/Borderline|~|39443036|Female|Anaplastic astrocytoma|2020
0-19|0.0|0.1|0.0|Malignant|19|39443036|Female|Anaplastic astrocytoma|2020
0-19|~|~|~|Benign/Borderline|~|38944115|Female|Anaplastic astrocytoma|2021
0-19|~|~|~|Malignant|~|38944115|Female|Anaplastic astrocytoma|2021
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Anaplastic oligodendroglioma|2004
0-19|~|~|~|Malignant|~|39865121|Female|Anaplastic oligodendroglioma|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Anaplastic oligodendroglioma|2005
0-19|~|~|~|Malignant|~|39998876|Female|Anaplastic oligodendroglioma|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Anaplastic oligodendroglioma|2006
0-19|~|~|~|Malignant|~|40165421|Female|Anaplastic oligodendroglioma|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Anaplastic oligodendroglioma|2007
0-19|~|~|~|Malignant|~|40382360|Female|Anaplastic oligodendroglioma|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Anaplastic oligodendroglioma|2008
0-19|~|~|~|Malignant|~|40576293|Female|Anaplastic oligodendroglioma|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Anaplastic oligodendroglioma|2009
0-19|~|~|~|Malignant|~|40670476|Female|Anaplastic oligodendroglioma|2009
0-19|~|~|~|Benign/Borderline|~|40649165|Female|Anaplastic oligodendroglioma|2010
0-19|~|~|~|Malignant|~|40649165|Female|Anaplastic oligodendroglioma|2010
0-19|~|~|~|Benign/Borderline|~|40540942|Female|Anaplastic oligodendroglioma|2011
0-19|~|~|~|Malignant|~|40540942|Female|Anaplastic oligodendroglioma|2011
0-19|~|~|~|Benign/Borderline|~|40450188|Female|Anaplastic oligodendroglioma|2012
0-19|~|~|~|Malignant|~|40450188|Female|Anaplastic oligodendroglioma|2012
0-19|~|~|~|Benign/Borderline|~|40416682|Female|Anaplastic oligodendroglioma|2013
0-19|~|~|~|Malignant|~|40416682|Female|Anaplastic oligodendroglioma|2013
0-19|~|~|~|Benign/Borderline|~|40420522|Female|Anaplastic oligodendroglioma|2014
0-19|~|~|~|Malignant|~|40420522|Female|Anaplastic oligodendroglioma|2014
0-19|~|~|~|Benign/Borderline|~|40478360|Female|Anaplastic oligodendroglioma|2015
0-19|~|~|~|Malignant|~|40478360|Female|Anaplastic oligodendroglioma|2015
0-19|~|~|~|Benign/Borderline|~|40566497|Female|Anaplastic oligodendroglioma|2016
0-19|~|~|~|Malignant|~|40566497|Female|Anaplastic oligodendroglioma|2016
0-19|~|~|~|Benign/Borderline|~|40607151|Female|Anaplastic oligodendroglioma|2017
0-19|~|~|~|Malignant|~|40607151|Female|Anaplastic oligodendroglioma|2017
0-19|~|~|~|Benign/Borderline|~|197530982|Female|Anaplastic oligodendroglioma|2017-2021
0-19|~|~|~|Malignant|~|197530982|Female|Anaplastic oligodendroglioma|2017-2021
0-19|~|~|~|Benign/Borderline|~|40600164|Female|Anaplastic oligodendroglioma|2018
0-19|~|~|~|Malignant|~|40600164|Female|Anaplastic oligodendroglioma|2018
0-19|~|~|~|Benign/Borderline|~|40536667|Female|Anaplastic oligodendroglioma|2019
0-19|~|~|~|Malignant|~|40536667|Female|Anaplastic oligodendroglioma|2019
0-19|~|~|~|Benign/Borderline|~|39443036|Female|Anaplastic oligodendroglioma|2020
0-19|~|~|~|Malignant|~|39443036|Female|Anaplastic oligodendroglioma|2020
0-19|~|~|~|Benign/Borderline|~|38944115|Female|Anaplastic oligodendroglioma|2021
0-19|~|~|~|Malignant|~|38944115|Female|Anaplastic oligodendroglioma|2021
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Astrocytoma, NOS|2004
0-19|0.2|0.3|0.2|Malignant|92|39865121|Female|Astrocytoma, NOS|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Astrocytoma, NOS|2005
0-19|0.2|0.3|0.2|Malignant|93|39998876|Female|Astrocytoma, NOS|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Astrocytoma, NOS|2006
0-19|0.2|0.3|0.2|Malignant|89|40165421|Female|Astrocytoma, NOS|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Astrocytoma, NOS|2007
0-19|0.2|0.3|0.2|Malignant|86|40382360|Female|Astrocytoma, NOS|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Astrocytoma, NOS|2008
0-19|0.2|0.3|0.2|Malignant|86|40576293|Female|Astrocytoma, NOS|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Astrocytoma, NOS|2009
0-19|0.2|0.3|0.2|Malignant|98|40670476|Female|Astrocytoma, NOS|2009
0-19|~|~|~|Benign/Borderline|~|40649165|Female|Astrocytoma, NOS|2010
0-19|0.2|0.3|0.2|Malignant|91|40649165|Female|Astrocytoma, NOS|2010
0-19|~|~|~|Benign/Borderline|~|40540942|Female|Astrocytoma, NOS|2011
0-19|0.2|0.2|0.2|Malignant|80|40540942|Female|Astrocytoma, NOS|2011
0-19|~|~|~|Benign/Borderline|~|40450188|Female|Astrocytoma, NOS|2012
0-19|0.2|0.3|0.2|Malignant|83|40450188|Female|Astrocytoma, NOS|2012
0-19|~|~|~|Benign/Borderline|~|40416682|Female|Astrocytoma, NOS|2013
0-19|0.2|0.3|0.2|Malignant|98|40416682|Female|Astrocytoma, NOS|2013
0-19|~|~|~|Benign/Borderline|~|40420522|Female|Astrocytoma, NOS|2014
0-19|0.2|0.3|0.3|Malignant|104|40420522|Female|Astrocytoma, NOS|2014
0-19|~|~|~|Benign/Borderline|~|40478360|Female|Astrocytoma, NOS|2015
0-19|0.1|0.2|0.2|Malignant|76|40478360|Female|Astrocytoma, NOS|2015
0-19|~|~|~|Benign/Borderline|~|40566497|Female|Astrocytoma, NOS|2016
0-19|0.2|0.2|0.2|Malignant|82|40566497|Female|Astrocytoma, NOS|2016
0-19|~|~|~|Benign/Borderline|~|40607151|Female|Astrocytoma, NOS|2017
0-19|0.2|0.2|0.2|Malignant|80|40607151|Female|Astrocytoma, NOS|2017
0-19|~|~|~|Benign/Borderline|~|197530982|Female|Astrocytoma, NOS|2017-2021
0-19|0.2|0.2|0.2|Malignant|352|197530982|Female|Astrocytoma, NOS|2017-2021
0-19|~|~|~|Benign/Borderline|~|40600164|Female|Astrocytoma, NOS|2018
0-19|0.2|0.3|0.2|Malignant|87|40600164|Female|Astrocytoma, NOS|2018
0-19|~|~|~|Benign/Borderline|~|40536667|Female|Astrocytoma, NOS|2019
0-19|0.1|0.2|0.2|Malignant|74|40536667|Female|Astrocytoma, NOS|2019
0-19|~|~|~|Benign/Borderline|~|39443036|Female|Astrocytoma, NOS|2020
0-19|0.1|0.2|0.1|Malignant|53|39443036|Female|Astrocytoma, NOS|2020
0-19|~|~|~|Benign/Borderline|~|38944115|Female|Astrocytoma, NOS|2021
0-19|0.1|0.2|0.2|Malignant|63|38944115|Female|Astrocytoma, NOS|2021
0-19|0.1|0.1|0.1|Benign/Borderline|30|39865121|Female|Choroid plexus|2004
0-19|~|~|~|Malignant|~|39865121|Female|Choroid plexus|2004
0-19|0.0|0.1|0.1|Benign/Borderline|22|39998876|Female|Choroid plexus|2005
0-19|~|~|~|Malignant|~|39998876|Female|Choroid plexus|2005
0-19|0.0|0.1|0.1|Benign/Borderline|28|40165421|Female|Choroid plexus|2006
0-19|~|~|~|Malignant|~|40165421|Female|Choroid plexus|2006
0-19|0.1|0.1|0.1|Benign/Borderline|31|40382360|Female|Choroid plexus|2007
0-19|~|~|~|Malignant|~|40382360|Female|Choroid plexus|2007
0-19|0.1|0.1|0.1|Benign/Borderline|42|40576293|Female|Choroid plexus|2008
0-19|~|~|~|Malignant|~|40576293|Female|Choroid plexus|2008
0-19|0.0|0.1|0.1|Benign/Borderline|24|40670476|Female|Choroid plexus|2009
0-19|~|~|~|Malignant|~|40670476|Female|Choroid plexus|2009
0-19|0.0|0.1|0.1|Benign/Borderline|29|40649165|Female|Choroid plexus|2010
0-19|~|~|~|Malignant|~|40649165|Female|Choroid plexus|2010
0-19|0.0|0.1|0.1|Benign/Borderline|27|40540942|Female|Choroid plexus|2011
0-19|~|~|~|Malignant|~|40540942|Female|Choroid plexus|2011
0-19|0.0|0.1|0.1|Benign/Borderline|26|40450188|Female|Choroid plexus|2012
0-19|~|~|~|Malignant|~|40450188|Female|Choroid plexus|2012
0-19|0.1|0.1|0.1|Benign/Borderline|30|40416682|Female|Choroid plexus|2013
0-19|~|~|~|Malignant|~|40416682|Female|Choroid plexus|2013
0-19|0.0|0.1|0.0|Benign/Borderline|20|40420522|Female|Choroid plexus|2014
0-19|~|~|~|Malignant|~|40420522|Female|Choroid plexus|2014
0-19|0.1|0.1|0.1|Benign/Borderline|31|40478360|Female|Choroid plexus|2015
0-19|~|~|~|Malignant|~|40478360|Female|Choroid plexus|2015
0-19|0.0|0.1|0.1|Benign/Borderline|23|40566497|Female|Choroid plexus|2016
0-19|~|~|~|Malignant|~|40566497|Female|Choroid plexus|2016
0-19|0.1|0.1|0.1|Benign/Borderline|34|40607151|Female|Choroid plexus|2017
0-19|~|~|~|Malignant|~|40607151|Female|Choroid plexus|2017
0-19|0.1|0.1|0.1|Benign/Borderline|128|197530982|Female|Choroid plexus|2017-2021
0-19|0.0|0.0|0.0|Malignant|33|197530982|Female|Choroid plexus|2017-2021
0-19|0.0|0.1|0.1|Benign/Borderline|27|40600164|Female|Choroid plexus|2018
0-19|~|~|~|Malignant|~|40600164|Female|Choroid plexus|2018
0-19|0.0|0.1|0.1|Benign/Borderline|24|40536667|Female|Choroid plexus|2019
0-19|~|~|~|Malignant|~|40536667|Female|Choroid plexus|2019
0-19|0.0|0.1|0.1|Benign/Borderline|26|39443036|Female|Choroid plexus|2020
0-19|~|~|~|Malignant|~|39443036|Female|Choroid plexus|2020
0-19|0.0|0.1|0.0|Benign/Borderline|19|38944115|Female|Choroid plexus|2021
0-19|~|~|~|Malignant|~|38944115|Female|Choroid plexus|2021
0-19|0.2|0.3|0.2|Benign/Borderline|85|39865121|Female|Craniopharyngioma|2004
0-19|~|~|~|Malignant|~|39865121|Female|Craniopharyngioma|2004
0-19|0.2|0.2|0.2|Benign/Borderline|78|39998876|Female|Craniopharyngioma|2005
0-19|~|~|~|Malignant|~|39998876|Female|Craniopharyngioma|2005
0-19|0.2|0.2|0.2|Benign/Borderline|77|40165421|Female|Craniopharyngioma|2006
0-19|~|~|~|Malignant|~|40165421|Female|Craniopharyngioma|2006
0-19|0.2|0.3|0.2|Benign/Borderline|96|40382360|Female|Craniopharyngioma|2007
0-19|~|~|~|Malignant|~|40382360|Female|Craniopharyngioma|2007
0-19|0.1|0.2|0.2|Benign/Borderline|67|40576293|Female|Craniopharyngioma|2008
0-19|~|~|~|Malignant|~|40576293|Female|Craniopharyngioma|2008
0-19|0.2|0.3|0.2|Benign/Borderline|90|40670476|Female|Craniopharyngioma|2009
0-19|~|~|~|Malignant|~|40670476|Female|Craniopharyngioma|2009
0-19|0.2|0.3|0.2|Benign/Borderline|95|40649165|Female|Craniopharyngioma|2010
0-19|~|~|~|Malignant|~|40649165|Female|Craniopharyngioma|2010
0-19|0.2|0.3|0.2|Benign/Borderline|86|40540942|Female|Craniopharyngioma|2011
0-19|~|~|~|Malignant|~|40540942|Female|Craniopharyngioma|2011
0-19|0.2|0.2|0.2|Benign/Borderline|78|40450188|Female|Craniopharyngioma|2012
0-19|~|~|~|Malignant|~|40450188|Female|Craniopharyngioma|2012
0-19|0.2|0.3|0.2|Benign/Borderline|89|40416682|Female|Craniopharyngioma|2013
0-19|~|~|~|Malignant|~|40416682|Female|Craniopharyngioma|2013
0-19|0.2|0.3|0.2|Benign/Borderline|93|40420522|Female|Craniopharyngioma|2014
0-19|~|~|~|Malignant|~|40420522|Female|Craniopharyngioma|2014
0-19|0.2|0.2|0.2|Benign/Borderline|81|40478360|Female|Craniopharyngioma|2015
0-19|~|~|~|Malignant|~|40478360|Female|Craniopharyngioma|2015
0-19|0.1|0.2|0.2|Benign/Borderline|68|40566497|Female|Craniopharyngioma|2016
0-19|~|~|~|Malignant|~|40566497|Female|Craniopharyngioma|2016
0-19|0.2|0.2|0.2|Benign/Borderline|79|40607151|Female|Craniopharyngioma|2017
0-19|~|~|~|Malignant|~|40607151|Female|Craniopharyngioma|2017
0-19|0.2|0.2|0.2|Benign/Borderline|351|197530982|Female|Craniopharyngioma|2017-2021
0-19|~|~|~|Malignant|~|197530982|Female|Craniopharyngioma|2017-2021
0-19|0.1|0.2|0.1|Benign/Borderline|52|40600164|Female|Craniopharyngioma|2018
0-19|~|~|~|Malignant|~|40600164|Female|Craniopharyngioma|2018
0-19|0.2|0.3|0.2|Benign/Borderline|84|40536667|Female|Craniopharyngioma|2019
0-19|~|~|~|Malignant|~|40536667|Female|Craniopharyngioma|2019
0-19|0.1|0.2|0.2|Benign/Borderline|71|39443036|Female|Craniopharyngioma|2020
0-19|~|~|~|Malignant|~|39443036|Female|Craniopharyngioma|2020
0-19|0.1|0.2|0.2|Benign/Borderline|69|38944115|Female|Craniopharyngioma|2021
0-19|~|~|~|Malignant|~|38944115|Female|Craniopharyngioma|2021
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Diffuse astrocytoma|2004
0-19|0.0|0.1|0.1|Malignant|20|39865121|Female|Diffuse astrocytoma|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Diffuse astrocytoma|2005
0-19|0.0|0.1|0.0|Malignant|20|39998876|Female|Diffuse astrocytoma|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Diffuse astrocytoma|2006
0-19|~|~|~|Malignant|~|40165421|Female|Diffuse astrocytoma|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Diffuse astrocytoma|2007
0-19|0.0|0.1|0.0|Malignant|16|40382360|Female|Diffuse astrocytoma|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Diffuse astrocytoma|2008
0-19|0.0|0.1|0.1|Malignant|21|40576293|Female|Diffuse astrocytoma|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Diffuse astrocytoma|2009
0-19|0.0|0.1|0.0|Malignant|19|40670476|Female|Diffuse astrocytoma|2009
0-19|~|~|~|Benign/Borderline|~|40649165|Female|Diffuse astrocytoma|2010
0-19|0.0|0.1|0.0|Malignant|19|40649165|Female|Diffuse astrocytoma|2010
0-19|~|~|~|Benign/Borderline|~|40540942|Female|Diffuse astrocytoma|2011
0-19|~|~|~|Malignant|~|40540942|Female|Diffuse astrocytoma|2011
0-19|~|~|~|Benign/Borderline|~|40450188|Female|Diffuse astrocytoma|2012
0-19|~|~|~|Malignant|~|40450188|Female|Diffuse astrocytoma|2012
0-19|~|~|~|Benign/Borderline|~|40416682|Female|Diffuse astrocytoma|2013
0-19|~|~|~|Malignant|~|40416682|Female|Diffuse astrocytoma|2013
0-19|~|~|~|Benign/Borderline|~|40420522|Female|Diffuse astrocytoma|2014
0-19|~|~|~|Malignant|~|40420522|Female|Diffuse astrocytoma|2014
0-19|~|~|~|Benign/Borderline|~|40478360|Female|Diffuse astrocytoma|2015
0-19|~|~|~|Malignant|~|40478360|Female|Diffuse astrocytoma|2015
0-19|~|~|~|Benign/Borderline|~|40566497|Female|Diffuse astrocytoma|2016
0-19|~|~|~|Malignant|~|40566497|Female|Diffuse astrocytoma|2016
0-19|~|~|~|Benign/Borderline|~|40607151|Female|Diffuse astrocytoma|2017
0-19|~|~|~|Malignant|~|40607151|Female|Diffuse astrocytoma|2017
0-19|~|~|~|Benign/Borderline|~|197530982|Female|Diffuse astrocytoma|2017-2021
0-19|~|~|~|Malignant|~|197530982|Female|Diffuse astrocytoma|2017-2021
0-19|~|~|~|Benign/Borderline|~|40600164|Female|Diffuse astrocytoma|2018
0-19|~|~|~|Malignant|~|40600164|Female|Diffuse astrocytoma|2018
0-19|~|~|~|Benign/Borderline|~|40536667|Female|Diffuse astrocytoma|2019
0-19|~|~|~|Malignant|~|40536667|Female|Diffuse astrocytoma|2019
0-19|~|~|~|Benign/Borderline|~|39443036|Female|Diffuse astrocytoma|2020
0-19|~|~|~|Malignant|~|39443036|Female|Diffuse astrocytoma|2020
0-19|~|~|~|Benign/Borderline|~|38944115|Female|Diffuse astrocytoma|2021
0-19|~|~|~|Malignant|~|38944115|Female|Diffuse astrocytoma|2021
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Embryonal/primitive/medulloblastoma|2004
0-19|0.5|0.6|0.5|Malignant|213|39865121|Female|Embryonal/primitive/medulloblastoma|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Embryonal/primitive/medulloblastoma|2005
0-19|0.4|0.5|0.5|Malignant|185|39998876|Female|Embryonal/primitive/medulloblastoma|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Embryonal/primitive/medulloblastoma|2006
0-19|0.4|0.6|0.5|Malignant|204|40165421|Female|Embryonal/primitive/medulloblastoma|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Embryonal/primitive/medulloblastoma|2007
0-19|0.5|0.6|0.5|Malignant|218|40382360|Female|Embryonal/primitive/medulloblastoma|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Embryonal/primitive/medulloblastoma|2008
0-19|0.5|0.6|0.6|Malignant|229|40576293|Female|Embryonal/primitive/medulloblastoma|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Embryonal/primitive/medulloblastoma|2009
0-19|0.4|0.6|0.5|Malignant|204|40670476|Female|Embryonal/primitive/medulloblastoma|2009
0-19|~|~|~|Benign/Borderline|~|40649165|Female|Embryonal/primitive/medulloblastoma|2010
0-19|0.4|0.5|0.4|Malignant|173|40649165|Female|Embryonal/primitive/medulloblastoma|2010
0-19|~|~|~|Benign/Borderline|~|40540942|Female|Embryonal/primitive/medulloblastoma|2011
0-19|0.4|0.6|0.5|Malignant|196|40540942|Female|Embryonal/primitive/medulloblastoma|2011
0-19|~|~|~|Benign/Borderline|~|40450188|Female|Embryonal/primitive/medulloblastoma|2012
0-19|0.4|0.5|0.4|Malignant|181|40450188|Female|Embryonal/primitive/medulloblastoma|2012
0-19|~|~|~|Benign/Borderline|~|40416682|Female|Embryonal/primitive/medulloblastoma|2013
0-19|0.4|0.5|0.5|Malignant|187|40416682|Female|Embryonal/primitive/medulloblastoma|2013
0-19|~|~|~|Benign/Borderline|~|40420522|Female|Embryonal/primitive/medulloblastoma|2014
0-19|0.5|0.6|0.5|Malignant|212|40420522|Female|Embryonal/primitive/medulloblastoma|2014
0-19|~|~|~|Benign/Borderline|~|40478360|Female|Embryonal/primitive/medulloblastoma|2015
0-19|0.4|0.6|0.5|Malignant|193|40478360|Female|Embryonal/primitive/medulloblastoma|2015
0-19|~|~|~|Benign/Borderline|~|40566497|Female|Embryonal/primitive/medulloblastoma|2016
0-19|0.4|0.5|0.4|Malignant|177|40566497|Female|Embryonal/primitive/medulloblastoma|2016
0-19|~|~|~|Benign/Borderline|~|40607151|Female|Embryonal/primitive/medulloblastoma|2017
0-19|0.4|0.5|0.4|Malignant|170|40607151|Female|Embryonal/primitive/medulloblastoma|2017
0-19|~|~|~|Benign/Borderline|~|197530982|Female|Embryonal/primitive/medulloblastoma|2017-2021
0-19|0.3|0.4|0.4|Malignant|679|197530982|Female|Embryonal/primitive/medulloblastoma|2017-2021
0-19|~|~|~|Benign/Borderline|~|40600164|Female|Embryonal/primitive/medulloblastoma|2018
0-19|0.3|0.5|0.4|Malignant|157|40600164|Female|Embryonal/primitive/medulloblastoma|2018
0-19|~|~|~|Benign/Borderline|~|40536667|Female|Embryonal/primitive/medulloblastoma|2019
0-19|0.2|0.4|0.3|Malignant|117|40536667|Female|Embryonal/primitive/medulloblastoma|2019
0-19|~|~|~|Benign/Borderline|~|39443036|Female|Embryonal/primitive/medulloblastoma|2020
0-19|0.3|0.4|0.3|Malignant|127|39443036|Female|Embryonal/primitive/medulloblastoma|2020
0-19|~|~|~|Benign/Borderline|~|38944115|Female|Embryonal/primitive/medulloblastoma|2021
0-19|0.3|0.4|0.3|Malignant|116|38944115|Female|Embryonal/primitive/medulloblastoma|2021
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Ependymoma variants|2004
0-19|~|~|~|Malignant|~|39865121|Female|Ependymoma variants|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Ependymoma variants|2005
0-19|~|~|~|Malignant|~|39998876|Female|Ependymoma variants|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Ependymoma variants|2006
0-19|~|~|~|Malignant|~|40165421|Female|Ependymoma variants|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Ependymoma variants|2007
0-19|~|~|~|Malignant|~|40382360|Female|Ependymoma variants|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Ependymoma variants|2008
0-19|~|~|~|Malignant|~|40576293|Female|Ependymoma variants|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Ependymoma variants|2009
0-19|~|~|~|Malignant|~|40670476|Female|Ependymoma variants|2009
0-19|~|~|~|Benign/Borderline|~|40649165|Female|Ependymoma variants|2010
0-19|~|~|~|Malignant|~|40649165|Female|Ependymoma variants|2010
0-19|0.0|0.1|0.1|Benign/Borderline|21|40540942|Female|Ependymoma variants|2011
0-19|~|~|~|Malignant|~|40540942|Female|Ependymoma variants|2011
0-19|0.0|0.1|0.0|Benign/Borderline|16|40450188|Female|Ependymoma variants|2012
0-19|~|~|~|Malignant|~|40450188|Female|Ependymoma variants|2012
0-19|0.0|0.1|0.0|Benign/Borderline|17|40416682|Female|Ependymoma variants|2013
0-19|~|~|~|Malignant|~|40416682|Female|Ependymoma variants|2013
0-19|~|~|~|Benign/Borderline|~|40420522|Female|Ependymoma variants|2014
0-19|~|~|~|Malignant|~|40420522|Female|Ependymoma variants|2014
0-19|~|~|~|Benign/Borderline|~|40478360|Female|Ependymoma variants|2015
0-19|~|~|~|Malignant|~|40478360|Female|Ependymoma variants|2015
0-19|~|~|~|Benign/Borderline|~|40566497|Female|Ependymoma variants|2016
0-19|~|~|~|Malignant|~|40566497|Female|Ependymoma variants|2016
0-19|~|~|~|Benign/Borderline|~|40607151|Female|Ependymoma variants|2017
0-19|~|~|~|Malignant|~|40607151|Female|Ependymoma variants|2017
0-19|0.0|0.0|0.0|Benign/Borderline|65|197530982|Female|Ependymoma variants|2017-2021
0-19|~|~|~|Malignant|~|197530982|Female|Ependymoma variants|2017-2021
0-19|~|~|~|Benign/Borderline|~|40600164|Female|Ependymoma variants|2018
0-19|~|~|~|Malignant|~|40600164|Female|Ependymoma variants|2018
0-19|~|~|~|Benign/Borderline|~|40536667|Female|Ependymoma variants|2019
0-19|~|~|~|Malignant|~|40536667|Female|Ependymoma variants|2019
0-19|~|~|~|Benign/Borderline|~|39443036|Female|Ependymoma variants|2020
0-19|~|~|~|Malignant|~|39443036|Female|Ependymoma variants|2020
0-19|~|~|~|Benign/Borderline|~|38944115|Female|Ependymoma variants|2021
0-19|~|~|~|Malignant|~|38944115|Female|Ependymoma variants|2021
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Ependymoma/anaplastic ependymoma|2004
0-19|0.2|0.3|0.2|Malignant|97|39865121|Female|Ependymoma/anaplastic ependymoma|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Ependymoma/anaplastic ependymoma|2005
0-19|0.2|0.3|0.3|Malignant|111|39998876|Female|Ependymoma/anaplastic ependymoma|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Ependymoma/anaplastic ependymoma|2006
0-19|0.2|0.3|0.2|Malignant|99|40165421|Female|Ependymoma/anaplastic ependymoma|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Ependymoma/anaplastic ependymoma|2007
0-19|0.1|0.2|0.2|Malignant|72|40382360|Female|Ependymoma/anaplastic ependymoma|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Ependymoma/anaplastic ependymoma|2008
0-19|0.1|0.2|0.2|Malignant|75|40576293|Female|Ependymoma/anaplastic ependymoma|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Ependymoma/anaplastic ependymoma|2009
0-19|0.2|0.2|0.2|Malignant|80|40670476|Female|Ependymoma/anaplastic ependymoma|2009
0-19|~|~|~|Benign/Borderline|~|40649165|Female|Ependymoma/anaplastic ependymoma|2010
0-19|0.2|0.3|0.2|Malignant|93|40649165|Female|Ependymoma/anaplastic ependymoma|2010
0-19|~|~|~|Benign/Borderline|~|40540942|Female|Ependymoma/anaplastic ependymoma|2011
0-19|0.2|0.3|0.2|Malignant|98|40540942|Female|Ependymoma/anaplastic ependymoma|2011
0-19|~|~|~|Benign/Borderline|~|40450188|Female|Ependymoma/anaplastic ependymoma|2012
0-19|0.2|0.3|0.2|Malignant|88|40450188|Female|Ependymoma/anaplastic ependymoma|2012
0-19|~|~|~|Benign/Borderline|~|40416682|Female|Ependymoma/anaplastic ependymoma|2013
0-19|0.2|0.3|0.2|Malignant|89|40416682|Female|Ependymoma/anaplastic ependymoma|2013
0-19|~|~|~|Benign/Borderline|~|40420522|Female|Ependymoma/anaplastic ependymoma|2014
0-19|0.2|0.3|0.2|Malignant|91|40420522|Female|Ependymoma/anaplastic ependymoma|2014
0-19|~|~|~|Benign/Borderline|~|40478360|Female|Ependymoma/anaplastic ependymoma|2015
0-19|0.2|0.3|0.2|Malignant|89|40478360|Female|Ependymoma/anaplastic ependymoma|2015
0-19|~|~|~|Benign/Borderline|~|40566497|Female|Ependymoma/anaplastic ependymoma|2016
0-19|0.2|0.2|0.2|Malignant|80|40566497|Female|Ependymoma/anaplastic ependymoma|2016
0-19|~|~|~|Benign/Borderline|~|40607151|Female|Ependymoma/anaplastic ependymoma|2017
0-19|0.2|0.3|0.2|Malignant|98|40607151|Female|Ependymoma/anaplastic ependymoma|2017
0-19|~|~|~|Benign/Borderline|~|197530982|Female|Ependymoma/anaplastic ependymoma|2017-2021
0-19|0.2|0.2|0.2|Malignant|368|197530982|Female|Ependymoma/anaplastic ependymoma|2017-2021
0-19|~|~|~|Benign/Borderline|~|40600164|Female|Ependymoma/anaplastic ependymoma|2018
0-19|0.1|0.2|0.2|Malignant|71|40600164|Female|Ependymoma/anaplastic ependymoma|2018
0-19|~|~|~|Benign/Borderline|~|40536667|Female|Ependymoma/anaplastic ependymoma|2019
0-19|0.1|0.2|0.2|Malignant|70|40536667|Female|Ependymoma/anaplastic ependymoma|2019
0-19|~|~|~|Benign/Borderline|~|39443036|Female|Ependymoma/anaplastic ependymoma|2020
0-19|0.1|0.2|0.2|Malignant|70|39443036|Female|Ependymoma/anaplastic ependymoma|2020
0-19|~|~|~|Benign/Borderline|~|38944115|Female|Ependymoma/anaplastic ependymoma|2021
0-19|0.1|0.2|0.2|Malignant|63|38944115|Female|Ependymoma/anaplastic ependymoma|2021
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Germ Cell Tumors|2004
0-19|0.1|0.1|0.1|Malignant|42|39865121|Female|Germ Cell Tumors|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Germ Cell Tumors|2005
0-19|0.1|0.2|0.1|Malignant|47|39998876|Female|Germ Cell Tumors|2005
0-19|0.0|0.1|0.0|Benign/Borderline|18|40165421|Female|Germ Cell Tumors|2006
0-19|0.0|0.1|0.1|Malignant|25|40165421|Female|Germ Cell Tumors|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Germ Cell Tumors|2007
0-19|0.1|0.1|0.1|Malignant|32|40382360|Female|Germ Cell Tumors|2007
0-19|0.0|0.1|0.0|Benign/Borderline|18|40576293|Female|Germ Cell Tumors|2008
0-19|0.1|0.1|0.1|Malignant|30|40576293|Female|Germ Cell Tumors|2008
0-19|0.0|0.1|0.0|Benign/Borderline|20|40670476|Female|Germ Cell Tumors|2009
0-19|0.1|0.1|0.1|Malignant|43|40670476|Female|Germ Cell Tumors|2009
0-19|0.0|0.1|0.1|Benign/Borderline|21|40649165|Female|Germ Cell Tumors|2010
0-19|0.1|0.2|0.1|Malignant|53|40649165|Female|Germ Cell Tumors|2010
0-19|0.0|0.1|0.1|Benign/Borderline|23|40540942|Female|Germ Cell Tumors|2011
0-19|0.1|0.1|0.1|Malignant|36|40540942|Female|Germ Cell Tumors|2011
0-19|0.0|0.1|0.0|Benign/Borderline|17|40450188|Female|Germ Cell Tumors|2012
0-19|0.0|0.1|0.1|Malignant|21|40450188|Female|Germ Cell Tumors|2012
0-19|0.0|0.1|0.1|Benign/Borderline|21|40416682|Female|Germ Cell Tumors|2013
0-19|0.1|0.2|0.1|Malignant|48|40416682|Female|Germ Cell Tumors|2013
0-19|0.0|0.1|0.1|Benign/Borderline|23|40420522|Female|Germ Cell Tumors|2014
0-19|0.1|0.1|0.1|Malignant|34|40420522|Female|Germ Cell Tumors|2014
0-19|0.0|0.1|0.0|Benign/Borderline|18|40478360|Female|Germ Cell Tumors|2015
0-19|0.1|0.2|0.1|Malignant|46|40478360|Female|Germ Cell Tumors|2015
0-19|0.0|0.1|0.1|Benign/Borderline|27|40566497|Female|Germ Cell Tumors|2016
0-19|0.1|0.2|0.1|Malignant|58|40566497|Female|Germ Cell Tumors|2016
0-19|~|~|~|Benign/Borderline|~|40607151|Female|Germ Cell Tumors|2017
0-19|0.1|0.2|0.1|Malignant|46|40607151|Female|Germ Cell Tumors|2017
0-19|0.0|0.1|0.0|Benign/Borderline|79|197530982|Female|Germ Cell Tumors|2017-2021
0-19|0.1|0.1|0.1|Malignant|215|197530982|Female|Germ Cell Tumors|2017-2021
0-19|0.0|0.1|0.1|Benign/Borderline|25|40600164|Female|Germ Cell Tumors|2018
0-19|0.1|0.1|0.1|Malignant|40|40600164|Female|Germ Cell Tumors|2018
0-19|0.0|0.1|0.0|Benign/Borderline|17|40536667|Female|Germ Cell Tumors|2019
0-19|0.1|0.2|0.1|Malignant|50|40536667|Female|Germ Cell Tumors|2019
0-19|~|~|~|Benign/Borderline|~|39443036|Female|Germ Cell Tumors|2020
0-19|0.1|0.2|0.1|Malignant|47|39443036|Female|Germ Cell Tumors|2020
0-19|~|~|~|Benign/Borderline|~|38944115|Female|Germ Cell Tumors|2021
0-19|0.1|0.1|0.1|Malignant|38|38944115|Female|Germ Cell Tumors|2021
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Glioblastoma|2004
0-19|0.1|0.2|0.1|Malignant|53|39865121|Female|Glioblastoma|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Glioblastoma|2005
0-19|0.1|0.1|0.1|Malignant|39|39998876|Female|Glioblastoma|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Glioblastoma|2006
0-19|0.1|0.1|0.1|Malignant|43|40165421|Female|Glioblastoma|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Glioblastoma|2007
0-19|0.1|0.2|0.1|Malignant|58|40382360|Female|Glioblastoma|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Glioblastoma|2008
0-19|0.1|0.2|0.2|Malignant|62|40576293|Female|Glioblastoma|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Glioblastoma|2009
0-19|0.1|0.1|0.1|Malignant|38|40670476|Female|Glioblastoma|2009
0-19|~|~|~|Benign/Borderline|~|40649165|Female|Glioblastoma|2010
0-19|0.1|0.2|0.1|Malignant|51|40649165|Female|Glioblastoma|2010
0-19|~|~|~|Benign/Borderline|~|40540942|Female|Glioblastoma|2011
0-19|0.1|0.2|0.2|Malignant|75|40540942|Female|Glioblastoma|2011
0-19|~|~|~|Benign/Borderline|~|40450188|Female|Glioblastoma|2012
0-19|0.1|0.2|0.2|Malignant|76|40450188|Female|Glioblastoma|2012
0-19|~|~|~|Benign/Borderline|~|40416682|Female|Glioblastoma|2013
0-19|0.1|0.2|0.2|Malignant|71|40416682|Female|Glioblastoma|2013
0-19|~|~|~|Benign/Borderline|~|40420522|Female|Glioblastoma|2014
0-19|0.1|0.2|0.2|Malignant|67|40420522|Female|Glioblastoma|2014
0-19|~|~|~|Benign/Borderline|~|40478360|Female|Glioblastoma|2015
0-19|0.1|0.2|0.2|Malignant|68|40478360|Female|Glioblastoma|2015
0-19|~|~|~|Benign/Borderline|~|40566497|Female|Glioblastoma|2016
0-19|0.1|0.2|0.1|Malignant|54|40566497|Female|Glioblastoma|2016
0-19|~|~|~|Benign/Borderline|~|40607151|Female|Glioblastoma|2017
0-19|0.1|0.2|0.2|Malignant|68|40607151|Female|Glioblastoma|2017
0-19|~|~|~|Benign/Borderline|~|197530982|Female|Glioblastoma|2017-2021
0-19|0.1|0.1|0.1|Malignant|255|197530982|Female|Glioblastoma|2017-2021
0-19|~|~|~|Benign/Borderline|~|40600164|Female|Glioblastoma|2018
0-19|0.1|0.2|0.1|Malignant|59|40600164|Female|Glioblastoma|2018
0-19|~|~|~|Benign/Borderline|~|40536667|Female|Glioblastoma|2019
0-19|0.1|0.2|0.1|Malignant|55|40536667|Female|Glioblastoma|2019
0-19|~|~|~|Benign/Borderline|~|39443036|Female|Glioblastoma|2020
0-19|0.1|0.1|0.1|Malignant|37|39443036|Female|Glioblastoma|2020
0-19|~|~|~|Benign/Borderline|~|38944115|Female|Glioblastoma|2021
0-19|0.1|0.1|0.1|Malignant|37|38944115|Female|Glioblastoma|2021
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Glioma malignant, NOS|2004
0-19|0.5|0.7|0.6|Malignant|235|39865121|Female|Glioma malignant, NOS|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Glioma malignant, NOS|2005
0-19|0.5|0.7|0.6|Malignant|236|39998876|Female|Glioma malignant, NOS|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Glioma malignant, NOS|2006
0-19|0.5|0.7|0.6|Malignant|247|40165421|Female|Glioma malignant, NOS|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Glioma malignant, NOS|2007
0-19|0.6|0.8|0.7|Malignant|268|40382360|Female|Glioma malignant, NOS|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Glioma malignant, NOS|2008
0-19|0.6|0.8|0.7|Malignant|280|40576293|Female|Glioma malignant, NOS|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Glioma malignant, NOS|2009
0-19|0.7|0.8|0.7|Malignant|299|40670476|Female|Glioma malignant, NOS|2009
0-19|~|~|~|Benign/Borderline|~|40649165|Female|Glioma malignant, NOS|2010
0-19|0.6|0.7|0.7|Malignant|265|40649165|Female|Glioma malignant, NOS|2010
0-19|0.0|0.1|0.0|Benign/Borderline|20|40540942|Female|Glioma malignant, NOS|2011
0-19|0.7|0.9|0.8|Malignant|319|40540942|Female|Glioma malignant, NOS|2011
0-19|0.0|0.1|0.0|Benign/Borderline|18|40450188|Female|Glioma malignant, NOS|2012
0-19|0.5|0.7|0.6|Malignant|231|40450188|Female|Glioma malignant, NOS|2012
0-19|~|~|~|Benign/Borderline|~|40416682|Female|Glioma malignant, NOS|2013
0-19|0.7|0.8|0.8|Malignant|304|40416682|Female|Glioma malignant, NOS|2013
0-19|0.0|0.1|0.0|Benign/Borderline|18|40420522|Female|Glioma malignant, NOS|2014
0-19|0.6|0.8|0.7|Malignant|277|40420522|Female|Glioma malignant, NOS|2014
0-19|~|~|~|Benign/Borderline|~|40478360|Female|Glioma malignant, NOS|2015
0-19|0.6|0.8|0.7|Malignant|283|40478360|Female|Glioma malignant, NOS|2015
0-19|0.0|0.1|0.1|Benign/Borderline|23|40566497|Female|Glioma malignant, NOS|2016
0-19|0.7|0.9|0.8|Malignant|322|40566497|Female|Glioma malignant, NOS|2016
0-19|0.0|0.1|0.1|Benign/Borderline|25|40607151|Female|Glioma malignant, NOS|2017
0-19|0.7|0.9|0.8|Malignant|326|40607151|Female|Glioma malignant, NOS|2017
0-19|0.0|0.1|0.0|Benign/Borderline|85|197530982|Female|Glioma malignant, NOS|2017-2021
0-19|0.6|0.7|0.6|Malignant|1268|197530982|Female|Glioma malignant, NOS|2017-2021
0-19|0.0|0.1|0.1|Benign/Borderline|21|40600164|Female|Glioma malignant, NOS|2018
0-19|0.6|0.7|0.6|Malignant|255|40600164|Female|Glioma malignant, NOS|2018
0-19|~|~|~|Benign/Borderline|~|40536667|Female|Glioma malignant, NOS|2019
0-19|0.5|0.6|0.6|Malignant|228|40536667|Female|Glioma malignant, NOS|2019
0-19|~|~|~|Benign/Borderline|~|39443036|Female|Glioma malignant, NOS|2020
0-19|0.5|0.7|0.6|Malignant|231|39443036|Female|Glioma malignant, NOS|2020
0-19|0.0|0.1|0.0|Benign/Borderline|16|38944115|Female|Glioma malignant, NOS|2021
0-19|0.6|0.7|0.7|Malignant|252|38944115|Female|Glioma malignant, NOS|2021
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Hemangioblastoma|2004
0-19|~|~|~|Malignant|~|39865121|Female|Hemangioblastoma|2004
0-19|0.0|0.1|0.0|Benign/Borderline|19|39998876|Female|Hemangioblastoma|2005
0-19|~|~|~|Malignant|~|39998876|Female|Hemangioblastoma|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Hemangioblastoma|2006
0-19|~|~|~|Malignant|~|40165421|Female|Hemangioblastoma|2006
0-19|0.0|0.1|0.0|Benign/Borderline|19|40382360|Female|Hemangioblastoma|2007
0-19|~|~|~|Malignant|~|40382360|Female|Hemangioblastoma|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Hemangioblastoma|2008
0-19|~|~|~|Malignant|~|40576293|Female|Hemangioblastoma|2008
0-19|0.0|0.1|0.0|Benign/Borderline|17|40670476|Female|Hemangioblastoma|2009
0-19|~|~|~|Malignant|~|40670476|Female|Hemangioblastoma|2009
0-19|~|~|~|Benign/Borderline|~|40649165|Female|Hemangioblastoma|2010
0-19|~|~|~|Malignant|~|40649165|Female|Hemangioblastoma|2010
0-19|0.0|0.1|0.0|Benign/Borderline|17|40540942|Female|Hemangioblastoma|2011
0-19|~|~|~|Malignant|~|40540942|Female|Hemangioblastoma|2011
0-19|0.0|0.1|0.0|Benign/Borderline|17|40450188|Female|Hemangioblastoma|2012
0-19|~|~|~|Malignant|~|40450188|Female|Hemangioblastoma|2012
0-19|0.0|0.1|0.0|Benign/Borderline|20|40416682|Female|Hemangioblastoma|2013
0-19|~|~|~|Malignant|~|40416682|Female|Hemangioblastoma|2013
0-19|0.1|0.1|0.1|Benign/Borderline|32|40420522|Female|Hemangioblastoma|2014
0-19|~|~|~|Malignant|~|40420522|Female|Hemangioblastoma|2014
0-19|0.0|0.1|0.0|Benign/Borderline|17|40478360|Female|Hemangioblastoma|2015
0-19|~|~|~|Malignant|~|40478360|Female|Hemangioblastoma|2015
0-19|0.0|0.1|0.1|Benign/Borderline|24|40566497|Female|Hemangioblastoma|2016
0-19|~|~|~|Malignant|~|40566497|Female|Hemangioblastoma|2016
0-19|~|~|~|Benign/Borderline|~|40607151|Female|Hemangioblastoma|2017
0-19|~|~|~|Malignant|~|40607151|Female|Hemangioblastoma|2017
0-19|0.0|0.0|0.0|Benign/Borderline|73|197530982|Female|Hemangioblastoma|2017-2021
0-19|~|~|~|Malignant|~|197530982|Female|Hemangioblastoma|2017-2021
0-19|0.0|0.1|0.0|Benign/Borderline|20|40600164|Female|Hemangioblastoma|2018
0-19|~|~|~|Malignant|~|40600164|Female|Hemangioblastoma|2018
0-19|~|~|~|Benign/Borderline|~|40536667|Female|Hemangioblastoma|2019
0-19|~|~|~|Malignant|~|40536667|Female|Hemangioblastoma|2019
0-19|0.0|0.1|0.0|Benign/Borderline|19|39443036|Female|Hemangioblastoma|2020
0-19|~|~|~|Malignant|~|39443036|Female|Hemangioblastoma|2020
0-19|~|~|~|Benign/Borderline|~|38944115|Female|Hemangioblastoma|2021
0-19|~|~|~|Malignant|~|38944115|Female|Hemangioblastoma|2021
0-19|0.0|0.1|0.0|Benign/Borderline|18|39865121|Female|Hemangioma|2004
0-19|~|~|~|Malignant|~|39865121|Female|Hemangioma|2004
0-19|0.0|0.1|0.1|Benign/Borderline|25|39998876|Female|Hemangioma|2005
0-19|~|~|~|Malignant|~|39998876|Female|Hemangioma|2005
0-19|0.1|0.1|0.1|Benign/Borderline|34|40165421|Female|Hemangioma|2006
0-19|~|~|~|Malignant|~|40165421|Female|Hemangioma|2006
0-19|0.1|0.1|0.1|Benign/Borderline|32|40382360|Female|Hemangioma|2007
0-19|~|~|~|Malignant|~|40382360|Female|Hemangioma|2007
0-19|0.1|0.2|0.1|Benign/Borderline|50|40576293|Female|Hemangioma|2008
0-19|~|~|~|Malignant|~|40576293|Female|Hemangioma|2008
0-19|0.1|0.2|0.1|Benign/Borderline|54|40670476|Female|Hemangioma|2009
0-19|~|~|~|Malignant|~|40670476|Female|Hemangioma|2009
0-19|0.1|0.1|0.1|Benign/Borderline|46|40649165|Female|Hemangioma|2010
0-19|~|~|~|Malignant|~|40649165|Female|Hemangioma|2010
0-19|0.1|0.2|0.2|Benign/Borderline|73|40540942|Female|Hemangioma|2011
0-19|~|~|~|Malignant|~|40540942|Female|Hemangioma|2011
0-19|0.1|0.2|0.2|Benign/Borderline|68|40450188|Female|Hemangioma|2012
0-19|~|~|~|Malignant|~|40450188|Female|Hemangioma|2012
0-19|0.1|0.2|0.2|Benign/Borderline|65|40416682|Female|Hemangioma|2013
0-19|~|~|~|Malignant|~|40416682|Female|Hemangioma|2013
0-19|0.1|0.2|0.2|Benign/Borderline|65|40420522|Female|Hemangioma|2014
0-19|~|~|~|Malignant|~|40420522|Female|Hemangioma|2014
0-19|0.1|0.2|0.2|Benign/Borderline|76|40478360|Female|Hemangioma|2015
0-19|~|~|~|Malignant|~|40478360|Female|Hemangioma|2015
0-19|0.1|0.2|0.1|Benign/Borderline|56|40566497|Female|Hemangioma|2016
0-19|~|~|~|Malignant|~|40566497|Female|Hemangioma|2016
0-19|0.1|0.2|0.1|Benign/Borderline|55|40607151|Female|Hemangioma|2017
0-19|~|~|~|Malignant|~|40607151|Female|Hemangioma|2017
0-19|0.1|0.2|0.1|Benign/Borderline|268|197530982|Female|Hemangioma|2017-2021
0-19|~|~|~|Malignant|~|197530982|Female|Hemangioma|2017-2021
0-19|0.1|0.2|0.1|Benign/Borderline|58|40600164|Female|Hemangioma|2018
0-19|~|~|~|Malignant|~|40600164|Female|Hemangioma|2018
0-19|0.1|0.2|0.1|Benign/Borderline|51|40536667|Female|Hemangioma|2019
0-19|~|~|~|Malignant|~|40536667|Female|Hemangioma|2019
0-19|0.1|0.2|0.1|Benign/Borderline|58|39443036|Female|Hemangioma|2020
0-19|~|~|~|Malignant|~|39443036|Female|Hemangioma|2020
0-19|0.1|0.2|0.1|Benign/Borderline|47|38944115|Female|Hemangioma|2021
0-19|~|~|~|Malignant|~|38944115|Female|Hemangioma|2021
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Local Extensions from Regional Tumors|2004
0-19|~|~|~|Malignant|~|39865121|Female|Local Extensions from Regional Tumors|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Local Extensions from Regional Tumors|2005
0-19|~|~|~|Malignant|~|39998876|Female|Local Extensions from Regional Tumors|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Local Extensions from Regional Tumors|2006
0-19|~|~|~|Malignant|~|40165421|Female|Local Extensions from Regional Tumors|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Local Extensions from Regional Tumors|2007
0-19|~|~|~|Malignant|~|40382360|Female|Local Extensions from Regional Tumors|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Local Extensions from Regional Tumors|2008
0-19|~|~|~|Malignant|~|40576293|Female|Local Extensions from Regional Tumors|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Local Extensions from Regional Tumors|2009
0-19|~|~|~|Malignant|~|40670476|Female|Local Extensions from Regional Tumors|2009
0-19|~|~|~|Benign/Borderline|~|40649165|Female|Local Extensions from Regional Tumors|2010
0-19|~|~|~|Malignant|~|40649165|Female|Local Extensions from Regional Tumors|2010
0-19|~|~|~|Benign/Borderline|~|40540942|Female|Local Extensions from Regional Tumors|2011
0-19|~|~|~|Malignant|~|40540942|Female|Local Extensions from Regional Tumors|2011
0-19|~|~|~|Benign/Borderline|~|40450188|Female|Local Extensions from Regional Tumors|2012
0-19|~|~|~|Malignant|~|40450188|Female|Local Extensions from Regional Tumors|2012
0-19|~|~|~|Benign/Borderline|~|40416682|Female|Local Extensions from Regional Tumors|2013
0-19|~|~|~|Malignant|~|40416682|Female|Local Extensions from Regional Tumors|2013
0-19|~|~|~|Benign/Borderline|~|40420522|Female|Local Extensions from Regional Tumors|2014
0-19|~|~|~|Malignant|~|40420522|Female|Local Extensions from Regional Tumors|2014
0-19|~|~|~|Benign/Borderline|~|40478360|Female|Local Extensions from Regional Tumors|2015
0-19|~|~|~|Malignant|~|40478360|Female|Local Extensions from Regional Tumors|2015
0-19|~|~|~|Benign/Borderline|~|40566497|Female|Local Extensions from Regional Tumors|2016
0-19|~|~|~|Malignant|~|40566497|Female|Local Extensions from Regional Tumors|2016
0-19|~|~|~|Benign/Borderline|~|40607151|Female|Local Extensions from Regional Tumors|2017
0-19|~|~|~|Malignant|~|40607151|Female|Local Extensions from Regional Tumors|2017
0-19|~|~|~|Benign/Borderline|~|197530982|Female|Local Extensions from Regional Tumors|2017-2021
0-19|~|~|~|Malignant|~|197530982|Female|Local Extensions from Regional Tumors|2017-2021
0-19|~|~|~|Benign/Borderline|~|40600164|Female|Local Extensions from Regional Tumors|2018
0-19|~|~|~|Malignant|~|40600164|Female|Local Extensions from Regional Tumors|2018
0-19|~|~|~|Benign/Borderline|~|40536667|Female|Local Extensions from Regional Tumors|2019
0-19|~|~|~|Malignant|~|40536667|Female|Local Extensions from Regional Tumors|2019
0-19|~|~|~|Benign/Borderline|~|39443036|Female|Local Extensions from Regional Tumors|2020
0-19|~|~|~|Malignant|~|39443036|Female|Local Extensions from Regional Tumors|2020
0-19|~|~|~|Benign/Borderline|~|38944115|Female|Local Extensions from Regional Tumors|2021
0-19|~|~|~|Malignant|~|38944115|Female|Local Extensions from Regional Tumors|2021
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Lymphomas and Hematopoietic Neoplasms|2004
0-19|~|~|~|Malignant|~|39865121|Female|Lymphomas and Hematopoietic Neoplasms|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Lymphomas and Hematopoietic Neoplasms|2005
0-19|~|~|~|Malignant|~|39998876|Female|Lymphomas and Hematopoietic Neoplasms|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Lymphomas and Hematopoietic Neoplasms|2006
0-19|~|~|~|Malignant|~|40165421|Female|Lymphomas and Hematopoietic Neoplasms|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Lymphomas and Hematopoietic Neoplasms|2007
0-19|~|~|~|Malignant|~|40382360|Female|Lymphomas and Hematopoietic Neoplasms|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Lymphomas and Hematopoietic Neoplasms|2008
0-19|~|~|~|Malignant|~|40576293|Female|Lymphomas and Hematopoietic Neoplasms|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Lymphomas and Hematopoietic Neoplasms|2009
0-19|~|~|~|Malignant|~|40670476|Female|Lymphomas and Hematopoietic Neoplasms|2009
0-19|~|~|~|Benign/Borderline|~|40649165|Female|Lymphomas and Hematopoietic Neoplasms|2010
0-19|~|~|~|Malignant|~|40649165|Female|Lymphomas and Hematopoietic Neoplasms|2010
0-19|~|~|~|Benign/Borderline|~|40540942|Female|Lymphomas and Hematopoietic Neoplasms|2011
0-19|~|~|~|Malignant|~|40540942|Female|Lymphomas and Hematopoietic Neoplasms|2011
0-19|~|~|~|Benign/Borderline|~|40450188|Female|Lymphomas and Hematopoietic Neoplasms|2012
0-19|~|~|~|Malignant|~|40450188|Female|Lymphomas and Hematopoietic Neoplasms|2012
0-19|~|~|~|Benign/Borderline|~|40416682|Female|Lymphomas and Hematopoietic Neoplasms|2013
0-19|~|~|~|Malignant|~|40416682|Female|Lymphomas and Hematopoietic Neoplasms|2013
0-19|~|~|~|Benign/Borderline|~|40420522|Female|Lymphomas and Hematopoietic Neoplasms|2014
0-19|~|~|~|Malignant|~|40420522|Female|Lymphomas and Hematopoietic Neoplasms|2014
0-19|~|~|~|Benign/Borderline|~|40478360|Female|Lymphomas and Hematopoietic Neoplasms|2015
0-19|~|~|~|Malignant|~|40478360|Female|Lymphomas and Hematopoietic Neoplasms|2015
0-19|~|~|~|Benign/Borderline|~|40566497|Female|Lymphomas and Hematopoietic Neoplasms|2016
0-19|~|~|~|Malignant|~|40566497|Female|Lymphomas and Hematopoietic Neoplasms|2016
0-19|~|~|~|Benign/Borderline|~|40607151|Female|Lymphomas and Hematopoietic Neoplasms|2017
0-19|~|~|~|Malignant|~|40607151|Female|Lymphomas and Hematopoietic Neoplasms|2017
0-19|~|~|~|Benign/Borderline|~|197530982|Female|Lymphomas and Hematopoietic Neoplasms|2017-2021
0-19|~|~|~|Malignant|~|197530982|Female|Lymphomas and Hematopoietic Neoplasms|2017-2021
0-19|~|~|~|Benign/Borderline|~|40600164|Female|Lymphomas and Hematopoietic Neoplasms|2018
0-19|~|~|~|Malignant|~|40600164|Female|Lymphomas and Hematopoietic Neoplasms|2018
0-19|~|~|~|Benign/Borderline|~|40536667|Female|Lymphomas and Hematopoietic Neoplasms|2019
0-19|~|~|~|Malignant|~|40536667|Female|Lymphomas and Hematopoietic Neoplasms|2019
0-19|~|~|~|Benign/Borderline|~|39443036|Female|Lymphomas and Hematopoietic Neoplasms|2020
0-19|~|~|~|Malignant|~|39443036|Female|Lymphomas and Hematopoietic Neoplasms|2020
0-19|~|~|~|Benign/Borderline|~|38944115|Female|Lymphomas and Hematopoietic Neoplasms|2021
0-19|~|~|~|Malignant|~|38944115|Female|Lymphomas and Hematopoietic Neoplasms|2021
0-19|0.1|0.2|0.1|Benign/Borderline|47|39865121|Female|Meningioma|2004
0-19|~|~|~|Malignant|~|39865121|Female|Meningioma|2004
0-19|0.1|0.2|0.2|Benign/Borderline|74|39998876|Female|Meningioma|2005
0-19|~|~|~|Malignant|~|39998876|Female|Meningioma|2005
0-19|0.1|0.2|0.1|Benign/Borderline|50|40165421|Female|Meningioma|2006
0-19|~|~|~|Malignant|~|40165421|Female|Meningioma|2006
0-19|0.1|0.2|0.1|Benign/Borderline|55|40382360|Female|Meningioma|2007
0-19|~|~|~|Malignant|~|40382360|Female|Meningioma|2007
0-19|0.1|0.2|0.2|Benign/Borderline|63|40576293|Female|Meningioma|2008
0-19|~|~|~|Malignant|~|40576293|Female|Meningioma|2008
0-19|0.1|0.2|0.1|Benign/Borderline|59|40670476|Female|Meningioma|2009
0-19|~|~|~|Malignant|~|40670476|Female|Meningioma|2009
0-19|0.1|0.2|0.1|Benign/Borderline|61|40649165|Female|Meningioma|2010
0-19|~|~|~|Malignant|~|40649165|Female|Meningioma|2010
0-19|0.1|0.2|0.2|Benign/Borderline|69|40540942|Female|Meningioma|2011
0-19|~|~|~|Malignant|~|40540942|Female|Meningioma|2011
0-19|0.1|0.2|0.2|Benign/Borderline|65|40450188|Female|Meningioma|2012
0-19|~|~|~|Malignant|~|40450188|Female|Meningioma|2012
0-19|0.1|0.2|0.2|Benign/Borderline|77|40416682|Female|Meningioma|2013
0-19|~|~|~|Malignant|~|40416682|Female|Meningioma|2013
0-19|0.1|0.2|0.2|Benign/Borderline|73|40420522|Female|Meningioma|2014
0-19|~|~|~|Malignant|~|40420522|Female|Meningioma|2014
0-19|0.1|0.2|0.2|Benign/Borderline|72|40478360|Female|Meningioma|2015
0-19|~|~|~|Malignant|~|40478360|Female|Meningioma|2015
0-19|0.1|0.2|0.2|Benign/Borderline|74|40566497|Female|Meningioma|2016
0-19|~|~|~|Malignant|~|40566497|Female|Meningioma|2016
0-19|0.1|0.2|0.2|Benign/Borderline|67|40607151|Female|Meningioma|2017
0-19|~|~|~|Malignant|~|40607151|Female|Meningioma|2017
0-19|0.2|0.2|0.2|Benign/Borderline|347|197530982|Female|Meningioma|2017-2021
0-19|~|~|~|Malignant|~|197530982|Female|Meningioma|2017-2021
0-19|0.1|0.2|0.2|Benign/Borderline|68|40600164|Female|Meningioma|2018
0-19|~|~|~|Malignant|~|40600164|Female|Meningioma|2018
0-19|0.1|0.2|0.2|Benign/Borderline|77|40536667|Female|Meningioma|2019
0-19|~|~|~|Malignant|~|40536667|Female|Meningioma|2019
0-19|0.1|0.2|0.1|Benign/Borderline|59|39443036|Female|Meningioma|2020
0-19|~|~|~|Malignant|~|39443036|Female|Meningioma|2020
0-19|0.2|0.3|0.2|Benign/Borderline|81|38944115|Female|Meningioma|2021
0-19|~|~|~|Malignant|~|38944115|Female|Meningioma|2021
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Mixed glioma|2004
0-19|0.0|0.1|0.1|Malignant|22|39865121|Female|Mixed glioma|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Mixed glioma|2005
0-19|0.0|0.1|0.0|Malignant|17|39998876|Female|Mixed glioma|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Mixed glioma|2006
0-19|~|~|~|Malignant|~|40165421|Female|Mixed glioma|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Mixed glioma|2007
0-19|0.0|0.1|0.0|Malignant|17|40382360|Female|Mixed glioma|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Mixed glioma|2008
0-19|0.0|0.1|0.1|Malignant|21|40576293|Female|Mixed glioma|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Mixed glioma|2009
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Mixed glioma|2009
0-19|~|~|~|Benign/Borderline|~|40649165|Female|Mixed glioma|2010
0-19|~|~|~|Malignant|~|40649165|Female|Mixed glioma|2010
0-19|~|~|~|Benign/Borderline|~|40540942|Female|Mixed glioma|2011
0-19|~|~|~|Malignant|~|40540942|Female|Mixed glioma|2011
0-19|~|~|~|Benign/Borderline|~|40450188|Female|Mixed glioma|2012
0-19|~|~|~|Malignant|~|40450188|Female|Mixed glioma|2012
0-19|~|~|~|Benign/Borderline|~|40416682|Female|Mixed glioma|2013
0-19|~|~|~|Malignant|~|40416682|Female|Mixed glioma|2013
0-19|~|~|~|Benign/Borderline|~|40420522|Female|Mixed glioma|2014
0-19|~|~|~|Malignant|~|40420522|Female|Mixed glioma|2014
0-19|~|~|~|Benign/Borderline|~|40478360|Female|Mixed glioma|2015
0-19|~|~|~|Malignant|~|40478360|Female|Mixed glioma|2015
0-19|~|~|~|Benign/Borderline|~|40566497|Female|Mixed glioma|2016
0-19|~|~|~|Malignant|~|40566497|Female|Mixed glioma|2016
0-19|~|~|~|Benign/Borderline|~|40607151|Female|Mixed glioma|2017
0-19|~|~|~|Malignant|~|40607151|Female|Mixed glioma|2017
0-19|~|~|~|Benign/Borderline|~|197530982|Female|Mixed glioma|2017-2021
0-19|~|~|~|Malignant|~|197530982|Female|Mixed glioma|2017-2021
0-19|~|~|~|Benign/Borderline|~|40600164|Female|Mixed glioma|2018
0-19|~|~|~|Malignant|~|40600164|Female|Mixed glioma|2018
0-19|~|~|~|Benign/Borderline|~|40536667|Female|Mixed glioma|2019
0-19|~|~|~|Malignant|~|40536667|Female|Mixed glioma|2019
0-19|~|~|~|Benign/Borderline|~|39443036|Female|Mixed glioma|2020
0-19|~|~|~|Malignant|~|39443036|Female|Mixed glioma|2020
0-19|~|~|~|Benign/Borderline|~|38944115|Female|Mixed glioma|2021
0-19|~|~|~|Malignant|~|38944115|Female|Mixed glioma|2021
0-19|0.1|0.1|0.1|Benign/Borderline|32|39865121|Female|Neoplasm, unspecified|2004
0-19|0.0|0.1|0.1|Malignant|27|39865121|Female|Neoplasm, unspecified|2004
0-19|0.1|0.2|0.1|Benign/Borderline|58|39998876|Female|Neoplasm, unspecified|2005
0-19|0.0|0.1|0.0|Malignant|18|39998876|Female|Neoplasm, unspecified|2005
0-19|0.1|0.2|0.1|Benign/Borderline|51|40165421|Female|Neoplasm, unspecified|2006
0-19|0.0|0.1|0.1|Malignant|27|40165421|Female|Neoplasm, unspecified|2006
0-19|0.1|0.2|0.1|Benign/Borderline|53|40382360|Female|Neoplasm, unspecified|2007
0-19|0.0|0.1|0.0|Malignant|16|40382360|Female|Neoplasm, unspecified|2007
0-19|0.2|0.2|0.2|Benign/Borderline|79|40576293|Female|Neoplasm, unspecified|2008
0-19|~|~|~|Malignant|~|40576293|Female|Neoplasm, unspecified|2008
0-19|0.1|0.2|0.2|Benign/Borderline|62|40670476|Female|Neoplasm, unspecified|2009
0-19|~|~|~|Malignant|~|40670476|Female|Neoplasm, unspecified|2009
0-19|0.2|0.3|0.2|Benign/Borderline|90|40649165|Female|Neoplasm, unspecified|2010
0-19|~|~|~|Malignant|~|40649165|Female|Neoplasm, unspecified|2010
0-19|0.1|0.2|0.2|Benign/Borderline|68|40540942|Female|Neoplasm, unspecified|2011
0-19|0.0|0.1|0.0|Malignant|19|40540942|Female|Neoplasm, unspecified|2011
0-19|0.1|0.2|0.2|Benign/Borderline|77|40450188|Female|Neoplasm, unspecified|2012
0-19|0.0|0.1|0.1|Malignant|24|40450188|Female|Neoplasm, unspecified|2012
0-19|0.1|0.2|0.2|Benign/Borderline|76|40416682|Female|Neoplasm, unspecified|2013
0-19|0.0|0.1|0.1|Malignant|23|40416682|Female|Neoplasm, unspecified|2013
0-19|0.2|0.2|0.2|Benign/Borderline|81|40420522|Female|Neoplasm, unspecified|2014
0-19|0.0|0.1|0.0|Malignant|20|40420522|Female|Neoplasm, unspecified|2014
0-19|0.2|0.2|0.2|Benign/Borderline|81|40478360|Female|Neoplasm, unspecified|2015
0-19|0.0|0.1|0.0|Malignant|16|40478360|Female|Neoplasm, unspecified|2015
0-19|0.1|0.2|0.1|Benign/Borderline|56|40566497|Female|Neoplasm, unspecified|2016
0-19|0.0|0.1|0.1|Malignant|23|40566497|Female|Neoplasm, unspecified|2016
0-19|0.1|0.2|0.1|Benign/Borderline|57|40607151|Female|Neoplasm, unspecified|2017
0-19|0.0|0.1|0.0|Malignant|20|40607151|Female|Neoplasm, unspecified|2017
0-19|0.1|0.2|0.1|Benign/Borderline|277|197530982|Female|Neoplasm, unspecified|2017-2021
0-19|0.0|0.1|0.1|Malignant|113|197530982|Female|Neoplasm, unspecified|2017-2021
0-19|0.1|0.2|0.2|Benign/Borderline|72|40600164|Female|Neoplasm, unspecified|2018
0-19|0.0|0.1|0.1|Malignant|26|40600164|Female|Neoplasm, unspecified|2018
0-19|0.1|0.2|0.1|Benign/Borderline|49|40536667|Female|Neoplasm, unspecified|2019
0-19|0.0|0.1|0.0|Malignant|16|40536667|Female|Neoplasm, unspecified|2019
0-19|0.1|0.2|0.1|Benign/Borderline|47|39443036|Female|Neoplasm, unspecified|2020
0-19|0.0|0.1|0.1|Malignant|24|39443036|Female|Neoplasm, unspecified|2020
0-19|0.1|0.2|0.1|Benign/Borderline|52|38944115|Female|Neoplasm, unspecified|2021
0-19|0.0|0.1|0.1|Malignant|27|38944115|Female|Neoplasm, unspecified|2021
0-19|0.2|0.3|0.3|Benign/Borderline|116|39865121|Female|Nerve sheath, benign and malignant|2004
0-19|~|~|~|Malignant|~|39865121|Female|Nerve sheath, benign and malignant|2004
0-19|0.4|0.5|0.4|Benign/Borderline|166|39998876|Female|Nerve sheath, benign and malignant|2005
0-19|~|~|~|Malignant|~|39998876|Female|Nerve sheath, benign and malignant|2005
0-19|0.3|0.5|0.4|Benign/Borderline|164|40165421|Female|Nerve sheath, benign and malignant|2006
0-19|~|~|~|Malignant|~|40165421|Female|Nerve sheath, benign and malignant|2006
0-19|0.3|0.4|0.3|Benign/Borderline|135|40382360|Female|Nerve sheath, benign and malignant|2007
0-19|~|~|~|Malignant|~|40382360|Female|Nerve sheath, benign and malignant|2007
0-19|0.3|0.4|0.4|Benign/Borderline|151|40576293|Female|Nerve sheath, benign and malignant|2008
0-19|~|~|~|Malignant|~|40576293|Female|Nerve sheath, benign and malignant|2008
0-19|0.3|0.5|0.4|Benign/Borderline|157|40670476|Female|Nerve sheath, benign and malignant|2009
0-19|~|~|~|Malignant|~|40670476|Female|Nerve sheath, benign and malignant|2009
0-19|0.3|0.4|0.3|Benign/Borderline|138|40649165|Female|Nerve sheath, benign and malignant|2010
0-19|~|~|~|Malignant|~|40649165|Female|Nerve sheath, benign and malignant|2010
0-19|0.3|0.4|0.3|Benign/Borderline|133|40540942|Female|Nerve sheath, benign and malignant|2011
0-19|~|~|~|Malignant|~|40540942|Female|Nerve sheath, benign and malignant|2011
0-19|0.3|0.4|0.4|Benign/Borderline|146|40450188|Female|Nerve sheath, benign and malignant|2012
0-19|~|~|~|Malignant|~|40450188|Female|Nerve sheath, benign and malignant|2012
0-19|0.3|0.5|0.4|Benign/Borderline|156|40416682|Female|Nerve sheath, benign and malignant|2013
0-19|~|~|~|Malignant|~|40416682|Female|Nerve sheath, benign and malignant|2013
0-19|0.2|0.3|0.3|Benign/Borderline|110|40420522|Female|Nerve sheath, benign and malignant|2014
0-19|~|~|~|Malignant|~|40420522|Female|Nerve sheath, benign and malignant|2014
0-19|0.3|0.5|0.4|Benign/Borderline|160|40478360|Female|Nerve sheath, benign and malignant|2015
0-19|~|~|~|Malignant|~|40478360|Female|Nerve sheath, benign and malignant|2015
0-19|0.3|0.4|0.3|Benign/Borderline|130|40566497|Female|Nerve sheath, benign and malignant|2016
0-19|~|~|~|Malignant|~|40566497|Female|Nerve sheath, benign and malignant|2016
0-19|0.3|0.4|0.3|Benign/Borderline|129|40607151|Female|Nerve sheath, benign and malignant|2017
0-19|~|~|~|Malignant|~|40607151|Female|Nerve sheath, benign and malignant|2017
0-19|0.2|0.2|0.2|Benign/Borderline|435|197530982|Female|Nerve sheath, benign and malignant|2017-2021
0-19|~|~|~|Malignant|~|197530982|Female|Nerve sheath, benign and malignant|2017-2021
0-19|0.2|0.2|0.2|Benign/Borderline|80|40600164|Female|Nerve sheath, benign and malignant|2018
0-19|~|~|~|Malignant|~|40600164|Female|Nerve sheath, benign and malignant|2018
0-19|0.1|0.2|0.2|Benign/Borderline|75|40536667|Female|Nerve sheath, benign and malignant|2019
0-19|~|~|~|Malignant|~|40536667|Female|Nerve sheath, benign and malignant|2019
0-19|0.1|0.2|0.2|Benign/Borderline|77|39443036|Female|Nerve sheath, benign and malignant|2020
0-19|~|~|~|Malignant|~|39443036|Female|Nerve sheath, benign and malignant|2020
0-19|0.2|0.2|0.2|Benign/Borderline|76|38944115|Female|Nerve sheath, benign and malignant|2021
0-19|~|~|~|Malignant|~|38944115|Female|Nerve sheath, benign and malignant|2021
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Neuroepithelial|2004
0-19|~|~|~|Malignant|~|39865121|Female|Neuroepithelial|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Neuroepithelial|2005
0-19|~|~|~|Malignant|~|39998876|Female|Neuroepithelial|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Neuroepithelial|2006
0-19|~|~|~|Malignant|~|40165421|Female|Neuroepithelial|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Neuroepithelial|2007
0-19|~|~|~|Malignant|~|40382360|Female|Neuroepithelial|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Neuroepithelial|2008
0-19|~|~|~|Malignant|~|40576293|Female|Neuroepithelial|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Neuroepithelial|2009
0-19|~|~|~|Malignant|~|40670476|Female|Neuroepithelial|2009
0-19|~|~|~|Benign/Borderline|~|40649165|Female|Neuroepithelial|2010
0-19|~|~|~|Malignant|~|40649165|Female|Neuroepithelial|2010
0-19|~|~|~|Benign/Borderline|~|40540942|Female|Neuroepithelial|2011
0-19|~|~|~|Malignant|~|40540942|Female|Neuroepithelial|2011
0-19|~|~|~|Benign/Borderline|~|40450188|Female|Neuroepithelial|2012
0-19|~|~|~|Malignant|~|40450188|Female|Neuroepithelial|2012
0-19|~|~|~|Benign/Borderline|~|40416682|Female|Neuroepithelial|2013
0-19|~|~|~|Malignant|~|40416682|Female|Neuroepithelial|2013
0-19|~|~|~|Benign/Borderline|~|40420522|Female|Neuroepithelial|2014
0-19|~|~|~|Malignant|~|40420522|Female|Neuroepithelial|2014
0-19|~|~|~|Benign/Borderline|~|40478360|Female|Neuroepithelial|2015
0-19|~|~|~|Malignant|~|40478360|Female|Neuroepithelial|2015
0-19|~|~|~|Benign/Borderline|~|40566497|Female|Neuroepithelial|2016
0-19|~|~|~|Malignant|~|40566497|Female|Neuroepithelial|2016
0-19|~|~|~|Benign/Borderline|~|40607151|Female|Neuroepithelial|2017
0-19|~|~|~|Malignant|~|40607151|Female|Neuroepithelial|2017
0-19|~|~|~|Benign/Borderline|~|197530982|Female|Neuroepithelial|2017-2021
0-19|0.0|0.0|0.0|Malignant|19|197530982|Female|Neuroepithelial|2017-2021
0-19|~|~|~|Benign/Borderline|~|40600164|Female|Neuroepithelial|2018
0-19|~|~|~|Malignant|~|40600164|Female|Neuroepithelial|2018
0-19|~|~|~|Benign/Borderline|~|40536667|Female|Neuroepithelial|2019
0-19|~|~|~|Malignant|~|40536667|Female|Neuroepithelial|2019
0-19|~|~|~|Benign/Borderline|~|39443036|Female|Neuroepithelial|2020
0-19|~|~|~|Malignant|~|39443036|Female|Neuroepithelial|2020
0-19|~|~|~|Benign/Borderline|~|38944115|Female|Neuroepithelial|2021
0-19|~|~|~|Malignant|~|38944115|Female|Neuroepithelial|2021
0-19|0.2|0.3|0.3|Benign/Borderline|114|39865121|Female|Neuronal/glial, neuronal|2004
0-19|0.0|0.1|0.1|Malignant|22|39865121|Female|Neuronal/glial, neuronal|2004
0-19|0.3|0.4|0.3|Benign/Borderline|137|39998876|Female|Neuronal/glial, neuronal|2005
0-19|0.0|0.1|0.1|Malignant|26|39998876|Female|Neuronal/glial, neuronal|2005
0-19|0.3|0.4|0.3|Benign/Borderline|126|40165421|Female|Neuronal/glial, neuronal|2006
0-19|0.0|0.1|0.1|Malignant|25|40165421|Female|Neuronal/glial, neuronal|2006
0-19|0.3|0.4|0.3|Benign/Borderline|139|40382360|Female|Neuronal/glial, neuronal|2007
0-19|0.1|0.1|0.1|Malignant|32|40382360|Female|Neuronal/glial, neuronal|2007
0-19|0.3|0.4|0.3|Benign/Borderline|134|40576293|Female|Neuronal/glial, neuronal|2008
0-19|0.0|0.1|0.1|Malignant|28|40576293|Female|Neuronal/glial, neuronal|2008
0-19|0.3|0.4|0.3|Benign/Borderline|137|40670476|Female|Neuronal/glial, neuronal|2009
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Neuronal/glial, neuronal|2009
0-19|0.3|0.4|0.4|Benign/Borderline|143|40649165|Female|Neuronal/glial, neuronal|2010
0-19|0.0|0.1|0.0|Malignant|19|40649165|Female|Neuronal/glial, neuronal|2010
0-19|0.3|0.4|0.4|Benign/Borderline|153|40540942|Female|Neuronal/glial, neuronal|2011
0-19|~|~|~|Malignant|~|40540942|Female|Neuronal/glial, neuronal|2011
0-19|0.3|0.4|0.4|Benign/Borderline|155|40450188|Female|Neuronal/glial, neuronal|2012
0-19|0.0|0.1|0.0|Malignant|18|40450188|Female|Neuronal/glial, neuronal|2012
0-19|0.3|0.5|0.4|Benign/Borderline|164|40416682|Female|Neuronal/glial, neuronal|2013
0-19|0.0|0.1|0.1|Malignant|23|40416682|Female|Neuronal/glial, neuronal|2013
0-19|0.3|0.5|0.4|Benign/Borderline|163|40420522|Female|Neuronal/glial, neuronal|2014
0-19|0.0|0.1|0.1|Malignant|26|40420522|Female|Neuronal/glial, neuronal|2014
0-19|0.4|0.5|0.4|Benign/Borderline|173|40478360|Female|Neuronal/glial, neuronal|2015
0-19|0.0|0.1|0.0|Malignant|17|40478360|Female|Neuronal/glial, neuronal|2015
0-19|0.4|0.5|0.5|Benign/Borderline|190|40566497|Female|Neuronal/glial, neuronal|2016
0-19|0.0|0.1|0.1|Malignant|29|40566497|Female|Neuronal/glial, neuronal|2016
0-19|0.4|0.5|0.4|Benign/Borderline|180|40607151|Female|Neuronal/glial, neuronal|2017
0-19|0.0|0.1|0.1|Malignant|23|40607151|Female|Neuronal/glial, neuronal|2017
0-19|0.3|0.4|0.4|Benign/Borderline|748|197530982|Female|Neuronal/glial, neuronal|2017-2021
0-19|0.0|0.1|0.1|Malignant|117|197530982|Female|Neuronal/glial, neuronal|2017-2021
0-19|0.3|0.4|0.4|Benign/Borderline|155|40600164|Female|Neuronal/glial, neuronal|2018
0-19|0.1|0.1|0.1|Malignant|30|40600164|Female|Neuronal/glial, neuronal|2018
0-19|0.3|0.4|0.4|Benign/Borderline|146|40536667|Female|Neuronal/glial, neuronal|2019
0-19|0.0|0.1|0.1|Malignant|21|40536667|Female|Neuronal/glial, neuronal|2019
0-19|0.3|0.4|0.4|Benign/Borderline|146|39443036|Female|Neuronal/glial, neuronal|2020
0-19|0.0|0.1|0.1|Malignant|25|39443036|Female|Neuronal/glial, neuronal|2020
0-19|0.3|0.4|0.3|Benign/Borderline|128|38944115|Female|Neuronal/glial, neuronal|2021
0-19|0.0|0.1|0.0|Malignant|18|38944115|Female|Neuronal/glial, neuronal|2021
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Oligodendroglioma|2004
0-19|0.0|0.1|0.1|Malignant|24|39865121|Female|Oligodendroglioma|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Oligodendroglioma|2005
0-19|0.0|0.1|0.1|Malignant|23|39998876|Female|Oligodendroglioma|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Oligodendroglioma|2006
0-19|0.0|0.1|0.1|Malignant|27|40165421|Female|Oligodendroglioma|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Oligodendroglioma|2007
0-19|0.0|0.1|0.1|Malignant|30|40382360|Female|Oligodendroglioma|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Oligodendroglioma|2008
0-19|0.0|0.1|0.0|Malignant|17|40576293|Female|Oligodendroglioma|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Oligodendroglioma|2009
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Oligodendroglioma|2009
0-19|~|~|~|Benign/Borderline|~|40649165|Female|Oligodendroglioma|2010
0-19|0.0|0.1|0.1|Malignant|24|40649165|Female|Oligodendroglioma|2010
0-19|~|~|~|Benign/Borderline|~|40540942|Female|Oligodendroglioma|2011
0-19|0.0|0.1|0.0|Malignant|20|40540942|Female|Oligodendroglioma|2011
0-19|~|~|~|Benign/Borderline|~|40450188|Female|Oligodendroglioma|2012
0-19|0.0|0.1|0.1|Malignant|22|40450188|Female|Oligodendroglioma|2012
0-19|~|~|~|Benign/Borderline|~|40416682|Female|Oligodendroglioma|2013
0-19|0.0|0.1|0.0|Malignant|16|40416682|Female|Oligodendroglioma|2013
0-19|~|~|~|Benign/Borderline|~|40420522|Female|Oligodendroglioma|2014
0-19|0.0|0.1|0.0|Malignant|19|40420522|Female|Oligodendroglioma|2014
0-19|~|~|~|Benign/Borderline|~|40478360|Female|Oligodendroglioma|2015
0-19|0.0|0.1|0.0|Malignant|18|40478360|Female|Oligodendroglioma|2015
0-19|~|~|~|Benign/Borderline|~|40566497|Female|Oligodendroglioma|2016
0-19|0.0|0.1|0.1|Malignant|21|40566497|Female|Oligodendroglioma|2016
0-19|~|~|~|Benign/Borderline|~|40607151|Female|Oligodendroglioma|2017
0-19|~|~|~|Malignant|~|40607151|Female|Oligodendroglioma|2017
0-19|~|~|~|Benign/Borderline|~|197530982|Female|Oligodendroglioma|2017-2021
0-19|0.0|0.0|0.0|Malignant|59|197530982|Female|Oligodendroglioma|2017-2021
0-19|~|~|~|Benign/Borderline|~|40600164|Female|Oligodendroglioma|2018
0-19|~|~|~|Malignant|~|40600164|Female|Oligodendroglioma|2018
0-19|~|~|~|Benign/Borderline|~|40536667|Female|Oligodendroglioma|2019
0-19|~|~|~|Malignant|~|40536667|Female|Oligodendroglioma|2019
0-19|~|~|~|Benign/Borderline|~|39443036|Female|Oligodendroglioma|2020
0-19|~|~|~|Malignant|~|39443036|Female|Oligodendroglioma|2020
0-19|~|~|~|Benign/Borderline|~|38944115|Female|Oligodendroglioma|2021
0-19|0.0|0.1|0.0|Malignant|16|38944115|Female|Oligodendroglioma|2021
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Other mesenchymal|2004
0-19|~|~|~|Malignant|~|39865121|Female|Other mesenchymal|2004
0-19|0.0|0.1|0.0|Benign/Borderline|18|39998876|Female|Other mesenchymal|2005
0-19|~|~|~|Malignant|~|39998876|Female|Other mesenchymal|2005
0-19|0.0|0.1|0.0|Benign/Borderline|19|40165421|Female|Other mesenchymal|2006
0-19|~|~|~|Malignant|~|40165421|Female|Other mesenchymal|2006
0-19|0.0|0.1|0.1|Benign/Borderline|21|40382360|Female|Other mesenchymal|2007
0-19|~|~|~|Malignant|~|40382360|Female|Other mesenchymal|2007
0-19|0.0|0.1|0.0|Benign/Borderline|19|40576293|Female|Other mesenchymal|2008
0-19|~|~|~|Malignant|~|40576293|Female|Other mesenchymal|2008
0-19|0.1|0.1|0.1|Benign/Borderline|31|40670476|Female|Other mesenchymal|2009
0-19|~|~|~|Malignant|~|40670476|Female|Other mesenchymal|2009
0-19|0.0|0.1|0.1|Benign/Borderline|27|40649165|Female|Other mesenchymal|2010
0-19|~|~|~|Malignant|~|40649165|Female|Other mesenchymal|2010
0-19|0.0|0.1|0.1|Benign/Borderline|29|40540942|Female|Other mesenchymal|2011
0-19|~|~|~|Malignant|~|40540942|Female|Other mesenchymal|2011
0-19|0.1|0.2|0.1|Benign/Borderline|52|40450188|Female|Other mesenchymal|2012
0-19|~|~|~|Malignant|~|40450188|Female|Other mesenchymal|2012
0-19|0.1|0.1|0.1|Benign/Borderline|42|40416682|Female|Other mesenchymal|2013
0-19|~|~|~|Malignant|~|40416682|Female|Other mesenchymal|2013
0-19|0.1|0.1|0.1|Benign/Borderline|45|40420522|Female|Other mesenchymal|2014
0-19|~|~|~|Malignant|~|40420522|Female|Other mesenchymal|2014
0-19|0.1|0.2|0.1|Benign/Borderline|50|40478360|Female|Other mesenchymal|2015
0-19|~|~|~|Malignant|~|40478360|Female|Other mesenchymal|2015
0-19|0.1|0.2|0.1|Benign/Borderline|53|40566497|Female|Other mesenchymal|2016
0-19|~|~|~|Malignant|~|40566497|Female|Other mesenchymal|2016
0-19|0.1|0.2|0.1|Benign/Borderline|51|40607151|Female|Other mesenchymal|2017
0-19|~|~|~|Malignant|~|40607151|Female|Other mesenchymal|2017
0-19|0.1|0.1|0.1|Benign/Borderline|238|197530982|Female|Other mesenchymal|2017-2021
0-19|0.0|0.0|0.0|Malignant|29|197530982|Female|Other mesenchymal|2017-2021
0-19|0.1|0.2|0.1|Benign/Borderline|48|40600164|Female|Other mesenchymal|2018
0-19|~|~|~|Malignant|~|40600164|Female|Other mesenchymal|2018
0-19|0.1|0.1|0.1|Benign/Borderline|35|40536667|Female|Other mesenchymal|2019
0-19|~|~|~|Malignant|~|40536667|Female|Other mesenchymal|2019
0-19|0.1|0.2|0.1|Benign/Borderline|47|39443036|Female|Other mesenchymal|2020
0-19|~|~|~|Malignant|~|39443036|Female|Other mesenchymal|2020
0-19|0.1|0.2|0.2|Benign/Borderline|57|38944115|Female|Other mesenchymal|2021
0-19|~|~|~|Malignant|~|38944115|Female|Other mesenchymal|2021
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Pilocytic astrocytoma|2004
0-19|0.7|0.9|0.8|Malignant|331|39865121|Female|Pilocytic astrocytoma|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Pilocytic astrocytoma|2005
0-19|0.7|0.9|0.8|Malignant|326|39998876|Female|Pilocytic astrocytoma|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Pilocytic astrocytoma|2006
0-19|0.7|0.9|0.8|Malignant|320|40165421|Female|Pilocytic astrocytoma|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Pilocytic astrocytoma|2007
0-19|0.8|1.0|0.9|Malignant|348|40382360|Female|Pilocytic astrocytoma|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Pilocytic astrocytoma|2008
0-19|0.8|0.9|0.8|Malignant|341|40576293|Female|Pilocytic astrocytoma|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Pilocytic astrocytoma|2009
0-19|0.8|1.0|0.9|Malignant|357|40670476|Female|Pilocytic astrocytoma|2009
0-19|~|~|~|Benign/Borderline|~|40649165|Female|Pilocytic astrocytoma|2010
0-19|0.9|1.1|1.0|Malignant|402|40649165|Female|Pilocytic astrocytoma|2010
0-19|~|~|~|Benign/Borderline|~|40540942|Female|Pilocytic astrocytoma|2011
0-19|0.8|1.0|0.9|Malignant|359|40540942|Female|Pilocytic astrocytoma|2011
0-19|~|~|~|Benign/Borderline|~|40450188|Female|Pilocytic astrocytoma|2012
0-19|0.9|1.0|0.9|Malignant|382|40450188|Female|Pilocytic astrocytoma|2012
0-19|~|~|~|Benign/Borderline|~|40416682|Female|Pilocytic astrocytoma|2013
0-19|0.8|1.0|0.9|Malignant|367|40416682|Female|Pilocytic astrocytoma|2013
0-19|~|~|~|Benign/Borderline|~|40420522|Female|Pilocytic astrocytoma|2014
0-19|0.9|1.1|1.0|Malignant|409|40420522|Female|Pilocytic astrocytoma|2014
0-19|~|~|~|Benign/Borderline|~|40478360|Female|Pilocytic astrocytoma|2015
0-19|0.8|1.0|0.9|Malignant|362|40478360|Female|Pilocytic astrocytoma|2015
0-19|~|~|~|Benign/Borderline|~|40566497|Female|Pilocytic astrocytoma|2016
0-19|0.8|0.9|0.8|Malignant|337|40566497|Female|Pilocytic astrocytoma|2016
0-19|~|~|~|Benign/Borderline|~|40607151|Female|Pilocytic astrocytoma|2017
0-19|0.9|1.1|1.0|Malignant|404|40607151|Female|Pilocytic astrocytoma|2017
0-19|0.1|0.2|0.1|Benign/Borderline|275|197530982|Female|Pilocytic astrocytoma|2017-2021
0-19|0.7|0.8|0.8|Malignant|1524|197530982|Female|Pilocytic astrocytoma|2017-2021
0-19|0.2|0.3|0.2|Benign/Borderline|87|40600164|Female|Pilocytic astrocytoma|2018
0-19|0.7|0.9|0.8|Malignant|331|40600164|Female|Pilocytic astrocytoma|2018
0-19|0.1|0.2|0.2|Benign/Borderline|61|40536667|Female|Pilocytic astrocytoma|2019
0-19|0.7|0.8|0.7|Malignant|297|40536667|Female|Pilocytic astrocytoma|2019
0-19|0.1|0.2|0.2|Benign/Borderline|67|39443036|Female|Pilocytic astrocytoma|2020
0-19|0.6|0.7|0.7|Malignant|260|39443036|Female|Pilocytic astrocytoma|2020
0-19|0.1|0.2|0.2|Benign/Borderline|62|38944115|Female|Pilocytic astrocytoma|2021
0-19|0.6|0.7|0.7|Malignant|253|38944115|Female|Pilocytic astrocytoma|2021
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Pineal parenchymal|2004
0-19|~|~|~|Malignant|~|39865121|Female|Pineal parenchymal|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Pineal parenchymal|2005
0-19|~|~|~|Malignant|~|39998876|Female|Pineal parenchymal|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Pineal parenchymal|2006
0-19|~|~|~|Malignant|~|40165421|Female|Pineal parenchymal|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Pineal parenchymal|2007
0-19|~|~|~|Malignant|~|40382360|Female|Pineal parenchymal|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Pineal parenchymal|2008
0-19|0.0|0.1|0.0|Malignant|20|40576293|Female|Pineal parenchymal|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Pineal parenchymal|2009
0-19|~|~|~|Malignant|~|40670476|Female|Pineal parenchymal|2009
0-19|~|~|~|Benign/Borderline|~|40649165|Female|Pineal parenchymal|2010
0-19|~|~|~|Malignant|~|40649165|Female|Pineal parenchymal|2010
0-19|~|~|~|Benign/Borderline|~|40540942|Female|Pineal parenchymal|2011
0-19|~|~|~|Malignant|~|40540942|Female|Pineal parenchymal|2011
0-19|~|~|~|Benign/Borderline|~|40450188|Female|Pineal parenchymal|2012
0-19|~|~|~|Malignant|~|40450188|Female|Pineal parenchymal|2012
0-19|~|~|~|Benign/Borderline|~|40416682|Female|Pineal parenchymal|2013
0-19|~|~|~|Malignant|~|40416682|Female|Pineal parenchymal|2013
0-19|~|~|~|Benign/Borderline|~|40420522|Female|Pineal parenchymal|2014
0-19|0.0|0.1|0.0|Malignant|16|40420522|Female|Pineal parenchymal|2014
0-19|~|~|~|Benign/Borderline|~|40478360|Female|Pineal parenchymal|2015
0-19|0.0|0.1|0.1|Malignant|25|40478360|Female|Pineal parenchymal|2015
0-19|~|~|~|Benign/Borderline|~|40566497|Female|Pineal parenchymal|2016
0-19|~|~|~|Malignant|~|40566497|Female|Pineal parenchymal|2016
0-19|~|~|~|Benign/Borderline|~|40607151|Female|Pineal parenchymal|2017
0-19|~|~|~|Malignant|~|40607151|Female|Pineal parenchymal|2017
0-19|0.0|0.0|0.0|Benign/Borderline|19|197530982|Female|Pineal parenchymal|2017-2021
0-19|0.0|0.0|0.0|Malignant|77|197530982|Female|Pineal parenchymal|2017-2021
0-19|~|~|~|Benign/Borderline|~|40600164|Female|Pineal parenchymal|2018
0-19|0.0|0.1|0.0|Malignant|18|40600164|Female|Pineal parenchymal|2018
0-19|~|~|~|Benign/Borderline|~|40536667|Female|Pineal parenchymal|2019
0-19|0.0|0.1|0.0|Malignant|20|40536667|Female|Pineal parenchymal|2019
0-19|~|~|~|Benign/Borderline|~|39443036|Female|Pineal parenchymal|2020
0-19|~|~|~|Malignant|~|39443036|Female|Pineal parenchymal|2020
0-19|~|~|~|Benign/Borderline|~|38944115|Female|Pineal parenchymal|2021
0-19|~|~|~|Malignant|~|38944115|Female|Pineal parenchymal|2021
0-19|0.6|0.8|0.7|Benign/Borderline|288|39865121|Female|Pituitary|2004
0-19|~|~|~|Malignant|~|39865121|Female|Pituitary|2004
0-19|0.7|0.9|0.8|Benign/Borderline|328|39998876|Female|Pituitary|2005
0-19|~|~|~|Malignant|~|39998876|Female|Pituitary|2005
0-19|0.8|1.0|0.9|Benign/Borderline|374|40165421|Female|Pituitary|2006
0-19|~|~|~|Malignant|~|40165421|Female|Pituitary|2006
0-19|0.8|1.0|0.9|Benign/Borderline|360|40382360|Female|Pituitary|2007
0-19|~|~|~|Malignant|~|40382360|Female|Pituitary|2007
0-19|0.9|1.1|1.0|Benign/Borderline|426|40576293|Female|Pituitary|2008
0-19|~|~|~|Malignant|~|40576293|Female|Pituitary|2008
0-19|0.9|1.1|1.0|Benign/Borderline|425|40670476|Female|Pituitary|2009
0-19|~|~|~|Malignant|~|40670476|Female|Pituitary|2009
0-19|1.1|1.3|1.2|Benign/Borderline|483|40649165|Female|Pituitary|2010
0-19|~|~|~|Malignant|~|40649165|Female|Pituitary|2010
0-19|1.1|1.3|1.2|Benign/Borderline|487|40540942|Female|Pituitary|2011
0-19|~|~|~|Malignant|~|40540942|Female|Pituitary|2011
0-19|1.2|1.4|1.3|Benign/Borderline|525|40450188|Female|Pituitary|2012
0-19|~|~|~|Malignant|~|40450188|Female|Pituitary|2012
0-19|1.1|1.4|1.3|Benign/Borderline|516|40416682|Female|Pituitary|2013
0-19|~|~|~|Malignant|~|40416682|Female|Pituitary|2013
0-19|1.2|1.5|1.4|Benign/Borderline|561|40420522|Female|Pituitary|2014
0-19|~|~|~|Malignant|~|40420522|Female|Pituitary|2014
0-19|1.2|1.5|1.3|Benign/Borderline|559|40478360|Female|Pituitary|2015
0-19|~|~|~|Malignant|~|40478360|Female|Pituitary|2015
0-19|1.4|1.6|1.5|Benign/Borderline|614|40566497|Female|Pituitary|2016
0-19|~|~|~|Malignant|~|40566497|Female|Pituitary|2016
0-19|1.4|1.7|1.5|Benign/Borderline|647|40607151|Female|Pituitary|2017
0-19|~|~|~|Malignant|~|40607151|Female|Pituitary|2017
0-19|1.4|1.5|1.5|Benign/Borderline|2979|197530982|Female|Pituitary|2017-2021
0-19|~|~|~|Malignant|~|197530982|Female|Pituitary|2017-2021
0-19|1.4|1.6|1.5|Benign/Borderline|630|40600164|Female|Pituitary|2018
0-19|~|~|~|Malignant|~|40600164|Female|Pituitary|2018
0-19|1.3|1.6|1.4|Benign/Borderline|607|40536667|Female|Pituitary|2019
0-19|~|~|~|Malignant|~|40536667|Female|Pituitary|2019
0-19|1.3|1.5|1.4|Benign/Borderline|565|39443036|Female|Pituitary|2020
0-19|~|~|~|Malignant|~|39443036|Female|Pituitary|2020
0-19|1.3|1.5|1.4|Benign/Borderline|557|38944115|Female|Pituitary|2021
0-19|~|~|~|Malignant|~|38944115|Female|Pituitary|2021
0-19|1.9|2.2|2.0|Benign/Borderline|815|39865121|Female|Total|2004
0-19|3.1|3.5|3.3|Malignant|1308|39865121|Female|Total|2004
0-19|2.3|2.6|2.4|Benign/Borderline|981|39998876|Female|Total|2005
0-19|2.9|3.3|3.1|Malignant|1240|39998876|Female|Total|2005
0-19|2.3|2.6|2.5|Benign/Borderline|1003|40165421|Female|Total|2006
0-19|2.9|3.3|3.1|Malignant|1237|40165421|Female|Total|2006
0-19|2.3|2.6|2.5|Benign/Borderline|1018|40382360|Female|Total|2007
0-19|3.1|3.4|3.2|Malignant|1306|40382360|Female|Total|2007
0-19|2.5|2.9|2.7|Benign/Borderline|1115|40576293|Female|Total|2008
0-19|3.0|3.4|3.2|Malignant|1294|40576293|Female|Total|2008
0-19|2.6|2.9|2.7|Benign/Borderline|1133|40670476|Female|Total|2009
0-19|3.0|3.4|3.2|Malignant|1302|40670476|Female|Total|2009
0-19|2.8|3.1|2.9|Benign/Borderline|1210|40649165|Female|Total|2010
0-19|3.1|3.4|3.2|Malignant|1310|40649165|Female|Total|2010
0-19|2.8|3.2|3.0|Benign/Borderline|1234|40540942|Female|Total|2011
0-19|3.2|3.5|3.4|Malignant|1361|40540942|Female|Total|2011
0-19|3.0|3.4|3.2|Benign/Borderline|1302|40450188|Female|Total|2012
0-19|2.9|3.3|3.1|Malignant|1244|40450188|Female|Total|2012
0-19|3.1|3.5|3.3|Benign/Borderline|1336|40416682|Female|Total|2013
0-19|3.2|3.6|3.4|Malignant|1361|40416682|Female|Total|2013
0-19|3.1|3.5|3.3|Benign/Borderline|1342|40420522|Female|Total|2014
0-19|3.3|3.6|3.5|Malignant|1393|40420522|Female|Total|2014
0-19|3.2|3.5|3.4|Benign/Borderline|1374|40478360|Female|Total|2015
0-19|3.1|3.4|3.2|Malignant|1300|40478360|Female|Total|2015
0-19|3.2|3.5|3.4|Benign/Borderline|1386|40566497|Female|Total|2016
0-19|3.0|3.4|3.2|Malignant|1292|40566497|Female|Total|2016
0-19|3.2|3.6|3.4|Benign/Borderline|1398|40607151|Female|Total|2017
0-19|3.2|3.5|3.3|Malignant|1344|40607151|Female|Total|2017
0-19|3.2|3.3|3.2|Benign/Borderline|6495|197530982|Female|Total|2017-2021
0-19|2.7|2.8|2.7|Malignant|5391|197530982|Female|Total|2017-2021
0-19|3.2|3.5|3.4|Benign/Borderline|1386|40600164|Female|Total|2018
0-19|2.7|3.1|2.9|Malignant|1166|40600164|Female|Total|2018
0-19|3.0|3.3|3.1|Benign/Borderline|1298|40536667|Female|Total|2019
0-19|2.4|2.7|2.6|Malignant|1032|40536667|Female|Total|2019
0-19|2.9|3.3|3.1|Benign/Borderline|1244|39443036|Female|Total|2020
0-19|2.3|2.6|2.5|Malignant|965|39443036|Female|Total|2020
0-19|2.9|3.3|3.1|Benign/Borderline|1222|38944115|Female|Total|2021
0-19|2.3|2.6|2.5|Malignant|959|38944115|Female|Total|2021
0-19|0.2|0.3|0.3|Benign/Borderline|116|39865121|Female|Tumors of Cranial and Spinal Nerves|2004
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of Cranial and Spinal Nerves|2004
0-19|0.4|0.5|0.4|Benign/Borderline|166|39998876|Female|Tumors of Cranial and Spinal Nerves|2005
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of Cranial and Spinal Nerves|2005
0-19|0.3|0.5|0.4|Benign/Borderline|164|40165421|Female|Tumors of Cranial and Spinal Nerves|2006
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of Cranial and Spinal Nerves|2006
0-19|0.3|0.4|0.3|Benign/Borderline|135|40382360|Female|Tumors of Cranial and Spinal Nerves|2007
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of Cranial and Spinal Nerves|2007
0-19|0.3|0.4|0.4|Benign/Borderline|151|40576293|Female|Tumors of Cranial and Spinal Nerves|2008
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of Cranial and Spinal Nerves|2008
0-19|0.3|0.5|0.4|Benign/Borderline|157|40670476|Female|Tumors of Cranial and Spinal Nerves|2009
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of Cranial and Spinal Nerves|2009
0-19|0.3|0.4|0.3|Benign/Borderline|138|40649165|Female|Tumors of Cranial and Spinal Nerves|2010
0-19|~|~|~|Malignant|~|40649165|Female|Tumors of Cranial and Spinal Nerves|2010
0-19|0.3|0.4|0.3|Benign/Borderline|133|40540942|Female|Tumors of Cranial and Spinal Nerves|2011
0-19|~|~|~|Malignant|~|40540942|Female|Tumors of Cranial and Spinal Nerves|2011
0-19|0.3|0.4|0.4|Benign/Borderline|146|40450188|Female|Tumors of Cranial and Spinal Nerves|2012
0-19|~|~|~|Malignant|~|40450188|Female|Tumors of Cranial and Spinal Nerves|2012
0-19|0.3|0.5|0.4|Benign/Borderline|156|40416682|Female|Tumors of Cranial and Spinal Nerves|2013
0-19|~|~|~|Malignant|~|40416682|Female|Tumors of Cranial and Spinal Nerves|2013
0-19|0.2|0.3|0.3|Benign/Borderline|110|40420522|Female|Tumors of Cranial and Spinal Nerves|2014
0-19|~|~|~|Malignant|~|40420522|Female|Tumors of Cranial and Spinal Nerves|2014
0-19|0.3|0.5|0.4|Benign/Borderline|160|40478360|Female|Tumors of Cranial and Spinal Nerves|2015
0-19|~|~|~|Malignant|~|40478360|Female|Tumors of Cranial and Spinal Nerves|2015
0-19|0.3|0.4|0.3|Benign/Borderline|130|40566497|Female|Tumors of Cranial and Spinal Nerves|2016
0-19|~|~|~|Malignant|~|40566497|Female|Tumors of Cranial and Spinal Nerves|2016
0-19|0.3|0.4|0.3|Benign/Borderline|130|40607151|Female|Tumors of Cranial and Spinal Nerves|2017
0-19|~|~|~|Malignant|~|40607151|Female|Tumors of Cranial and Spinal Nerves|2017
0-19|0.2|0.2|0.2|Benign/Borderline|436|197530982|Female|Tumors of Cranial and Spinal Nerves|2017-2021
0-19|~|~|~|Malignant|~|197530982|Female|Tumors of Cranial and Spinal Nerves|2017-2021
0-19|0.2|0.2|0.2|Benign/Borderline|80|40600164|Female|Tumors of Cranial and Spinal Nerves|2018
0-19|~|~|~|Malignant|~|40600164|Female|Tumors of Cranial and Spinal Nerves|2018
0-19|0.1|0.2|0.2|Benign/Borderline|75|40536667|Female|Tumors of Cranial and Spinal Nerves|2019
0-19|~|~|~|Malignant|~|40536667|Female|Tumors of Cranial and Spinal Nerves|2019
0-19|0.1|0.2|0.2|Benign/Borderline|77|39443036|Female|Tumors of Cranial and Spinal Nerves|2020
0-19|~|~|~|Malignant|~|39443036|Female|Tumors of Cranial and Spinal Nerves|2020
0-19|0.2|0.2|0.2|Benign/Borderline|76|38944115|Female|Tumors of Cranial and Spinal Nerves|2021
0-19|~|~|~|Malignant|~|38944115|Female|Tumors of Cranial and Spinal Nerves|2021
0-19|0.4|0.5|0.5|Benign/Borderline|190|39865121|Female|Tumors of Neuroepthelial Tissue|2004
0-19|2.9|3.2|3.0|Malignant|1211|39865121|Female|Tumors of Neuroepthelial Tissue|2004
0-19|0.4|0.6|0.5|Benign/Borderline|201|39998876|Female|Tumors of Neuroepthelial Tissue|2005
0-19|2.7|3.1|2.9|Malignant|1150|39998876|Female|Tumors of Neuroepthelial Tissue|2005
0-19|0.4|0.6|0.5|Benign/Borderline|208|40165421|Female|Tumors of Neuroepthelial Tissue|2006
0-19|2.7|3.1|2.9|Malignant|1165|40165421|Female|Tumors of Neuroepthelial Tissue|2006
0-19|0.5|0.7|0.6|Benign/Borderline|232|40382360|Female|Tumors of Neuroepthelial Tissue|2007
0-19|2.9|3.3|3.1|Malignant|1244|40382360|Female|Tumors of Neuroepthelial Tissue|2007
0-19|0.5|0.6|0.6|Benign/Borderline|230|40576293|Female|Tumors of Neuroepthelial Tissue|2008
0-19|2.9|3.2|3.1|Malignant|1239|40576293|Female|Tumors of Neuroepthelial Tissue|2008
0-19|0.5|0.6|0.5|Benign/Borderline|218|40670476|Female|Tumors of Neuroepthelial Tissue|2009
0-19|2.9|3.2|3.0|Malignant|1223|40670476|Female|Tumors of Neuroepthelial Tissue|2009
0-19|0.5|0.7|0.6|Benign/Borderline|235|40649165|Female|Tumors of Neuroepthelial Tissue|2010
0-19|2.9|3.2|3.0|Malignant|1230|40649165|Female|Tumors of Neuroepthelial Tissue|2010
0-19|0.5|0.7|0.6|Benign/Borderline|249|40540942|Female|Tumors of Neuroepthelial Tissue|2011
0-19|3.0|3.4|3.2|Malignant|1284|40540942|Female|Tumors of Neuroepthelial Tissue|2011
0-19|0.6|0.7|0.6|Benign/Borderline|257|40450188|Female|Tumors of Neuroepthelial Tissue|2012
0-19|2.8|3.1|2.9|Malignant|1182|40450188|Female|Tumors of Neuroepthelial Tissue|2012
0-19|0.6|0.8|0.7|Benign/Borderline|272|40416682|Female|Tumors of Neuroepthelial Tissue|2013
0-19|3.0|3.3|3.2|Malignant|1271|40416682|Female|Tumors of Neuroepthelial Tissue|2013
0-19|0.6|0.7|0.6|Benign/Borderline|259|40420522|Female|Tumors of Neuroepthelial Tissue|2014
0-19|3.1|3.5|3.3|Malignant|1320|40420522|Female|Tumors of Neuroepthelial Tissue|2014
0-19|0.6|0.7|0.6|Benign/Borderline|260|40478360|Female|Tumors of Neuroepthelial Tissue|2015
0-19|2.9|3.2|3.0|Malignant|1217|40478360|Female|Tumors of Neuroepthelial Tissue|2015
0-19|0.6|0.8|0.7|Benign/Borderline|283|40566497|Female|Tumors of Neuroepthelial Tissue|2016
0-19|2.8|3.1|3.0|Malignant|1191|40566497|Female|Tumors of Neuroepthelial Tissue|2016
0-19|0.6|0.8|0.7|Benign/Borderline|285|40607151|Female|Tumors of Neuroepthelial Tissue|2017
0-19|3.0|3.3|3.1|Malignant|1264|40607151|Female|Tumors of Neuroepthelial Tissue|2017
0-19|0.7|0.8|0.7|Benign/Borderline|1447|197530982|Female|Tumors of Neuroepthelial Tissue|2017-2021
0-19|2.5|2.6|2.5|Malignant|4983|197530982|Female|Tumors of Neuroepthelial Tissue|2017-2021
0-19|0.7|0.9|0.8|Benign/Borderline|333|40600164|Female|Tumors of Neuroepthelial Tissue|2018
0-19|2.5|2.8|2.7|Malignant|1083|40600164|Female|Tumors of Neuroepthelial Tissue|2018
0-19|0.6|0.8|0.7|Benign/Borderline|291|40536667|Female|Tumors of Neuroepthelial Tissue|2019
0-19|2.2|2.5|2.4|Malignant|954|40536667|Female|Tumors of Neuroepthelial Tissue|2019
0-19|0.6|0.8|0.7|Benign/Borderline|288|39443036|Female|Tumors of Neuroepthelial Tissue|2020
0-19|2.1|2.4|2.2|Malignant|877|39443036|Female|Tumors of Neuroepthelial Tissue|2020
0-19|0.6|0.8|0.7|Benign/Borderline|261|38944115|Female|Tumors of Neuroepthelial Tissue|2021
0-19|2.1|2.4|2.3|Malignant|873|38944115|Female|Tumors of Neuroepthelial Tissue|2021
0-19|0.8|1.0|0.9|Benign/Borderline|373|39865121|Female|Tumors of Sellar Region|2004
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of Sellar Region|2004
0-19|0.9|1.1|1.0|Benign/Borderline|406|39998876|Female|Tumors of Sellar Region|2005
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of Sellar Region|2005
0-19|1.0|1.2|1.1|Benign/Borderline|451|40165421|Female|Tumors of Sellar Region|2006
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of Sellar Region|2006
0-19|1.0|1.2|1.1|Benign/Borderline|456|40382360|Female|Tumors of Sellar Region|2007
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of Sellar Region|2007
0-19|1.1|1.3|1.2|Benign/Borderline|493|40576293|Female|Tumors of Sellar Region|2008
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of Sellar Region|2008
0-19|1.1|1.3|1.2|Benign/Borderline|515|40670476|Female|Tumors of Sellar Region|2009
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of Sellar Region|2009
0-19|1.3|1.5|1.4|Benign/Borderline|578|40649165|Female|Tumors of Sellar Region|2010
0-19|~|~|~|Malignant|~|40649165|Female|Tumors of Sellar Region|2010
0-19|1.3|1.5|1.4|Benign/Borderline|573|40540942|Female|Tumors of Sellar Region|2011
0-19|~|~|~|Malignant|~|40540942|Female|Tumors of Sellar Region|2011
0-19|1.3|1.6|1.5|Benign/Borderline|603|40450188|Female|Tumors of Sellar Region|2012
0-19|~|~|~|Malignant|~|40450188|Female|Tumors of Sellar Region|2012
0-19|1.4|1.6|1.5|Benign/Borderline|605|40416682|Female|Tumors of Sellar Region|2013
0-19|~|~|~|Malignant|~|40416682|Female|Tumors of Sellar Region|2013
0-19|1.5|1.7|1.6|Benign/Borderline|654|40420522|Female|Tumors of Sellar Region|2014
0-19|~|~|~|Malignant|~|40420522|Female|Tumors of Sellar Region|2014
0-19|1.4|1.7|1.5|Benign/Borderline|640|40478360|Female|Tumors of Sellar Region|2015
0-19|~|~|~|Malignant|~|40478360|Female|Tumors of Sellar Region|2015
0-19|1.5|1.8|1.6|Benign/Borderline|682|40566497|Female|Tumors of Sellar Region|2016
0-19|~|~|~|Malignant|~|40566497|Female|Tumors of Sellar Region|2016
0-19|1.6|1.9|1.7|Benign/Borderline|726|40607151|Female|Tumors of Sellar Region|2017
0-19|~|~|~|Malignant|~|40607151|Female|Tumors of Sellar Region|2017
0-19|1.6|1.7|1.6|Benign/Borderline|3330|197530982|Female|Tumors of Sellar Region|2017-2021
0-19|~|~|~|Malignant|~|197530982|Female|Tumors of Sellar Region|2017-2021
0-19|1.5|1.8|1.6|Benign/Borderline|682|40600164|Female|Tumors of Sellar Region|2018
0-19|~|~|~|Malignant|~|40600164|Female|Tumors of Sellar Region|2018
0-19|1.5|1.8|1.7|Benign/Borderline|691|40536667|Female|Tumors of Sellar Region|2019
0-19|~|~|~|Malignant|~|40536667|Female|Tumors of Sellar Region|2019
0-19|1.4|1.7|1.6|Benign/Borderline|636|39443036|Female|Tumors of Sellar Region|2020
0-19|~|~|~|Malignant|~|39443036|Female|Tumors of Sellar Region|2020
0-19|1.4|1.7|1.6|Benign/Borderline|626|38944115|Female|Tumors of Sellar Region|2021
0-19|~|~|~|Malignant|~|38944115|Female|Tumors of Sellar Region|2021
0-19|0.1|0.2|0.2|Benign/Borderline|72|39865121|Female|Tumors of the Meninges|2004
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of the Meninges|2004
0-19|0.2|0.3|0.3|Benign/Borderline|111|39998876|Female|Tumors of the Meninges|2005
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of the Meninges|2005
0-19|0.1|0.2|0.2|Benign/Borderline|77|40165421|Female|Tumors of the Meninges|2006
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of the Meninges|2006
0-19|0.2|0.3|0.2|Benign/Borderline|95|40382360|Female|Tumors of the Meninges|2007
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of the Meninges|2007
0-19|0.2|0.3|0.2|Benign/Borderline|92|40576293|Female|Tumors of the Meninges|2008
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of the Meninges|2008
0-19|0.2|0.3|0.3|Benign/Borderline|107|40670476|Female|Tumors of the Meninges|2009
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of the Meninges|2009
0-19|0.2|0.3|0.2|Benign/Borderline|102|40649165|Female|Tumors of the Meninges|2010
0-19|~|~|~|Malignant|~|40649165|Female|Tumors of the Meninges|2010
0-19|0.2|0.3|0.3|Benign/Borderline|115|40540942|Female|Tumors of the Meninges|2011
0-19|~|~|~|Malignant|~|40540942|Female|Tumors of the Meninges|2011
0-19|0.3|0.4|0.3|Benign/Borderline|134|40450188|Female|Tumors of the Meninges|2012
0-19|~|~|~|Malignant|~|40450188|Female|Tumors of the Meninges|2012
0-19|0.3|0.4|0.3|Benign/Borderline|139|40416682|Female|Tumors of the Meninges|2013
0-19|~|~|~|Malignant|~|40416682|Female|Tumors of the Meninges|2013
0-19|0.3|0.4|0.4|Benign/Borderline|150|40420522|Female|Tumors of the Meninges|2014
0-19|~|~|~|Malignant|~|40420522|Female|Tumors of the Meninges|2014
0-19|0.3|0.4|0.3|Benign/Borderline|139|40478360|Female|Tumors of the Meninges|2015
0-19|~|~|~|Malignant|~|40478360|Female|Tumors of the Meninges|2015
0-19|0.3|0.4|0.4|Benign/Borderline|151|40566497|Female|Tumors of the Meninges|2016
0-19|~|~|~|Malignant|~|40566497|Female|Tumors of the Meninges|2016
0-19|0.3|0.4|0.3|Benign/Borderline|131|40607151|Female|Tumors of the Meninges|2017
0-19|~|~|~|Malignant|~|40607151|Female|Tumors of the Meninges|2017
0-19|0.3|0.4|0.3|Benign/Borderline|658|197530982|Female|Tumors of the Meninges|2017-2021
0-19|0.0|0.0|0.0|Malignant|43|197530982|Female|Tumors of the Meninges|2017-2021
0-19|0.3|0.4|0.3|Benign/Borderline|136|40600164|Female|Tumors of the Meninges|2018
0-19|~|~|~|Malignant|~|40600164|Female|Tumors of the Meninges|2018
0-19|0.3|0.4|0.3|Benign/Borderline|124|40536667|Female|Tumors of the Meninges|2019
0-19|~|~|~|Malignant|~|40536667|Female|Tumors of the Meninges|2019
0-19|0.3|0.4|0.3|Benign/Borderline|125|39443036|Female|Tumors of the Meninges|2020
0-19|~|~|~|Malignant|~|39443036|Female|Tumors of the Meninges|2020
0-19|0.3|0.5|0.4|Benign/Borderline|150|38944115|Female|Tumors of the Meninges|2021
0-19|~|~|~|Malignant|~|38944115|Female|Tumors of the Meninges|2021
0-19|0.1|0.2|0.1|Benign/Borderline|50|39865121|Female|Unclassified Tumors|2004
0-19|0.0|0.1|0.1|Malignant|27|39865121|Female|Unclassified Tumors|2004
0-19|0.2|0.3|0.2|Benign/Borderline|83|39998876|Female|Unclassified Tumors|2005
0-19|0.0|0.1|0.0|Malignant|19|39998876|Female|Unclassified Tumors|2005
0-19|0.2|0.3|0.2|Benign/Borderline|85|40165421|Female|Unclassified Tumors|2006
0-19|0.0|0.1|0.1|Malignant|28|40165421|Female|Unclassified Tumors|2006
0-19|0.2|0.3|0.2|Benign/Borderline|85|40382360|Female|Unclassified Tumors|2007
0-19|0.0|0.1|0.0|Malignant|16|40382360|Female|Unclassified Tumors|2007
0-19|0.3|0.4|0.3|Benign/Borderline|129|40576293|Female|Unclassified Tumors|2008
0-19|~|~|~|Malignant|~|40576293|Female|Unclassified Tumors|2008
0-19|0.2|0.3|0.3|Benign/Borderline|116|40670476|Female|Unclassified Tumors|2009
0-19|0.0|0.1|0.0|Malignant|16|40670476|Female|Unclassified Tumors|2009
0-19|0.3|0.4|0.3|Benign/Borderline|136|40649165|Female|Unclassified Tumors|2010
0-19|~|~|~|Malignant|~|40649165|Female|Unclassified Tumors|2010
0-19|0.3|0.4|0.3|Benign/Borderline|141|40540942|Female|Unclassified Tumors|2011
0-19|0.0|0.1|0.0|Malignant|19|40540942|Female|Unclassified Tumors|2011
0-19|0.3|0.4|0.4|Benign/Borderline|145|40450188|Female|Unclassified Tumors|2012
0-19|0.0|0.1|0.1|Malignant|24|40450188|Female|Unclassified Tumors|2012
0-19|0.3|0.4|0.4|Benign/Borderline|142|40416682|Female|Unclassified Tumors|2013
0-19|0.0|0.1|0.1|Malignant|24|40416682|Female|Unclassified Tumors|2013
0-19|0.3|0.4|0.4|Benign/Borderline|146|40420522|Female|Unclassified Tumors|2014
0-19|0.0|0.1|0.1|Malignant|22|40420522|Female|Unclassified Tumors|2014
0-19|0.3|0.5|0.4|Benign/Borderline|157|40478360|Female|Unclassified Tumors|2015
0-19|0.0|0.1|0.0|Malignant|17|40478360|Female|Unclassified Tumors|2015
0-19|0.2|0.3|0.3|Benign/Borderline|112|40566497|Female|Unclassified Tumors|2016
0-19|0.0|0.1|0.1|Malignant|24|40566497|Female|Unclassified Tumors|2016
0-19|0.2|0.3|0.3|Benign/Borderline|112|40607151|Female|Unclassified Tumors|2017
0-19|0.0|0.1|0.1|Malignant|21|40607151|Female|Unclassified Tumors|2017
0-19|0.3|0.3|0.3|Benign/Borderline|545|197530982|Female|Unclassified Tumors|2017-2021
0-19|0.0|0.1|0.1|Malignant|117|197530982|Female|Unclassified Tumors|2017-2021
0-19|0.3|0.4|0.3|Benign/Borderline|130|40600164|Female|Unclassified Tumors|2018
0-19|0.0|0.1|0.1|Malignant|27|40600164|Female|Unclassified Tumors|2018
0-19|0.2|0.3|0.2|Benign/Borderline|100|40536667|Female|Unclassified Tumors|2019
0-19|0.0|0.1|0.0|Malignant|16|40536667|Female|Unclassified Tumors|2019
0-19|0.2|0.3|0.3|Benign/Borderline|105|39443036|Female|Unclassified Tumors|2020
0-19|0.0|0.1|0.1|Malignant|25|39443036|Female|Unclassified Tumors|2020
0-19|0.2|0.3|0.3|Benign/Borderline|99|38944115|Female|Unclassified Tumors|2021
0-19|0.0|0.1|0.1|Malignant|28|38944115|Female|Unclassified Tumors|2021
0-19|0.0|0.1|0.1|Benign/Borderline|21|39865121|Female|Unique astrocytoma variants|2004
0-19|0.0|0.1|0.0|Malignant|19|39865121|Female|Unique astrocytoma variants|2004
0-19|0.0|0.1|0.1|Benign/Borderline|25|39998876|Female|Unique astrocytoma variants|2005
0-19|0.0|0.1|0.0|Malignant|20|39998876|Female|Unique astrocytoma variants|2005
0-19|0.0|0.1|0.1|Benign/Borderline|24|40165421|Female|Unique astrocytoma variants|2006
0-19|0.0|0.1|0.0|Malignant|19|40165421|Female|Unique astrocytoma variants|2006
0-19|0.1|0.1|0.1|Benign/Borderline|36|40382360|Female|Unique astrocytoma variants|2007
0-19|0.1|0.1|0.1|Malignant|35|40382360|Female|Unique astrocytoma variants|2007
0-19|0.0|0.1|0.1|Benign/Borderline|27|40576293|Female|Unique astrocytoma variants|2008
0-19|~|~|~|Malignant|~|40576293|Female|Unique astrocytoma variants|2008
0-19|0.1|0.1|0.1|Benign/Borderline|36|40670476|Female|Unique astrocytoma variants|2009
0-19|0.0|0.1|0.1|Malignant|21|40670476|Female|Unique astrocytoma variants|2009
0-19|0.1|0.1|0.1|Benign/Borderline|32|40649165|Female|Unique astrocytoma variants|2010
0-19|~|~|~|Malignant|~|40649165|Female|Unique astrocytoma variants|2010
0-19|0.0|0.1|0.0|Benign/Borderline|20|40540942|Female|Unique astrocytoma variants|2011
0-19|0.0|0.1|0.1|Malignant|24|40540942|Female|Unique astrocytoma variants|2011
0-19|0.1|0.1|0.1|Benign/Borderline|34|40450188|Female|Unique astrocytoma variants|2012
0-19|0.0|0.1|0.0|Malignant|19|40450188|Female|Unique astrocytoma variants|2012
0-19|0.1|0.1|0.1|Benign/Borderline|39|40416682|Female|Unique astrocytoma variants|2013
0-19|0.0|0.1|0.0|Malignant|18|40416682|Female|Unique astrocytoma variants|2013
0-19|0.1|0.1|0.1|Benign/Borderline|44|40420522|Female|Unique astrocytoma variants|2014
0-19|0.0|0.1|0.0|Malignant|16|40420522|Female|Unique astrocytoma variants|2014
0-19|0.0|0.1|0.1|Benign/Borderline|21|40478360|Female|Unique astrocytoma variants|2015
0-19|0.0|0.1|0.1|Malignant|26|40478360|Female|Unique astrocytoma variants|2015
0-19|0.0|0.1|0.1|Benign/Borderline|22|40566497|Female|Unique astrocytoma variants|2016
0-19|0.0|0.1|0.1|Malignant|21|40566497|Female|Unique astrocytoma variants|2016
0-19|0.0|0.1|0.1|Benign/Borderline|25|40607151|Female|Unique astrocytoma variants|2017
0-19|0.0|0.1|0.1|Malignant|25|40607151|Female|Unique astrocytoma variants|2017
0-19|0.0|0.1|0.1|Benign/Borderline|118|197530982|Female|Unique astrocytoma variants|2017-2021
0-19|0.0|0.1|0.1|Malignant|110|197530982|Female|Unique astrocytoma variants|2017-2021
0-19|0.0|0.1|0.1|Benign/Borderline|25|40600164|Female|Unique astrocytoma variants|2018
0-19|0.0|0.1|0.1|Malignant|24|40600164|Female|Unique astrocytoma variants|2018
0-19|0.0|0.1|0.1|Benign/Borderline|29|40536667|Female|Unique astrocytoma variants|2019
0-19|0.0|0.1|0.1|Malignant|21|40536667|Female|Unique astrocytoma variants|2019
0-19|0.0|0.1|0.1|Benign/Borderline|23|39443036|Female|Unique astrocytoma variants|2020
0-19|0.0|0.1|0.1|Malignant|21|39443036|Female|Unique astrocytoma variants|2020
0-19|0.0|0.1|0.0|Benign/Borderline|16|38944115|Female|Unique astrocytoma variants|2021
0-19|0.0|0.1|0.1|Malignant|22|38944115|Female|Unique astrocytoma variants|2021
0-19|~|~|~|Benign/Borderline|~|41889233|Male|All other|2004
0-19|~|~|~|Malignant|~|41889233|Male|All other|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|All other|2005
0-19|~|~|~|Malignant|~|42006384|Male|All other|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|All other|2006
0-19|~|~|~|Malignant|~|42158997|Male|All other|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|All other|2007
0-19|~|~|~|Malignant|~|42367071|Male|All other|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|All other|2008
0-19|~|~|~|Malignant|~|42541971|Male|All other|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|All other|2009
0-19|~|~|~|Malignant|~|42609915|Male|All other|2009
0-19|~|~|~|Benign/Borderline|~|42569785|Male|All other|2010
0-19|~|~|~|Malignant|~|42569785|Male|All other|2010
0-19|~|~|~|Benign/Borderline|~|42470382|Male|All other|2011
0-19|~|~|~|Malignant|~|42470382|Male|All other|2011
0-19|~|~|~|Benign/Borderline|~|42360866|Male|All other|2012
0-19|~|~|~|Malignant|~|42360866|Male|All other|2012
0-19|~|~|~|Benign/Borderline|~|42299716|Male|All other|2013
0-19|~|~|~|Malignant|~|42299716|Male|All other|2013
0-19|~|~|~|Benign/Borderline|~|42297680|Male|All other|2014
0-19|~|~|~|Malignant|~|42297680|Male|All other|2014
0-19|~|~|~|Benign/Borderline|~|42356807|Male|All other|2015
0-19|~|~|~|Malignant|~|42356807|Male|All other|2015
0-19|~|~|~|Benign/Borderline|~|42451872|Male|All other|2016
0-19|~|~|~|Malignant|~|42451872|Male|All other|2016
0-19|~|~|~|Benign/Borderline|~|42510556|Male|All other|2017
0-19|~|~|~|Malignant|~|42510556|Male|All other|2017
0-19|0.1|0.1|0.1|Benign/Borderline|141|206836549|Male|All other|2017-2021
0-19|0.3|0.3|0.3|Malignant|605|206836549|Male|All other|2017-2021
0-19|0.0|0.1|0.1|Benign/Borderline|24|42511405|Male|All other|2018
0-19|0.3|0.4|0.3|Malignant|128|42511405|Male|All other|2018
0-19|0.1|0.1|0.1|Benign/Borderline|38|42449660|Male|All other|2019
0-19|0.3|0.4|0.4|Malignant|151|42449660|Male|All other|2019
0-19|0.1|0.1|0.1|Benign/Borderline|34|41306203|Male|All other|2020
0-19|0.3|0.4|0.4|Malignant|148|41306203|Male|All other|2020
0-19|0.1|0.1|0.1|Benign/Borderline|40|40796026|Male|All other|2021
0-19|0.4|0.5|0.4|Malignant|176|40796026|Male|All other|2021
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Anaplastic astrocytoma|2004
0-19|0.0|0.1|0.1|Malignant|24|41889233|Male|Anaplastic astrocytoma|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Anaplastic astrocytoma|2005
0-19|0.1|0.1|0.1|Malignant|36|42006384|Male|Anaplastic astrocytoma|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Anaplastic astrocytoma|2006
0-19|0.1|0.1|0.1|Malignant|36|42158997|Male|Anaplastic astrocytoma|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Anaplastic astrocytoma|2007
0-19|0.1|0.2|0.1|Malignant|56|42367071|Male|Anaplastic astrocytoma|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Anaplastic astrocytoma|2008
0-19|0.1|0.1|0.1|Malignant|42|42541971|Male|Anaplastic astrocytoma|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Anaplastic astrocytoma|2009
0-19|0.1|0.1|0.1|Malignant|40|42609915|Male|Anaplastic astrocytoma|2009
0-19|~|~|~|Benign/Borderline|~|42569785|Male|Anaplastic astrocytoma|2010
0-19|0.1|0.1|0.1|Malignant|44|42569785|Male|Anaplastic astrocytoma|2010
0-19|~|~|~|Benign/Borderline|~|42470382|Male|Anaplastic astrocytoma|2011
0-19|0.1|0.1|0.1|Malignant|33|42470382|Male|Anaplastic astrocytoma|2011
0-19|~|~|~|Benign/Borderline|~|42360866|Male|Anaplastic astrocytoma|2012
0-19|0.1|0.1|0.1|Malignant|44|42360866|Male|Anaplastic astrocytoma|2012
0-19|~|~|~|Benign/Borderline|~|42299716|Male|Anaplastic astrocytoma|2013
0-19|0.1|0.1|0.1|Malignant|45|42299716|Male|Anaplastic astrocytoma|2013
0-19|~|~|~|Benign/Borderline|~|42297680|Male|Anaplastic astrocytoma|2014
0-19|0.1|0.2|0.1|Malignant|57|42297680|Male|Anaplastic astrocytoma|2014
0-19|~|~|~|Benign/Borderline|~|42356807|Male|Anaplastic astrocytoma|2015
0-19|0.1|0.1|0.1|Malignant|46|42356807|Male|Anaplastic astrocytoma|2015
0-19|~|~|~|Benign/Borderline|~|42451872|Male|Anaplastic astrocytoma|2016
0-19|0.1|0.1|0.1|Malignant|44|42451872|Male|Anaplastic astrocytoma|2016
0-19|~|~|~|Benign/Borderline|~|42510556|Male|Anaplastic astrocytoma|2017
0-19|0.1|0.1|0.1|Malignant|33|42510556|Male|Anaplastic astrocytoma|2017
0-19|~|~|~|Benign/Borderline|~|206836549|Male|Anaplastic astrocytoma|2017-2021
0-19|0.1|0.1|0.1|Malignant|149|206836549|Male|Anaplastic astrocytoma|2017-2021
0-19|~|~|~|Benign/Borderline|~|42511405|Male|Anaplastic astrocytoma|2018
0-19|0.1|0.1|0.1|Malignant|38|42511405|Male|Anaplastic astrocytoma|2018
0-19|~|~|~|Benign/Borderline|~|42449660|Male|Anaplastic astrocytoma|2019
0-19|0.1|0.1|0.1|Malignant|37|42449660|Male|Anaplastic astrocytoma|2019
0-19|~|~|~|Benign/Borderline|~|41306203|Male|Anaplastic astrocytoma|2020
0-19|0.0|0.1|0.1|Malignant|25|41306203|Male|Anaplastic astrocytoma|2020
0-19|~|~|~|Benign/Borderline|~|40796026|Male|Anaplastic astrocytoma|2021
0-19|0.0|0.1|0.0|Malignant|17|40796026|Male|Anaplastic astrocytoma|2021
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Anaplastic oligodendroglioma|2004
0-19|~|~|~|Malignant|~|41889233|Male|Anaplastic oligodendroglioma|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Anaplastic oligodendroglioma|2005
0-19|~|~|~|Malignant|~|42006384|Male|Anaplastic oligodendroglioma|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Anaplastic oligodendroglioma|2006
0-19|~|~|~|Malignant|~|42158997|Male|Anaplastic oligodendroglioma|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Anaplastic oligodendroglioma|2007
0-19|~|~|~|Malignant|~|42367071|Male|Anaplastic oligodendroglioma|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Anaplastic oligodendroglioma|2008
0-19|~|~|~|Malignant|~|42541971|Male|Anaplastic oligodendroglioma|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Anaplastic oligodendroglioma|2009
0-19|~|~|~|Malignant|~|42609915|Male|Anaplastic oligodendroglioma|2009
0-19|~|~|~|Benign/Borderline|~|42569785|Male|Anaplastic oligodendroglioma|2010
0-19|~|~|~|Malignant|~|42569785|Male|Anaplastic oligodendroglioma|2010
0-19|~|~|~|Benign/Borderline|~|42470382|Male|Anaplastic oligodendroglioma|2011
0-19|~|~|~|Malignant|~|42470382|Male|Anaplastic oligodendroglioma|2011
0-19|~|~|~|Benign/Borderline|~|42360866|Male|Anaplastic oligodendroglioma|2012
0-19|~|~|~|Malignant|~|42360866|Male|Anaplastic oligodendroglioma|2012
0-19|~|~|~|Benign/Borderline|~|42299716|Male|Anaplastic oligodendroglioma|2013
0-19|~|~|~|Malignant|~|42299716|Male|Anaplastic oligodendroglioma|2013
0-19|~|~|~|Benign/Borderline|~|42297680|Male|Anaplastic oligodendroglioma|2014
0-19|~|~|~|Malignant|~|42297680|Male|Anaplastic oligodendroglioma|2014
0-19|~|~|~|Benign/Borderline|~|42356807|Male|Anaplastic oligodendroglioma|2015
0-19|~|~|~|Malignant|~|42356807|Male|Anaplastic oligodendroglioma|2015
0-19|~|~|~|Benign/Borderline|~|42451872|Male|Anaplastic oligodendroglioma|2016
0-19|~|~|~|Malignant|~|42451872|Male|Anaplastic oligodendroglioma|2016
0-19|~|~|~|Benign/Borderline|~|42510556|Male|Anaplastic oligodendroglioma|2017
0-19|~|~|~|Malignant|~|42510556|Male|Anaplastic oligodendroglioma|2017
0-19|~|~|~|Benign/Borderline|~|206836549|Male|Anaplastic oligodendroglioma|2017-2021
0-19|~|~|~|Malignant|~|206836549|Male|Anaplastic oligodendroglioma|2017-2021
0-19|~|~|~|Benign/Borderline|~|42511405|Male|Anaplastic oligodendroglioma|2018
0-19|~|~|~|Malignant|~|42511405|Male|Anaplastic oligodendroglioma|2018
0-19|~|~|~|Benign/Borderline|~|42449660|Male|Anaplastic oligodendroglioma|2019
0-19|~|~|~|Malignant|~|42449660|Male|Anaplastic oligodendroglioma|2019
0-19|~|~|~|Benign/Borderline|~|41306203|Male|Anaplastic oligodendroglioma|2020
0-19|~|~|~|Malignant|~|41306203|Male|Anaplastic oligodendroglioma|2020
0-19|~|~|~|Benign/Borderline|~|40796026|Male|Anaplastic oligodendroglioma|2021
0-19|~|~|~|Malignant|~|40796026|Male|Anaplastic oligodendroglioma|2021
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Astrocytoma, NOS|2004
0-19|0.2|0.3|0.3|Malignant|108|41889233|Male|Astrocytoma, NOS|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Astrocytoma, NOS|2005
0-19|0.2|0.3|0.2|Malignant|97|42006384|Male|Astrocytoma, NOS|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Astrocytoma, NOS|2006
0-19|0.2|0.3|0.3|Malignant|108|42158997|Male|Astrocytoma, NOS|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Astrocytoma, NOS|2007
0-19|0.2|0.3|0.2|Malignant|98|42367071|Male|Astrocytoma, NOS|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Astrocytoma, NOS|2008
0-19|0.2|0.3|0.2|Malignant|95|42541971|Male|Astrocytoma, NOS|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Astrocytoma, NOS|2009
0-19|0.2|0.3|0.3|Malignant|107|42609915|Male|Astrocytoma, NOS|2009
0-19|~|~|~|Benign/Borderline|~|42569785|Male|Astrocytoma, NOS|2010
0-19|0.2|0.3|0.3|Malignant|121|42569785|Male|Astrocytoma, NOS|2010
0-19|~|~|~|Benign/Borderline|~|42470382|Male|Astrocytoma, NOS|2011
0-19|0.2|0.3|0.2|Malignant|102|42470382|Male|Astrocytoma, NOS|2011
0-19|~|~|~|Benign/Borderline|~|42360866|Male|Astrocytoma, NOS|2012
0-19|0.2|0.2|0.2|Malignant|81|42360866|Male|Astrocytoma, NOS|2012
0-19|~|~|~|Benign/Borderline|~|42299716|Male|Astrocytoma, NOS|2013
0-19|0.2|0.3|0.2|Malignant|92|42299716|Male|Astrocytoma, NOS|2013
0-19|~|~|~|Benign/Borderline|~|42297680|Male|Astrocytoma, NOS|2014
0-19|0.2|0.3|0.3|Malignant|113|42297680|Male|Astrocytoma, NOS|2014
0-19|~|~|~|Benign/Borderline|~|42356807|Male|Astrocytoma, NOS|2015
0-19|0.2|0.3|0.2|Malignant|94|42356807|Male|Astrocytoma, NOS|2015
0-19|~|~|~|Benign/Borderline|~|42451872|Male|Astrocytoma, NOS|2016
0-19|0.2|0.3|0.2|Malignant|93|42451872|Male|Astrocytoma, NOS|2016
0-19|~|~|~|Benign/Borderline|~|42510556|Male|Astrocytoma, NOS|2017
0-19|0.2|0.3|0.2|Malignant|106|42510556|Male|Astrocytoma, NOS|2017
0-19|~|~|~|Benign/Borderline|~|206836549|Male|Astrocytoma, NOS|2017-2021
0-19|0.2|0.2|0.2|Malignant|380|206836549|Male|Astrocytoma, NOS|2017-2021
0-19|~|~|~|Benign/Borderline|~|42511405|Male|Astrocytoma, NOS|2018
0-19|0.2|0.3|0.2|Malignant|93|42511405|Male|Astrocytoma, NOS|2018
0-19|~|~|~|Benign/Borderline|~|42449660|Male|Astrocytoma, NOS|2019
0-19|0.1|0.2|0.2|Malignant|75|42449660|Male|Astrocytoma, NOS|2019
0-19|~|~|~|Benign/Borderline|~|41306203|Male|Astrocytoma, NOS|2020
0-19|0.1|0.1|0.1|Malignant|46|41306203|Male|Astrocytoma, NOS|2020
0-19|~|~|~|Benign/Borderline|~|40796026|Male|Astrocytoma, NOS|2021
0-19|0.1|0.2|0.2|Malignant|67|40796026|Male|Astrocytoma, NOS|2021
0-19|0.0|0.1|0.1|Benign/Borderline|27|41889233|Male|Choroid plexus|2004
0-19|~|~|~|Malignant|~|41889233|Male|Choroid plexus|2004
0-19|0.1|0.1|0.1|Benign/Borderline|34|42006384|Male|Choroid plexus|2005
0-19|~|~|~|Malignant|~|42006384|Male|Choroid plexus|2005
0-19|0.1|0.1|0.1|Benign/Borderline|40|42158997|Male|Choroid plexus|2006
0-19|~|~|~|Malignant|~|42158997|Male|Choroid plexus|2006
0-19|0.1|0.1|0.1|Benign/Borderline|35|42367071|Male|Choroid plexus|2007
0-19|~|~|~|Malignant|~|42367071|Male|Choroid plexus|2007
0-19|0.1|0.1|0.1|Benign/Borderline|37|42541971|Male|Choroid plexus|2008
0-19|~|~|~|Malignant|~|42541971|Male|Choroid plexus|2008
0-19|0.1|0.1|0.1|Benign/Borderline|38|42609915|Male|Choroid plexus|2009
0-19|~|~|~|Malignant|~|42609915|Male|Choroid plexus|2009
0-19|0.1|0.1|0.1|Benign/Borderline|40|42569785|Male|Choroid plexus|2010
0-19|0.0|0.1|0.0|Malignant|17|42569785|Male|Choroid plexus|2010
0-19|0.1|0.1|0.1|Benign/Borderline|34|42470382|Male|Choroid plexus|2011
0-19|~|~|~|Malignant|~|42470382|Male|Choroid plexus|2011
0-19|0.1|0.1|0.1|Benign/Borderline|36|42360866|Male|Choroid plexus|2012
0-19|~|~|~|Malignant|~|42360866|Male|Choroid plexus|2012
0-19|0.1|0.1|0.1|Benign/Borderline|38|42299716|Male|Choroid plexus|2013
0-19|~|~|~|Malignant|~|42299716|Male|Choroid plexus|2013
0-19|0.1|0.1|0.1|Benign/Borderline|36|42297680|Male|Choroid plexus|2014
0-19|~|~|~|Malignant|~|42297680|Male|Choroid plexus|2014
0-19|0.1|0.1|0.1|Benign/Borderline|35|42356807|Male|Choroid plexus|2015
0-19|0.0|0.1|0.0|Malignant|18|42356807|Male|Choroid plexus|2015
0-19|0.1|0.1|0.1|Benign/Borderline|37|42451872|Male|Choroid plexus|2016
0-19|~|~|~|Malignant|~|42451872|Male|Choroid plexus|2016
0-19|0.1|0.1|0.1|Benign/Borderline|31|42510556|Male|Choroid plexus|2017
0-19|~|~|~|Malignant|~|42510556|Male|Choroid plexus|2017
0-19|0.1|0.1|0.1|Benign/Borderline|157|206836549|Male|Choroid plexus|2017-2021
0-19|0.0|0.0|0.0|Malignant|50|206836549|Male|Choroid plexus|2017-2021
0-19|0.1|0.1|0.1|Benign/Borderline|41|42511405|Male|Choroid plexus|2018
0-19|~|~|~|Malignant|~|42511405|Male|Choroid plexus|2018
0-19|0.1|0.1|0.1|Benign/Borderline|33|42449660|Male|Choroid plexus|2019
0-19|0.0|0.1|0.0|Malignant|16|42449660|Male|Choroid plexus|2019
0-19|0.0|0.1|0.1|Benign/Borderline|29|41306203|Male|Choroid plexus|2020
0-19|~|~|~|Malignant|~|41306203|Male|Choroid plexus|2020
0-19|0.0|0.1|0.1|Benign/Borderline|26|40796026|Male|Choroid plexus|2021
0-19|~|~|~|Malignant|~|40796026|Male|Choroid plexus|2021
0-19|0.2|0.3|0.2|Benign/Borderline|85|41889233|Male|Craniopharyngioma|2004
0-19|~|~|~|Malignant|~|41889233|Male|Craniopharyngioma|2004
0-19|0.2|0.3|0.2|Benign/Borderline|94|42006384|Male|Craniopharyngioma|2005
0-19|~|~|~|Malignant|~|42006384|Male|Craniopharyngioma|2005
0-19|0.2|0.2|0.2|Benign/Borderline|81|42158997|Male|Craniopharyngioma|2006
0-19|~|~|~|Malignant|~|42158997|Male|Craniopharyngioma|2006
0-19|0.2|0.3|0.2|Benign/Borderline|89|42367071|Male|Craniopharyngioma|2007
0-19|~|~|~|Malignant|~|42367071|Male|Craniopharyngioma|2007
0-19|0.2|0.3|0.2|Benign/Borderline|96|42541971|Male|Craniopharyngioma|2008
0-19|~|~|~|Malignant|~|42541971|Male|Craniopharyngioma|2008
0-19|0.2|0.2|0.2|Benign/Borderline|83|42609915|Male|Craniopharyngioma|2009
0-19|~|~|~|Malignant|~|42609915|Male|Craniopharyngioma|2009
0-19|0.2|0.2|0.2|Benign/Borderline|84|42569785|Male|Craniopharyngioma|2010
0-19|~|~|~|Malignant|~|42569785|Male|Craniopharyngioma|2010
0-19|0.1|0.2|0.2|Benign/Borderline|70|42470382|Male|Craniopharyngioma|2011
0-19|~|~|~|Malignant|~|42470382|Male|Craniopharyngioma|2011
0-19|0.1|0.2|0.2|Benign/Borderline|79|42360866|Male|Craniopharyngioma|2012
0-19|~|~|~|Malignant|~|42360866|Male|Craniopharyngioma|2012
0-19|0.2|0.3|0.2|Benign/Borderline|93|42299716|Male|Craniopharyngioma|2013
0-19|~|~|~|Malignant|~|42299716|Male|Craniopharyngioma|2013
0-19|0.2|0.3|0.3|Benign/Borderline|107|42297680|Male|Craniopharyngioma|2014
0-19|~|~|~|Malignant|~|42297680|Male|Craniopharyngioma|2014
0-19|0.2|0.3|0.2|Benign/Borderline|98|42356807|Male|Craniopharyngioma|2015
0-19|~|~|~|Malignant|~|42356807|Male|Craniopharyngioma|2015
0-19|0.1|0.2|0.2|Benign/Borderline|79|42451872|Male|Craniopharyngioma|2016
0-19|~|~|~|Malignant|~|42451872|Male|Craniopharyngioma|2016
0-19|0.2|0.3|0.2|Benign/Borderline|103|42510556|Male|Craniopharyngioma|2017
0-19|~|~|~|Malignant|~|42510556|Male|Craniopharyngioma|2017
0-19|0.2|0.2|0.2|Benign/Borderline|426|206836549|Male|Craniopharyngioma|2017-2021
0-19|~|~|~|Malignant|~|206836549|Male|Craniopharyngioma|2017-2021
0-19|0.2|0.3|0.2|Benign/Borderline|102|42511405|Male|Craniopharyngioma|2018
0-19|~|~|~|Malignant|~|42511405|Male|Craniopharyngioma|2018
0-19|0.1|0.2|0.2|Benign/Borderline|79|42449660|Male|Craniopharyngioma|2019
0-19|~|~|~|Malignant|~|42449660|Male|Craniopharyngioma|2019
0-19|0.1|0.2|0.1|Benign/Borderline|52|41306203|Male|Craniopharyngioma|2020
0-19|~|~|~|Malignant|~|41306203|Male|Craniopharyngioma|2020
0-19|0.2|0.3|0.2|Benign/Borderline|99|40796026|Male|Craniopharyngioma|2021
0-19|~|~|~|Malignant|~|40796026|Male|Craniopharyngioma|2021
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Diffuse astrocytoma|2004
0-19|0.0|0.1|0.1|Malignant|24|41889233|Male|Diffuse astrocytoma|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Diffuse astrocytoma|2005
0-19|0.0|0.1|0.1|Malignant|23|42006384|Male|Diffuse astrocytoma|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Diffuse astrocytoma|2006
0-19|0.0|0.1|0.0|Malignant|18|42158997|Male|Diffuse astrocytoma|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Diffuse astrocytoma|2007
0-19|0.0|0.1|0.1|Malignant|25|42367071|Male|Diffuse astrocytoma|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Diffuse astrocytoma|2008
0-19|0.0|0.1|0.1|Malignant|23|42541971|Male|Diffuse astrocytoma|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Diffuse astrocytoma|2009
0-19|0.0|0.1|0.0|Malignant|20|42609915|Male|Diffuse astrocytoma|2009
0-19|~|~|~|Benign/Borderline|~|42569785|Male|Diffuse astrocytoma|2010
0-19|~|~|~|Malignant|~|42569785|Male|Diffuse astrocytoma|2010
0-19|~|~|~|Benign/Borderline|~|42470382|Male|Diffuse astrocytoma|2011
0-19|0.0|0.1|0.1|Malignant|24|42470382|Male|Diffuse astrocytoma|2011
0-19|~|~|~|Benign/Borderline|~|42360866|Male|Diffuse astrocytoma|2012
0-19|0.0|0.1|0.0|Malignant|19|42360866|Male|Diffuse astrocytoma|2012
0-19|~|~|~|Benign/Borderline|~|42299716|Male|Diffuse astrocytoma|2013
0-19|~|~|~|Malignant|~|42299716|Male|Diffuse astrocytoma|2013
0-19|~|~|~|Benign/Borderline|~|42297680|Male|Diffuse astrocytoma|2014
0-19|~|~|~|Malignant|~|42297680|Male|Diffuse astrocytoma|2014
0-19|~|~|~|Benign/Borderline|~|42356807|Male|Diffuse astrocytoma|2015
0-19|~|~|~|Malignant|~|42356807|Male|Diffuse astrocytoma|2015
0-19|~|~|~|Benign/Borderline|~|42451872|Male|Diffuse astrocytoma|2016
0-19|~|~|~|Malignant|~|42451872|Male|Diffuse astrocytoma|2016
0-19|~|~|~|Benign/Borderline|~|42510556|Male|Diffuse astrocytoma|2017
0-19|~|~|~|Malignant|~|42510556|Male|Diffuse astrocytoma|2017
0-19|~|~|~|Benign/Borderline|~|206836549|Male|Diffuse astrocytoma|2017-2021
0-19|~|~|~|Malignant|~|206836549|Male|Diffuse astrocytoma|2017-2021
0-19|~|~|~|Benign/Borderline|~|42511405|Male|Diffuse astrocytoma|2018
0-19|~|~|~|Malignant|~|42511405|Male|Diffuse astrocytoma|2018
0-19|~|~|~|Benign/Borderline|~|42449660|Male|Diffuse astrocytoma|2019
0-19|~|~|~|Malignant|~|42449660|Male|Diffuse astrocytoma|2019
0-19|~|~|~|Benign/Borderline|~|41306203|Male|Diffuse astrocytoma|2020
0-19|~|~|~|Malignant|~|41306203|Male|Diffuse astrocytoma|2020
0-19|~|~|~|Benign/Borderline|~|40796026|Male|Diffuse astrocytoma|2021
0-19|~|~|~|Malignant|~|40796026|Male|Diffuse astrocytoma|2021
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Embryonal/primitive/medulloblastoma|2004
0-19|0.6|0.8|0.7|Malignant|294|41889233|Male|Embryonal/primitive/medulloblastoma|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Embryonal/primitive/medulloblastoma|2005
0-19|0.6|0.8|0.7|Malignant|277|42006384|Male|Embryonal/primitive/medulloblastoma|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Embryonal/primitive/medulloblastoma|2006
0-19|0.6|0.8|0.7|Malignant|297|42158997|Male|Embryonal/primitive/medulloblastoma|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Embryonal/primitive/medulloblastoma|2007
0-19|0.6|0.8|0.7|Malignant|296|42367071|Male|Embryonal/primitive/medulloblastoma|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Embryonal/primitive/medulloblastoma|2008
0-19|0.7|0.9|0.8|Malignant|322|42541971|Male|Embryonal/primitive/medulloblastoma|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Embryonal/primitive/medulloblastoma|2009
0-19|0.7|0.8|0.7|Malignant|311|42609915|Male|Embryonal/primitive/medulloblastoma|2009
0-19|~|~|~|Benign/Borderline|~|42569785|Male|Embryonal/primitive/medulloblastoma|2010
0-19|0.7|0.8|0.7|Malignant|315|42569785|Male|Embryonal/primitive/medulloblastoma|2010
0-19|~|~|~|Benign/Borderline|~|42470382|Male|Embryonal/primitive/medulloblastoma|2011
0-19|0.6|0.8|0.7|Malignant|302|42470382|Male|Embryonal/primitive/medulloblastoma|2011
0-19|~|~|~|Benign/Borderline|~|42360866|Male|Embryonal/primitive/medulloblastoma|2012
0-19|0.6|0.8|0.7|Malignant|286|42360866|Male|Embryonal/primitive/medulloblastoma|2012
0-19|~|~|~|Benign/Borderline|~|42299716|Male|Embryonal/primitive/medulloblastoma|2013
0-19|0.6|0.7|0.7|Malignant|273|42299716|Male|Embryonal/primitive/medulloblastoma|2013
0-19|~|~|~|Benign/Borderline|~|42297680|Male|Embryonal/primitive/medulloblastoma|2014
0-19|0.6|0.8|0.7|Malignant|280|42297680|Male|Embryonal/primitive/medulloblastoma|2014
0-19|~|~|~|Benign/Borderline|~|42356807|Male|Embryonal/primitive/medulloblastoma|2015
0-19|0.6|0.8|0.7|Malignant|299|42356807|Male|Embryonal/primitive/medulloblastoma|2015
0-19|~|~|~|Benign/Borderline|~|42451872|Male|Embryonal/primitive/medulloblastoma|2016
0-19|0.6|0.8|0.7|Malignant|288|42451872|Male|Embryonal/primitive/medulloblastoma|2016
0-19|~|~|~|Benign/Borderline|~|42510556|Male|Embryonal/primitive/medulloblastoma|2017
0-19|0.6|0.8|0.7|Malignant|303|42510556|Male|Embryonal/primitive/medulloblastoma|2017
0-19|~|~|~|Benign/Borderline|~|206836549|Male|Embryonal/primitive/medulloblastoma|2017-2021
0-19|0.5|0.5|0.5|Malignant|1031|206836549|Male|Embryonal/primitive/medulloblastoma|2017-2021
0-19|~|~|~|Benign/Borderline|~|42511405|Male|Embryonal/primitive/medulloblastoma|2018
0-19|0.4|0.6|0.5|Malignant|203|42511405|Male|Embryonal/primitive/medulloblastoma|2018
0-19|~|~|~|Benign/Borderline|~|42449660|Male|Embryonal/primitive/medulloblastoma|2019
0-19|0.4|0.5|0.4|Malignant|176|42449660|Male|Embryonal/primitive/medulloblastoma|2019
0-19|~|~|~|Benign/Borderline|~|41306203|Male|Embryonal/primitive/medulloblastoma|2020
0-19|0.4|0.5|0.5|Malignant|189|41306203|Male|Embryonal/primitive/medulloblastoma|2020
0-19|~|~|~|Benign/Borderline|~|40796026|Male|Embryonal/primitive/medulloblastoma|2021
0-19|0.4|0.5|0.4|Malignant|174|40796026|Male|Embryonal/primitive/medulloblastoma|2021
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Ependymoma variants|2004
0-19|~|~|~|Malignant|~|41889233|Male|Ependymoma variants|2004
0-19|0.0|0.1|0.0|Benign/Borderline|20|42006384|Male|Ependymoma variants|2005
0-19|~|~|~|Malignant|~|42006384|Male|Ependymoma variants|2005
0-19|0.0|0.1|0.1|Benign/Borderline|27|42158997|Male|Ependymoma variants|2006
0-19|~|~|~|Malignant|~|42158997|Male|Ependymoma variants|2006
0-19|0.0|0.1|0.0|Benign/Borderline|20|42367071|Male|Ependymoma variants|2007
0-19|~|~|~|Malignant|~|42367071|Male|Ependymoma variants|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Ependymoma variants|2008
0-19|~|~|~|Malignant|~|42541971|Male|Ependymoma variants|2008
0-19|0.0|0.1|0.0|Benign/Borderline|21|42609915|Male|Ependymoma variants|2009
0-19|~|~|~|Malignant|~|42609915|Male|Ependymoma variants|2009
0-19|0.0|0.1|0.1|Benign/Borderline|28|42569785|Male|Ependymoma variants|2010
0-19|~|~|~|Malignant|~|42569785|Male|Ependymoma variants|2010
0-19|0.0|0.1|0.1|Benign/Borderline|22|42470382|Male|Ependymoma variants|2011
0-19|~|~|~|Malignant|~|42470382|Male|Ependymoma variants|2011
0-19|0.0|0.1|0.0|Benign/Borderline|17|42360866|Male|Ependymoma variants|2012
0-19|~|~|~|Malignant|~|42360866|Male|Ependymoma variants|2012
0-19|0.0|0.1|0.0|Benign/Borderline|21|42299716|Male|Ependymoma variants|2013
0-19|~|~|~|Malignant|~|42299716|Male|Ependymoma variants|2013
0-19|~|~|~|Benign/Borderline|~|42297680|Male|Ependymoma variants|2014
0-19|~|~|~|Malignant|~|42297680|Male|Ependymoma variants|2014
0-19|0.0|0.1|0.0|Benign/Borderline|16|42356807|Male|Ependymoma variants|2015
0-19|~|~|~|Malignant|~|42356807|Male|Ependymoma variants|2015
0-19|0.0|0.1|0.1|Benign/Borderline|23|42451872|Male|Ependymoma variants|2016
0-19|~|~|~|Malignant|~|42451872|Male|Ependymoma variants|2016
0-19|0.0|0.1|0.0|Benign/Borderline|21|42510556|Male|Ependymoma variants|2017
0-19|~|~|~|Malignant|~|42510556|Male|Ependymoma variants|2017
0-19|0.0|0.1|0.1|Benign/Borderline|110|206836549|Male|Ependymoma variants|2017-2021
0-19|~|~|~|Malignant|~|206836549|Male|Ependymoma variants|2017-2021
0-19|0.0|0.1|0.1|Benign/Borderline|26|42511405|Male|Ependymoma variants|2018
0-19|~|~|~|Malignant|~|42511405|Male|Ependymoma variants|2018
0-19|0.0|0.1|0.1|Benign/Borderline|28|42449660|Male|Ependymoma variants|2019
0-19|~|~|~|Malignant|~|42449660|Male|Ependymoma variants|2019
0-19|0.0|0.1|0.0|Benign/Borderline|17|41306203|Male|Ependymoma variants|2020
0-19|~|~|~|Malignant|~|41306203|Male|Ependymoma variants|2020
0-19|0.0|0.1|0.0|Benign/Borderline|20|40796026|Male|Ependymoma variants|2021
0-19|~|~|~|Malignant|~|40796026|Male|Ependymoma variants|2021
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Ependymoma/anaplastic ependymoma|2004
0-19|0.2|0.3|0.2|Malignant|102|41889233|Male|Ependymoma/anaplastic ependymoma|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Ependymoma/anaplastic ependymoma|2005
0-19|0.2|0.3|0.3|Malignant|107|42006384|Male|Ependymoma/anaplastic ependymoma|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Ependymoma/anaplastic ependymoma|2006
0-19|0.2|0.3|0.3|Malignant|109|42158997|Male|Ependymoma/anaplastic ependymoma|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Ependymoma/anaplastic ependymoma|2007
0-19|0.2|0.3|0.3|Malignant|115|42367071|Male|Ependymoma/anaplastic ependymoma|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Ependymoma/anaplastic ependymoma|2008
0-19|0.2|0.3|0.2|Malignant|95|42541971|Male|Ependymoma/anaplastic ependymoma|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Ependymoma/anaplastic ependymoma|2009
0-19|0.2|0.3|0.3|Malignant|114|42609915|Male|Ependymoma/anaplastic ependymoma|2009
0-19|~|~|~|Benign/Borderline|~|42569785|Male|Ependymoma/anaplastic ependymoma|2010
0-19|0.2|0.3|0.3|Malignant|120|42569785|Male|Ependymoma/anaplastic ependymoma|2010
0-19|~|~|~|Benign/Borderline|~|42470382|Male|Ependymoma/anaplastic ependymoma|2011
0-19|0.2|0.3|0.3|Malignant|113|42470382|Male|Ependymoma/anaplastic ependymoma|2011
0-19|~|~|~|Benign/Borderline|~|42360866|Male|Ependymoma/anaplastic ependymoma|2012
0-19|0.2|0.3|0.3|Malignant|116|42360866|Male|Ependymoma/anaplastic ependymoma|2012
0-19|~|~|~|Benign/Borderline|~|42299716|Male|Ependymoma/anaplastic ependymoma|2013
0-19|0.2|0.3|0.3|Malignant|115|42299716|Male|Ependymoma/anaplastic ependymoma|2013
0-19|~|~|~|Benign/Borderline|~|42297680|Male|Ependymoma/anaplastic ependymoma|2014
0-19|0.2|0.3|0.3|Malignant|110|42297680|Male|Ependymoma/anaplastic ependymoma|2014
0-19|~|~|~|Benign/Borderline|~|42356807|Male|Ependymoma/anaplastic ependymoma|2015
0-19|0.2|0.3|0.3|Malignant|115|42356807|Male|Ependymoma/anaplastic ependymoma|2015
0-19|~|~|~|Benign/Borderline|~|42451872|Male|Ependymoma/anaplastic ependymoma|2016
0-19|0.2|0.3|0.2|Malignant|102|42451872|Male|Ependymoma/anaplastic ependymoma|2016
0-19|~|~|~|Benign/Borderline|~|42510556|Male|Ependymoma/anaplastic ependymoma|2017
0-19|0.2|0.4|0.3|Malignant|125|42510556|Male|Ependymoma/anaplastic ependymoma|2017
0-19|~|~|~|Benign/Borderline|~|206836549|Male|Ependymoma/anaplastic ependymoma|2017-2021
0-19|0.2|0.3|0.2|Malignant|484|206836549|Male|Ependymoma/anaplastic ependymoma|2017-2021
0-19|~|~|~|Benign/Borderline|~|42511405|Male|Ependymoma/anaplastic ependymoma|2018
0-19|0.2|0.3|0.2|Malignant|102|42511405|Male|Ependymoma/anaplastic ependymoma|2018
0-19|~|~|~|Benign/Borderline|~|42449660|Male|Ependymoma/anaplastic ependymoma|2019
0-19|0.2|0.3|0.2|Malignant|99|42449660|Male|Ependymoma/anaplastic ependymoma|2019
0-19|~|~|~|Benign/Borderline|~|41306203|Male|Ependymoma/anaplastic ependymoma|2020
0-19|0.2|0.3|0.2|Malignant|90|41306203|Male|Ependymoma/anaplastic ependymoma|2020
0-19|~|~|~|Benign/Borderline|~|40796026|Male|Ependymoma/anaplastic ependymoma|2021
0-19|0.1|0.2|0.2|Malignant|75|40796026|Male|Ependymoma/anaplastic ependymoma|2021
0-19|0.0|0.1|0.0|Benign/Borderline|18|41889233|Male|Germ Cell Tumors|2004
0-19|0.2|0.3|0.2|Malignant|105|41889233|Male|Germ Cell Tumors|2004
0-19|0.0|0.1|0.1|Benign/Borderline|23|42006384|Male|Germ Cell Tumors|2005
0-19|0.2|0.2|0.2|Malignant|86|42006384|Male|Germ Cell Tumors|2005
0-19|0.0|0.1|0.1|Benign/Borderline|28|42158997|Male|Germ Cell Tumors|2006
0-19|0.2|0.3|0.2|Malignant|101|42158997|Male|Germ Cell Tumors|2006
0-19|0.0|0.1|0.0|Benign/Borderline|20|42367071|Male|Germ Cell Tumors|2007
0-19|0.2|0.3|0.2|Malignant|97|42367071|Male|Germ Cell Tumors|2007
0-19|0.0|0.1|0.0|Benign/Borderline|20|42541971|Male|Germ Cell Tumors|2008
0-19|0.2|0.3|0.3|Malignant|116|42541971|Male|Germ Cell Tumors|2008
0-19|0.0|0.1|0.1|Benign/Borderline|30|42609915|Male|Germ Cell Tumors|2009
0-19|0.2|0.3|0.2|Malignant|98|42609915|Male|Germ Cell Tumors|2009
0-19|0.0|0.1|0.1|Benign/Borderline|23|42569785|Male|Germ Cell Tumors|2010
0-19|0.2|0.3|0.3|Malignant|112|42569785|Male|Germ Cell Tumors|2010
0-19|~|~|~|Benign/Borderline|~|42470382|Male|Germ Cell Tumors|2011
0-19|0.2|0.3|0.2|Malignant|101|42470382|Male|Germ Cell Tumors|2011
0-19|0.0|0.1|0.1|Benign/Borderline|25|42360866|Male|Germ Cell Tumors|2012
0-19|0.2|0.3|0.3|Malignant|110|42360866|Male|Germ Cell Tumors|2012
0-19|0.0|0.1|0.1|Benign/Borderline|26|42299716|Male|Germ Cell Tumors|2013
0-19|0.2|0.3|0.3|Malignant|111|42299716|Male|Germ Cell Tumors|2013
0-19|0.0|0.1|0.1|Benign/Borderline|27|42297680|Male|Germ Cell Tumors|2014
0-19|0.2|0.3|0.2|Malignant|103|42297680|Male|Germ Cell Tumors|2014
0-19|0.0|0.1|0.0|Benign/Borderline|20|42356807|Male|Germ Cell Tumors|2015
0-19|0.2|0.3|0.2|Malignant|106|42356807|Male|Germ Cell Tumors|2015
0-19|0.1|0.1|0.1|Benign/Borderline|34|42451872|Male|Germ Cell Tumors|2016
0-19|0.2|0.3|0.3|Malignant|111|42451872|Male|Germ Cell Tumors|2016
0-19|0.0|0.1|0.1|Benign/Borderline|25|42510556|Male|Germ Cell Tumors|2017
0-19|0.3|0.4|0.3|Malignant|131|42510556|Male|Germ Cell Tumors|2017
0-19|0.0|0.1|0.1|Benign/Borderline|120|206836549|Male|Germ Cell Tumors|2017-2021
0-19|0.2|0.3|0.2|Malignant|515|206836549|Male|Germ Cell Tumors|2017-2021
0-19|0.1|0.1|0.1|Benign/Borderline|34|42511405|Male|Germ Cell Tumors|2018
0-19|0.2|0.2|0.2|Malignant|86|42511405|Male|Germ Cell Tumors|2018
0-19|0.0|0.1|0.1|Benign/Borderline|24|42449660|Male|Germ Cell Tumors|2019
0-19|0.2|0.3|0.2|Malignant|108|42449660|Male|Germ Cell Tumors|2019
0-19|~|~|~|Benign/Borderline|~|41306203|Male|Germ Cell Tumors|2020
0-19|0.2|0.3|0.2|Malignant|94|41306203|Male|Germ Cell Tumors|2020
0-19|0.0|0.1|0.1|Benign/Borderline|25|40796026|Male|Germ Cell Tumors|2021
0-19|0.2|0.3|0.2|Malignant|103|40796026|Male|Germ Cell Tumors|2021
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Glioblastoma|2004
0-19|0.1|0.2|0.2|Malignant|74|41889233|Male|Glioblastoma|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Glioblastoma|2005
0-19|0.1|0.2|0.1|Malignant|61|42006384|Male|Glioblastoma|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Glioblastoma|2006
0-19|0.1|0.2|0.2|Malignant|68|42158997|Male|Glioblastoma|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Glioblastoma|2007
0-19|0.1|0.2|0.2|Malignant|68|42367071|Male|Glioblastoma|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Glioblastoma|2008
0-19|0.1|0.2|0.2|Malignant|68|42541971|Male|Glioblastoma|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Glioblastoma|2009
0-19|0.2|0.2|0.2|Malignant|83|42609915|Male|Glioblastoma|2009
0-19|~|~|~|Benign/Borderline|~|42569785|Male|Glioblastoma|2010
0-19|0.1|0.2|0.2|Malignant|68|42569785|Male|Glioblastoma|2010
0-19|~|~|~|Benign/Borderline|~|42470382|Male|Glioblastoma|2011
0-19|0.2|0.2|0.2|Malignant|84|42470382|Male|Glioblastoma|2011
0-19|~|~|~|Benign/Borderline|~|42360866|Male|Glioblastoma|2012
0-19|0.1|0.2|0.2|Malignant|80|42360866|Male|Glioblastoma|2012
0-19|~|~|~|Benign/Borderline|~|42299716|Male|Glioblastoma|2013
0-19|0.2|0.3|0.2|Malignant|92|42299716|Male|Glioblastoma|2013
0-19|~|~|~|Benign/Borderline|~|42297680|Male|Glioblastoma|2014
0-19|0.1|0.2|0.2|Malignant|77|42297680|Male|Glioblastoma|2014
0-19|~|~|~|Benign/Borderline|~|42356807|Male|Glioblastoma|2015
0-19|0.2|0.2|0.2|Malignant|82|42356807|Male|Glioblastoma|2015
0-19|~|~|~|Benign/Borderline|~|42451872|Male|Glioblastoma|2016
0-19|0.1|0.2|0.2|Malignant|78|42451872|Male|Glioblastoma|2016
0-19|~|~|~|Benign/Borderline|~|42510556|Male|Glioblastoma|2017
0-19|0.1|0.2|0.2|Malignant|72|42510556|Male|Glioblastoma|2017
0-19|~|~|~|Benign/Borderline|~|206836549|Male|Glioblastoma|2017-2021
0-19|0.1|0.2|0.2|Malignant|334|206836549|Male|Glioblastoma|2017-2021
0-19|~|~|~|Benign/Borderline|~|42511405|Male|Glioblastoma|2018
0-19|0.1|0.2|0.2|Malignant|80|42511405|Male|Glioblastoma|2018
0-19|~|~|~|Benign/Borderline|~|42449660|Male|Glioblastoma|2019
0-19|0.1|0.2|0.2|Malignant|72|42449660|Male|Glioblastoma|2019
0-19|~|~|~|Benign/Borderline|~|41306203|Male|Glioblastoma|2020
0-19|0.1|0.2|0.1|Malignant|62|41306203|Male|Glioblastoma|2020
0-19|~|~|~|Benign/Borderline|~|40796026|Male|Glioblastoma|2021
0-19|0.1|0.2|0.1|Malignant|50|40796026|Male|Glioblastoma|2021
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Glioma malignant, NOS|2004
0-19|0.5|0.6|0.6|Malignant|230|41889233|Male|Glioma malignant, NOS|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Glioma malignant, NOS|2005
0-19|0.5|0.6|0.5|Malignant|222|42006384|Male|Glioma malignant, NOS|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Glioma malignant, NOS|2006
0-19|0.5|0.7|0.6|Malignant|243|42158997|Male|Glioma malignant, NOS|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Glioma malignant, NOS|2007
0-19|0.5|0.7|0.6|Malignant|249|42367071|Male|Glioma malignant, NOS|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Glioma malignant, NOS|2008
0-19|0.6|0.7|0.6|Malignant|272|42541971|Male|Glioma malignant, NOS|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Glioma malignant, NOS|2009
0-19|0.6|0.7|0.6|Malignant|272|42609915|Male|Glioma malignant, NOS|2009
0-19|~|~|~|Benign/Borderline|~|42569785|Male|Glioma malignant, NOS|2010
0-19|0.6|0.8|0.7|Malignant|284|42569785|Male|Glioma malignant, NOS|2010
0-19|~|~|~|Benign/Borderline|~|42470382|Male|Glioma malignant, NOS|2011
0-19|0.6|0.8|0.7|Malignant|285|42470382|Male|Glioma malignant, NOS|2011
0-19|0.0|0.1|0.0|Benign/Borderline|18|42360866|Male|Glioma malignant, NOS|2012
0-19|0.6|0.8|0.7|Malignant|289|42360866|Male|Glioma malignant, NOS|2012
0-19|0.0|0.1|0.0|Benign/Borderline|19|42299716|Male|Glioma malignant, NOS|2013
0-19|0.6|0.7|0.7|Malignant|277|42299716|Male|Glioma malignant, NOS|2013
0-19|0.0|0.1|0.1|Benign/Borderline|24|42297680|Male|Glioma malignant, NOS|2014
0-19|0.6|0.7|0.6|Malignant|266|42297680|Male|Glioma malignant, NOS|2014
0-19|0.0|0.1|0.1|Benign/Borderline|23|42356807|Male|Glioma malignant, NOS|2015
0-19|0.7|0.8|0.7|Malignant|309|42356807|Male|Glioma malignant, NOS|2015
0-19|0.0|0.1|0.1|Benign/Borderline|30|42451872|Male|Glioma malignant, NOS|2016
0-19|0.6|0.8|0.7|Malignant|304|42451872|Male|Glioma malignant, NOS|2016
0-19|0.0|0.1|0.1|Benign/Borderline|23|42510556|Male|Glioma malignant, NOS|2017
0-19|0.7|0.9|0.8|Malignant|335|42510556|Male|Glioma malignant, NOS|2017
0-19|0.0|0.1|0.0|Benign/Borderline|93|206836549|Male|Glioma malignant, NOS|2017-2021
0-19|0.6|0.6|0.6|Malignant|1223|206836549|Male|Glioma malignant, NOS|2017-2021
0-19|0.0|0.1|0.1|Benign/Borderline|30|42511405|Male|Glioma malignant, NOS|2018
0-19|0.5|0.6|0.5|Malignant|222|42511405|Male|Glioma malignant, NOS|2018
0-19|~|~|~|Benign/Borderline|~|42449660|Male|Glioma malignant, NOS|2019
0-19|0.5|0.6|0.5|Malignant|223|42449660|Male|Glioma malignant, NOS|2019
0-19|0.0|0.1|0.0|Benign/Borderline|17|41306203|Male|Glioma malignant, NOS|2020
0-19|0.5|0.6|0.5|Malignant|217|41306203|Male|Glioma malignant, NOS|2020
0-19|~|~|~|Benign/Borderline|~|40796026|Male|Glioma malignant, NOS|2021
0-19|0.5|0.7|0.6|Malignant|243|40796026|Male|Glioma malignant, NOS|2021
0-19|0.0|0.1|0.0|Benign/Borderline|17|41889233|Male|Hemangioblastoma|2004
0-19|~|~|~|Malignant|~|41889233|Male|Hemangioblastoma|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Hemangioblastoma|2005
0-19|~|~|~|Malignant|~|42006384|Male|Hemangioblastoma|2005
0-19|0.0|0.1|0.0|Benign/Borderline|17|42158997|Male|Hemangioblastoma|2006
0-19|~|~|~|Malignant|~|42158997|Male|Hemangioblastoma|2006
0-19|0.0|0.1|0.0|Benign/Borderline|20|42367071|Male|Hemangioblastoma|2007
0-19|~|~|~|Malignant|~|42367071|Male|Hemangioblastoma|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Hemangioblastoma|2008
0-19|~|~|~|Malignant|~|42541971|Male|Hemangioblastoma|2008
0-19|0.0|0.1|0.0|Benign/Borderline|16|42609915|Male|Hemangioblastoma|2009
0-19|~|~|~|Malignant|~|42609915|Male|Hemangioblastoma|2009
0-19|~|~|~|Benign/Borderline|~|42569785|Male|Hemangioblastoma|2010
0-19|~|~|~|Malignant|~|42569785|Male|Hemangioblastoma|2010
0-19|0.0|0.1|0.1|Benign/Borderline|23|42470382|Male|Hemangioblastoma|2011
0-19|~|~|~|Malignant|~|42470382|Male|Hemangioblastoma|2011
0-19|0.0|0.1|0.1|Benign/Borderline|23|42360866|Male|Hemangioblastoma|2012
0-19|~|~|~|Malignant|~|42360866|Male|Hemangioblastoma|2012
0-19|0.0|0.1|0.0|Benign/Borderline|18|42299716|Male|Hemangioblastoma|2013
0-19|~|~|~|Malignant|~|42299716|Male|Hemangioblastoma|2013
0-19|0.0|0.1|0.0|Benign/Borderline|20|42297680|Male|Hemangioblastoma|2014
0-19|~|~|~|Malignant|~|42297680|Male|Hemangioblastoma|2014
0-19|0.0|0.1|0.0|Benign/Borderline|17|42356807|Male|Hemangioblastoma|2015
0-19|~|~|~|Malignant|~|42356807|Male|Hemangioblastoma|2015
0-19|0.0|0.1|0.0|Benign/Borderline|19|42451872|Male|Hemangioblastoma|2016
0-19|~|~|~|Malignant|~|42451872|Male|Hemangioblastoma|2016
0-19|0.0|0.1|0.0|Benign/Borderline|21|42510556|Male|Hemangioblastoma|2017
0-19|~|~|~|Malignant|~|42510556|Male|Hemangioblastoma|2017
0-19|0.0|0.1|0.0|Benign/Borderline|97|206836549|Male|Hemangioblastoma|2017-2021
0-19|~|~|~|Malignant|~|206836549|Male|Hemangioblastoma|2017-2021
0-19|0.0|0.1|0.0|Benign/Borderline|19|42511405|Male|Hemangioblastoma|2018
0-19|~|~|~|Malignant|~|42511405|Male|Hemangioblastoma|2018
0-19|0.0|0.1|0.0|Benign/Borderline|22|42449660|Male|Hemangioblastoma|2019
0-19|~|~|~|Malignant|~|42449660|Male|Hemangioblastoma|2019
0-19|0.0|0.1|0.0|Benign/Borderline|18|41306203|Male|Hemangioblastoma|2020
0-19|~|~|~|Malignant|~|41306203|Male|Hemangioblastoma|2020
0-19|0.0|0.1|0.0|Benign/Borderline|19|40796026|Male|Hemangioblastoma|2021
0-19|~|~|~|Malignant|~|40796026|Male|Hemangioblastoma|2021
0-19|0.1|0.1|0.1|Benign/Borderline|33|41889233|Male|Hemangioma|2004
0-19|~|~|~|Malignant|~|41889233|Male|Hemangioma|2004
0-19|0.0|0.1|0.1|Benign/Borderline|22|42006384|Male|Hemangioma|2005
0-19|~|~|~|Malignant|~|42006384|Male|Hemangioma|2005
0-19|0.1|0.1|0.1|Benign/Borderline|40|42158997|Male|Hemangioma|2006
0-19|~|~|~|Malignant|~|42158997|Male|Hemangioma|2006
0-19|0.1|0.2|0.1|Benign/Borderline|56|42367071|Male|Hemangioma|2007
0-19|~|~|~|Malignant|~|42367071|Male|Hemangioma|2007
0-19|0.1|0.2|0.1|Benign/Borderline|49|42541971|Male|Hemangioma|2008
0-19|~|~|~|Malignant|~|42541971|Male|Hemangioma|2008
0-19|0.1|0.2|0.1|Benign/Borderline|62|42609915|Male|Hemangioma|2009
0-19|~|~|~|Malignant|~|42609915|Male|Hemangioma|2009
0-19|0.1|0.2|0.1|Benign/Borderline|57|42569785|Male|Hemangioma|2010
0-19|~|~|~|Malignant|~|42569785|Male|Hemangioma|2010
0-19|0.1|0.2|0.2|Benign/Borderline|77|42470382|Male|Hemangioma|2011
0-19|~|~|~|Malignant|~|42470382|Male|Hemangioma|2011
0-19|0.1|0.2|0.2|Benign/Borderline|66|42360866|Male|Hemangioma|2012
0-19|~|~|~|Malignant|~|42360866|Male|Hemangioma|2012
0-19|0.1|0.2|0.2|Benign/Borderline|64|42299716|Male|Hemangioma|2013
0-19|~|~|~|Malignant|~|42299716|Male|Hemangioma|2013
0-19|0.1|0.2|0.1|Benign/Borderline|62|42297680|Male|Hemangioma|2014
0-19|~|~|~|Malignant|~|42297680|Male|Hemangioma|2014
0-19|0.1|0.2|0.1|Benign/Borderline|58|42356807|Male|Hemangioma|2015
0-19|~|~|~|Malignant|~|42356807|Male|Hemangioma|2015
0-19|0.2|0.2|0.2|Benign/Borderline|86|42451872|Male|Hemangioma|2016
0-19|~|~|~|Malignant|~|42451872|Male|Hemangioma|2016
0-19|0.1|0.2|0.1|Benign/Borderline|64|42510556|Male|Hemangioma|2017
0-19|~|~|~|Malignant|~|42510556|Male|Hemangioma|2017
0-19|0.1|0.2|0.1|Benign/Borderline|285|206836549|Male|Hemangioma|2017-2021
0-19|~|~|~|Malignant|~|206836549|Male|Hemangioma|2017-2021
0-19|0.1|0.2|0.2|Benign/Borderline|67|42511405|Male|Hemangioma|2018
0-19|~|~|~|Malignant|~|42511405|Male|Hemangioma|2018
0-19|0.1|0.2|0.1|Benign/Borderline|52|42449660|Male|Hemangioma|2019
0-19|~|~|~|Malignant|~|42449660|Male|Hemangioma|2019
0-19|0.1|0.2|0.1|Benign/Borderline|50|41306203|Male|Hemangioma|2020
0-19|~|~|~|Malignant|~|41306203|Male|Hemangioma|2020
0-19|0.1|0.2|0.1|Benign/Borderline|52|40796026|Male|Hemangioma|2021
0-19|~|~|~|Malignant|~|40796026|Male|Hemangioma|2021
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Local Extensions from Regional Tumors|2004
0-19|~|~|~|Malignant|~|41889233|Male|Local Extensions from Regional Tumors|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Local Extensions from Regional Tumors|2005
0-19|~|~|~|Malignant|~|42006384|Male|Local Extensions from Regional Tumors|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Local Extensions from Regional Tumors|2006
0-19|~|~|~|Malignant|~|42158997|Male|Local Extensions from Regional Tumors|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Local Extensions from Regional Tumors|2007
0-19|~|~|~|Malignant|~|42367071|Male|Local Extensions from Regional Tumors|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Local Extensions from Regional Tumors|2008
0-19|~|~|~|Malignant|~|42541971|Male|Local Extensions from Regional Tumors|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Local Extensions from Regional Tumors|2009
0-19|~|~|~|Malignant|~|42609915|Male|Local Extensions from Regional Tumors|2009
0-19|~|~|~|Benign/Borderline|~|42569785|Male|Local Extensions from Regional Tumors|2010
0-19|~|~|~|Malignant|~|42569785|Male|Local Extensions from Regional Tumors|2010
0-19|~|~|~|Benign/Borderline|~|42470382|Male|Local Extensions from Regional Tumors|2011
0-19|~|~|~|Malignant|~|42470382|Male|Local Extensions from Regional Tumors|2011
0-19|~|~|~|Benign/Borderline|~|42360866|Male|Local Extensions from Regional Tumors|2012
0-19|~|~|~|Malignant|~|42360866|Male|Local Extensions from Regional Tumors|2012
0-19|~|~|~|Benign/Borderline|~|42299716|Male|Local Extensions from Regional Tumors|2013
0-19|~|~|~|Malignant|~|42299716|Male|Local Extensions from Regional Tumors|2013
0-19|~|~|~|Benign/Borderline|~|42297680|Male|Local Extensions from Regional Tumors|2014
0-19|~|~|~|Malignant|~|42297680|Male|Local Extensions from Regional Tumors|2014
0-19|~|~|~|Benign/Borderline|~|42356807|Male|Local Extensions from Regional Tumors|2015
0-19|~|~|~|Malignant|~|42356807|Male|Local Extensions from Regional Tumors|2015
0-19|~|~|~|Benign/Borderline|~|42451872|Male|Local Extensions from Regional Tumors|2016
0-19|~|~|~|Malignant|~|42451872|Male|Local Extensions from Regional Tumors|2016
0-19|~|~|~|Benign/Borderline|~|42510556|Male|Local Extensions from Regional Tumors|2017
0-19|~|~|~|Malignant|~|42510556|Male|Local Extensions from Regional Tumors|2017
0-19|~|~|~|Benign/Borderline|~|206836549|Male|Local Extensions from Regional Tumors|2017-2021
0-19|~|~|~|Malignant|~|206836549|Male|Local Extensions from Regional Tumors|2017-2021
0-19|~|~|~|Benign/Borderline|~|42511405|Male|Local Extensions from Regional Tumors|2018
0-19|~|~|~|Malignant|~|42511405|Male|Local Extensions from Regional Tumors|2018
0-19|~|~|~|Benign/Borderline|~|42449660|Male|Local Extensions from Regional Tumors|2019
0-19|~|~|~|Malignant|~|42449660|Male|Local Extensions from Regional Tumors|2019
0-19|~|~|~|Benign/Borderline|~|41306203|Male|Local Extensions from Regional Tumors|2020
0-19|~|~|~|Malignant|~|41306203|Male|Local Extensions from Regional Tumors|2020
0-19|~|~|~|Benign/Borderline|~|40796026|Male|Local Extensions from Regional Tumors|2021
0-19|~|~|~|Malignant|~|40796026|Male|Local Extensions from Regional Tumors|2021
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Lymphomas and Hematopoietic Neoplasms|2004
0-19|~|~|~|Malignant|~|41889233|Male|Lymphomas and Hematopoietic Neoplasms|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Lymphomas and Hematopoietic Neoplasms|2005
0-19|~|~|~|Malignant|~|42006384|Male|Lymphomas and Hematopoietic Neoplasms|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Lymphomas and Hematopoietic Neoplasms|2006
0-19|~|~|~|Malignant|~|42158997|Male|Lymphomas and Hematopoietic Neoplasms|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Lymphomas and Hematopoietic Neoplasms|2007
0-19|~|~|~|Malignant|~|42367071|Male|Lymphomas and Hematopoietic Neoplasms|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Lymphomas and Hematopoietic Neoplasms|2008
0-19|~|~|~|Malignant|~|42541971|Male|Lymphomas and Hematopoietic Neoplasms|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Lymphomas and Hematopoietic Neoplasms|2009
0-19|~|~|~|Malignant|~|42609915|Male|Lymphomas and Hematopoietic Neoplasms|2009
0-19|~|~|~|Benign/Borderline|~|42569785|Male|Lymphomas and Hematopoietic Neoplasms|2010
0-19|~|~|~|Malignant|~|42569785|Male|Lymphomas and Hematopoietic Neoplasms|2010
0-19|~|~|~|Benign/Borderline|~|42470382|Male|Lymphomas and Hematopoietic Neoplasms|2011
0-19|~|~|~|Malignant|~|42470382|Male|Lymphomas and Hematopoietic Neoplasms|2011
0-19|~|~|~|Benign/Borderline|~|42360866|Male|Lymphomas and Hematopoietic Neoplasms|2012
0-19|~|~|~|Malignant|~|42360866|Male|Lymphomas and Hematopoietic Neoplasms|2012
0-19|~|~|~|Benign/Borderline|~|42299716|Male|Lymphomas and Hematopoietic Neoplasms|2013
0-19|~|~|~|Malignant|~|42299716|Male|Lymphomas and Hematopoietic Neoplasms|2013
0-19|~|~|~|Benign/Borderline|~|42297680|Male|Lymphomas and Hematopoietic Neoplasms|2014
0-19|~|~|~|Malignant|~|42297680|Male|Lymphomas and Hematopoietic Neoplasms|2014
0-19|~|~|~|Benign/Borderline|~|42356807|Male|Lymphomas and Hematopoietic Neoplasms|2015
0-19|~|~|~|Malignant|~|42356807|Male|Lymphomas and Hematopoietic Neoplasms|2015
0-19|~|~|~|Benign/Borderline|~|42451872|Male|Lymphomas and Hematopoietic Neoplasms|2016
0-19|~|~|~|Malignant|~|42451872|Male|Lymphomas and Hematopoietic Neoplasms|2016
0-19|~|~|~|Benign/Borderline|~|42510556|Male|Lymphomas and Hematopoietic Neoplasms|2017
0-19|~|~|~|Malignant|~|42510556|Male|Lymphomas and Hematopoietic Neoplasms|2017
0-19|~|~|~|Benign/Borderline|~|206836549|Male|Lymphomas and Hematopoietic Neoplasms|2017-2021
0-19|0.0|0.0|0.0|Malignant|30|206836549|Male|Lymphomas and Hematopoietic Neoplasms|2017-2021
0-19|~|~|~|Benign/Borderline|~|42511405|Male|Lymphomas and Hematopoietic Neoplasms|2018
0-19|~|~|~|Malignant|~|42511405|Male|Lymphomas and Hematopoietic Neoplasms|2018
0-19|~|~|~|Benign/Borderline|~|42449660|Male|Lymphomas and Hematopoietic Neoplasms|2019
0-19|~|~|~|Malignant|~|42449660|Male|Lymphomas and Hematopoietic Neoplasms|2019
0-19|~|~|~|Benign/Borderline|~|41306203|Male|Lymphomas and Hematopoietic Neoplasms|2020
0-19|~|~|~|Malignant|~|41306203|Male|Lymphomas and Hematopoietic Neoplasms|2020
0-19|~|~|~|Benign/Borderline|~|40796026|Male|Lymphomas and Hematopoietic Neoplasms|2021
0-19|~|~|~|Malignant|~|40796026|Male|Lymphomas and Hematopoietic Neoplasms|2021
0-19|0.1|0.1|0.1|Benign/Borderline|47|41889233|Male|Meningioma|2004
0-19|~|~|~|Malignant|~|41889233|Male|Meningioma|2004
0-19|0.1|0.2|0.1|Benign/Borderline|53|42006384|Male|Meningioma|2005
0-19|~|~|~|Malignant|~|42006384|Male|Meningioma|2005
0-19|0.1|0.2|0.1|Benign/Borderline|51|42158997|Male|Meningioma|2006
0-19|~|~|~|Malignant|~|42158997|Male|Meningioma|2006
0-19|0.1|0.2|0.1|Benign/Borderline|53|42367071|Male|Meningioma|2007
0-19|~|~|~|Malignant|~|42367071|Male|Meningioma|2007
0-19|0.1|0.2|0.1|Benign/Borderline|56|42541971|Male|Meningioma|2008
0-19|~|~|~|Malignant|~|42541971|Male|Meningioma|2008
0-19|0.1|0.2|0.1|Benign/Borderline|64|42609915|Male|Meningioma|2009
0-19|~|~|~|Malignant|~|42609915|Male|Meningioma|2009
0-19|0.1|0.2|0.1|Benign/Borderline|54|42569785|Male|Meningioma|2010
0-19|~|~|~|Malignant|~|42569785|Male|Meningioma|2010
0-19|0.1|0.2|0.1|Benign/Borderline|64|42470382|Male|Meningioma|2011
0-19|~|~|~|Malignant|~|42470382|Male|Meningioma|2011
0-19|0.1|0.2|0.1|Benign/Borderline|63|42360866|Male|Meningioma|2012
0-19|~|~|~|Malignant|~|42360866|Male|Meningioma|2012
0-19|0.1|0.2|0.1|Benign/Borderline|57|42299716|Male|Meningioma|2013
0-19|~|~|~|Malignant|~|42299716|Male|Meningioma|2013
0-19|0.1|0.2|0.1|Benign/Borderline|60|42297680|Male|Meningioma|2014
0-19|~|~|~|Malignant|~|42297680|Male|Meningioma|2014
0-19|0.1|0.2|0.2|Benign/Borderline|71|42356807|Male|Meningioma|2015
0-19|~|~|~|Malignant|~|42356807|Male|Meningioma|2015
0-19|0.1|0.1|0.1|Benign/Borderline|48|42451872|Male|Meningioma|2016
0-19|~|~|~|Malignant|~|42451872|Male|Meningioma|2016
0-19|0.1|0.2|0.1|Benign/Borderline|64|42510556|Male|Meningioma|2017
0-19|~|~|~|Malignant|~|42510556|Male|Meningioma|2017
0-19|0.1|0.2|0.1|Benign/Borderline|309|206836549|Male|Meningioma|2017-2021
0-19|~|~|~|Malignant|~|206836549|Male|Meningioma|2017-2021
0-19|0.2|0.2|0.2|Benign/Borderline|85|42511405|Male|Meningioma|2018
0-19|~|~|~|Malignant|~|42511405|Male|Meningioma|2018
0-19|0.1|0.2|0.1|Benign/Borderline|56|42449660|Male|Meningioma|2019
0-19|~|~|~|Malignant|~|42449660|Male|Meningioma|2019
0-19|0.1|0.2|0.2|Benign/Borderline|65|41306203|Male|Meningioma|2020
0-19|~|~|~|Malignant|~|41306203|Male|Meningioma|2020
0-19|0.1|0.1|0.1|Benign/Borderline|41|40796026|Male|Meningioma|2021
0-19|~|~|~|Malignant|~|40796026|Male|Meningioma|2021
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Mixed glioma|2004
0-19|~|~|~|Malignant|~|41889233|Male|Mixed glioma|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Mixed glioma|2005
0-19|~|~|~|Malignant|~|42006384|Male|Mixed glioma|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Mixed glioma|2006
0-19|~|~|~|Malignant|~|42158997|Male|Mixed glioma|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Mixed glioma|2007
0-19|0.0|0.1|0.0|Malignant|16|42367071|Male|Mixed glioma|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Mixed glioma|2008
0-19|~|~|~|Malignant|~|42541971|Male|Mixed glioma|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Mixed glioma|2009
0-19|~|~|~|Malignant|~|42609915|Male|Mixed glioma|2009
0-19|~|~|~|Benign/Borderline|~|42569785|Male|Mixed glioma|2010
0-19|0.0|0.1|0.0|Malignant|19|42569785|Male|Mixed glioma|2010
0-19|~|~|~|Benign/Borderline|~|42470382|Male|Mixed glioma|2011
0-19|~|~|~|Malignant|~|42470382|Male|Mixed glioma|2011
0-19|~|~|~|Benign/Borderline|~|42360866|Male|Mixed glioma|2012
0-19|~|~|~|Malignant|~|42360866|Male|Mixed glioma|2012
0-19|~|~|~|Benign/Borderline|~|42299716|Male|Mixed glioma|2013
0-19|~|~|~|Malignant|~|42299716|Male|Mixed glioma|2013
0-19|~|~|~|Benign/Borderline|~|42297680|Male|Mixed glioma|2014
0-19|~|~|~|Malignant|~|42297680|Male|Mixed glioma|2014
0-19|~|~|~|Benign/Borderline|~|42356807|Male|Mixed glioma|2015
0-19|~|~|~|Malignant|~|42356807|Male|Mixed glioma|2015
0-19|~|~|~|Benign/Borderline|~|42451872|Male|Mixed glioma|2016
0-19|~|~|~|Malignant|~|42451872|Male|Mixed glioma|2016
0-19|~|~|~|Benign/Borderline|~|42510556|Male|Mixed glioma|2017
0-19|~|~|~|Malignant|~|42510556|Male|Mixed glioma|2017
0-19|~|~|~|Benign/Borderline|~|206836549|Male|Mixed glioma|2017-2021
0-19|~|~|~|Malignant|~|206836549|Male|Mixed glioma|2017-2021
0-19|~|~|~|Benign/Borderline|~|42511405|Male|Mixed glioma|2018
0-19|~|~|~|Malignant|~|42511405|Male|Mixed glioma|2018
0-19|~|~|~|Benign/Borderline|~|42449660|Male|Mixed glioma|2019
0-19|~|~|~|Malignant|~|42449660|Male|Mixed glioma|2019
0-19|~|~|~|Benign/Borderline|~|41306203|Male|Mixed glioma|2020
0-19|~|~|~|Malignant|~|41306203|Male|Mixed glioma|2020
0-19|~|~|~|Benign/Borderline|~|40796026|Male|Mixed glioma|2021
0-19|~|~|~|Malignant|~|40796026|Male|Mixed glioma|2021
0-19|0.1|0.1|0.1|Benign/Borderline|31|41889233|Male|Neoplasm, unspecified|2004
0-19|0.0|0.1|0.0|Malignant|16|41889233|Male|Neoplasm, unspecified|2004
0-19|0.1|0.2|0.1|Benign/Borderline|59|42006384|Male|Neoplasm, unspecified|2005
0-19|0.0|0.1|0.0|Malignant|19|42006384|Male|Neoplasm, unspecified|2005
0-19|0.1|0.2|0.1|Benign/Borderline|54|42158997|Male|Neoplasm, unspecified|2006
0-19|0.0|0.1|0.1|Malignant|24|42158997|Male|Neoplasm, unspecified|2006
0-19|0.1|0.2|0.2|Benign/Borderline|65|42367071|Male|Neoplasm, unspecified|2007
0-19|0.0|0.1|0.0|Malignant|21|42367071|Male|Neoplasm, unspecified|2007
0-19|0.1|0.2|0.1|Benign/Borderline|50|42541971|Male|Neoplasm, unspecified|2008
0-19|0.0|0.1|0.0|Malignant|18|42541971|Male|Neoplasm, unspecified|2008
0-19|0.2|0.3|0.2|Benign/Borderline|90|42609915|Male|Neoplasm, unspecified|2009
0-19|0.0|0.1|0.1|Malignant|22|42609915|Male|Neoplasm, unspecified|2009
0-19|0.1|0.2|0.2|Benign/Borderline|80|42569785|Male|Neoplasm, unspecified|2010
0-19|0.0|0.1|0.0|Malignant|17|42569785|Male|Neoplasm, unspecified|2010
0-19|0.1|0.2|0.2|Benign/Borderline|73|42470382|Male|Neoplasm, unspecified|2011
0-19|~|~|~|Malignant|~|42470382|Male|Neoplasm, unspecified|2011
0-19|0.1|0.2|0.1|Benign/Borderline|62|42360866|Male|Neoplasm, unspecified|2012
0-19|0.0|0.1|0.1|Malignant|28|42360866|Male|Neoplasm, unspecified|2012
0-19|0.1|0.2|0.2|Benign/Borderline|71|42299716|Male|Neoplasm, unspecified|2013
0-19|0.0|0.1|0.0|Malignant|19|42299716|Male|Neoplasm, unspecified|2013
0-19|0.1|0.2|0.2|Benign/Borderline|72|42297680|Male|Neoplasm, unspecified|2014
0-19|0.0|0.1|0.1|Malignant|23|42297680|Male|Neoplasm, unspecified|2014
0-19|0.1|0.2|0.1|Benign/Borderline|63|42356807|Male|Neoplasm, unspecified|2015
0-19|0.0|0.1|0.0|Malignant|20|42356807|Male|Neoplasm, unspecified|2015
0-19|0.1|0.2|0.2|Benign/Borderline|69|42451872|Male|Neoplasm, unspecified|2016
0-19|0.0|0.1|0.1|Malignant|22|42451872|Male|Neoplasm, unspecified|2016
0-19|0.1|0.2|0.2|Benign/Borderline|70|42510556|Male|Neoplasm, unspecified|2017
0-19|0.0|0.1|0.1|Malignant|29|42510556|Male|Neoplasm, unspecified|2017
0-19|0.1|0.1|0.1|Benign/Borderline|267|206836549|Male|Neoplasm, unspecified|2017-2021
0-19|0.1|0.1|0.1|Malignant|128|206836549|Male|Neoplasm, unspecified|2017-2021
0-19|0.1|0.2|0.1|Benign/Borderline|62|42511405|Male|Neoplasm, unspecified|2018
0-19|0.0|0.1|0.0|Malignant|18|42511405|Male|Neoplasm, unspecified|2018
0-19|0.1|0.2|0.1|Benign/Borderline|53|42449660|Male|Neoplasm, unspecified|2019
0-19|0.0|0.1|0.1|Malignant|21|42449660|Male|Neoplasm, unspecified|2019
0-19|0.1|0.1|0.1|Benign/Borderline|43|41306203|Male|Neoplasm, unspecified|2020
0-19|0.0|0.1|0.1|Malignant|30|41306203|Male|Neoplasm, unspecified|2020
0-19|0.1|0.1|0.1|Benign/Borderline|43|40796026|Male|Neoplasm, unspecified|2021
0-19|0.1|0.1|0.1|Malignant|31|40796026|Male|Neoplasm, unspecified|2021
0-19|0.3|0.4|0.3|Benign/Borderline|126|41889233|Male|Nerve sheath, benign and malignant|2004
0-19|~|~|~|Malignant|~|41889233|Male|Nerve sheath, benign and malignant|2004
0-19|0.2|0.4|0.3|Benign/Borderline|124|42006384|Male|Nerve sheath, benign and malignant|2005
0-19|~|~|~|Malignant|~|42006384|Male|Nerve sheath, benign and malignant|2005
0-19|0.4|0.5|0.4|Benign/Borderline|174|42158997|Male|Nerve sheath, benign and malignant|2006
0-19|~|~|~|Malignant|~|42158997|Male|Nerve sheath, benign and malignant|2006
0-19|0.3|0.5|0.4|Benign/Borderline|165|42367071|Male|Nerve sheath, benign and malignant|2007
0-19|~|~|~|Malignant|~|42367071|Male|Nerve sheath, benign and malignant|2007
0-19|0.3|0.4|0.4|Benign/Borderline|152|42541971|Male|Nerve sheath, benign and malignant|2008
0-19|~|~|~|Malignant|~|42541971|Male|Nerve sheath, benign and malignant|2008
0-19|0.3|0.4|0.4|Benign/Borderline|157|42609915|Male|Nerve sheath, benign and malignant|2009
0-19|~|~|~|Malignant|~|42609915|Male|Nerve sheath, benign and malignant|2009
0-19|0.3|0.4|0.3|Benign/Borderline|145|42569785|Male|Nerve sheath, benign and malignant|2010
0-19|~|~|~|Malignant|~|42569785|Male|Nerve sheath, benign and malignant|2010
0-19|0.3|0.4|0.4|Benign/Borderline|157|42470382|Male|Nerve sheath, benign and malignant|2011
0-19|~|~|~|Malignant|~|42470382|Male|Nerve sheath, benign and malignant|2011
0-19|0.3|0.4|0.4|Benign/Borderline|162|42360866|Male|Nerve sheath, benign and malignant|2012
0-19|~|~|~|Malignant|~|42360866|Male|Nerve sheath, benign and malignant|2012
0-19|0.3|0.5|0.4|Benign/Borderline|166|42299716|Male|Nerve sheath, benign and malignant|2013
0-19|~|~|~|Malignant|~|42299716|Male|Nerve sheath, benign and malignant|2013
0-19|0.3|0.4|0.4|Benign/Borderline|154|42297680|Male|Nerve sheath, benign and malignant|2014
0-19|~|~|~|Malignant|~|42297680|Male|Nerve sheath, benign and malignant|2014
0-19|0.3|0.4|0.4|Benign/Borderline|154|42356807|Male|Nerve sheath, benign and malignant|2015
0-19|~|~|~|Malignant|~|42356807|Male|Nerve sheath, benign and malignant|2015
0-19|0.4|0.5|0.4|Benign/Borderline|184|42451872|Male|Nerve sheath, benign and malignant|2016
0-19|~|~|~|Malignant|~|42451872|Male|Nerve sheath, benign and malignant|2016
0-19|0.2|0.3|0.3|Benign/Borderline|117|42510556|Male|Nerve sheath, benign and malignant|2017
0-19|~|~|~|Malignant|~|42510556|Male|Nerve sheath, benign and malignant|2017
0-19|0.2|0.2|0.2|Benign/Borderline|426|206836549|Male|Nerve sheath, benign and malignant|2017-2021
0-19|~|~|~|Malignant|~|206836549|Male|Nerve sheath, benign and malignant|2017-2021
0-19|0.2|0.3|0.2|Benign/Borderline|92|42511405|Male|Nerve sheath, benign and malignant|2018
0-19|~|~|~|Malignant|~|42511405|Male|Nerve sheath, benign and malignant|2018
0-19|0.2|0.3|0.2|Benign/Borderline|98|42449660|Male|Nerve sheath, benign and malignant|2019
0-19|~|~|~|Malignant|~|42449660|Male|Nerve sheath, benign and malignant|2019
0-19|0.1|0.2|0.2|Benign/Borderline|65|41306203|Male|Nerve sheath, benign and malignant|2020
0-19|~|~|~|Malignant|~|41306203|Male|Nerve sheath, benign and malignant|2020
0-19|0.1|0.2|0.1|Benign/Borderline|59|40796026|Male|Nerve sheath, benign and malignant|2021
0-19|~|~|~|Malignant|~|40796026|Male|Nerve sheath, benign and malignant|2021
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Neuroepithelial|2004
0-19|~|~|~|Malignant|~|41889233|Male|Neuroepithelial|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Neuroepithelial|2005
0-19|~|~|~|Malignant|~|42006384|Male|Neuroepithelial|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Neuroepithelial|2006
0-19|~|~|~|Malignant|~|42158997|Male|Neuroepithelial|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Neuroepithelial|2007
0-19|~|~|~|Malignant|~|42367071|Male|Neuroepithelial|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Neuroepithelial|2008
0-19|~|~|~|Malignant|~|42541971|Male|Neuroepithelial|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Neuroepithelial|2009
0-19|~|~|~|Malignant|~|42609915|Male|Neuroepithelial|2009
0-19|~|~|~|Benign/Borderline|~|42569785|Male|Neuroepithelial|2010
0-19|~|~|~|Malignant|~|42569785|Male|Neuroepithelial|2010
0-19|~|~|~|Benign/Borderline|~|42470382|Male|Neuroepithelial|2011
0-19|~|~|~|Malignant|~|42470382|Male|Neuroepithelial|2011
0-19|~|~|~|Benign/Borderline|~|42360866|Male|Neuroepithelial|2012
0-19|~|~|~|Malignant|~|42360866|Male|Neuroepithelial|2012
0-19|~|~|~|Benign/Borderline|~|42299716|Male|Neuroepithelial|2013
0-19|~|~|~|Malignant|~|42299716|Male|Neuroepithelial|2013
0-19|~|~|~|Benign/Borderline|~|42297680|Male|Neuroepithelial|2014
0-19|~|~|~|Malignant|~|42297680|Male|Neuroepithelial|2014
0-19|~|~|~|Benign/Borderline|~|42356807|Male|Neuroepithelial|2015
0-19|~|~|~|Malignant|~|42356807|Male|Neuroepithelial|2015
0-19|~|~|~|Benign/Borderline|~|42451872|Male|Neuroepithelial|2016
0-19|~|~|~|Malignant|~|42451872|Male|Neuroepithelial|2016
0-19|~|~|~|Benign/Borderline|~|42510556|Male|Neuroepithelial|2017
0-19|~|~|~|Malignant|~|42510556|Male|Neuroepithelial|2017
0-19|~|~|~|Benign/Borderline|~|206836549|Male|Neuroepithelial|2017-2021
0-19|~|~|~|Malignant|~|206836549|Male|Neuroepithelial|2017-2021
0-19|~|~|~|Benign/Borderline|~|42511405|Male|Neuroepithelial|2018
0-19|~|~|~|Malignant|~|42511405|Male|Neuroepithelial|2018
0-19|~|~|~|Benign/Borderline|~|42449660|Male|Neuroepithelial|2019
0-19|~|~|~|Malignant|~|42449660|Male|Neuroepithelial|2019
0-19|~|~|~|Benign/Borderline|~|41306203|Male|Neuroepithelial|2020
0-19|~|~|~|Malignant|~|41306203|Male|Neuroepithelial|2020
0-19|~|~|~|Benign/Borderline|~|40796026|Male|Neuroepithelial|2021
0-19|~|~|~|Malignant|~|40796026|Male|Neuroepithelial|2021
0-19|0.3|0.4|0.4|Benign/Borderline|151|41889233|Male|Neuronal/glial, neuronal|2004
0-19|0.0|0.1|0.1|Malignant|29|41889233|Male|Neuronal/glial, neuronal|2004
0-19|0.3|0.4|0.4|Benign/Borderline|159|42006384|Male|Neuronal/glial, neuronal|2005
0-19|0.0|0.1|0.1|Malignant|30|42006384|Male|Neuronal/glial, neuronal|2005
0-19|0.3|0.4|0.4|Benign/Borderline|158|42158997|Male|Neuronal/glial, neuronal|2006
0-19|0.0|0.1|0.1|Malignant|28|42158997|Male|Neuronal/glial, neuronal|2006
0-19|0.4|0.5|0.4|Benign/Borderline|174|42367071|Male|Neuronal/glial, neuronal|2007
0-19|0.0|0.1|0.1|Malignant|30|42367071|Male|Neuronal/glial, neuronal|2007
0-19|0.4|0.5|0.4|Benign/Borderline|182|42541971|Male|Neuronal/glial, neuronal|2008
0-19|0.0|0.1|0.1|Malignant|29|42541971|Male|Neuronal/glial, neuronal|2008
0-19|0.3|0.4|0.4|Benign/Borderline|159|42609915|Male|Neuronal/glial, neuronal|2009
0-19|0.0|0.1|0.0|Malignant|18|42609915|Male|Neuronal/glial, neuronal|2009
0-19|0.4|0.5|0.4|Benign/Borderline|174|42569785|Male|Neuronal/glial, neuronal|2010
0-19|0.0|0.1|0.0|Malignant|16|42569785|Male|Neuronal/glial, neuronal|2010
0-19|0.4|0.5|0.4|Benign/Borderline|191|42470382|Male|Neuronal/glial, neuronal|2011
0-19|0.0|0.1|0.0|Malignant|21|42470382|Male|Neuronal/glial, neuronal|2011
0-19|0.4|0.6|0.5|Benign/Borderline|209|42360866|Male|Neuronal/glial, neuronal|2012
0-19|0.0|0.1|0.1|Malignant|22|42360866|Male|Neuronal/glial, neuronal|2012
0-19|0.4|0.5|0.5|Benign/Borderline|193|42299716|Male|Neuronal/glial, neuronal|2013
0-19|0.0|0.1|0.1|Malignant|23|42299716|Male|Neuronal/glial, neuronal|2013
0-19|0.4|0.5|0.4|Benign/Borderline|175|42297680|Male|Neuronal/glial, neuronal|2014
0-19|0.1|0.1|0.1|Malignant|31|42297680|Male|Neuronal/glial, neuronal|2014
0-19|0.5|0.6|0.5|Benign/Borderline|224|42356807|Male|Neuronal/glial, neuronal|2015
0-19|0.0|0.1|0.1|Malignant|26|42356807|Male|Neuronal/glial, neuronal|2015
0-19|0.5|0.6|0.5|Benign/Borderline|229|42451872|Male|Neuronal/glial, neuronal|2016
0-19|0.0|0.1|0.1|Malignant|26|42451872|Male|Neuronal/glial, neuronal|2016
0-19|0.5|0.6|0.6|Benign/Borderline|239|42510556|Male|Neuronal/glial, neuronal|2017
0-19|0.0|0.1|0.0|Malignant|17|42510556|Male|Neuronal/glial, neuronal|2017
0-19|0.5|0.5|0.5|Benign/Borderline|1015|206836549|Male|Neuronal/glial, neuronal|2017-2021
0-19|0.0|0.1|0.0|Malignant|92|206836549|Male|Neuronal/glial, neuronal|2017-2021
0-19|0.4|0.6|0.5|Benign/Borderline|212|42511405|Male|Neuronal/glial, neuronal|2018
0-19|0.0|0.1|0.0|Malignant|20|42511405|Male|Neuronal/glial, neuronal|2018
0-19|0.5|0.6|0.5|Benign/Borderline|236|42449660|Male|Neuronal/glial, neuronal|2019
0-19|0.0|0.1|0.1|Malignant|23|42449660|Male|Neuronal/glial, neuronal|2019
0-19|0.3|0.5|0.4|Benign/Borderline|170|41306203|Male|Neuronal/glial, neuronal|2020
0-19|~|~|~|Malignant|~|41306203|Male|Neuronal/glial, neuronal|2020
0-19|0.4|0.5|0.4|Benign/Borderline|172|40796026|Male|Neuronal/glial, neuronal|2021
0-19|0.0|0.1|0.0|Malignant|17|40796026|Male|Neuronal/glial, neuronal|2021
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Oligodendroglioma|2004
0-19|0.1|0.1|0.1|Malignant|38|41889233|Male|Oligodendroglioma|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Oligodendroglioma|2005
0-19|0.0|0.1|0.1|Malignant|29|42006384|Male|Oligodendroglioma|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Oligodendroglioma|2006
0-19|0.0|0.1|0.1|Malignant|29|42158997|Male|Oligodendroglioma|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Oligodendroglioma|2007
0-19|0.0|0.1|0.1|Malignant|23|42367071|Male|Oligodendroglioma|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Oligodendroglioma|2008
0-19|0.0|0.1|0.1|Malignant|31|42541971|Male|Oligodendroglioma|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Oligodendroglioma|2009
0-19|0.0|0.1|0.1|Malignant|27|42609915|Male|Oligodendroglioma|2009
0-19|~|~|~|Benign/Borderline|~|42569785|Male|Oligodendroglioma|2010
0-19|0.0|0.1|0.1|Malignant|22|42569785|Male|Oligodendroglioma|2010
0-19|~|~|~|Benign/Borderline|~|42470382|Male|Oligodendroglioma|2011
0-19|0.0|0.1|0.0|Malignant|17|42470382|Male|Oligodendroglioma|2011
0-19|~|~|~|Benign/Borderline|~|42360866|Male|Oligodendroglioma|2012
0-19|0.0|0.1|0.1|Malignant|25|42360866|Male|Oligodendroglioma|2012
0-19|~|~|~|Benign/Borderline|~|42299716|Male|Oligodendroglioma|2013
0-19|0.0|0.1|0.0|Malignant|20|42299716|Male|Oligodendroglioma|2013
0-19|~|~|~|Benign/Borderline|~|42297680|Male|Oligodendroglioma|2014
0-19|0.0|0.1|0.0|Malignant|19|42297680|Male|Oligodendroglioma|2014
0-19|~|~|~|Benign/Borderline|~|42356807|Male|Oligodendroglioma|2015
0-19|0.0|0.1|0.0|Malignant|18|42356807|Male|Oligodendroglioma|2015
0-19|~|~|~|Benign/Borderline|~|42451872|Male|Oligodendroglioma|2016
0-19|0.0|0.1|0.0|Malignant|17|42451872|Male|Oligodendroglioma|2016
0-19|~|~|~|Benign/Borderline|~|42510556|Male|Oligodendroglioma|2017
0-19|~|~|~|Malignant|~|42510556|Male|Oligodendroglioma|2017
0-19|~|~|~|Benign/Borderline|~|206836549|Male|Oligodendroglioma|2017-2021
0-19|0.0|0.0|0.0|Malignant|51|206836549|Male|Oligodendroglioma|2017-2021
0-19|~|~|~|Benign/Borderline|~|42511405|Male|Oligodendroglioma|2018
0-19|~|~|~|Malignant|~|42511405|Male|Oligodendroglioma|2018
0-19|~|~|~|Benign/Borderline|~|42449660|Male|Oligodendroglioma|2019
0-19|~|~|~|Malignant|~|42449660|Male|Oligodendroglioma|2019
0-19|~|~|~|Benign/Borderline|~|41306203|Male|Oligodendroglioma|2020
0-19|~|~|~|Malignant|~|41306203|Male|Oligodendroglioma|2020
0-19|~|~|~|Benign/Borderline|~|40796026|Male|Oligodendroglioma|2021
0-19|~|~|~|Malignant|~|40796026|Male|Oligodendroglioma|2021
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Other mesenchymal|2004
0-19|~|~|~|Malignant|~|41889233|Male|Other mesenchymal|2004
0-19|0.0|0.1|0.1|Benign/Borderline|22|42006384|Male|Other mesenchymal|2005
0-19|~|~|~|Malignant|~|42006384|Male|Other mesenchymal|2005
0-19|0.0|0.1|0.0|Benign/Borderline|21|42158997|Male|Other mesenchymal|2006
0-19|~|~|~|Malignant|~|42158997|Male|Other mesenchymal|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Other mesenchymal|2007
0-19|~|~|~|Malignant|~|42367071|Male|Other mesenchymal|2007
0-19|0.0|0.1|0.0|Benign/Borderline|21|42541971|Male|Other mesenchymal|2008
0-19|~|~|~|Malignant|~|42541971|Male|Other mesenchymal|2008
0-19|0.0|0.1|0.0|Benign/Borderline|20|42609915|Male|Other mesenchymal|2009
0-19|~|~|~|Malignant|~|42609915|Male|Other mesenchymal|2009
0-19|0.0|0.1|0.1|Benign/Borderline|27|42569785|Male|Other mesenchymal|2010
0-19|~|~|~|Malignant|~|42569785|Male|Other mesenchymal|2010
0-19|0.1|0.1|0.1|Benign/Borderline|35|42470382|Male|Other mesenchymal|2011
0-19|~|~|~|Malignant|~|42470382|Male|Other mesenchymal|2011
0-19|0.1|0.1|0.1|Benign/Borderline|46|42360866|Male|Other mesenchymal|2012
0-19|~|~|~|Malignant|~|42360866|Male|Other mesenchymal|2012
0-19|0.1|0.1|0.1|Benign/Borderline|35|42299716|Male|Other mesenchymal|2013
0-19|~|~|~|Malignant|~|42299716|Male|Other mesenchymal|2013
0-19|0.1|0.1|0.1|Benign/Borderline|34|42297680|Male|Other mesenchymal|2014
0-19|~|~|~|Malignant|~|42297680|Male|Other mesenchymal|2014
0-19|0.1|0.1|0.1|Benign/Borderline|35|42356807|Male|Other mesenchymal|2015
0-19|~|~|~|Malignant|~|42356807|Male|Other mesenchymal|2015
0-19|0.1|0.2|0.1|Benign/Borderline|51|42451872|Male|Other mesenchymal|2016
0-19|~|~|~|Malignant|~|42451872|Male|Other mesenchymal|2016
0-19|0.1|0.2|0.1|Benign/Borderline|49|42510556|Male|Other mesenchymal|2017
0-19|~|~|~|Malignant|~|42510556|Male|Other mesenchymal|2017
0-19|0.1|0.1|0.1|Benign/Borderline|194|206836549|Male|Other mesenchymal|2017-2021
0-19|0.0|0.0|0.0|Malignant|54|206836549|Male|Other mesenchymal|2017-2021
0-19|0.1|0.2|0.1|Benign/Borderline|50|42511405|Male|Other mesenchymal|2018
0-19|~|~|~|Malignant|~|42511405|Male|Other mesenchymal|2018
0-19|0.0|0.1|0.1|Benign/Borderline|28|42449660|Male|Other mesenchymal|2019
0-19|~|~|~|Malignant|~|42449660|Male|Other mesenchymal|2019
0-19|0.0|0.1|0.1|Benign/Borderline|25|41306203|Male|Other mesenchymal|2020
0-19|0.0|0.1|0.0|Malignant|16|41306203|Male|Other mesenchymal|2020
0-19|0.1|0.1|0.1|Benign/Borderline|42|40796026|Male|Other mesenchymal|2021
0-19|~|~|~|Malignant|~|40796026|Male|Other mesenchymal|2021
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Pilocytic astrocytoma|2004
0-19|0.8|1.0|0.9|Malignant|371|41889233|Male|Pilocytic astrocytoma|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Pilocytic astrocytoma|2005
0-19|0.8|0.9|0.9|Malignant|355|42006384|Male|Pilocytic astrocytoma|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Pilocytic astrocytoma|2006
0-19|0.8|0.9|0.9|Malignant|359|42158997|Male|Pilocytic astrocytoma|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Pilocytic astrocytoma|2007
0-19|0.7|0.9|0.8|Malignant|351|42367071|Male|Pilocytic astrocytoma|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Pilocytic astrocytoma|2008
0-19|0.8|1.0|0.9|Malignant|396|42541971|Male|Pilocytic astrocytoma|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Pilocytic astrocytoma|2009
0-19|0.8|1.0|0.9|Malignant|372|42609915|Male|Pilocytic astrocytoma|2009
0-19|~|~|~|Benign/Borderline|~|42569785|Male|Pilocytic astrocytoma|2010
0-19|0.8|1.0|0.9|Malignant|383|42569785|Male|Pilocytic astrocytoma|2010
0-19|~|~|~|Benign/Borderline|~|42470382|Male|Pilocytic astrocytoma|2011
0-19|0.9|1.1|1.0|Malignant|408|42470382|Male|Pilocytic astrocytoma|2011
0-19|~|~|~|Benign/Borderline|~|42360866|Male|Pilocytic astrocytoma|2012
0-19|0.9|1.1|1.0|Malignant|434|42360866|Male|Pilocytic astrocytoma|2012
0-19|~|~|~|Benign/Borderline|~|42299716|Male|Pilocytic astrocytoma|2013
0-19|0.9|1.1|1.0|Malignant|435|42299716|Male|Pilocytic astrocytoma|2013
0-19|~|~|~|Benign/Borderline|~|42297680|Male|Pilocytic astrocytoma|2014
0-19|0.8|1.0|0.9|Malignant|384|42297680|Male|Pilocytic astrocytoma|2014
0-19|~|~|~|Benign/Borderline|~|42356807|Male|Pilocytic astrocytoma|2015
0-19|0.8|1.0|0.9|Malignant|385|42356807|Male|Pilocytic astrocytoma|2015
0-19|~|~|~|Benign/Borderline|~|42451872|Male|Pilocytic astrocytoma|2016
0-19|0.8|1.0|0.9|Malignant|388|42451872|Male|Pilocytic astrocytoma|2016
0-19|~|~|~|Benign/Borderline|~|42510556|Male|Pilocytic astrocytoma|2017
0-19|1.0|1.2|1.1|Malignant|447|42510556|Male|Pilocytic astrocytoma|2017
0-19|0.1|0.2|0.1|Benign/Borderline|274|206836549|Male|Pilocytic astrocytoma|2017-2021
0-19|0.8|0.9|0.9|Malignant|1802|206836549|Male|Pilocytic astrocytoma|2017-2021
0-19|0.1|0.2|0.2|Benign/Borderline|72|42511405|Male|Pilocytic astrocytoma|2018
0-19|0.8|0.9|0.8|Malignant|355|42511405|Male|Pilocytic astrocytoma|2018
0-19|0.2|0.2|0.2|Benign/Borderline|79|42449660|Male|Pilocytic astrocytoma|2019
0-19|0.7|0.9|0.8|Malignant|344|42449660|Male|Pilocytic astrocytoma|2019
0-19|0.1|0.2|0.2|Benign/Borderline|68|41306203|Male|Pilocytic astrocytoma|2020
0-19|0.8|0.9|0.8|Malignant|348|41306203|Male|Pilocytic astrocytoma|2020
0-19|0.1|0.2|0.1|Benign/Borderline|57|40796026|Male|Pilocytic astrocytoma|2021
0-19|0.7|0.9|0.8|Malignant|338|40796026|Male|Pilocytic astrocytoma|2021
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Pineal parenchymal|2004
0-19|0.0|0.1|0.0|Malignant|19|41889233|Male|Pineal parenchymal|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Pineal parenchymal|2005
0-19|~|~|~|Malignant|~|42006384|Male|Pineal parenchymal|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Pineal parenchymal|2006
0-19|~|~|~|Malignant|~|42158997|Male|Pineal parenchymal|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Pineal parenchymal|2007
0-19|0.0|0.1|0.0|Malignant|18|42367071|Male|Pineal parenchymal|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Pineal parenchymal|2008
0-19|~|~|~|Malignant|~|42541971|Male|Pineal parenchymal|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Pineal parenchymal|2009
0-19|~|~|~|Malignant|~|42609915|Male|Pineal parenchymal|2009
0-19|~|~|~|Benign/Borderline|~|42569785|Male|Pineal parenchymal|2010
0-19|~|~|~|Malignant|~|42569785|Male|Pineal parenchymal|2010
0-19|~|~|~|Benign/Borderline|~|42470382|Male|Pineal parenchymal|2011
0-19|0.0|0.1|0.0|Malignant|20|42470382|Male|Pineal parenchymal|2011
0-19|~|~|~|Benign/Borderline|~|42360866|Male|Pineal parenchymal|2012
0-19|0.0|0.1|0.0|Malignant|19|42360866|Male|Pineal parenchymal|2012
0-19|~|~|~|Benign/Borderline|~|42299716|Male|Pineal parenchymal|2013
0-19|0.0|0.1|0.0|Malignant|17|42299716|Male|Pineal parenchymal|2013
0-19|~|~|~|Benign/Borderline|~|42297680|Male|Pineal parenchymal|2014
0-19|0.0|0.1|0.1|Malignant|23|42297680|Male|Pineal parenchymal|2014
0-19|~|~|~|Benign/Borderline|~|42356807|Male|Pineal parenchymal|2015
0-19|0.0|0.1|0.0|Malignant|20|42356807|Male|Pineal parenchymal|2015
0-19|~|~|~|Benign/Borderline|~|42451872|Male|Pineal parenchymal|2016
0-19|0.0|0.1|0.1|Malignant|25|42451872|Male|Pineal parenchymal|2016
0-19|~|~|~|Benign/Borderline|~|42510556|Male|Pineal parenchymal|2017
0-19|~|~|~|Malignant|~|42510556|Male|Pineal parenchymal|2017
0-19|~|~|~|Benign/Borderline|~|206836549|Male|Pineal parenchymal|2017-2021
0-19|0.0|0.0|0.0|Malignant|75|206836549|Male|Pineal parenchymal|2017-2021
0-19|~|~|~|Benign/Borderline|~|42511405|Male|Pineal parenchymal|2018
0-19|~|~|~|Malignant|~|42511405|Male|Pineal parenchymal|2018
0-19|~|~|~|Benign/Borderline|~|42449660|Male|Pineal parenchymal|2019
0-19|0.0|0.1|0.0|Malignant|16|42449660|Male|Pineal parenchymal|2019
0-19|~|~|~|Benign/Borderline|~|41306203|Male|Pineal parenchymal|2020
0-19|0.0|0.1|0.0|Malignant|20|41306203|Male|Pineal parenchymal|2020
0-19|~|~|~|Benign/Borderline|~|40796026|Male|Pineal parenchymal|2021
0-19|~|~|~|Malignant|~|40796026|Male|Pineal parenchymal|2021
0-19|0.2|0.2|0.2|Benign/Borderline|86|41889233|Male|Pituitary|2004
0-19|~|~|~|Malignant|~|41889233|Male|Pituitary|2004
0-19|0.2|0.3|0.3|Benign/Borderline|124|42006384|Male|Pituitary|2005
0-19|~|~|~|Malignant|~|42006384|Male|Pituitary|2005
0-19|0.2|0.3|0.2|Benign/Borderline|102|42158997|Male|Pituitary|2006
0-19|~|~|~|Malignant|~|42158997|Male|Pituitary|2006
0-19|0.2|0.3|0.3|Benign/Borderline|116|42367071|Male|Pituitary|2007
0-19|~|~|~|Malignant|~|42367071|Male|Pituitary|2007
0-19|0.3|0.4|0.3|Benign/Borderline|136|42541971|Male|Pituitary|2008
0-19|~|~|~|Malignant|~|42541971|Male|Pituitary|2008
0-19|0.3|0.4|0.4|Benign/Borderline|161|42609915|Male|Pituitary|2009
0-19|~|~|~|Malignant|~|42609915|Male|Pituitary|2009
0-19|0.3|0.4|0.3|Benign/Borderline|143|42569785|Male|Pituitary|2010
0-19|~|~|~|Malignant|~|42569785|Male|Pituitary|2010
0-19|0.3|0.4|0.4|Benign/Borderline|154|42470382|Male|Pituitary|2011
0-19|~|~|~|Malignant|~|42470382|Male|Pituitary|2011
0-19|0.4|0.5|0.4|Benign/Borderline|181|42360866|Male|Pituitary|2012
0-19|~|~|~|Malignant|~|42360866|Male|Pituitary|2012
0-19|0.4|0.5|0.4|Benign/Borderline|182|42299716|Male|Pituitary|2013
0-19|~|~|~|Malignant|~|42299716|Male|Pituitary|2013
0-19|0.4|0.5|0.5|Benign/Borderline|205|42297680|Male|Pituitary|2014
0-19|~|~|~|Malignant|~|42297680|Male|Pituitary|2014
0-19|0.3|0.5|0.4|Benign/Borderline|175|42356807|Male|Pituitary|2015
0-19|~|~|~|Malignant|~|42356807|Male|Pituitary|2015
0-19|0.4|0.6|0.5|Benign/Borderline|212|42451872|Male|Pituitary|2016
0-19|~|~|~|Malignant|~|42451872|Male|Pituitary|2016
0-19|0.5|0.6|0.5|Benign/Borderline|234|42510556|Male|Pituitary|2017
0-19|~|~|~|Malignant|~|42510556|Male|Pituitary|2017
0-19|0.4|0.5|0.5|Benign/Borderline|988|206836549|Male|Pituitary|2017-2021
0-19|~|~|~|Malignant|~|206836549|Male|Pituitary|2017-2021
0-19|0.4|0.5|0.5|Benign/Borderline|206|42511405|Male|Pituitary|2018
0-19|~|~|~|Malignant|~|42511405|Male|Pituitary|2018
0-19|0.4|0.6|0.5|Benign/Borderline|212|42449660|Male|Pituitary|2019
0-19|~|~|~|Malignant|~|42449660|Male|Pituitary|2019
0-19|0.4|0.5|0.4|Benign/Borderline|187|41306203|Male|Pituitary|2020
0-19|~|~|~|Malignant|~|41306203|Male|Pituitary|2020
0-19|0.3|0.4|0.4|Benign/Borderline|159|40796026|Male|Pituitary|2021
0-19|~|~|~|Malignant|~|40796026|Male|Pituitary|2021
0-19|1.5|1.8|1.7|Benign/Borderline|694|41889233|Male|Total|2004
0-19|3.4|3.8|3.6|Malignant|1503|41889233|Male|Total|2004
0-19|1.8|2.0|1.9|Benign/Borderline|795|42006384|Male|Total|2005
0-19|3.2|3.6|3.4|Malignant|1429|42006384|Male|Total|2005
0-19|1.8|2.1|1.9|Benign/Borderline|829|42158997|Male|Total|2006
0-19|3.4|3.8|3.6|Malignant|1512|42158997|Male|Total|2006
0-19|1.9|2.2|2.0|Benign/Borderline|869|42367071|Male|Total|2007
0-19|3.4|3.8|3.6|Malignant|1527|42367071|Male|Total|2007
0-19|1.9|2.2|2.1|Benign/Borderline|882|42541971|Male|Total|2008
0-19|3.6|4.0|3.8|Malignant|1605|42541971|Male|Total|2008
0-19|2.1|2.4|2.2|Benign/Borderline|959|42609915|Male|Total|2009
0-19|3.5|3.9|3.7|Malignant|1564|42609915|Male|Total|2009
0-19|2.0|2.3|2.2|Benign/Borderline|921|42569785|Male|Total|2010
0-19|3.6|4.0|3.8|Malignant|1613|42569785|Male|Total|2010
0-19|2.2|2.4|2.3|Benign/Borderline|983|42470382|Male|Total|2011
0-19|3.6|4.0|3.8|Malignant|1607|42470382|Male|Total|2011
0-19|2.3|2.6|2.4|Benign/Borderline|1035|42360866|Male|Total|2012
0-19|3.7|4.1|3.9|Malignant|1638|42360866|Male|Total|2012
0-19|2.3|2.6|2.4|Benign/Borderline|1025|42299716|Male|Total|2013
0-19|3.6|4.0|3.8|Malignant|1609|42299716|Male|Total|2013
0-19|2.3|2.6|2.5|Benign/Borderline|1043|42297680|Male|Total|2014
0-19|3.5|3.9|3.7|Malignant|1570|42297680|Male|Total|2014
0-19|2.3|2.6|2.4|Benign/Borderline|1026|42356807|Male|Total|2015
0-19|3.6|4.0|3.8|Malignant|1611|42356807|Male|Total|2015
0-19|2.5|2.8|2.7|Benign/Borderline|1146|42451872|Male|Total|2016
0-19|3.6|3.9|3.7|Malignant|1578|42451872|Male|Total|2016
0-19|2.4|2.7|2.6|Benign/Borderline|1103|42510556|Male|Total|2017
0-19|3.8|4.2|4.0|Malignant|1683|42510556|Male|Total|2017
0-19|2.3|2.4|2.4|Benign/Borderline|4938|206836549|Male|Total|2017-2021
0-19|3.1|3.3|3.2|Malignant|6544|206836549|Male|Total|2017-2021
0-19|2.5|2.8|2.7|Benign/Borderline|1142|42511405|Male|Total|2018
0-19|2.9|3.2|3.1|Malignant|1302|42511405|Male|Total|2018
0-19|2.3|2.6|2.4|Benign/Borderline|1052|42449660|Male|Total|2019
0-19|2.8|3.2|3.0|Malignant|1266|42449660|Male|Total|2019
0-19|1.9|2.2|2.0|Benign/Borderline|845|41306203|Male|Total|2020
0-19|2.7|3.1|2.9|Malignant|1197|41306203|Male|Total|2020
0-19|1.9|2.2|2.1|Benign/Borderline|855|40796026|Male|Total|2021
0-19|2.8|3.1|2.9|Malignant|1190|40796026|Male|Total|2021
0-19|0.3|0.4|0.3|Benign/Borderline|126|41889233|Male|Tumors of Cranial and Spinal Nerves|2004
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of Cranial and Spinal Nerves|2004
0-19|0.2|0.4|0.3|Benign/Borderline|124|42006384|Male|Tumors of Cranial and Spinal Nerves|2005
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of Cranial and Spinal Nerves|2005
0-19|0.4|0.5|0.4|Benign/Borderline|174|42158997|Male|Tumors of Cranial and Spinal Nerves|2006
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of Cranial and Spinal Nerves|2006
0-19|0.3|0.5|0.4|Benign/Borderline|165|42367071|Male|Tumors of Cranial and Spinal Nerves|2007
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of Cranial and Spinal Nerves|2007
0-19|0.3|0.4|0.4|Benign/Borderline|152|42541971|Male|Tumors of Cranial and Spinal Nerves|2008
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of Cranial and Spinal Nerves|2008
0-19|0.3|0.4|0.4|Benign/Borderline|157|42609915|Male|Tumors of Cranial and Spinal Nerves|2009
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of Cranial and Spinal Nerves|2009
0-19|0.3|0.4|0.3|Benign/Borderline|145|42569785|Male|Tumors of Cranial and Spinal Nerves|2010
0-19|~|~|~|Malignant|~|42569785|Male|Tumors of Cranial and Spinal Nerves|2010
0-19|0.3|0.4|0.4|Benign/Borderline|157|42470382|Male|Tumors of Cranial and Spinal Nerves|2011
0-19|~|~|~|Malignant|~|42470382|Male|Tumors of Cranial and Spinal Nerves|2011
0-19|0.3|0.4|0.4|Benign/Borderline|162|42360866|Male|Tumors of Cranial and Spinal Nerves|2012
0-19|~|~|~|Malignant|~|42360866|Male|Tumors of Cranial and Spinal Nerves|2012
0-19|0.3|0.5|0.4|Benign/Borderline|167|42299716|Male|Tumors of Cranial and Spinal Nerves|2013
0-19|~|~|~|Malignant|~|42299716|Male|Tumors of Cranial and Spinal Nerves|2013
0-19|0.3|0.4|0.4|Benign/Borderline|156|42297680|Male|Tumors of Cranial and Spinal Nerves|2014
0-19|~|~|~|Malignant|~|42297680|Male|Tumors of Cranial and Spinal Nerves|2014
0-19|0.3|0.4|0.4|Benign/Borderline|154|42356807|Male|Tumors of Cranial and Spinal Nerves|2015
0-19|~|~|~|Malignant|~|42356807|Male|Tumors of Cranial and Spinal Nerves|2015
0-19|0.4|0.5|0.4|Benign/Borderline|184|42451872|Male|Tumors of Cranial and Spinal Nerves|2016
0-19|~|~|~|Malignant|~|42451872|Male|Tumors of Cranial and Spinal Nerves|2016
0-19|0.2|0.3|0.3|Benign/Borderline|117|42510556|Male|Tumors of Cranial and Spinal Nerves|2017
0-19|~|~|~|Malignant|~|42510556|Male|Tumors of Cranial and Spinal Nerves|2017
0-19|0.2|0.2|0.2|Benign/Borderline|426|206836549|Male|Tumors of Cranial and Spinal Nerves|2017-2021
0-19|~|~|~|Malignant|~|206836549|Male|Tumors of Cranial and Spinal Nerves|2017-2021
0-19|0.2|0.3|0.2|Benign/Borderline|92|42511405|Male|Tumors of Cranial and Spinal Nerves|2018
0-19|~|~|~|Malignant|~|42511405|Male|Tumors of Cranial and Spinal Nerves|2018
0-19|0.2|0.3|0.2|Benign/Borderline|98|42449660|Male|Tumors of Cranial and Spinal Nerves|2019
0-19|~|~|~|Malignant|~|42449660|Male|Tumors of Cranial and Spinal Nerves|2019
0-19|0.1|0.2|0.2|Benign/Borderline|65|41306203|Male|Tumors of Cranial and Spinal Nerves|2020
0-19|~|~|~|Malignant|~|41306203|Male|Tumors of Cranial and Spinal Nerves|2020
0-19|0.1|0.2|0.1|Benign/Borderline|59|40796026|Male|Tumors of Cranial and Spinal Nerves|2021
0-19|~|~|~|Malignant|~|40796026|Male|Tumors of Cranial and Spinal Nerves|2021
0-19|0.5|0.6|0.6|Benign/Borderline|236|41889233|Male|Tumors of Neuroepthelial Tissue|2004
0-19|3.1|3.4|3.3|Malignant|1361|41889233|Male|Tumors of Neuroepthelial Tissue|2004
0-19|0.5|0.7|0.6|Benign/Borderline|263|42006384|Male|Tumors of Neuroepthelial Tissue|2005
0-19|2.9|3.3|3.1|Malignant|1296|42006384|Male|Tumors of Neuroepthelial Tissue|2005
0-19|0.5|0.7|0.6|Benign/Borderline|261|42158997|Male|Tumors of Neuroepthelial Tissue|2006
0-19|3.1|3.4|3.3|Malignant|1364|42158997|Male|Tumors of Neuroepthelial Tissue|2006
0-19|0.6|0.7|0.6|Benign/Borderline|272|42367071|Male|Tumors of Neuroepthelial Tissue|2007
0-19|3.1|3.5|3.3|Malignant|1383|42367071|Male|Tumors of Neuroepthelial Tissue|2007
0-19|0.6|0.8|0.7|Benign/Borderline|287|42541971|Male|Tumors of Neuroepthelial Tissue|2008
0-19|3.2|3.6|3.4|Malignant|1442|42541971|Male|Tumors of Neuroepthelial Tissue|2008
0-19|0.6|0.7|0.6|Benign/Borderline|276|42609915|Male|Tumors of Neuroepthelial Tissue|2009
0-19|3.2|3.5|3.3|Malignant|1420|42609915|Male|Tumors of Neuroepthelial Tissue|2009
0-19|0.6|0.8|0.7|Benign/Borderline|294|42569785|Male|Tumors of Neuroepthelial Tissue|2010
0-19|3.3|3.6|3.4|Malignant|1457|42569785|Male|Tumors of Neuroepthelial Tissue|2010
0-19|0.7|0.8|0.7|Benign/Borderline|315|42470382|Male|Tumors of Neuroepthelial Tissue|2011
0-19|3.3|3.7|3.5|Malignant|1469|42470382|Male|Tumors of Neuroepthelial Tissue|2011
0-19|0.7|0.9|0.8|Benign/Borderline|328|42360866|Male|Tumors of Neuroepthelial Tissue|2012
0-19|3.3|3.7|3.5|Malignant|1471|42360866|Male|Tumors of Neuroepthelial Tissue|2012
0-19|0.7|0.8|0.7|Benign/Borderline|312|42299716|Male|Tumors of Neuroepthelial Tissue|2013
0-19|3.3|3.6|3.4|Malignant|1449|42299716|Male|Tumors of Neuroepthelial Tissue|2013
0-19|0.6|0.8|0.7|Benign/Borderline|300|42297680|Male|Tumors of Neuroepthelial Tissue|2014
0-19|3.2|3.6|3.4|Malignant|1421|42297680|Male|Tumors of Neuroepthelial Tissue|2014
0-19|0.7|0.9|0.8|Benign/Borderline|333|42356807|Male|Tumors of Neuroepthelial Tissue|2015
0-19|3.3|3.6|3.5|Malignant|1456|42356807|Male|Tumors of Neuroepthelial Tissue|2015
0-19|0.8|0.9|0.9|Benign/Borderline|364|42451872|Male|Tumors of Neuroepthelial Tissue|2016
0-19|3.2|3.5|3.4|Malignant|1417|42451872|Male|Tumors of Neuroepthelial Tissue|2016
0-19|0.8|0.9|0.8|Benign/Borderline|356|42510556|Male|Tumors of Neuroepthelial Tissue|2017
0-19|3.4|3.7|3.6|Malignant|1504|42510556|Male|Tumors of Neuroepthelial Tissue|2017
0-19|0.8|0.9|0.9|Benign/Borderline|1824|206836549|Male|Tumors of Neuroepthelial Tissue|2017-2021
0-19|2.7|2.9|2.8|Malignant|5789|206836549|Male|Tumors of Neuroepthelial Tissue|2017-2021
0-19|0.9|1.1|1.0|Benign/Borderline|425|42511405|Male|Tumors of Neuroepthelial Tissue|2018
0-19|2.6|3.0|2.8|Malignant|1179|42511405|Male|Tumors of Neuroepthelial Tissue|2018
0-19|0.9|1.1|1.0|Benign/Borderline|427|42449660|Male|Tumors of Neuroepthelial Tissue|2019
0-19|2.5|2.8|2.7|Malignant|1117|42449660|Male|Tumors of Neuroepthelial Tissue|2019
0-19|0.7|0.9|0.8|Benign/Borderline|326|41306203|Male|Tumors of Neuroepthelial Tissue|2020
0-19|2.4|2.7|2.6|Malignant|1047|41306203|Male|Tumors of Neuroepthelial Tissue|2020
0-19|0.7|0.9|0.8|Benign/Borderline|315|40796026|Male|Tumors of Neuroepthelial Tissue|2021
0-19|2.4|2.7|2.5|Malignant|1028|40796026|Male|Tumors of Neuroepthelial Tissue|2021
0-19|0.3|0.5|0.4|Benign/Borderline|171|41889233|Male|Tumors of Sellar Region|2004
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of Sellar Region|2004
0-19|0.4|0.6|0.5|Benign/Borderline|218|42006384|Male|Tumors of Sellar Region|2005
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of Sellar Region|2005
0-19|0.4|0.5|0.4|Benign/Borderline|183|42158997|Male|Tumors of Sellar Region|2006
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of Sellar Region|2006
0-19|0.4|0.5|0.5|Benign/Borderline|205|42367071|Male|Tumors of Sellar Region|2007
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of Sellar Region|2007
0-19|0.5|0.6|0.5|Benign/Borderline|232|42541971|Male|Tumors of Sellar Region|2008
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of Sellar Region|2008
0-19|0.5|0.6|0.6|Benign/Borderline|244|42609915|Male|Tumors of Sellar Region|2009
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of Sellar Region|2009
0-19|0.5|0.6|0.5|Benign/Borderline|227|42569785|Male|Tumors of Sellar Region|2010
0-19|~|~|~|Malignant|~|42569785|Male|Tumors of Sellar Region|2010
0-19|0.5|0.6|0.5|Benign/Borderline|224|42470382|Male|Tumors of Sellar Region|2011
0-19|~|~|~|Malignant|~|42470382|Male|Tumors of Sellar Region|2011
0-19|0.5|0.7|0.6|Benign/Borderline|260|42360866|Male|Tumors of Sellar Region|2012
0-19|~|~|~|Malignant|~|42360866|Male|Tumors of Sellar Region|2012
0-19|0.6|0.7|0.6|Benign/Borderline|275|42299716|Male|Tumors of Sellar Region|2013
0-19|~|~|~|Malignant|~|42299716|Male|Tumors of Sellar Region|2013
0-19|0.7|0.8|0.7|Benign/Borderline|312|42297680|Male|Tumors of Sellar Region|2014
0-19|~|~|~|Malignant|~|42297680|Male|Tumors of Sellar Region|2014
0-19|0.6|0.7|0.6|Benign/Borderline|273|42356807|Male|Tumors of Sellar Region|2015
0-19|~|~|~|Malignant|~|42356807|Male|Tumors of Sellar Region|2015
0-19|0.6|0.8|0.7|Benign/Borderline|291|42451872|Male|Tumors of Sellar Region|2016
0-19|~|~|~|Malignant|~|42451872|Male|Tumors of Sellar Region|2016
0-19|0.7|0.9|0.8|Benign/Borderline|337|42510556|Male|Tumors of Sellar Region|2017
0-19|~|~|~|Malignant|~|42510556|Male|Tumors of Sellar Region|2017
0-19|0.6|0.7|0.7|Benign/Borderline|1414|206836549|Male|Tumors of Sellar Region|2017-2021
0-19|~|~|~|Malignant|~|206836549|Male|Tumors of Sellar Region|2017-2021
0-19|0.6|0.8|0.7|Benign/Borderline|308|42511405|Male|Tumors of Sellar Region|2018
0-19|~|~|~|Malignant|~|42511405|Male|Tumors of Sellar Region|2018
0-19|0.6|0.8|0.7|Benign/Borderline|291|42449660|Male|Tumors of Sellar Region|2019
0-19|~|~|~|Malignant|~|42449660|Male|Tumors of Sellar Region|2019
0-19|0.5|0.6|0.6|Benign/Borderline|239|41306203|Male|Tumors of Sellar Region|2020
0-19|~|~|~|Malignant|~|41306203|Male|Tumors of Sellar Region|2020
0-19|0.5|0.7|0.6|Benign/Borderline|258|40796026|Male|Tumors of Sellar Region|2021
0-19|~|~|~|Malignant|~|40796026|Male|Tumors of Sellar Region|2021
0-19|0.1|0.2|0.2|Benign/Borderline|79|41889233|Male|Tumors of the Meninges|2004
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of the Meninges|2004
0-19|0.2|0.2|0.2|Benign/Borderline|86|42006384|Male|Tumors of the Meninges|2005
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of the Meninges|2005
0-19|0.2|0.3|0.2|Benign/Borderline|89|42158997|Male|Tumors of the Meninges|2006
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of the Meninges|2006
0-19|0.2|0.2|0.2|Benign/Borderline|85|42367071|Male|Tumors of the Meninges|2007
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of the Meninges|2007
0-19|0.2|0.3|0.2|Benign/Borderline|91|42541971|Male|Tumors of the Meninges|2008
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of the Meninges|2008
0-19|0.2|0.3|0.2|Benign/Borderline|100|42609915|Male|Tumors of the Meninges|2009
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of the Meninges|2009
0-19|0.2|0.3|0.2|Benign/Borderline|94|42569785|Male|Tumors of the Meninges|2010
0-19|~|~|~|Malignant|~|42569785|Male|Tumors of the Meninges|2010
0-19|0.2|0.3|0.3|Benign/Borderline|122|42470382|Male|Tumors of the Meninges|2011
0-19|~|~|~|Malignant|~|42470382|Male|Tumors of the Meninges|2011
0-19|0.3|0.4|0.3|Benign/Borderline|132|42360866|Male|Tumors of the Meninges|2012
0-19|~|~|~|Malignant|~|42360866|Male|Tumors of the Meninges|2012
0-19|0.2|0.3|0.3|Benign/Borderline|110|42299716|Male|Tumors of the Meninges|2013
0-19|~|~|~|Malignant|~|42299716|Male|Tumors of the Meninges|2013
0-19|0.2|0.3|0.3|Benign/Borderline|114|42297680|Male|Tumors of the Meninges|2014
0-19|~|~|~|Malignant|~|42297680|Male|Tumors of the Meninges|2014
0-19|0.2|0.3|0.3|Benign/Borderline|123|42356807|Male|Tumors of the Meninges|2015
0-19|~|~|~|Malignant|~|42356807|Male|Tumors of the Meninges|2015
0-19|0.2|0.3|0.3|Benign/Borderline|118|42451872|Male|Tumors of the Meninges|2016
0-19|~|~|~|Malignant|~|42451872|Male|Tumors of the Meninges|2016
0-19|0.3|0.4|0.3|Benign/Borderline|134|42510556|Male|Tumors of the Meninges|2017
0-19|~|~|~|Malignant|~|42510556|Male|Tumors of the Meninges|2017
0-19|0.3|0.3|0.3|Benign/Borderline|600|206836549|Male|Tumors of the Meninges|2017-2021
0-19|0.0|0.0|0.0|Malignant|60|206836549|Male|Tumors of the Meninges|2017-2021
0-19|0.3|0.4|0.4|Benign/Borderline|154|42511405|Male|Tumors of the Meninges|2018
0-19|~|~|~|Malignant|~|42511405|Male|Tumors of the Meninges|2018
0-19|0.2|0.3|0.2|Benign/Borderline|106|42449660|Male|Tumors of the Meninges|2019
0-19|~|~|~|Malignant|~|42449660|Male|Tumors of the Meninges|2019
0-19|0.2|0.3|0.3|Benign/Borderline|108|41306203|Male|Tumors of the Meninges|2020
0-19|0.0|0.1|0.0|Malignant|19|41306203|Male|Tumors of the Meninges|2020
0-19|0.2|0.3|0.2|Benign/Borderline|102|40796026|Male|Tumors of the Meninges|2021
0-19|0.0|0.1|0.0|Malignant|16|40796026|Male|Tumors of the Meninges|2021
0-19|0.1|0.2|0.2|Benign/Borderline|64|41889233|Male|Unclassified Tumors|2004
0-19|0.0|0.1|0.0|Malignant|16|41889233|Male|Unclassified Tumors|2004
0-19|0.2|0.2|0.2|Benign/Borderline|81|42006384|Male|Unclassified Tumors|2005
0-19|0.0|0.1|0.0|Malignant|19|42006384|Male|Unclassified Tumors|2005
0-19|0.2|0.3|0.2|Benign/Borderline|94|42158997|Male|Unclassified Tumors|2006
0-19|0.0|0.1|0.1|Malignant|24|42158997|Male|Unclassified Tumors|2006
0-19|0.2|0.3|0.3|Benign/Borderline|122|42367071|Male|Unclassified Tumors|2007
0-19|0.0|0.1|0.1|Malignant|25|42367071|Male|Unclassified Tumors|2007
0-19|0.2|0.3|0.2|Benign/Borderline|99|42541971|Male|Unclassified Tumors|2008
0-19|0.0|0.1|0.0|Malignant|21|42541971|Male|Unclassified Tumors|2008
0-19|0.3|0.4|0.4|Benign/Borderline|152|42609915|Male|Unclassified Tumors|2009
0-19|0.0|0.1|0.1|Malignant|22|42609915|Male|Unclassified Tumors|2009
0-19|0.3|0.4|0.3|Benign/Borderline|138|42569785|Male|Unclassified Tumors|2010
0-19|0.0|0.1|0.0|Malignant|18|42569785|Male|Unclassified Tumors|2010
0-19|0.3|0.4|0.3|Benign/Borderline|150|42470382|Male|Unclassified Tumors|2011
0-19|~|~|~|Malignant|~|42470382|Male|Unclassified Tumors|2011
0-19|0.3|0.4|0.3|Benign/Borderline|128|42360866|Male|Unclassified Tumors|2012
0-19|0.0|0.1|0.1|Malignant|31|42360866|Male|Unclassified Tumors|2012
0-19|0.3|0.4|0.3|Benign/Borderline|135|42299716|Male|Unclassified Tumors|2013
0-19|0.0|0.1|0.0|Malignant|21|42299716|Male|Unclassified Tumors|2013
0-19|0.3|0.4|0.3|Benign/Borderline|134|42297680|Male|Unclassified Tumors|2014
0-19|0.0|0.1|0.1|Malignant|24|42297680|Male|Unclassified Tumors|2014
0-19|0.2|0.3|0.3|Benign/Borderline|123|42356807|Male|Unclassified Tumors|2015
0-19|0.0|0.1|0.0|Malignant|21|42356807|Male|Unclassified Tumors|2015
0-19|0.3|0.4|0.4|Benign/Borderline|155|42451872|Male|Unclassified Tumors|2016
0-19|0.0|0.1|0.1|Malignant|22|42451872|Male|Unclassified Tumors|2016
0-19|0.3|0.4|0.3|Benign/Borderline|134|42510556|Male|Unclassified Tumors|2017
0-19|0.0|0.1|0.1|Malignant|30|42510556|Male|Unclassified Tumors|2017
0-19|0.2|0.3|0.3|Benign/Borderline|552|206836549|Male|Unclassified Tumors|2017-2021
0-19|0.1|0.1|0.1|Malignant|131|206836549|Male|Unclassified Tumors|2017-2021
0-19|0.3|0.4|0.3|Benign/Borderline|129|42511405|Male|Unclassified Tumors|2018
0-19|0.0|0.1|0.0|Malignant|20|42511405|Male|Unclassified Tumors|2018
0-19|0.2|0.3|0.2|Benign/Borderline|105|42449660|Male|Unclassified Tumors|2019
0-19|0.0|0.1|0.1|Malignant|21|42449660|Male|Unclassified Tumors|2019
0-19|0.2|0.3|0.2|Benign/Borderline|93|41306203|Male|Unclassified Tumors|2020
0-19|0.0|0.1|0.1|Malignant|30|41306203|Male|Unclassified Tumors|2020
0-19|0.2|0.3|0.2|Benign/Borderline|95|40796026|Male|Unclassified Tumors|2021
0-19|0.1|0.1|0.1|Malignant|31|40796026|Male|Unclassified Tumors|2021
0-19|0.1|0.1|0.1|Benign/Borderline|34|41889233|Male|Unique astrocytoma variants|2004
0-19|~|~|~|Malignant|~|41889233|Male|Unique astrocytoma variants|2004
0-19|0.1|0.1|0.1|Benign/Borderline|38|42006384|Male|Unique astrocytoma variants|2005
0-19|~|~|~|Malignant|~|42006384|Male|Unique astrocytoma variants|2005
0-19|0.0|0.1|0.1|Benign/Borderline|26|42158997|Male|Unique astrocytoma variants|2006
0-19|0.0|0.1|0.0|Malignant|18|42158997|Male|Unique astrocytoma variants|2006
0-19|0.1|0.1|0.1|Benign/Borderline|32|42367071|Male|Unique astrocytoma variants|2007
0-19|0.0|0.1|0.1|Malignant|23|42367071|Male|Unique astrocytoma variants|2007
0-19|0.1|0.1|0.1|Benign/Borderline|43|42541971|Male|Unique astrocytoma variants|2008
0-19|0.0|0.1|0.0|Malignant|19|42541971|Male|Unique astrocytoma variants|2008
0-19|0.1|0.1|0.1|Benign/Borderline|45|42609915|Male|Unique astrocytoma variants|2009
0-19|0.0|0.1|0.1|Malignant|24|42609915|Male|Unique astrocytoma variants|2009
0-19|0.1|0.1|0.1|Benign/Borderline|35|42569785|Male|Unique astrocytoma variants|2010
0-19|0.0|0.1|0.0|Malignant|16|42569785|Male|Unique astrocytoma variants|2010
0-19|0.1|0.2|0.1|Benign/Borderline|50|42470382|Male|Unique astrocytoma variants|2011
0-19|0.0|0.1|0.1|Malignant|29|42470382|Male|Unique astrocytoma variants|2011
0-19|0.1|0.1|0.1|Benign/Borderline|45|42360866|Male|Unique astrocytoma variants|2012
0-19|0.0|0.1|0.1|Malignant|26|42360866|Male|Unique astrocytoma variants|2012
0-19|0.1|0.1|0.1|Benign/Borderline|40|42299716|Male|Unique astrocytoma variants|2013
0-19|0.0|0.1|0.1|Malignant|26|42299716|Male|Unique astrocytoma variants|2013
0-19|0.1|0.2|0.1|Benign/Borderline|52|42297680|Male|Unique astrocytoma variants|2014
0-19|0.0|0.1|0.1|Malignant|26|42297680|Male|Unique astrocytoma variants|2014
0-19|0.0|0.1|0.1|Benign/Borderline|30|42356807|Male|Unique astrocytoma variants|2015
0-19|0.0|0.1|0.1|Malignant|26|42356807|Male|Unique astrocytoma variants|2015
0-19|0.1|0.1|0.1|Benign/Borderline|38|42451872|Male|Unique astrocytoma variants|2016
0-19|0.0|0.1|0.1|Malignant|28|42451872|Male|Unique astrocytoma variants|2016
0-19|0.1|0.1|0.1|Benign/Borderline|36|42510556|Male|Unique astrocytoma variants|2017
0-19|0.0|0.1|0.0|Malignant|17|42510556|Male|Unique astrocytoma variants|2017
0-19|0.1|0.1|0.1|Benign/Borderline|156|206836549|Male|Unique astrocytoma variants|2017-2021
0-19|0.0|0.1|0.0|Malignant|94|206836549|Male|Unique astrocytoma variants|2017-2021
0-19|0.1|0.1|0.1|Benign/Borderline|40|42511405|Male|Unique astrocytoma variants|2018
0-19|0.0|0.1|0.1|Malignant|23|42511405|Male|Unique astrocytoma variants|2018
0-19|0.1|0.1|0.1|Benign/Borderline|33|42449660|Male|Unique astrocytoma variants|2019
0-19|0.0|0.1|0.1|Malignant|23|42449660|Male|Unique astrocytoma variants|2019
0-19|0.0|0.1|0.0|Benign/Borderline|20|41306203|Male|Unique astrocytoma variants|2020
0-19|0.0|0.1|0.0|Malignant|16|41306203|Male|Unique astrocytoma variants|2020
0-19|0.0|0.1|0.1|Benign/Borderline|28|40796026|Male|Unique astrocytoma variants|2021
0-19|0.0|0.1|0.0|Malignant|20|40796026|Male|Unique astrocytoma variants|2021
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|All other|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|All other|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|All other|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|All other|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|All other|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|All other|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|All other|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|All other|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|All other|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|All other|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|All other|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|All other|2009
0-19|~|~|~|Benign/Borderline|~|83218950|Male and Female|All other|2010
0-19|0.0|0.0|0.0|Malignant|24|83218950|Male and Female|All other|2010
0-19|~|~|~|Benign/Borderline|~|83011324|Male and Female|All other|2011
0-19|~|~|~|Malignant|~|83011324|Male and Female|All other|2011
0-19|~|~|~|Benign/Borderline|~|82811054|Male and Female|All other|2012
0-19|~|~|~|Malignant|~|82811054|Male and Female|All other|2012
0-19|~|~|~|Benign/Borderline|~|82716398|Male and Female|All other|2013
0-19|~|~|~|Malignant|~|82716398|Male and Female|All other|2013
0-19|~|~|~|Benign/Borderline|~|82718202|Male and Female|All other|2014
0-19|~|~|~|Malignant|~|82718202|Male and Female|All other|2014
0-19|~|~|~|Benign/Borderline|~|82835167|Male and Female|All other|2015
0-19|0.0|0.0|0.0|Malignant|19|82835167|Male and Female|All other|2015
0-19|~|~|~|Benign/Borderline|~|83018369|Male and Female|All other|2016
0-19|0.0|0.0|0.0|Malignant|19|83018369|Male and Female|All other|2016
0-19|~|~|~|Benign/Borderline|~|83117707|Male and Female|All other|2017
0-19|~|~|~|Malignant|~|83117707|Male and Female|All other|2017
0-19|0.1|0.1|0.1|Benign/Borderline|269|404367531|Male and Female|All other|2017-2021
0-19|0.3|0.3|0.3|Malignant|1187|404367531|Male and Female|All other|2017-2021
0-19|0.0|0.1|0.1|Benign/Borderline|46|83111569|Male and Female|All other|2018
0-19|0.3|0.3|0.3|Malignant|254|83111569|Male and Female|All other|2018
0-19|0.1|0.1|0.1|Benign/Borderline|75|82986327|Male and Female|All other|2019
0-19|0.3|0.4|0.4|Malignant|313|82986327|Male and Female|All other|2019
0-19|0.1|0.1|0.1|Benign/Borderline|68|80749239|Male and Female|All other|2020
0-19|0.3|0.4|0.4|Malignant|294|80749239|Male and Female|All other|2020
0-19|0.1|0.1|0.1|Benign/Borderline|70|79740141|Male and Female|All other|2021
0-19|0.4|0.5|0.4|Malignant|327|79740141|Male and Female|All other|2021
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Anaplastic astrocytoma|2004
0-19|0.1|0.1|0.1|Malignant|70|81754354|Male and Female|Anaplastic astrocytoma|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Anaplastic astrocytoma|2005
0-19|0.1|0.1|0.1|Malignant|61|82005260|Male and Female|Anaplastic astrocytoma|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Anaplastic astrocytoma|2006
0-19|0.1|0.1|0.1|Malignant|67|82324418|Male and Female|Anaplastic astrocytoma|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Anaplastic astrocytoma|2007
0-19|0.1|0.1|0.1|Malignant|87|82749431|Male and Female|Anaplastic astrocytoma|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Anaplastic astrocytoma|2008
0-19|0.1|0.1|0.1|Malignant|74|83118264|Male and Female|Anaplastic astrocytoma|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Anaplastic astrocytoma|2009
0-19|0.1|0.1|0.1|Malignant|70|83280391|Male and Female|Anaplastic astrocytoma|2009
0-19|~|~|~|Benign/Borderline|~|83218950|Male and Female|Anaplastic astrocytoma|2010
0-19|0.1|0.1|0.1|Malignant|84|83218950|Male and Female|Anaplastic astrocytoma|2010
0-19|~|~|~|Benign/Borderline|~|83011324|Male and Female|Anaplastic astrocytoma|2011
0-19|0.1|0.1|0.1|Malignant|72|83011324|Male and Female|Anaplastic astrocytoma|2011
0-19|~|~|~|Benign/Borderline|~|82811054|Male and Female|Anaplastic astrocytoma|2012
0-19|0.1|0.1|0.1|Malignant|68|82811054|Male and Female|Anaplastic astrocytoma|2012
0-19|~|~|~|Benign/Borderline|~|82716398|Male and Female|Anaplastic astrocytoma|2013
0-19|0.1|0.1|0.1|Malignant|96|82716398|Male and Female|Anaplastic astrocytoma|2013
0-19|~|~|~|Benign/Borderline|~|82718202|Male and Female|Anaplastic astrocytoma|2014
0-19|0.1|0.1|0.1|Malignant|97|82718202|Male and Female|Anaplastic astrocytoma|2014
0-19|~|~|~|Benign/Borderline|~|82835167|Male and Female|Anaplastic astrocytoma|2015
0-19|0.1|0.1|0.1|Malignant|81|82835167|Male and Female|Anaplastic astrocytoma|2015
0-19|~|~|~|Benign/Borderline|~|83018369|Male and Female|Anaplastic astrocytoma|2016
0-19|0.1|0.1|0.1|Malignant|74|83018369|Male and Female|Anaplastic astrocytoma|2016
0-19|~|~|~|Benign/Borderline|~|83117707|Male and Female|Anaplastic astrocytoma|2017
0-19|0.1|0.1|0.1|Malignant|60|83117707|Male and Female|Anaplastic astrocytoma|2017
0-19|~|~|~|Benign/Borderline|~|404367531|Male and Female|Anaplastic astrocytoma|2017-2021
0-19|0.1|0.1|0.1|Malignant|256|404367531|Male and Female|Anaplastic astrocytoma|2017-2021
0-19|~|~|~|Benign/Borderline|~|83111569|Male and Female|Anaplastic astrocytoma|2018
0-19|0.1|0.1|0.1|Malignant|62|83111569|Male and Female|Anaplastic astrocytoma|2018
0-19|~|~|~|Benign/Borderline|~|82986327|Male and Female|Anaplastic astrocytoma|2019
0-19|0.1|0.1|0.1|Malignant|66|82986327|Male and Female|Anaplastic astrocytoma|2019
0-19|~|~|~|Benign/Borderline|~|80749239|Male and Female|Anaplastic astrocytoma|2020
0-19|0.0|0.1|0.1|Malignant|44|80749239|Male and Female|Anaplastic astrocytoma|2020
0-19|~|~|~|Benign/Borderline|~|79740141|Male and Female|Anaplastic astrocytoma|2021
0-19|0.0|0.0|0.0|Malignant|25|79740141|Male and Female|Anaplastic astrocytoma|2021
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Anaplastic oligodendroglioma|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Anaplastic oligodendroglioma|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Anaplastic oligodendroglioma|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Anaplastic oligodendroglioma|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Anaplastic oligodendroglioma|2006
0-19|0.0|0.0|0.0|Malignant|17|82324418|Male and Female|Anaplastic oligodendroglioma|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Anaplastic oligodendroglioma|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Anaplastic oligodendroglioma|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Anaplastic oligodendroglioma|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Anaplastic oligodendroglioma|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Anaplastic oligodendroglioma|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Anaplastic oligodendroglioma|2009
0-19|~|~|~|Benign/Borderline|~|83218950|Male and Female|Anaplastic oligodendroglioma|2010
0-19|~|~|~|Malignant|~|83218950|Male and Female|Anaplastic oligodendroglioma|2010
0-19|~|~|~|Benign/Borderline|~|83011324|Male and Female|Anaplastic oligodendroglioma|2011
0-19|~|~|~|Malignant|~|83011324|Male and Female|Anaplastic oligodendroglioma|2011
0-19|~|~|~|Benign/Borderline|~|82811054|Male and Female|Anaplastic oligodendroglioma|2012
0-19|~|~|~|Malignant|~|82811054|Male and Female|Anaplastic oligodendroglioma|2012
0-19|~|~|~|Benign/Borderline|~|82716398|Male and Female|Anaplastic oligodendroglioma|2013
0-19|~|~|~|Malignant|~|82716398|Male and Female|Anaplastic oligodendroglioma|2013
0-19|~|~|~|Benign/Borderline|~|82718202|Male and Female|Anaplastic oligodendroglioma|2014
0-19|~|~|~|Malignant|~|82718202|Male and Female|Anaplastic oligodendroglioma|2014
0-19|~|~|~|Benign/Borderline|~|82835167|Male and Female|Anaplastic oligodendroglioma|2015
0-19|~|~|~|Malignant|~|82835167|Male and Female|Anaplastic oligodendroglioma|2015
0-19|~|~|~|Benign/Borderline|~|83018369|Male and Female|Anaplastic oligodendroglioma|2016
0-19|~|~|~|Malignant|~|83018369|Male and Female|Anaplastic oligodendroglioma|2016
0-19|~|~|~|Benign/Borderline|~|83117707|Male and Female|Anaplastic oligodendroglioma|2017
0-19|~|~|~|Malignant|~|83117707|Male and Female|Anaplastic oligodendroglioma|2017
0-19|~|~|~|Benign/Borderline|~|404367531|Male and Female|Anaplastic oligodendroglioma|2017-2021
0-19|~|~|~|Malignant|~|404367531|Male and Female|Anaplastic oligodendroglioma|2017-2021
0-19|~|~|~|Benign/Borderline|~|83111569|Male and Female|Anaplastic oligodendroglioma|2018
0-19|~|~|~|Malignant|~|83111569|Male and Female|Anaplastic oligodendroglioma|2018
0-19|~|~|~|Benign/Borderline|~|82986327|Male and Female|Anaplastic oligodendroglioma|2019
0-19|~|~|~|Malignant|~|82986327|Male and Female|Anaplastic oligodendroglioma|2019
0-19|~|~|~|Benign/Borderline|~|80749239|Male and Female|Anaplastic oligodendroglioma|2020
0-19|~|~|~|Malignant|~|80749239|Male and Female|Anaplastic oligodendroglioma|2020
0-19|~|~|~|Benign/Borderline|~|79740141|Male and Female|Anaplastic oligodendroglioma|2021
0-19|~|~|~|Malignant|~|79740141|Male and Female|Anaplastic oligodendroglioma|2021
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Astrocytoma, NOS|2004
0-19|0.2|0.3|0.2|Malignant|200|81754354|Male and Female|Astrocytoma, NOS|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Astrocytoma, NOS|2005
0-19|0.2|0.3|0.2|Malignant|190|82005260|Male and Female|Astrocytoma, NOS|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Astrocytoma, NOS|2006
0-19|0.2|0.3|0.2|Malignant|197|82324418|Male and Female|Astrocytoma, NOS|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Astrocytoma, NOS|2007
0-19|0.2|0.3|0.2|Malignant|184|82749431|Male and Female|Astrocytoma, NOS|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Astrocytoma, NOS|2008
0-19|0.2|0.3|0.2|Malignant|181|83118264|Male and Female|Astrocytoma, NOS|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Astrocytoma, NOS|2009
0-19|0.2|0.3|0.2|Malignant|205|83280391|Male and Female|Astrocytoma, NOS|2009
0-19|~|~|~|Benign/Borderline|~|83218950|Male and Female|Astrocytoma, NOS|2010
0-19|0.2|0.3|0.3|Malignant|212|83218950|Male and Female|Astrocytoma, NOS|2010
0-19|~|~|~|Benign/Borderline|~|83011324|Male and Female|Astrocytoma, NOS|2011
0-19|0.2|0.3|0.2|Malignant|182|83011324|Male and Female|Astrocytoma, NOS|2011
0-19|~|~|~|Benign/Borderline|~|82811054|Male and Female|Astrocytoma, NOS|2012
0-19|0.2|0.2|0.2|Malignant|164|82811054|Male and Female|Astrocytoma, NOS|2012
0-19|~|~|~|Benign/Borderline|~|82716398|Male and Female|Astrocytoma, NOS|2013
0-19|0.2|0.3|0.2|Malignant|190|82716398|Male and Female|Astrocytoma, NOS|2013
0-19|~|~|~|Benign/Borderline|~|82718202|Male and Female|Astrocytoma, NOS|2014
0-19|0.2|0.3|0.3|Malignant|217|82718202|Male and Female|Astrocytoma, NOS|2014
0-19|~|~|~|Benign/Borderline|~|82835167|Male and Female|Astrocytoma, NOS|2015
0-19|0.2|0.2|0.2|Malignant|170|82835167|Male and Female|Astrocytoma, NOS|2015
0-19|~|~|~|Benign/Borderline|~|83018369|Male and Female|Astrocytoma, NOS|2016
0-19|0.2|0.2|0.2|Malignant|175|83018369|Male and Female|Astrocytoma, NOS|2016
0-19|~|~|~|Benign/Borderline|~|83117707|Male and Female|Astrocytoma, NOS|2017
0-19|0.2|0.3|0.2|Malignant|186|83117707|Male and Female|Astrocytoma, NOS|2017
0-19|~|~|~|Benign/Borderline|~|404367531|Male and Female|Astrocytoma, NOS|2017-2021
0-19|0.2|0.2|0.2|Malignant|732|404367531|Male and Female|Astrocytoma, NOS|2017-2021
0-19|~|~|~|Benign/Borderline|~|83111569|Male and Female|Astrocytoma, NOS|2018
0-19|0.2|0.3|0.2|Malignant|180|83111569|Male and Female|Astrocytoma, NOS|2018
0-19|~|~|~|Benign/Borderline|~|82986327|Male and Female|Astrocytoma, NOS|2019
0-19|0.2|0.2|0.2|Malignant|149|82986327|Male and Female|Astrocytoma, NOS|2019
0-19|~|~|~|Benign/Borderline|~|80749239|Male and Female|Astrocytoma, NOS|2020
0-19|0.1|0.1|0.1|Malignant|99|80749239|Male and Female|Astrocytoma, NOS|2020
0-19|~|~|~|Benign/Borderline|~|79740141|Male and Female|Astrocytoma, NOS|2021
0-19|0.1|0.2|0.2|Malignant|130|79740141|Male and Female|Astrocytoma, NOS|2021
0-19|0.1|0.1|0.1|Benign/Borderline|57|81754354|Male and Female|Choroid plexus|2004
0-19|0.0|0.0|0.0|Malignant|21|81754354|Male and Female|Choroid plexus|2004
0-19|0.1|0.1|0.1|Benign/Borderline|56|82005260|Male and Female|Choroid plexus|2005
0-19|0.0|0.0|0.0|Malignant|24|82005260|Male and Female|Choroid plexus|2005
0-19|0.1|0.1|0.1|Benign/Borderline|68|82324418|Male and Female|Choroid plexus|2006
0-19|0.0|0.0|0.0|Malignant|21|82324418|Male and Female|Choroid plexus|2006
0-19|0.1|0.1|0.1|Benign/Borderline|66|82749431|Male and Female|Choroid plexus|2007
0-19|0.0|0.0|0.0|Malignant|21|82749431|Male and Female|Choroid plexus|2007
0-19|0.1|0.1|0.1|Benign/Borderline|79|83118264|Male and Female|Choroid plexus|2008
0-19|0.0|0.0|0.0|Malignant|21|83118264|Male and Female|Choroid plexus|2008
0-19|0.1|0.1|0.1|Benign/Borderline|62|83280391|Male and Female|Choroid plexus|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Choroid plexus|2009
0-19|0.1|0.1|0.1|Benign/Borderline|69|83218950|Male and Female|Choroid plexus|2010
0-19|0.0|0.0|0.0|Malignant|23|83218950|Male and Female|Choroid plexus|2010
0-19|0.1|0.1|0.1|Benign/Borderline|61|83011324|Male and Female|Choroid plexus|2011
0-19|0.0|0.0|0.0|Malignant|21|83011324|Male and Female|Choroid plexus|2011
0-19|0.1|0.1|0.1|Benign/Borderline|62|82811054|Male and Female|Choroid plexus|2012
0-19|0.0|0.0|0.0|Malignant|19|82811054|Male and Female|Choroid plexus|2012
0-19|0.1|0.1|0.1|Benign/Borderline|68|82716398|Male and Female|Choroid plexus|2013
0-19|0.0|0.0|0.0|Malignant|16|82716398|Male and Female|Choroid plexus|2013
0-19|0.1|0.1|0.1|Benign/Borderline|56|82718202|Male and Female|Choroid plexus|2014
0-19|0.0|0.0|0.0|Malignant|28|82718202|Male and Female|Choroid plexus|2014
0-19|0.1|0.1|0.1|Benign/Borderline|66|82835167|Male and Female|Choroid plexus|2015
0-19|0.0|0.0|0.0|Malignant|22|82835167|Male and Female|Choroid plexus|2015
0-19|0.1|0.1|0.1|Benign/Borderline|60|83018369|Male and Female|Choroid plexus|2016
0-19|0.0|0.0|0.0|Malignant|21|83018369|Male and Female|Choroid plexus|2016
0-19|0.1|0.1|0.1|Benign/Borderline|65|83117707|Male and Female|Choroid plexus|2017
0-19|0.0|0.0|0.0|Malignant|16|83117707|Male and Female|Choroid plexus|2017
0-19|0.1|0.1|0.1|Benign/Borderline|285|404367531|Male and Female|Choroid plexus|2017-2021
0-19|0.0|0.0|0.0|Malignant|83|404367531|Male and Female|Choroid plexus|2017-2021
0-19|0.1|0.1|0.1|Benign/Borderline|68|83111569|Male and Female|Choroid plexus|2018
0-19|0.0|0.0|0.0|Malignant|17|83111569|Male and Female|Choroid plexus|2018
0-19|0.1|0.1|0.1|Benign/Borderline|57|82986327|Male and Female|Choroid plexus|2019
0-19|0.0|0.0|0.0|Malignant|25|82986327|Male and Female|Choroid plexus|2019
0-19|0.1|0.1|0.1|Benign/Borderline|55|80749239|Male and Female|Choroid plexus|2020
0-19|~|~|~|Malignant|~|80749239|Male and Female|Choroid plexus|2020
0-19|0.0|0.1|0.1|Benign/Borderline|45|79740141|Male and Female|Choroid plexus|2021
0-19|~|~|~|Malignant|~|79740141|Male and Female|Choroid plexus|2021
0-19|0.2|0.2|0.2|Benign/Borderline|170|81754354|Male and Female|Craniopharyngioma|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Craniopharyngioma|2004
0-19|0.2|0.2|0.2|Benign/Borderline|172|82005260|Male and Female|Craniopharyngioma|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Craniopharyngioma|2005
0-19|0.2|0.2|0.2|Benign/Borderline|158|82324418|Male and Female|Craniopharyngioma|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Craniopharyngioma|2006
0-19|0.2|0.3|0.2|Benign/Borderline|185|82749431|Male and Female|Craniopharyngioma|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Craniopharyngioma|2007
0-19|0.2|0.2|0.2|Benign/Borderline|163|83118264|Male and Female|Craniopharyngioma|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Craniopharyngioma|2008
0-19|0.2|0.2|0.2|Benign/Borderline|173|83280391|Male and Female|Craniopharyngioma|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Craniopharyngioma|2009
0-19|0.2|0.3|0.2|Benign/Borderline|179|83218950|Male and Female|Craniopharyngioma|2010
0-19|~|~|~|Malignant|~|83218950|Male and Female|Craniopharyngioma|2010
0-19|0.2|0.2|0.2|Benign/Borderline|156|83011324|Male and Female|Craniopharyngioma|2011
0-19|~|~|~|Malignant|~|83011324|Male and Female|Craniopharyngioma|2011
0-19|0.2|0.2|0.2|Benign/Borderline|157|82811054|Male and Female|Craniopharyngioma|2012
0-19|~|~|~|Malignant|~|82811054|Male and Female|Craniopharyngioma|2012
0-19|0.2|0.3|0.2|Benign/Borderline|182|82716398|Male and Female|Craniopharyngioma|2013
0-19|~|~|~|Malignant|~|82716398|Male and Female|Craniopharyngioma|2013
0-19|0.2|0.3|0.2|Benign/Borderline|200|82718202|Male and Female|Craniopharyngioma|2014
0-19|~|~|~|Malignant|~|82718202|Male and Female|Craniopharyngioma|2014
0-19|0.2|0.3|0.2|Benign/Borderline|179|82835167|Male and Female|Craniopharyngioma|2015
0-19|~|~|~|Malignant|~|82835167|Male and Female|Craniopharyngioma|2015
0-19|0.2|0.2|0.2|Benign/Borderline|147|83018369|Male and Female|Craniopharyngioma|2016
0-19|~|~|~|Malignant|~|83018369|Male and Female|Craniopharyngioma|2016
0-19|0.2|0.3|0.2|Benign/Borderline|182|83117707|Male and Female|Craniopharyngioma|2017
0-19|~|~|~|Malignant|~|83117707|Male and Female|Craniopharyngioma|2017
0-19|0.2|0.2|0.2|Benign/Borderline|777|404367531|Male and Female|Craniopharyngioma|2017-2021
0-19|~|~|~|Malignant|~|404367531|Male and Female|Craniopharyngioma|2017-2021
0-19|0.2|0.2|0.2|Benign/Borderline|154|83111569|Male and Female|Craniopharyngioma|2018
0-19|~|~|~|Malignant|~|83111569|Male and Female|Craniopharyngioma|2018
0-19|0.2|0.2|0.2|Benign/Borderline|163|82986327|Male and Female|Craniopharyngioma|2019
0-19|~|~|~|Malignant|~|82986327|Male and Female|Craniopharyngioma|2019
0-19|0.1|0.2|0.2|Benign/Borderline|123|80749239|Male and Female|Craniopharyngioma|2020
0-19|~|~|~|Malignant|~|80749239|Male and Female|Craniopharyngioma|2020
0-19|0.2|0.2|0.2|Benign/Borderline|168|79740141|Male and Female|Craniopharyngioma|2021
0-19|~|~|~|Malignant|~|79740141|Male and Female|Craniopharyngioma|2021
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Diffuse astrocytoma|2004
0-19|0.0|0.1|0.1|Malignant|44|81754354|Male and Female|Diffuse astrocytoma|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Diffuse astrocytoma|2005
0-19|0.0|0.1|0.1|Malignant|43|82005260|Male and Female|Diffuse astrocytoma|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Diffuse astrocytoma|2006
0-19|0.0|0.1|0.0|Malignant|32|82324418|Male and Female|Diffuse astrocytoma|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Diffuse astrocytoma|2007
0-19|0.0|0.1|0.0|Malignant|41|82749431|Male and Female|Diffuse astrocytoma|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Diffuse astrocytoma|2008
0-19|0.0|0.1|0.1|Malignant|44|83118264|Male and Female|Diffuse astrocytoma|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Diffuse astrocytoma|2009
0-19|0.0|0.1|0.0|Malignant|39|83280391|Male and Female|Diffuse astrocytoma|2009
0-19|~|~|~|Benign/Borderline|~|83218950|Male and Female|Diffuse astrocytoma|2010
0-19|0.0|0.1|0.0|Malignant|32|83218950|Male and Female|Diffuse astrocytoma|2010
0-19|~|~|~|Benign/Borderline|~|83011324|Male and Female|Diffuse astrocytoma|2011
0-19|0.0|0.1|0.0|Malignant|35|83011324|Male and Female|Diffuse astrocytoma|2011
0-19|~|~|~|Benign/Borderline|~|82811054|Male and Female|Diffuse astrocytoma|2012
0-19|0.0|0.0|0.0|Malignant|28|82811054|Male and Female|Diffuse astrocytoma|2012
0-19|~|~|~|Benign/Borderline|~|82716398|Male and Female|Diffuse astrocytoma|2013
0-19|0.0|0.0|0.0|Malignant|16|82716398|Male and Female|Diffuse astrocytoma|2013
0-19|~|~|~|Benign/Borderline|~|82718202|Male and Female|Diffuse astrocytoma|2014
0-19|~|~|~|Malignant|~|82718202|Male and Female|Diffuse astrocytoma|2014
0-19|~|~|~|Benign/Borderline|~|82835167|Male and Female|Diffuse astrocytoma|2015
0-19|~|~|~|Malignant|~|82835167|Male and Female|Diffuse astrocytoma|2015
0-19|~|~|~|Benign/Borderline|~|83018369|Male and Female|Diffuse astrocytoma|2016
0-19|~|~|~|Malignant|~|83018369|Male and Female|Diffuse astrocytoma|2016
0-19|~|~|~|Benign/Borderline|~|83117707|Male and Female|Diffuse astrocytoma|2017
0-19|~|~|~|Malignant|~|83117707|Male and Female|Diffuse astrocytoma|2017
0-19|~|~|~|Benign/Borderline|~|404367531|Male and Female|Diffuse astrocytoma|2017-2021
0-19|~|~|~|Malignant|~|404367531|Male and Female|Diffuse astrocytoma|2017-2021
0-19|~|~|~|Benign/Borderline|~|83111569|Male and Female|Diffuse astrocytoma|2018
0-19|~|~|~|Malignant|~|83111569|Male and Female|Diffuse astrocytoma|2018
0-19|~|~|~|Benign/Borderline|~|82986327|Male and Female|Diffuse astrocytoma|2019
0-19|~|~|~|Malignant|~|82986327|Male and Female|Diffuse astrocytoma|2019
0-19|~|~|~|Benign/Borderline|~|80749239|Male and Female|Diffuse astrocytoma|2020
0-19|~|~|~|Malignant|~|80749239|Male and Female|Diffuse astrocytoma|2020
0-19|~|~|~|Benign/Borderline|~|79740141|Male and Female|Diffuse astrocytoma|2021
0-19|~|~|~|Malignant|~|79740141|Male and Female|Diffuse astrocytoma|2021
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Embryonal/primitive/medulloblastoma|2004
0-19|0.6|0.7|0.6|Malignant|507|81754354|Male and Female|Embryonal/primitive/medulloblastoma|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Embryonal/primitive/medulloblastoma|2005
0-19|0.5|0.6|0.6|Malignant|462|82005260|Male and Female|Embryonal/primitive/medulloblastoma|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Embryonal/primitive/medulloblastoma|2006
0-19|0.6|0.7|0.6|Malignant|501|82324418|Male and Female|Embryonal/primitive/medulloblastoma|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Embryonal/primitive/medulloblastoma|2007
0-19|0.6|0.7|0.6|Malignant|514|82749431|Male and Female|Embryonal/primitive/medulloblastoma|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Embryonal/primitive/medulloblastoma|2008
0-19|0.6|0.7|0.7|Malignant|551|83118264|Male and Female|Embryonal/primitive/medulloblastoma|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Embryonal/primitive/medulloblastoma|2009
0-19|0.6|0.7|0.6|Malignant|515|83280391|Male and Female|Embryonal/primitive/medulloblastoma|2009
0-19|~|~|~|Benign/Borderline|~|83218950|Male and Female|Embryonal/primitive/medulloblastoma|2010
0-19|0.5|0.6|0.6|Malignant|488|83218950|Male and Female|Embryonal/primitive/medulloblastoma|2010
0-19|~|~|~|Benign/Borderline|~|83011324|Male and Female|Embryonal/primitive/medulloblastoma|2011
0-19|0.6|0.7|0.6|Malignant|498|83011324|Male and Female|Embryonal/primitive/medulloblastoma|2011
0-19|~|~|~|Benign/Borderline|~|82811054|Male and Female|Embryonal/primitive/medulloblastoma|2012
0-19|0.5|0.6|0.6|Malignant|467|82811054|Male and Female|Embryonal/primitive/medulloblastoma|2012
0-19|~|~|~|Benign/Borderline|~|82716398|Male and Female|Embryonal/primitive/medulloblastoma|2013
0-19|0.5|0.6|0.6|Malignant|460|82716398|Male and Female|Embryonal/primitive/medulloblastoma|2013
0-19|~|~|~|Benign/Borderline|~|82718202|Male and Female|Embryonal/primitive/medulloblastoma|2014
0-19|0.5|0.7|0.6|Malignant|492|82718202|Male and Female|Embryonal/primitive/medulloblastoma|2014
0-19|~|~|~|Benign/Borderline|~|82835167|Male and Female|Embryonal/primitive/medulloblastoma|2015
0-19|0.5|0.7|0.6|Malignant|492|82835167|Male and Female|Embryonal/primitive/medulloblastoma|2015
0-19|~|~|~|Benign/Borderline|~|83018369|Male and Female|Embryonal/primitive/medulloblastoma|2016
0-19|0.5|0.6|0.6|Malignant|465|83018369|Male and Female|Embryonal/primitive/medulloblastoma|2016
0-19|~|~|~|Benign/Borderline|~|83117707|Male and Female|Embryonal/primitive/medulloblastoma|2017
0-19|0.5|0.6|0.6|Malignant|473|83117707|Male and Female|Embryonal/primitive/medulloblastoma|2017
0-19|~|~|~|Benign/Borderline|~|404367531|Male and Female|Embryonal/primitive/medulloblastoma|2017-2021
0-19|0.4|0.5|0.4|Malignant|1710|404367531|Male and Female|Embryonal/primitive/medulloblastoma|2017-2021
0-19|~|~|~|Benign/Borderline|~|83111569|Male and Female|Embryonal/primitive/medulloblastoma|2018
0-19|0.4|0.5|0.4|Malignant|360|83111569|Male and Female|Embryonal/primitive/medulloblastoma|2018
0-19|~|~|~|Benign/Borderline|~|82986327|Male and Female|Embryonal/primitive/medulloblastoma|2019
0-19|0.3|0.4|0.4|Malignant|293|82986327|Male and Female|Embryonal/primitive/medulloblastoma|2019
0-19|~|~|~|Benign/Borderline|~|80749239|Male and Female|Embryonal/primitive/medulloblastoma|2020
0-19|0.4|0.4|0.4|Malignant|316|80749239|Male and Female|Embryonal/primitive/medulloblastoma|2020
0-19|~|~|~|Benign/Borderline|~|79740141|Male and Female|Embryonal/primitive/medulloblastoma|2021
0-19|0.3|0.4|0.4|Malignant|290|79740141|Male and Female|Embryonal/primitive/medulloblastoma|2021
0-19|0.0|0.0|0.0|Benign/Borderline|25|81754354|Male and Female|Ependymoma variants|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Ependymoma variants|2004
0-19|0.0|0.0|0.0|Benign/Borderline|26|82005260|Male and Female|Ependymoma variants|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Ependymoma variants|2005
0-19|0.0|0.1|0.0|Benign/Borderline|40|82324418|Male and Female|Ependymoma variants|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Ependymoma variants|2006
0-19|0.0|0.1|0.0|Benign/Borderline|30|82749431|Male and Female|Ependymoma variants|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Ependymoma variants|2007
0-19|0.0|0.0|0.0|Benign/Borderline|29|83118264|Male and Female|Ependymoma variants|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Ependymoma variants|2008
0-19|0.0|0.0|0.0|Benign/Borderline|29|83280391|Male and Female|Ependymoma variants|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Ependymoma variants|2009
0-19|0.0|0.1|0.0|Benign/Borderline|41|83218950|Male and Female|Ependymoma variants|2010
0-19|~|~|~|Malignant|~|83218950|Male and Female|Ependymoma variants|2010
0-19|0.0|0.1|0.1|Benign/Borderline|43|83011324|Male and Female|Ependymoma variants|2011
0-19|~|~|~|Malignant|~|83011324|Male and Female|Ependymoma variants|2011
0-19|0.0|0.1|0.0|Benign/Borderline|33|82811054|Male and Female|Ependymoma variants|2012
0-19|~|~|~|Malignant|~|82811054|Male and Female|Ependymoma variants|2012
0-19|0.0|0.1|0.0|Benign/Borderline|38|82716398|Male and Female|Ependymoma variants|2013
0-19|~|~|~|Malignant|~|82716398|Male and Female|Ependymoma variants|2013
0-19|~|~|~|Benign/Borderline|~|82718202|Male and Female|Ependymoma variants|2014
0-19|~|~|~|Malignant|~|82718202|Male and Female|Ependymoma variants|2014
0-19|0.0|0.1|0.0|Benign/Borderline|30|82835167|Male and Female|Ependymoma variants|2015
0-19|~|~|~|Malignant|~|82835167|Male and Female|Ependymoma variants|2015
0-19|0.0|0.1|0.0|Benign/Borderline|38|83018369|Male and Female|Ependymoma variants|2016
0-19|~|~|~|Malignant|~|83018369|Male and Female|Ependymoma variants|2016
0-19|0.0|0.1|0.0|Benign/Borderline|36|83117707|Male and Female|Ependymoma variants|2017
0-19|~|~|~|Malignant|~|83117707|Male and Female|Ependymoma variants|2017
0-19|0.0|0.0|0.0|Benign/Borderline|175|404367531|Male and Female|Ependymoma variants|2017-2021
0-19|~|~|~|Malignant|~|404367531|Male and Female|Ependymoma variants|2017-2021
0-19|0.0|0.1|0.0|Benign/Borderline|37|83111569|Male and Female|Ependymoma variants|2018
0-19|~|~|~|Malignant|~|83111569|Male and Female|Ependymoma variants|2018
0-19|0.0|0.1|0.0|Benign/Borderline|39|82986327|Male and Female|Ependymoma variants|2019
0-19|~|~|~|Malignant|~|82986327|Male and Female|Ependymoma variants|2019
0-19|0.0|0.1|0.0|Benign/Borderline|31|80749239|Male and Female|Ependymoma variants|2020
0-19|~|~|~|Malignant|~|80749239|Male and Female|Ependymoma variants|2020
0-19|0.0|0.1|0.0|Benign/Borderline|34|79740141|Male and Female|Ependymoma variants|2021
0-19|~|~|~|Malignant|~|79740141|Male and Female|Ependymoma variants|2021
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Ependymoma/anaplastic ependymoma|2004
0-19|0.2|0.3|0.2|Malignant|199|81754354|Male and Female|Ependymoma/anaplastic ependymoma|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Ependymoma/anaplastic ependymoma|2005
0-19|0.2|0.3|0.3|Malignant|218|82005260|Male and Female|Ependymoma/anaplastic ependymoma|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Ependymoma/anaplastic ependymoma|2006
0-19|0.2|0.3|0.3|Malignant|208|82324418|Male and Female|Ependymoma/anaplastic ependymoma|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Ependymoma/anaplastic ependymoma|2007
0-19|0.2|0.3|0.2|Malignant|187|82749431|Male and Female|Ependymoma/anaplastic ependymoma|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Ependymoma/anaplastic ependymoma|2008
0-19|0.2|0.2|0.2|Malignant|170|83118264|Male and Female|Ependymoma/anaplastic ependymoma|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Ependymoma/anaplastic ependymoma|2009
0-19|0.2|0.3|0.2|Malignant|194|83280391|Male and Female|Ependymoma/anaplastic ependymoma|2009
0-19|~|~|~|Benign/Borderline|~|83218950|Male and Female|Ependymoma/anaplastic ependymoma|2010
0-19|0.2|0.3|0.3|Malignant|213|83218950|Male and Female|Ependymoma/anaplastic ependymoma|2010
0-19|~|~|~|Benign/Borderline|~|83011324|Male and Female|Ependymoma/anaplastic ependymoma|2011
0-19|0.2|0.3|0.3|Malignant|211|83011324|Male and Female|Ependymoma/anaplastic ependymoma|2011
0-19|~|~|~|Benign/Borderline|~|82811054|Male and Female|Ependymoma/anaplastic ependymoma|2012
0-19|0.2|0.3|0.2|Malignant|204|82811054|Male and Female|Ependymoma/anaplastic ependymoma|2012
0-19|~|~|~|Benign/Borderline|~|82716398|Male and Female|Ependymoma/anaplastic ependymoma|2013
0-19|0.2|0.3|0.2|Malignant|204|82716398|Male and Female|Ependymoma/anaplastic ependymoma|2013
0-19|~|~|~|Benign/Borderline|~|82718202|Male and Female|Ependymoma/anaplastic ependymoma|2014
0-19|0.2|0.3|0.2|Malignant|201|82718202|Male and Female|Ependymoma/anaplastic ependymoma|2014
0-19|~|~|~|Benign/Borderline|~|82835167|Male and Female|Ependymoma/anaplastic ependymoma|2015
0-19|0.2|0.3|0.2|Malignant|204|82835167|Male and Female|Ependymoma/anaplastic ependymoma|2015
0-19|~|~|~|Benign/Borderline|~|83018369|Male and Female|Ependymoma/anaplastic ependymoma|2016
0-19|0.2|0.3|0.2|Malignant|182|83018369|Male and Female|Ependymoma/anaplastic ependymoma|2016
0-19|~|~|~|Benign/Borderline|~|83117707|Male and Female|Ependymoma/anaplastic ependymoma|2017
0-19|0.2|0.3|0.3|Malignant|223|83117707|Male and Female|Ependymoma/anaplastic ependymoma|2017
0-19|~|~|~|Benign/Borderline|~|404367531|Male and Female|Ependymoma/anaplastic ependymoma|2017-2021
0-19|0.2|0.2|0.2|Malignant|852|404367531|Male and Female|Ependymoma/anaplastic ependymoma|2017-2021
0-19|~|~|~|Benign/Borderline|~|83111569|Male and Female|Ependymoma/anaplastic ependymoma|2018
0-19|0.2|0.2|0.2|Malignant|173|83111569|Male and Female|Ependymoma/anaplastic ependymoma|2018
0-19|~|~|~|Benign/Borderline|~|82986327|Male and Female|Ependymoma/anaplastic ependymoma|2019
0-19|0.2|0.2|0.2|Malignant|169|82986327|Male and Female|Ependymoma/anaplastic ependymoma|2019
0-19|~|~|~|Benign/Borderline|~|80749239|Male and Female|Ependymoma/anaplastic ependymoma|2020
0-19|0.2|0.2|0.2|Malignant|160|80749239|Male and Female|Ependymoma/anaplastic ependymoma|2020
0-19|~|~|~|Benign/Borderline|~|79740141|Male and Female|Ependymoma/anaplastic ependymoma|2021
0-19|0.1|0.2|0.2|Malignant|138|79740141|Male and Female|Ependymoma/anaplastic ependymoma|2021
0-19|0.0|0.1|0.0|Benign/Borderline|32|81754354|Male and Female|Germ Cell Tumors|2004
0-19|0.1|0.2|0.2|Malignant|147|81754354|Male and Female|Germ Cell Tumors|2004
0-19|0.0|0.1|0.0|Benign/Borderline|37|82005260|Male and Female|Germ Cell Tumors|2005
0-19|0.1|0.2|0.2|Malignant|133|82005260|Male and Female|Germ Cell Tumors|2005
0-19|0.0|0.1|0.1|Benign/Borderline|46|82324418|Male and Female|Germ Cell Tumors|2006
0-19|0.1|0.2|0.2|Malignant|126|82324418|Male and Female|Germ Cell Tumors|2006
0-19|0.0|0.1|0.0|Benign/Borderline|35|82749431|Male and Female|Germ Cell Tumors|2007
0-19|0.1|0.2|0.2|Malignant|129|82749431|Male and Female|Germ Cell Tumors|2007
0-19|0.0|0.1|0.0|Benign/Borderline|38|83118264|Male and Female|Germ Cell Tumors|2008
0-19|0.1|0.2|0.2|Malignant|146|83118264|Male and Female|Germ Cell Tumors|2008
0-19|0.0|0.1|0.1|Benign/Borderline|50|83280391|Male and Female|Germ Cell Tumors|2009
0-19|0.1|0.2|0.2|Malignant|141|83280391|Male and Female|Germ Cell Tumors|2009
0-19|0.0|0.1|0.1|Benign/Borderline|44|83218950|Male and Female|Germ Cell Tumors|2010
0-19|0.2|0.2|0.2|Malignant|165|83218950|Male and Female|Germ Cell Tumors|2010
0-19|0.0|0.1|0.0|Benign/Borderline|38|83011324|Male and Female|Germ Cell Tumors|2011
0-19|0.1|0.2|0.2|Malignant|137|83011324|Male and Female|Germ Cell Tumors|2011
0-19|0.0|0.1|0.1|Benign/Borderline|42|82811054|Male and Female|Germ Cell Tumors|2012
0-19|0.1|0.2|0.2|Malignant|131|82811054|Male and Female|Germ Cell Tumors|2012
0-19|0.0|0.1|0.1|Benign/Borderline|47|82716398|Male and Female|Germ Cell Tumors|2013
0-19|0.2|0.2|0.2|Malignant|159|82716398|Male and Female|Germ Cell Tumors|2013
0-19|0.0|0.1|0.1|Benign/Borderline|50|82718202|Male and Female|Germ Cell Tumors|2014
0-19|0.1|0.2|0.2|Malignant|137|82718202|Male and Female|Germ Cell Tumors|2014
0-19|0.0|0.1|0.0|Benign/Borderline|38|82835167|Male and Female|Germ Cell Tumors|2015
0-19|0.2|0.2|0.2|Malignant|152|82835167|Male and Female|Germ Cell Tumors|2015
0-19|0.1|0.1|0.1|Benign/Borderline|61|83018369|Male and Female|Germ Cell Tumors|2016
0-19|0.2|0.2|0.2|Malignant|169|83018369|Male and Female|Germ Cell Tumors|2016
0-19|0.0|0.1|0.0|Benign/Borderline|39|83117707|Male and Female|Germ Cell Tumors|2017
0-19|0.2|0.2|0.2|Malignant|177|83117707|Male and Female|Germ Cell Tumors|2017
0-19|0.0|0.1|0.1|Benign/Borderline|199|404367531|Male and Female|Germ Cell Tumors|2017-2021
0-19|0.2|0.2|0.2|Malignant|730|404367531|Male and Female|Germ Cell Tumors|2017-2021
0-19|0.1|0.1|0.1|Benign/Borderline|59|83111569|Male and Female|Germ Cell Tumors|2018
0-19|0.1|0.2|0.2|Malignant|126|83111569|Male and Female|Germ Cell Tumors|2018
0-19|0.0|0.1|0.1|Benign/Borderline|41|82986327|Male and Female|Germ Cell Tumors|2019
0-19|0.2|0.2|0.2|Malignant|158|82986327|Male and Female|Germ Cell Tumors|2019
0-19|0.0|0.0|0.0|Benign/Borderline|27|80749239|Male and Female|Germ Cell Tumors|2020
0-19|0.1|0.2|0.2|Malignant|141|80749239|Male and Female|Germ Cell Tumors|2020
0-19|0.0|0.1|0.0|Benign/Borderline|35|79740141|Male and Female|Germ Cell Tumors|2021
0-19|0.1|0.2|0.2|Malignant|141|79740141|Male and Female|Germ Cell Tumors|2021
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Glioblastoma|2004
0-19|0.1|0.2|0.2|Malignant|127|81754354|Male and Female|Glioblastoma|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Glioblastoma|2005
0-19|0.1|0.1|0.1|Malignant|100|82005260|Male and Female|Glioblastoma|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Glioblastoma|2006
0-19|0.1|0.2|0.1|Malignant|111|82324418|Male and Female|Glioblastoma|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Glioblastoma|2007
0-19|0.1|0.2|0.2|Malignant|126|82749431|Male and Female|Glioblastoma|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Glioblastoma|2008
0-19|0.1|0.2|0.2|Malignant|130|83118264|Male and Female|Glioblastoma|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Glioblastoma|2009
0-19|0.1|0.2|0.1|Malignant|121|83280391|Male and Female|Glioblastoma|2009
0-19|~|~|~|Benign/Borderline|~|83218950|Male and Female|Glioblastoma|2010
0-19|0.1|0.2|0.1|Malignant|119|83218950|Male and Female|Glioblastoma|2010
0-19|~|~|~|Benign/Borderline|~|83011324|Male and Female|Glioblastoma|2011
0-19|0.2|0.2|0.2|Malignant|159|83011324|Male and Female|Glioblastoma|2011
0-19|~|~|~|Benign/Borderline|~|82811054|Male and Female|Glioblastoma|2012
0-19|0.2|0.2|0.2|Malignant|156|82811054|Male and Female|Glioblastoma|2012
0-19|~|~|~|Benign/Borderline|~|82716398|Male and Female|Glioblastoma|2013
0-19|0.2|0.2|0.2|Malignant|163|82716398|Male and Female|Glioblastoma|2013
0-19|~|~|~|Benign/Borderline|~|82718202|Male and Female|Glioblastoma|2014
0-19|0.1|0.2|0.2|Malignant|144|82718202|Male and Female|Glioblastoma|2014
0-19|~|~|~|Benign/Borderline|~|82835167|Male and Female|Glioblastoma|2015
0-19|0.2|0.2|0.2|Malignant|150|82835167|Male and Female|Glioblastoma|2015
0-19|~|~|~|Benign/Borderline|~|83018369|Male and Female|Glioblastoma|2016
0-19|0.1|0.2|0.2|Malignant|132|83018369|Male and Female|Glioblastoma|2016
0-19|~|~|~|Benign/Borderline|~|83117707|Male and Female|Glioblastoma|2017
0-19|0.1|0.2|0.2|Malignant|140|83117707|Male and Female|Glioblastoma|2017
0-19|~|~|~|Benign/Borderline|~|404367531|Male and Female|Glioblastoma|2017-2021
0-19|0.1|0.2|0.1|Malignant|589|404367531|Male and Female|Glioblastoma|2017-2021
0-19|~|~|~|Benign/Borderline|~|83111569|Male and Female|Glioblastoma|2018
0-19|0.1|0.2|0.2|Malignant|139|83111569|Male and Female|Glioblastoma|2018
0-19|~|~|~|Benign/Borderline|~|82986327|Male and Female|Glioblastoma|2019
0-19|0.1|0.2|0.2|Malignant|127|82986327|Male and Female|Glioblastoma|2019
0-19|~|~|~|Benign/Borderline|~|80749239|Male and Female|Glioblastoma|2020
0-19|0.1|0.1|0.1|Malignant|99|80749239|Male and Female|Glioblastoma|2020
0-19|~|~|~|Benign/Borderline|~|79740141|Male and Female|Glioblastoma|2021
0-19|0.1|0.1|0.1|Malignant|87|79740141|Male and Female|Glioblastoma|2021
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Glioma malignant, NOS|2004
0-19|0.5|0.6|0.6|Malignant|465|81754354|Male and Female|Glioma malignant, NOS|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Glioma malignant, NOS|2005
0-19|0.5|0.6|0.6|Malignant|458|82005260|Male and Female|Glioma malignant, NOS|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Glioma malignant, NOS|2006
0-19|0.6|0.7|0.6|Malignant|490|82324418|Male and Female|Glioma malignant, NOS|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Glioma malignant, NOS|2007
0-19|0.6|0.7|0.6|Malignant|517|82749431|Male and Female|Glioma malignant, NOS|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Glioma malignant, NOS|2008
0-19|0.6|0.7|0.7|Malignant|552|83118264|Male and Female|Glioma malignant, NOS|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Glioma malignant, NOS|2009
0-19|0.6|0.8|0.7|Malignant|571|83280391|Male and Female|Glioma malignant, NOS|2009
0-19|0.0|0.0|0.0|Benign/Borderline|22|83218950|Male and Female|Glioma malignant, NOS|2010
0-19|0.6|0.7|0.7|Malignant|549|83218950|Male and Female|Glioma malignant, NOS|2010
0-19|0.0|0.1|0.0|Benign/Borderline|33|83011324|Male and Female|Glioma malignant, NOS|2011
0-19|0.7|0.8|0.7|Malignant|604|83011324|Male and Female|Glioma malignant, NOS|2011
0-19|0.0|0.1|0.0|Benign/Borderline|36|82811054|Male and Female|Glioma malignant, NOS|2012
0-19|0.6|0.7|0.6|Malignant|520|82811054|Male and Female|Glioma malignant, NOS|2012
0-19|0.0|0.1|0.0|Benign/Borderline|34|82716398|Male and Female|Glioma malignant, NOS|2013
0-19|0.6|0.8|0.7|Malignant|581|82716398|Male and Female|Glioma malignant, NOS|2013
0-19|0.0|0.1|0.1|Benign/Borderline|42|82718202|Male and Female|Glioma malignant, NOS|2014
0-19|0.6|0.7|0.7|Malignant|543|82718202|Male and Female|Glioma malignant, NOS|2014
0-19|0.0|0.1|0.0|Benign/Borderline|38|82835167|Male and Female|Glioma malignant, NOS|2015
0-19|0.7|0.8|0.7|Malignant|592|82835167|Male and Female|Glioma malignant, NOS|2015
0-19|0.0|0.1|0.1|Benign/Borderline|53|83018369|Male and Female|Glioma malignant, NOS|2016
0-19|0.7|0.8|0.8|Malignant|626|83018369|Male and Female|Glioma malignant, NOS|2016
0-19|0.0|0.1|0.1|Benign/Borderline|48|83117707|Male and Female|Glioma malignant, NOS|2017
0-19|0.7|0.9|0.8|Malignant|661|83117707|Male and Female|Glioma malignant, NOS|2017
0-19|0.0|0.1|0.0|Benign/Borderline|178|404367531|Male and Female|Glioma malignant, NOS|2017-2021
0-19|0.6|0.6|0.6|Malignant|2491|404367531|Male and Female|Glioma malignant, NOS|2017-2021
0-19|0.0|0.1|0.1|Benign/Borderline|51|83111569|Male and Female|Glioma malignant, NOS|2018
0-19|0.5|0.6|0.6|Malignant|477|83111569|Male and Female|Glioma malignant, NOS|2018
0-19|0.0|0.1|0.0|Benign/Borderline|30|82986327|Male and Female|Glioma malignant, NOS|2019
0-19|0.5|0.6|0.5|Malignant|451|82986327|Male and Female|Glioma malignant, NOS|2019
0-19|0.0|0.0|0.0|Benign/Borderline|25|80749239|Male and Female|Glioma malignant, NOS|2020
0-19|0.5|0.6|0.6|Malignant|448|80749239|Male and Female|Glioma malignant, NOS|2020
0-19|0.0|0.0|0.0|Benign/Borderline|26|79740141|Male and Female|Glioma malignant, NOS|2021
0-19|0.6|0.7|0.6|Malignant|495|79740141|Male and Female|Glioma malignant, NOS|2021
0-19|0.0|0.0|0.0|Benign/Borderline|29|81754354|Male and Female|Hemangioblastoma|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Hemangioblastoma|2004
0-19|0.0|0.1|0.0|Benign/Borderline|30|82005260|Male and Female|Hemangioblastoma|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Hemangioblastoma|2005
0-19|0.0|0.0|0.0|Benign/Borderline|25|82324418|Male and Female|Hemangioblastoma|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Hemangioblastoma|2006
0-19|0.0|0.1|0.0|Benign/Borderline|39|82749431|Male and Female|Hemangioblastoma|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Hemangioblastoma|2007
0-19|0.0|0.0|0.0|Benign/Borderline|24|83118264|Male and Female|Hemangioblastoma|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Hemangioblastoma|2008
0-19|0.0|0.1|0.0|Benign/Borderline|33|83280391|Male and Female|Hemangioblastoma|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Hemangioblastoma|2009
0-19|0.0|0.0|0.0|Benign/Borderline|27|83218950|Male and Female|Hemangioblastoma|2010
0-19|~|~|~|Malignant|~|83218950|Male and Female|Hemangioblastoma|2010
0-19|0.0|0.1|0.0|Benign/Borderline|40|83011324|Male and Female|Hemangioblastoma|2011
0-19|~|~|~|Malignant|~|83011324|Male and Female|Hemangioblastoma|2011
0-19|0.0|0.1|0.0|Benign/Borderline|40|82811054|Male and Female|Hemangioblastoma|2012
0-19|~|~|~|Malignant|~|82811054|Male and Female|Hemangioblastoma|2012
0-19|0.0|0.1|0.0|Benign/Borderline|38|82716398|Male and Female|Hemangioblastoma|2013
0-19|~|~|~|Malignant|~|82716398|Male and Female|Hemangioblastoma|2013
0-19|0.0|0.1|0.1|Benign/Borderline|52|82718202|Male and Female|Hemangioblastoma|2014
0-19|~|~|~|Malignant|~|82718202|Male and Female|Hemangioblastoma|2014
0-19|0.0|0.1|0.0|Benign/Borderline|34|82835167|Male and Female|Hemangioblastoma|2015
0-19|~|~|~|Malignant|~|82835167|Male and Female|Hemangioblastoma|2015
0-19|0.0|0.1|0.0|Benign/Borderline|43|83018369|Male and Female|Hemangioblastoma|2016
0-19|~|~|~|Malignant|~|83018369|Male and Female|Hemangioblastoma|2016
0-19|0.0|0.1|0.0|Benign/Borderline|34|83117707|Male and Female|Hemangioblastoma|2017
0-19|~|~|~|Malignant|~|83117707|Male and Female|Hemangioblastoma|2017
0-19|0.0|0.0|0.0|Benign/Borderline|170|404367531|Male and Female|Hemangioblastoma|2017-2021
0-19|~|~|~|Malignant|~|404367531|Male and Female|Hemangioblastoma|2017-2021
0-19|0.0|0.1|0.0|Benign/Borderline|39|83111569|Male and Female|Hemangioblastoma|2018
0-19|~|~|~|Malignant|~|83111569|Male and Female|Hemangioblastoma|2018
0-19|0.0|0.1|0.0|Benign/Borderline|34|82986327|Male and Female|Hemangioblastoma|2019
0-19|~|~|~|Malignant|~|82986327|Male and Female|Hemangioblastoma|2019
0-19|0.0|0.1|0.0|Benign/Borderline|37|80749239|Male and Female|Hemangioblastoma|2020
0-19|~|~|~|Malignant|~|80749239|Male and Female|Hemangioblastoma|2020
0-19|0.0|0.1|0.0|Benign/Borderline|31|79740141|Male and Female|Hemangioblastoma|2021
0-19|~|~|~|Malignant|~|79740141|Male and Female|Hemangioblastoma|2021
0-19|0.0|0.1|0.1|Benign/Borderline|51|81754354|Male and Female|Hemangioma|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Hemangioma|2004
0-19|0.0|0.1|0.1|Benign/Borderline|47|82005260|Male and Female|Hemangioma|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Hemangioma|2005
0-19|0.1|0.1|0.1|Benign/Borderline|74|82324418|Male and Female|Hemangioma|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Hemangioma|2006
0-19|0.1|0.1|0.1|Benign/Borderline|88|82749431|Male and Female|Hemangioma|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Hemangioma|2007
0-19|0.1|0.1|0.1|Benign/Borderline|99|83118264|Male and Female|Hemangioma|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Hemangioma|2008
0-19|0.1|0.2|0.1|Benign/Borderline|116|83280391|Male and Female|Hemangioma|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Hemangioma|2009
0-19|0.1|0.1|0.1|Benign/Borderline|103|83218950|Male and Female|Hemangioma|2010
0-19|~|~|~|Malignant|~|83218950|Male and Female|Hemangioma|2010
0-19|0.2|0.2|0.2|Benign/Borderline|150|83011324|Male and Female|Hemangioma|2011
0-19|~|~|~|Malignant|~|83011324|Male and Female|Hemangioma|2011
0-19|0.1|0.2|0.2|Benign/Borderline|134|82811054|Male and Female|Hemangioma|2012
0-19|~|~|~|Malignant|~|82811054|Male and Female|Hemangioma|2012
0-19|0.1|0.2|0.2|Benign/Borderline|129|82716398|Male and Female|Hemangioma|2013
0-19|~|~|~|Malignant|~|82716398|Male and Female|Hemangioma|2013
0-19|0.1|0.2|0.2|Benign/Borderline|127|82718202|Male and Female|Hemangioma|2014
0-19|~|~|~|Malignant|~|82718202|Male and Female|Hemangioma|2014
0-19|0.1|0.2|0.2|Benign/Borderline|134|82835167|Male and Female|Hemangioma|2015
0-19|~|~|~|Malignant|~|82835167|Male and Female|Hemangioma|2015
0-19|0.1|0.2|0.2|Benign/Borderline|142|83018369|Male and Female|Hemangioma|2016
0-19|~|~|~|Malignant|~|83018369|Male and Female|Hemangioma|2016
0-19|0.1|0.2|0.1|Benign/Borderline|119|83117707|Male and Female|Hemangioma|2017
0-19|~|~|~|Malignant|~|83117707|Male and Female|Hemangioma|2017
0-19|0.1|0.1|0.1|Benign/Borderline|553|404367531|Male and Female|Hemangioma|2017-2021
0-19|~|~|~|Malignant|~|404367531|Male and Female|Hemangioma|2017-2021
0-19|0.1|0.2|0.1|Benign/Borderline|125|83111569|Male and Female|Hemangioma|2018
0-19|~|~|~|Malignant|~|83111569|Male and Female|Hemangioma|2018
0-19|0.1|0.1|0.1|Benign/Borderline|103|82986327|Male and Female|Hemangioma|2019
0-19|~|~|~|Malignant|~|82986327|Male and Female|Hemangioma|2019
0-19|0.1|0.2|0.1|Benign/Borderline|108|80749239|Male and Female|Hemangioma|2020
0-19|~|~|~|Malignant|~|80749239|Male and Female|Hemangioma|2020
0-19|0.1|0.2|0.1|Benign/Borderline|99|79740141|Male and Female|Hemangioma|2021
0-19|~|~|~|Malignant|~|79740141|Male and Female|Hemangioma|2021
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Local Extensions from Regional Tumors|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Local Extensions from Regional Tumors|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Local Extensions from Regional Tumors|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Local Extensions from Regional Tumors|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Local Extensions from Regional Tumors|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Local Extensions from Regional Tumors|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Local Extensions from Regional Tumors|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Local Extensions from Regional Tumors|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Local Extensions from Regional Tumors|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Local Extensions from Regional Tumors|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Local Extensions from Regional Tumors|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Local Extensions from Regional Tumors|2009
0-19|~|~|~|Benign/Borderline|~|83218950|Male and Female|Local Extensions from Regional Tumors|2010
0-19|~|~|~|Malignant|~|83218950|Male and Female|Local Extensions from Regional Tumors|2010
0-19|~|~|~|Benign/Borderline|~|83011324|Male and Female|Local Extensions from Regional Tumors|2011
0-19|~|~|~|Malignant|~|83011324|Male and Female|Local Extensions from Regional Tumors|2011
0-19|~|~|~|Benign/Borderline|~|82811054|Male and Female|Local Extensions from Regional Tumors|2012
0-19|~|~|~|Malignant|~|82811054|Male and Female|Local Extensions from Regional Tumors|2012
0-19|~|~|~|Benign/Borderline|~|82716398|Male and Female|Local Extensions from Regional Tumors|2013
0-19|~|~|~|Malignant|~|82716398|Male and Female|Local Extensions from Regional Tumors|2013
0-19|~|~|~|Benign/Borderline|~|82718202|Male and Female|Local Extensions from Regional Tumors|2014
0-19|~|~|~|Malignant|~|82718202|Male and Female|Local Extensions from Regional Tumors|2014
0-19|~|~|~|Benign/Borderline|~|82835167|Male and Female|Local Extensions from Regional Tumors|2015
0-19|~|~|~|Malignant|~|82835167|Male and Female|Local Extensions from Regional Tumors|2015
0-19|~|~|~|Benign/Borderline|~|83018369|Male and Female|Local Extensions from Regional Tumors|2016
0-19|~|~|~|Malignant|~|83018369|Male and Female|Local Extensions from Regional Tumors|2016
0-19|~|~|~|Benign/Borderline|~|83117707|Male and Female|Local Extensions from Regional Tumors|2017
0-19|~|~|~|Malignant|~|83117707|Male and Female|Local Extensions from Regional Tumors|2017
0-19|~|~|~|Benign/Borderline|~|404367531|Male and Female|Local Extensions from Regional Tumors|2017-2021
0-19|0.0|0.0|0.0|Malignant|16|404367531|Male and Female|Local Extensions from Regional Tumors|2017-2021
0-19|~|~|~|Benign/Borderline|~|83111569|Male and Female|Local Extensions from Regional Tumors|2018
0-19|~|~|~|Malignant|~|83111569|Male and Female|Local Extensions from Regional Tumors|2018
0-19|~|~|~|Benign/Borderline|~|82986327|Male and Female|Local Extensions from Regional Tumors|2019
0-19|~|~|~|Malignant|~|82986327|Male and Female|Local Extensions from Regional Tumors|2019
0-19|~|~|~|Benign/Borderline|~|80749239|Male and Female|Local Extensions from Regional Tumors|2020
0-19|~|~|~|Malignant|~|80749239|Male and Female|Local Extensions from Regional Tumors|2020
0-19|~|~|~|Benign/Borderline|~|79740141|Male and Female|Local Extensions from Regional Tumors|2021
0-19|~|~|~|Malignant|~|79740141|Male and Female|Local Extensions from Regional Tumors|2021
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004
0-19|0.0|0.0|0.0|Malignant|16|81754354|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005
0-19|0.0|0.0|0.0|Malignant|19|82005260|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009
0-19|0.0|0.0|0.0|Malignant|16|83280391|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009
0-19|~|~|~|Benign/Borderline|~|83218950|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010
0-19|~|~|~|Malignant|~|83218950|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010
0-19|~|~|~|Benign/Borderline|~|83011324|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011
0-19|~|~|~|Malignant|~|83011324|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011
0-19|~|~|~|Benign/Borderline|~|82811054|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012
0-19|0.0|0.0|0.0|Malignant|16|82811054|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012
0-19|~|~|~|Benign/Borderline|~|82716398|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013
0-19|~|~|~|Malignant|~|82716398|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013
0-19|~|~|~|Benign/Borderline|~|82718202|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014
0-19|~|~|~|Malignant|~|82718202|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014
0-19|~|~|~|Benign/Borderline|~|82835167|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015
0-19|0.0|0.0|0.0|Malignant|17|82835167|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015
0-19|~|~|~|Benign/Borderline|~|83018369|Male and Female|Lymphomas and Hematopoietic Neoplasms|2016
0-19|~|~|~|Malignant|~|83018369|Male and Female|Lymphomas and Hematopoietic Neoplasms|2016
0-19|~|~|~|Benign/Borderline|~|83117707|Male and Female|Lymphomas and Hematopoietic Neoplasms|2017
0-19|~|~|~|Malignant|~|83117707|Male and Female|Lymphomas and Hematopoietic Neoplasms|2017
0-19|~|~|~|Benign/Borderline|~|404367531|Male and Female|Lymphomas and Hematopoietic Neoplasms|2017-2021
0-19|0.0|0.0|0.0|Malignant|44|404367531|Male and Female|Lymphomas and Hematopoietic Neoplasms|2017-2021
0-19|~|~|~|Benign/Borderline|~|83111569|Male and Female|Lymphomas and Hematopoietic Neoplasms|2018
0-19|~|~|~|Malignant|~|83111569|Male and Female|Lymphomas and Hematopoietic Neoplasms|2018
0-19|~|~|~|Benign/Borderline|~|82986327|Male and Female|Lymphomas and Hematopoietic Neoplasms|2019
0-19|~|~|~|Malignant|~|82986327|Male and Female|Lymphomas and Hematopoietic Neoplasms|2019
0-19|~|~|~|Benign/Borderline|~|80749239|Male and Female|Lymphomas and Hematopoietic Neoplasms|2020
0-19|~|~|~|Malignant|~|80749239|Male and Female|Lymphomas and Hematopoietic Neoplasms|2020
0-19|~|~|~|Benign/Borderline|~|79740141|Male and Female|Lymphomas and Hematopoietic Neoplasms|2021
0-19|~|~|~|Malignant|~|79740141|Male and Female|Lymphomas and Hematopoietic Neoplasms|2021
0-19|0.1|0.1|0.1|Benign/Borderline|94|81754354|Male and Female|Meningioma|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Meningioma|2004
0-19|0.1|0.2|0.2|Benign/Borderline|127|82005260|Male and Female|Meningioma|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Meningioma|2005
0-19|0.1|0.1|0.1|Benign/Borderline|101|82324418|Male and Female|Meningioma|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Meningioma|2006
0-19|0.1|0.2|0.1|Benign/Borderline|108|82749431|Male and Female|Meningioma|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Meningioma|2007
0-19|0.1|0.2|0.1|Benign/Borderline|119|83118264|Male and Female|Meningioma|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Meningioma|2008
0-19|0.1|0.2|0.1|Benign/Borderline|123|83280391|Male and Female|Meningioma|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Meningioma|2009
0-19|0.1|0.2|0.1|Benign/Borderline|115|83218950|Male and Female|Meningioma|2010
0-19|~|~|~|Malignant|~|83218950|Male and Female|Meningioma|2010
0-19|0.1|0.2|0.2|Benign/Borderline|133|83011324|Male and Female|Meningioma|2011
0-19|~|~|~|Malignant|~|83011324|Male and Female|Meningioma|2011
0-19|0.1|0.2|0.2|Benign/Borderline|128|82811054|Male and Female|Meningioma|2012
0-19|~|~|~|Malignant|~|82811054|Male and Female|Meningioma|2012
0-19|0.1|0.2|0.2|Benign/Borderline|134|82716398|Male and Female|Meningioma|2013
0-19|~|~|~|Malignant|~|82716398|Male and Female|Meningioma|2013
0-19|0.1|0.2|0.2|Benign/Borderline|133|82718202|Male and Female|Meningioma|2014
0-19|~|~|~|Malignant|~|82718202|Male and Female|Meningioma|2014
0-19|0.1|0.2|0.2|Benign/Borderline|143|82835167|Male and Female|Meningioma|2015
0-19|~|~|~|Malignant|~|82835167|Male and Female|Meningioma|2015
0-19|0.1|0.2|0.1|Benign/Borderline|122|83018369|Male and Female|Meningioma|2016
0-19|~|~|~|Malignant|~|83018369|Male and Female|Meningioma|2016
0-19|0.1|0.2|0.2|Benign/Borderline|131|83117707|Male and Female|Meningioma|2017
0-19|~|~|~|Malignant|~|83117707|Male and Female|Meningioma|2017
0-19|0.1|0.2|0.2|Benign/Borderline|656|404367531|Male and Female|Meningioma|2017-2021
0-19|0.0|0.0|0.0|Malignant|18|404367531|Male and Female|Meningioma|2017-2021
0-19|0.2|0.2|0.2|Benign/Borderline|153|83111569|Male and Female|Meningioma|2018
0-19|~|~|~|Malignant|~|83111569|Male and Female|Meningioma|2018
0-19|0.1|0.2|0.2|Benign/Borderline|133|82986327|Male and Female|Meningioma|2019
0-19|~|~|~|Malignant|~|82986327|Male and Female|Meningioma|2019
0-19|0.1|0.2|0.1|Benign/Borderline|124|80749239|Male and Female|Meningioma|2020
0-19|~|~|~|Malignant|~|80749239|Male and Female|Meningioma|2020
0-19|0.1|0.2|0.1|Benign/Borderline|122|79740141|Male and Female|Meningioma|2021
0-19|~|~|~|Malignant|~|79740141|Male and Female|Meningioma|2021
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Mixed glioma|2004
0-19|0.0|0.1|0.0|Malignant|34|81754354|Male and Female|Mixed glioma|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Mixed glioma|2005
0-19|0.0|0.1|0.0|Malignant|32|82005260|Male and Female|Mixed glioma|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Mixed glioma|2006
0-19|0.0|0.0|0.0|Malignant|22|82324418|Male and Female|Mixed glioma|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Mixed glioma|2007
0-19|0.0|0.1|0.0|Malignant|33|82749431|Male and Female|Mixed glioma|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Mixed glioma|2008
0-19|0.0|0.1|0.0|Malignant|35|83118264|Male and Female|Mixed glioma|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Mixed glioma|2009
0-19|0.0|0.0|0.0|Malignant|27|83280391|Male and Female|Mixed glioma|2009
0-19|~|~|~|Benign/Borderline|~|83218950|Male and Female|Mixed glioma|2010
0-19|0.0|0.1|0.0|Malignant|33|83218950|Male and Female|Mixed glioma|2010
0-19|~|~|~|Benign/Borderline|~|83011324|Male and Female|Mixed glioma|2011
0-19|0.0|0.0|0.0|Malignant|28|83011324|Male and Female|Mixed glioma|2011
0-19|~|~|~|Benign/Borderline|~|82811054|Male and Female|Mixed glioma|2012
0-19|0.0|0.0|0.0|Malignant|25|82811054|Male and Female|Mixed glioma|2012
0-19|~|~|~|Benign/Borderline|~|82716398|Male and Female|Mixed glioma|2013
0-19|0.0|0.0|0.0|Malignant|18|82716398|Male and Female|Mixed glioma|2013
0-19|~|~|~|Benign/Borderline|~|82718202|Male and Female|Mixed glioma|2014
0-19|0.0|0.0|0.0|Malignant|19|82718202|Male and Female|Mixed glioma|2014
0-19|~|~|~|Benign/Borderline|~|82835167|Male and Female|Mixed glioma|2015
0-19|~|~|~|Malignant|~|82835167|Male and Female|Mixed glioma|2015
0-19|~|~|~|Benign/Borderline|~|83018369|Male and Female|Mixed glioma|2016
0-19|~|~|~|Malignant|~|83018369|Male and Female|Mixed glioma|2016
0-19|~|~|~|Benign/Borderline|~|83117707|Male and Female|Mixed glioma|2017
0-19|~|~|~|Malignant|~|83117707|Male and Female|Mixed glioma|2017
0-19|~|~|~|Benign/Borderline|~|404367531|Male and Female|Mixed glioma|2017-2021
0-19|~|~|~|Malignant|~|404367531|Male and Female|Mixed glioma|2017-2021
0-19|~|~|~|Benign/Borderline|~|83111569|Male and Female|Mixed glioma|2018
0-19|~|~|~|Malignant|~|83111569|Male and Female|Mixed glioma|2018
0-19|~|~|~|Benign/Borderline|~|82986327|Male and Female|Mixed glioma|2019
0-19|~|~|~|Malignant|~|82986327|Male and Female|Mixed glioma|2019
0-19|~|~|~|Benign/Borderline|~|80749239|Male and Female|Mixed glioma|2020
0-19|~|~|~|Malignant|~|80749239|Male and Female|Mixed glioma|2020
0-19|~|~|~|Benign/Borderline|~|79740141|Male and Female|Mixed glioma|2021
0-19|~|~|~|Malignant|~|79740141|Male and Female|Mixed glioma|2021
0-19|0.1|0.1|0.1|Benign/Borderline|63|81754354|Male and Female|Neoplasm, unspecified|2004
0-19|0.0|0.1|0.1|Malignant|43|81754354|Male and Female|Neoplasm, unspecified|2004
0-19|0.1|0.2|0.1|Benign/Borderline|117|82005260|Male and Female|Neoplasm, unspecified|2005
0-19|0.0|0.1|0.0|Malignant|37|82005260|Male and Female|Neoplasm, unspecified|2005
0-19|0.1|0.2|0.1|Benign/Borderline|105|82324418|Male and Female|Neoplasm, unspecified|2006
0-19|0.0|0.1|0.1|Malignant|51|82324418|Male and Female|Neoplasm, unspecified|2006
0-19|0.1|0.2|0.1|Benign/Borderline|118|82749431|Male and Female|Neoplasm, unspecified|2007
0-19|0.0|0.1|0.0|Malignant|37|82749431|Male and Female|Neoplasm, unspecified|2007
0-19|0.1|0.2|0.2|Benign/Borderline|129|83118264|Male and Female|Neoplasm, unspecified|2008
0-19|0.0|0.1|0.0|Malignant|32|83118264|Male and Female|Neoplasm, unspecified|2008
0-19|0.2|0.2|0.2|Benign/Borderline|152|83280391|Male and Female|Neoplasm, unspecified|2009
0-19|0.0|0.1|0.0|Malignant|36|83280391|Male and Female|Neoplasm, unspecified|2009
0-19|0.2|0.2|0.2|Benign/Borderline|170|83218950|Male and Female|Neoplasm, unspecified|2010
0-19|0.0|0.0|0.0|Malignant|26|83218950|Male and Female|Neoplasm, unspecified|2010
0-19|0.1|0.2|0.2|Benign/Borderline|141|83011324|Male and Female|Neoplasm, unspecified|2011
0-19|0.0|0.1|0.0|Malignant|33|83011324|Male and Female|Neoplasm, unspecified|2011
0-19|0.1|0.2|0.2|Benign/Borderline|139|82811054|Male and Female|Neoplasm, unspecified|2012
0-19|0.0|0.1|0.1|Malignant|52|82811054|Male and Female|Neoplasm, unspecified|2012
0-19|0.1|0.2|0.2|Benign/Borderline|147|82716398|Male and Female|Neoplasm, unspecified|2013
0-19|0.0|0.1|0.1|Malignant|42|82716398|Male and Female|Neoplasm, unspecified|2013
0-19|0.2|0.2|0.2|Benign/Borderline|153|82718202|Male and Female|Neoplasm, unspecified|2014
0-19|0.0|0.1|0.1|Malignant|43|82718202|Male and Female|Neoplasm, unspecified|2014
0-19|0.1|0.2|0.2|Benign/Borderline|144|82835167|Male and Female|Neoplasm, unspecified|2015
0-19|0.0|0.1|0.0|Malignant|36|82835167|Male and Female|Neoplasm, unspecified|2015
0-19|0.1|0.2|0.2|Benign/Borderline|125|83018369|Male and Female|Neoplasm, unspecified|2016
0-19|0.0|0.1|0.1|Malignant|45|83018369|Male and Female|Neoplasm, unspecified|2016
0-19|0.1|0.2|0.2|Benign/Borderline|127|83117707|Male and Female|Neoplasm, unspecified|2017
0-19|0.0|0.1|0.1|Malignant|49|83117707|Male and Female|Neoplasm, unspecified|2017
0-19|0.1|0.1|0.1|Benign/Borderline|544|404367531|Male and Female|Neoplasm, unspecified|2017-2021
0-19|0.1|0.1|0.1|Malignant|241|404367531|Male and Female|Neoplasm, unspecified|2017-2021
0-19|0.1|0.2|0.2|Benign/Borderline|134|83111569|Male and Female|Neoplasm, unspecified|2018
0-19|0.0|0.1|0.1|Malignant|44|83111569|Male and Female|Neoplasm, unspecified|2018
0-19|0.1|0.1|0.1|Benign/Borderline|102|82986327|Male and Female|Neoplasm, unspecified|2019
0-19|0.0|0.1|0.0|Malignant|37|82986327|Male and Female|Neoplasm, unspecified|2019
0-19|0.1|0.1|0.1|Benign/Borderline|90|80749239|Male and Female|Neoplasm, unspecified|2020
0-19|0.1|0.1|0.1|Malignant|54|80749239|Male and Female|Neoplasm, unspecified|2020
0-19|0.1|0.1|0.1|Benign/Borderline|95|79740141|Male and Female|Neoplasm, unspecified|2021
0-19|0.1|0.1|0.1|Malignant|58|79740141|Male and Female|Neoplasm, unspecified|2021
0-19|0.3|0.3|0.3|Benign/Borderline|242|81754354|Male and Female|Nerve sheath, benign and malignant|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Nerve sheath, benign and malignant|2004
0-19|0.3|0.4|0.4|Benign/Borderline|290|82005260|Male and Female|Nerve sheath, benign and malignant|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Nerve sheath, benign and malignant|2005
0-19|0.4|0.5|0.4|Benign/Borderline|338|82324418|Male and Female|Nerve sheath, benign and malignant|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Nerve sheath, benign and malignant|2006
0-19|0.3|0.4|0.4|Benign/Borderline|300|82749431|Male and Female|Nerve sheath, benign and malignant|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Nerve sheath, benign and malignant|2007
0-19|0.3|0.4|0.4|Benign/Borderline|303|83118264|Male and Female|Nerve sheath, benign and malignant|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Nerve sheath, benign and malignant|2008
0-19|0.3|0.4|0.4|Benign/Borderline|314|83280391|Male and Female|Nerve sheath, benign and malignant|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Nerve sheath, benign and malignant|2009
0-19|0.3|0.4|0.3|Benign/Borderline|283|83218950|Male and Female|Nerve sheath, benign and malignant|2010
0-19|~|~|~|Malignant|~|83218950|Male and Female|Nerve sheath, benign and malignant|2010
0-19|0.3|0.4|0.3|Benign/Borderline|290|83011324|Male and Female|Nerve sheath, benign and malignant|2011
0-19|~|~|~|Malignant|~|83011324|Male and Female|Nerve sheath, benign and malignant|2011
0-19|0.3|0.4|0.4|Benign/Borderline|308|82811054|Male and Female|Nerve sheath, benign and malignant|2012
0-19|~|~|~|Malignant|~|82811054|Male and Female|Nerve sheath, benign and malignant|2012
0-19|0.3|0.4|0.4|Benign/Borderline|322|82716398|Male and Female|Nerve sheath, benign and malignant|2013
0-19|~|~|~|Malignant|~|82716398|Male and Female|Nerve sheath, benign and malignant|2013
0-19|0.3|0.4|0.3|Benign/Borderline|264|82718202|Male and Female|Nerve sheath, benign and malignant|2014
0-19|~|~|~|Malignant|~|82718202|Male and Female|Nerve sheath, benign and malignant|2014
0-19|0.3|0.4|0.4|Benign/Borderline|314|82835167|Male and Female|Nerve sheath, benign and malignant|2015
0-19|~|~|~|Malignant|~|82835167|Male and Female|Nerve sheath, benign and malignant|2015
0-19|0.3|0.4|0.4|Benign/Borderline|314|83018369|Male and Female|Nerve sheath, benign and malignant|2016
0-19|~|~|~|Malignant|~|83018369|Male and Female|Nerve sheath, benign and malignant|2016
0-19|0.3|0.3|0.3|Benign/Borderline|246|83117707|Male and Female|Nerve sheath, benign and malignant|2017
0-19|~|~|~|Malignant|~|83117707|Male and Female|Nerve sheath, benign and malignant|2017
0-19|0.2|0.2|0.2|Benign/Borderline|861|404367531|Male and Female|Nerve sheath, benign and malignant|2017-2021
0-19|0.0|0.0|0.0|Malignant|17|404367531|Male and Female|Nerve sheath, benign and malignant|2017-2021
0-19|0.2|0.2|0.2|Benign/Borderline|172|83111569|Male and Female|Nerve sheath, benign and malignant|2018
0-19|~|~|~|Malignant|~|83111569|Male and Female|Nerve sheath, benign and malignant|2018
0-19|0.2|0.2|0.2|Benign/Borderline|173|82986327|Male and Female|Nerve sheath, benign and malignant|2019
0-19|~|~|~|Malignant|~|82986327|Male and Female|Nerve sheath, benign and malignant|2019
0-19|0.1|0.2|0.2|Benign/Borderline|142|80749239|Male and Female|Nerve sheath, benign and malignant|2020
0-19|~|~|~|Malignant|~|80749239|Male and Female|Nerve sheath, benign and malignant|2020
0-19|0.1|0.2|0.2|Benign/Borderline|135|79740141|Male and Female|Nerve sheath, benign and malignant|2021
0-19|~|~|~|Malignant|~|79740141|Male and Female|Nerve sheath, benign and malignant|2021
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Neuroepithelial|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Neuroepithelial|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Neuroepithelial|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Neuroepithelial|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Neuroepithelial|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Neuroepithelial|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Neuroepithelial|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Neuroepithelial|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Neuroepithelial|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Neuroepithelial|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Neuroepithelial|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Neuroepithelial|2009
0-19|~|~|~|Benign/Borderline|~|83218950|Male and Female|Neuroepithelial|2010
0-19|~|~|~|Malignant|~|83218950|Male and Female|Neuroepithelial|2010
0-19|~|~|~|Benign/Borderline|~|83011324|Male and Female|Neuroepithelial|2011
0-19|~|~|~|Malignant|~|83011324|Male and Female|Neuroepithelial|2011
0-19|~|~|~|Benign/Borderline|~|82811054|Male and Female|Neuroepithelial|2012
0-19|~|~|~|Malignant|~|82811054|Male and Female|Neuroepithelial|2012
0-19|~|~|~|Benign/Borderline|~|82716398|Male and Female|Neuroepithelial|2013
0-19|~|~|~|Malignant|~|82716398|Male and Female|Neuroepithelial|2013
0-19|~|~|~|Benign/Borderline|~|82718202|Male and Female|Neuroepithelial|2014
0-19|~|~|~|Malignant|~|82718202|Male and Female|Neuroepithelial|2014
0-19|~|~|~|Benign/Borderline|~|82835167|Male and Female|Neuroepithelial|2015
0-19|~|~|~|Malignant|~|82835167|Male and Female|Neuroepithelial|2015
0-19|~|~|~|Benign/Borderline|~|83018369|Male and Female|Neuroepithelial|2016
0-19|~|~|~|Malignant|~|83018369|Male and Female|Neuroepithelial|2016
0-19|~|~|~|Benign/Borderline|~|83117707|Male and Female|Neuroepithelial|2017
0-19|~|~|~|Malignant|~|83117707|Male and Female|Neuroepithelial|2017
0-19|~|~|~|Benign/Borderline|~|404367531|Male and Female|Neuroepithelial|2017-2021
0-19|0.0|0.0|0.0|Malignant|23|404367531|Male and Female|Neuroepithelial|2017-2021
0-19|~|~|~|Benign/Borderline|~|83111569|Male and Female|Neuroepithelial|2018
0-19|~|~|~|Malignant|~|83111569|Male and Female|Neuroepithelial|2018
0-19|~|~|~|Benign/Borderline|~|82986327|Male and Female|Neuroepithelial|2019
0-19|~|~|~|Malignant|~|82986327|Male and Female|Neuroepithelial|2019
0-19|~|~|~|Benign/Borderline|~|80749239|Male and Female|Neuroepithelial|2020
0-19|~|~|~|Malignant|~|80749239|Male and Female|Neuroepithelial|2020
0-19|~|~|~|Benign/Borderline|~|79740141|Male and Female|Neuroepithelial|2021
0-19|~|~|~|Malignant|~|79740141|Male and Female|Neuroepithelial|2021
0-19|0.3|0.4|0.3|Benign/Borderline|265|81754354|Male and Female|Neuronal/glial, neuronal|2004
0-19|0.0|0.1|0.1|Malignant|51|81754354|Male and Female|Neuronal/glial, neuronal|2004
0-19|0.3|0.4|0.4|Benign/Borderline|296|82005260|Male and Female|Neuronal/glial, neuronal|2005
0-19|0.1|0.1|0.1|Malignant|56|82005260|Male and Female|Neuronal/glial, neuronal|2005
0-19|0.3|0.4|0.3|Benign/Borderline|284|82324418|Male and Female|Neuronal/glial, neuronal|2006
0-19|0.0|0.1|0.1|Malignant|53|82324418|Male and Female|Neuronal/glial, neuronal|2006
0-19|0.3|0.4|0.4|Benign/Borderline|313|82749431|Male and Female|Neuronal/glial, neuronal|2007
0-19|0.1|0.1|0.1|Malignant|62|82749431|Male and Female|Neuronal/glial, neuronal|2007
0-19|0.3|0.4|0.4|Benign/Borderline|316|83118264|Male and Female|Neuronal/glial, neuronal|2008
0-19|0.1|0.1|0.1|Malignant|57|83118264|Male and Female|Neuronal/glial, neuronal|2008
0-19|0.3|0.4|0.4|Benign/Borderline|296|83280391|Male and Female|Neuronal/glial, neuronal|2009
0-19|0.0|0.1|0.0|Malignant|35|83280391|Male and Female|Neuronal/glial, neuronal|2009
0-19|0.3|0.4|0.4|Benign/Borderline|317|83218950|Male and Female|Neuronal/glial, neuronal|2010
0-19|0.0|0.1|0.0|Malignant|35|83218950|Male and Female|Neuronal/glial, neuronal|2010
0-19|0.4|0.5|0.4|Benign/Borderline|344|83011324|Male and Female|Neuronal/glial, neuronal|2011
0-19|0.0|0.1|0.0|Malignant|36|83011324|Male and Female|Neuronal/glial, neuronal|2011
0-19|0.4|0.5|0.4|Benign/Borderline|364|82811054|Male and Female|Neuronal/glial, neuronal|2012
0-19|0.0|0.1|0.0|Malignant|40|82811054|Male and Female|Neuronal/glial, neuronal|2012
0-19|0.4|0.5|0.4|Benign/Borderline|357|82716398|Male and Female|Neuronal/glial, neuronal|2013
0-19|0.0|0.1|0.1|Malignant|46|82716398|Male and Female|Neuronal/glial, neuronal|2013
0-19|0.4|0.5|0.4|Benign/Borderline|338|82718202|Male and Female|Neuronal/glial, neuronal|2014
0-19|0.1|0.1|0.1|Malignant|57|82718202|Male and Female|Neuronal/glial, neuronal|2014
0-19|0.4|0.5|0.5|Benign/Borderline|397|82835167|Male and Female|Neuronal/glial, neuronal|2015
0-19|0.0|0.1|0.1|Malignant|43|82835167|Male and Female|Neuronal/glial, neuronal|2015
0-19|0.5|0.6|0.5|Benign/Borderline|419|83018369|Male and Female|Neuronal/glial, neuronal|2016
0-19|0.1|0.1|0.1|Malignant|55|83018369|Male and Female|Neuronal/glial, neuronal|2016
0-19|0.5|0.6|0.5|Benign/Borderline|419|83117707|Male and Female|Neuronal/glial, neuronal|2017
0-19|0.0|0.1|0.0|Malignant|40|83117707|Male and Female|Neuronal/glial, neuronal|2017
0-19|0.4|0.5|0.4|Benign/Borderline|1763|404367531|Male and Female|Neuronal/glial, neuronal|2017-2021
0-19|0.0|0.1|0.1|Malignant|209|404367531|Male and Female|Neuronal/glial, neuronal|2017-2021
0-19|0.4|0.5|0.4|Benign/Borderline|367|83111569|Male and Female|Neuronal/glial, neuronal|2018
0-19|0.0|0.1|0.1|Malignant|50|83111569|Male and Female|Neuronal/glial, neuronal|2018
0-19|0.4|0.5|0.5|Benign/Borderline|382|82986327|Male and Female|Neuronal/glial, neuronal|2019
0-19|0.0|0.1|0.1|Malignant|44|82986327|Male and Female|Neuronal/glial, neuronal|2019
0-19|0.3|0.4|0.4|Benign/Borderline|316|80749239|Male and Female|Neuronal/glial, neuronal|2020
0-19|0.0|0.1|0.1|Malignant|40|80749239|Male and Female|Neuronal/glial, neuronal|2020
0-19|0.3|0.4|0.4|Benign/Borderline|300|79740141|Male and Female|Neuronal/glial, neuronal|2021
0-19|0.0|0.1|0.0|Malignant|35|79740141|Male and Female|Neuronal/glial, neuronal|2021
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Oligodendroglioma|2004
0-19|0.1|0.1|0.1|Malignant|62|81754354|Male and Female|Oligodendroglioma|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Oligodendroglioma|2005
0-19|0.0|0.1|0.1|Malignant|52|82005260|Male and Female|Oligodendroglioma|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Oligodendroglioma|2006
0-19|0.1|0.1|0.1|Malignant|56|82324418|Male and Female|Oligodendroglioma|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Oligodendroglioma|2007
0-19|0.0|0.1|0.1|Malignant|53|82749431|Male and Female|Oligodendroglioma|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Oligodendroglioma|2008
0-19|0.0|0.1|0.1|Malignant|48|83118264|Male and Female|Oligodendroglioma|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Oligodendroglioma|2009
0-19|0.0|0.1|0.1|Malignant|44|83280391|Male and Female|Oligodendroglioma|2009
0-19|~|~|~|Benign/Borderline|~|83218950|Male and Female|Oligodendroglioma|2010
0-19|0.0|0.1|0.1|Malignant|46|83218950|Male and Female|Oligodendroglioma|2010
0-19|~|~|~|Benign/Borderline|~|83011324|Male and Female|Oligodendroglioma|2011
0-19|0.0|0.1|0.0|Malignant|37|83011324|Male and Female|Oligodendroglioma|2011
0-19|~|~|~|Benign/Borderline|~|82811054|Male and Female|Oligodendroglioma|2012
0-19|0.0|0.1|0.1|Malignant|47|82811054|Male and Female|Oligodendroglioma|2012
0-19|~|~|~|Benign/Borderline|~|82716398|Male and Female|Oligodendroglioma|2013
0-19|0.0|0.1|0.0|Malignant|36|82716398|Male and Female|Oligodendroglioma|2013
0-19|~|~|~|Benign/Borderline|~|82718202|Male and Female|Oligodendroglioma|2014
0-19|0.0|0.1|0.0|Malignant|38|82718202|Male and Female|Oligodendroglioma|2014
0-19|~|~|~|Benign/Borderline|~|82835167|Male and Female|Oligodendroglioma|2015
0-19|0.0|0.1|0.0|Malignant|36|82835167|Male and Female|Oligodendroglioma|2015
0-19|~|~|~|Benign/Borderline|~|83018369|Male and Female|Oligodendroglioma|2016
0-19|0.0|0.1|0.0|Malignant|38|83018369|Male and Female|Oligodendroglioma|2016
0-19|~|~|~|Benign/Borderline|~|83117707|Male and Female|Oligodendroglioma|2017
0-19|0.0|0.0|0.0|Malignant|27|83117707|Male and Female|Oligodendroglioma|2017
0-19|~|~|~|Benign/Borderline|~|404367531|Male and Female|Oligodendroglioma|2017-2021
0-19|0.0|0.0|0.0|Malignant|110|404367531|Male and Female|Oligodendroglioma|2017-2021
0-19|~|~|~|Benign/Borderline|~|83111569|Male and Female|Oligodendroglioma|2018
0-19|0.0|0.0|0.0|Malignant|25|83111569|Male and Female|Oligodendroglioma|2018
0-19|~|~|~|Benign/Borderline|~|82986327|Male and Female|Oligodendroglioma|2019
0-19|0.0|0.0|0.0|Malignant|19|82986327|Male and Female|Oligodendroglioma|2019
0-19|~|~|~|Benign/Borderline|~|80749239|Male and Female|Oligodendroglioma|2020
0-19|0.0|0.0|0.0|Malignant|17|80749239|Male and Female|Oligodendroglioma|2020
0-19|~|~|~|Benign/Borderline|~|79740141|Male and Female|Oligodendroglioma|2021
0-19|0.0|0.0|0.0|Malignant|23|79740141|Male and Female|Oligodendroglioma|2021
0-19|0.0|0.0|0.0|Benign/Borderline|28|81754354|Male and Female|Other mesenchymal|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Other mesenchymal|2004
0-19|0.0|0.1|0.0|Benign/Borderline|40|82005260|Male and Female|Other mesenchymal|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Other mesenchymal|2005
0-19|0.0|0.1|0.0|Benign/Borderline|40|82324418|Male and Female|Other mesenchymal|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Other mesenchymal|2006
0-19|0.0|0.1|0.0|Benign/Borderline|33|82749431|Male and Female|Other mesenchymal|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Other mesenchymal|2007
0-19|0.0|0.1|0.0|Benign/Borderline|40|83118264|Male and Female|Other mesenchymal|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Other mesenchymal|2008
0-19|0.0|0.1|0.1|Benign/Borderline|51|83280391|Male and Female|Other mesenchymal|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Other mesenchymal|2009
0-19|0.0|0.1|0.1|Benign/Borderline|54|83218950|Male and Female|Other mesenchymal|2010
0-19|~|~|~|Malignant|~|83218950|Male and Female|Other mesenchymal|2010
0-19|0.1|0.1|0.1|Benign/Borderline|64|83011324|Male and Female|Other mesenchymal|2011
0-19|~|~|~|Malignant|~|83011324|Male and Female|Other mesenchymal|2011
0-19|0.1|0.1|0.1|Benign/Borderline|98|82811054|Male and Female|Other mesenchymal|2012
0-19|0.0|0.0|0.0|Malignant|16|82811054|Male and Female|Other mesenchymal|2012
0-19|0.1|0.1|0.1|Benign/Borderline|77|82716398|Male and Female|Other mesenchymal|2013
0-19|~|~|~|Malignant|~|82716398|Male and Female|Other mesenchymal|2013
0-19|0.1|0.1|0.1|Benign/Borderline|79|82718202|Male and Female|Other mesenchymal|2014
0-19|~|~|~|Malignant|~|82718202|Male and Female|Other mesenchymal|2014
0-19|0.1|0.1|0.1|Benign/Borderline|85|82835167|Male and Female|Other mesenchymal|2015
0-19|~|~|~|Malignant|~|82835167|Male and Female|Other mesenchymal|2015
0-19|0.1|0.2|0.1|Benign/Borderline|104|83018369|Male and Female|Other mesenchymal|2016
0-19|~|~|~|Malignant|~|83018369|Male and Female|Other mesenchymal|2016
0-19|0.1|0.1|0.1|Benign/Borderline|100|83117707|Male and Female|Other mesenchymal|2017
0-19|~|~|~|Malignant|~|83117707|Male and Female|Other mesenchymal|2017
0-19|0.1|0.1|0.1|Benign/Borderline|432|404367531|Male and Female|Other mesenchymal|2017-2021
0-19|0.0|0.0|0.0|Malignant|83|404367531|Male and Female|Other mesenchymal|2017-2021
0-19|0.1|0.1|0.1|Benign/Borderline|98|83111569|Male and Female|Other mesenchymal|2018
0-19|~|~|~|Malignant|~|83111569|Male and Female|Other mesenchymal|2018
0-19|0.1|0.1|0.1|Benign/Borderline|63|82986327|Male and Female|Other mesenchymal|2019
0-19|~|~|~|Malignant|~|82986327|Male and Female|Other mesenchymal|2019
0-19|0.1|0.1|0.1|Benign/Borderline|72|80749239|Male and Female|Other mesenchymal|2020
0-19|0.0|0.0|0.0|Malignant|23|80749239|Male and Female|Other mesenchymal|2020
0-19|0.1|0.2|0.1|Benign/Borderline|99|79740141|Male and Female|Other mesenchymal|2021
0-19|0.0|0.0|0.0|Malignant|20|79740141|Male and Female|Other mesenchymal|2021
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Pilocytic astrocytoma|2004
0-19|0.8|0.9|0.9|Malignant|702|81754354|Male and Female|Pilocytic astrocytoma|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Pilocytic astrocytoma|2005
0-19|0.8|0.9|0.8|Malignant|681|82005260|Male and Female|Pilocytic astrocytoma|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Pilocytic astrocytoma|2006
0-19|0.8|0.9|0.8|Malignant|679|82324418|Male and Female|Pilocytic astrocytoma|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Pilocytic astrocytoma|2007
0-19|0.8|0.9|0.8|Malignant|699|82749431|Male and Female|Pilocytic astrocytoma|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Pilocytic astrocytoma|2008
0-19|0.8|1.0|0.9|Malignant|737|83118264|Male and Female|Pilocytic astrocytoma|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Pilocytic astrocytoma|2009
0-19|0.8|0.9|0.9|Malignant|729|83280391|Male and Female|Pilocytic astrocytoma|2009
0-19|~|~|~|Benign/Borderline|~|83218950|Male and Female|Pilocytic astrocytoma|2010
0-19|0.9|1.0|0.9|Malignant|785|83218950|Male and Female|Pilocytic astrocytoma|2010
0-19|~|~|~|Benign/Borderline|~|83011324|Male and Female|Pilocytic astrocytoma|2011
0-19|0.9|1.0|0.9|Malignant|767|83011324|Male and Female|Pilocytic astrocytoma|2011
0-19|~|~|~|Benign/Borderline|~|82811054|Male and Female|Pilocytic astrocytoma|2012
0-19|0.9|1.1|1.0|Malignant|816|82811054|Male and Female|Pilocytic astrocytoma|2012
0-19|~|~|~|Benign/Borderline|~|82716398|Male and Female|Pilocytic astrocytoma|2013
0-19|0.9|1.0|1.0|Malignant|802|82716398|Male and Female|Pilocytic astrocytoma|2013
0-19|~|~|~|Benign/Borderline|~|82718202|Male and Female|Pilocytic astrocytoma|2014
0-19|0.9|1.0|1.0|Malignant|793|82718202|Male and Female|Pilocytic astrocytoma|2014
0-19|~|~|~|Benign/Borderline|~|82835167|Male and Female|Pilocytic astrocytoma|2015
0-19|0.8|1.0|0.9|Malignant|747|82835167|Male and Female|Pilocytic astrocytoma|2015
0-19|~|~|~|Benign/Borderline|~|83018369|Male and Female|Pilocytic astrocytoma|2016
0-19|0.8|0.9|0.9|Malignant|725|83018369|Male and Female|Pilocytic astrocytoma|2016
0-19|~|~|~|Benign/Borderline|~|83117707|Male and Female|Pilocytic astrocytoma|2017
0-19|1.0|1.1|1.0|Malignant|851|83117707|Male and Female|Pilocytic astrocytoma|2017
0-19|0.1|0.2|0.1|Benign/Borderline|549|404367531|Male and Female|Pilocytic astrocytoma|2017-2021
0-19|0.8|0.9|0.8|Malignant|3326|404367531|Male and Female|Pilocytic astrocytoma|2017-2021
0-19|0.2|0.2|0.2|Benign/Borderline|159|83111569|Male and Female|Pilocytic astrocytoma|2018
0-19|0.8|0.9|0.8|Malignant|686|83111569|Male and Female|Pilocytic astrocytoma|2018
0-19|0.1|0.2|0.2|Benign/Borderline|140|82986327|Male and Female|Pilocytic astrocytoma|2019
0-19|0.7|0.8|0.8|Malignant|641|82986327|Male and Female|Pilocytic astrocytoma|2019
0-19|0.1|0.2|0.2|Benign/Borderline|135|80749239|Male and Female|Pilocytic astrocytoma|2020
0-19|0.7|0.8|0.8|Malignant|608|80749239|Male and Female|Pilocytic astrocytoma|2020
0-19|0.1|0.2|0.2|Benign/Borderline|119|79740141|Male and Female|Pilocytic astrocytoma|2021
0-19|0.7|0.8|0.7|Malignant|591|79740141|Male and Female|Pilocytic astrocytoma|2021
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Pineal parenchymal|2004
0-19|0.0|0.1|0.0|Malignant|32|81754354|Male and Female|Pineal parenchymal|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Pineal parenchymal|2005
0-19|0.0|0.0|0.0|Malignant|22|82005260|Male and Female|Pineal parenchymal|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Pineal parenchymal|2006
0-19|0.0|0.0|0.0|Malignant|24|82324418|Male and Female|Pineal parenchymal|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Pineal parenchymal|2007
0-19|0.0|0.0|0.0|Malignant|28|82749431|Male and Female|Pineal parenchymal|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Pineal parenchymal|2008
0-19|0.0|0.1|0.0|Malignant|35|83118264|Male and Female|Pineal parenchymal|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Pineal parenchymal|2009
0-19|0.0|0.0|0.0|Malignant|26|83280391|Male and Female|Pineal parenchymal|2009
0-19|~|~|~|Benign/Borderline|~|83218950|Male and Female|Pineal parenchymal|2010
0-19|0.0|0.0|0.0|Malignant|26|83218950|Male and Female|Pineal parenchymal|2010
0-19|~|~|~|Benign/Borderline|~|83011324|Male and Female|Pineal parenchymal|2011
0-19|0.0|0.1|0.0|Malignant|35|83011324|Male and Female|Pineal parenchymal|2011
0-19|~|~|~|Benign/Borderline|~|82811054|Male and Female|Pineal parenchymal|2012
0-19|0.0|0.1|0.0|Malignant|33|82811054|Male and Female|Pineal parenchymal|2012
0-19|~|~|~|Benign/Borderline|~|82716398|Male and Female|Pineal parenchymal|2013
0-19|0.0|0.1|0.0|Malignant|32|82716398|Male and Female|Pineal parenchymal|2013
0-19|~|~|~|Benign/Borderline|~|82718202|Male and Female|Pineal parenchymal|2014
0-19|0.0|0.1|0.0|Malignant|39|82718202|Male and Female|Pineal parenchymal|2014
0-19|~|~|~|Benign/Borderline|~|82835167|Male and Female|Pineal parenchymal|2015
0-19|0.0|0.1|0.1|Malignant|45|82835167|Male and Female|Pineal parenchymal|2015
0-19|~|~|~|Benign/Borderline|~|83018369|Male and Female|Pineal parenchymal|2016
0-19|0.0|0.1|0.0|Malignant|40|83018369|Male and Female|Pineal parenchymal|2016
0-19|~|~|~|Benign/Borderline|~|83117707|Male and Female|Pineal parenchymal|2017
0-19|0.0|0.0|0.0|Malignant|27|83117707|Male and Female|Pineal parenchymal|2017
0-19|0.0|0.0|0.0|Benign/Borderline|31|404367531|Male and Female|Pineal parenchymal|2017-2021
0-19|0.0|0.0|0.0|Malignant|152|404367531|Male and Female|Pineal parenchymal|2017-2021
0-19|~|~|~|Benign/Borderline|~|83111569|Male and Female|Pineal parenchymal|2018
0-19|0.0|0.1|0.0|Malignant|32|83111569|Male and Female|Pineal parenchymal|2018
0-19|~|~|~|Benign/Borderline|~|82986327|Male and Female|Pineal parenchymal|2019
0-19|0.0|0.1|0.0|Malignant|36|82986327|Male and Female|Pineal parenchymal|2019
0-19|~|~|~|Benign/Borderline|~|80749239|Male and Female|Pineal parenchymal|2020
0-19|0.0|0.1|0.0|Malignant|34|80749239|Male and Female|Pineal parenchymal|2020
0-19|~|~|~|Benign/Borderline|~|79740141|Male and Female|Pineal parenchymal|2021
0-19|0.0|0.0|0.0|Malignant|25|79740141|Male and Female|Pineal parenchymal|2021
0-19|0.4|0.5|0.4|Benign/Borderline|374|81754354|Male and Female|Pituitary|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Pituitary|2004
0-19|0.5|0.6|0.5|Benign/Borderline|452|82005260|Male and Female|Pituitary|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Pituitary|2005
0-19|0.5|0.6|0.6|Benign/Borderline|476|82324418|Male and Female|Pituitary|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Pituitary|2006
0-19|0.5|0.6|0.6|Benign/Borderline|476|82749431|Male and Female|Pituitary|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Pituitary|2007
0-19|0.6|0.7|0.7|Benign/Borderline|562|83118264|Male and Female|Pituitary|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Pituitary|2008
0-19|0.6|0.7|0.7|Benign/Borderline|586|83280391|Male and Female|Pituitary|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Pituitary|2009
0-19|0.7|0.8|0.7|Benign/Borderline|626|83218950|Male and Female|Pituitary|2010
0-19|~|~|~|Malignant|~|83218950|Male and Female|Pituitary|2010
0-19|0.7|0.8|0.8|Benign/Borderline|641|83011324|Male and Female|Pituitary|2011
0-19|~|~|~|Malignant|~|83011324|Male and Female|Pituitary|2011
0-19|0.8|0.9|0.8|Benign/Borderline|706|82811054|Male and Female|Pituitary|2012
0-19|~|~|~|Malignant|~|82811054|Male and Female|Pituitary|2012
0-19|0.8|0.9|0.8|Benign/Borderline|698|82716398|Male and Female|Pituitary|2013
0-19|~|~|~|Malignant|~|82716398|Male and Female|Pituitary|2013
0-19|0.8|1.0|0.9|Benign/Borderline|766|82718202|Male and Female|Pituitary|2014
0-19|~|~|~|Malignant|~|82718202|Male and Female|Pituitary|2014
0-19|0.8|0.9|0.9|Benign/Borderline|734|82835167|Male and Female|Pituitary|2015
0-19|~|~|~|Malignant|~|82835167|Male and Female|Pituitary|2015
0-19|0.9|1.0|1.0|Benign/Borderline|826|83018369|Male and Female|Pituitary|2016
0-19|~|~|~|Malignant|~|83018369|Male and Female|Pituitary|2016
0-19|1.0|1.1|1.0|Benign/Borderline|881|83117707|Male and Female|Pituitary|2017
0-19|~|~|~|Malignant|~|83117707|Male and Female|Pituitary|2017
0-19|0.9|1.0|0.9|Benign/Borderline|3967|404367531|Male and Female|Pituitary|2017-2021
0-19|~|~|~|Malignant|~|404367531|Male and Female|Pituitary|2017-2021
0-19|0.9|1.0|1.0|Benign/Borderline|836|83111569|Male and Female|Pituitary|2018
0-19|~|~|~|Malignant|~|83111569|Male and Female|Pituitary|2018
0-19|0.9|1.0|1.0|Benign/Borderline|819|82986327|Male and Female|Pituitary|2019
0-19|~|~|~|Malignant|~|82986327|Male and Female|Pituitary|2019
0-19|0.8|1.0|0.9|Benign/Borderline|752|80749239|Male and Female|Pituitary|2020
0-19|~|~|~|Malignant|~|80749239|Male and Female|Pituitary|2020
0-19|0.8|0.9|0.9|Benign/Borderline|716|79740141|Male and Female|Pituitary|2021
0-19|~|~|~|Malignant|~|79740141|Male and Female|Pituitary|2021
0-19|1.7|1.9|1.8|Benign/Borderline|1509|81754354|Male and Female|Total|2004
0-19|3.3|3.6|3.5|Malignant|2811|81754354|Male and Female|Total|2004
0-19|2.0|2.2|2.1|Benign/Borderline|1776|82005260|Male and Female|Total|2005
0-19|3.1|3.4|3.3|Malignant|2669|82005260|Male and Female|Total|2005
0-19|2.1|2.3|2.2|Benign/Borderline|1832|82324418|Male and Female|Total|2006
0-19|3.2|3.5|3.4|Malignant|2749|82324418|Male and Female|Total|2006
0-19|2.1|2.4|2.2|Benign/Borderline|1887|82749431|Male and Female|Total|2007
0-19|3.3|3.6|3.4|Malignant|2833|82749431|Male and Female|Total|2007
0-19|2.3|2.5|2.4|Benign/Borderline|1997|83118264|Male and Female|Total|2008
0-19|3.4|3.6|3.5|Malignant|2899|83118264|Male and Female|Total|2008
0-19|2.4|2.6|2.5|Benign/Borderline|2092|83280391|Male and Female|Total|2009
0-19|3.3|3.6|3.5|Malignant|2866|83280391|Male and Female|Total|2009
0-19|2.4|2.6|2.5|Benign/Borderline|2131|83218950|Male and Female|Total|2010
0-19|3.4|3.7|3.5|Malignant|2923|83218950|Male and Female|Total|2010
0-19|2.5|2.8|2.6|Benign/Borderline|2217|83011324|Male and Female|Total|2011
0-19|3.5|3.7|3.6|Malignant|2968|83011324|Male and Female|Total|2011
0-19|2.7|2.9|2.8|Benign/Borderline|2337|82811054|Male and Female|Total|2012
0-19|3.4|3.6|3.5|Malignant|2882|82811054|Male and Female|Total|2012
0-19|2.7|3.0|2.8|Benign/Borderline|2361|82716398|Male and Female|Total|2013
0-19|3.5|3.7|3.6|Malignant|2970|82716398|Male and Female|Total|2013
0-19|2.7|3.0|2.9|Benign/Borderline|2385|82718202|Male and Female|Total|2014
0-19|3.5|3.7|3.6|Malignant|2963|82718202|Male and Female|Total|2014
0-19|2.8|3.0|2.9|Benign/Borderline|2400|82835167|Male and Female|Total|2015
0-19|3.4|3.7|3.5|Malignant|2911|82835167|Male and Female|Total|2015
0-19|2.9|3.1|3.0|Benign/Borderline|2532|83018369|Male and Female|Total|2016
0-19|3.3|3.6|3.5|Malignant|2870|83018369|Male and Female|Total|2016
0-19|2.9|3.1|3.0|Benign/Borderline|2501|83117707|Male and Female|Total|2017
0-19|3.5|3.8|3.7|Malignant|3027|83117707|Male and Female|Total|2017
0-19|2.7|2.8|2.8|Benign/Borderline|11433|404367531|Male and Female|Total|2017-2021
0-19|2.9|3.0|3.0|Malignant|11935|404367531|Male and Female|Total|2017-2021
0-19|2.9|3.1|3.0|Benign/Borderline|2528|83111569|Male and Female|Total|2018
0-19|2.9|3.1|3.0|Malignant|2468|83111569|Male and Female|Total|2018
0-19|2.7|2.9|2.8|Benign/Borderline|2350|82986327|Male and Female|Total|2019
0-19|2.7|2.9|2.8|Malignant|2298|82986327|Male and Female|Total|2019
0-19|2.4|2.7|2.5|Benign/Borderline|2089|80749239|Male and Female|Total|2020
0-19|2.6|2.8|2.7|Malignant|2162|80749239|Male and Female|Total|2020
0-19|2.5|2.7|2.6|Benign/Borderline|2077|79740141|Male and Female|Total|2021
0-19|2.6|2.8|2.7|Malignant|2149|79740141|Male and Female|Total|2021
0-19|0.3|0.3|0.3|Benign/Borderline|242|81754354|Male and Female|Tumors of Cranial and Spinal Nerves|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Tumors of Cranial and Spinal Nerves|2004
0-19|0.3|0.4|0.4|Benign/Borderline|290|82005260|Male and Female|Tumors of Cranial and Spinal Nerves|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Tumors of Cranial and Spinal Nerves|2005
0-19|0.4|0.5|0.4|Benign/Borderline|338|82324418|Male and Female|Tumors of Cranial and Spinal Nerves|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Tumors of Cranial and Spinal Nerves|2006
0-19|0.3|0.4|0.4|Benign/Borderline|300|82749431|Male and Female|Tumors of Cranial and Spinal Nerves|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Tumors of Cranial and Spinal Nerves|2007
0-19|0.3|0.4|0.4|Benign/Borderline|303|83118264|Male and Female|Tumors of Cranial and Spinal Nerves|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of Cranial and Spinal Nerves|2008
0-19|0.3|0.4|0.4|Benign/Borderline|314|83280391|Male and Female|Tumors of Cranial and Spinal Nerves|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Tumors of Cranial and Spinal Nerves|2009
0-19|0.3|0.4|0.3|Benign/Borderline|283|83218950|Male and Female|Tumors of Cranial and Spinal Nerves|2010
0-19|~|~|~|Malignant|~|83218950|Male and Female|Tumors of Cranial and Spinal Nerves|2010
0-19|0.3|0.4|0.3|Benign/Borderline|290|83011324|Male and Female|Tumors of Cranial and Spinal Nerves|2011
0-19|~|~|~|Malignant|~|83011324|Male and Female|Tumors of Cranial and Spinal Nerves|2011
0-19|0.3|0.4|0.4|Benign/Borderline|308|82811054|Male and Female|Tumors of Cranial and Spinal Nerves|2012
0-19|~|~|~|Malignant|~|82811054|Male and Female|Tumors of Cranial and Spinal Nerves|2012
0-19|0.3|0.4|0.4|Benign/Borderline|323|82716398|Male and Female|Tumors of Cranial and Spinal Nerves|2013
0-19|~|~|~|Malignant|~|82716398|Male and Female|Tumors of Cranial and Spinal Nerves|2013
0-19|0.3|0.4|0.3|Benign/Borderline|266|82718202|Male and Female|Tumors of Cranial and Spinal Nerves|2014
0-19|~|~|~|Malignant|~|82718202|Male and Female|Tumors of Cranial and Spinal Nerves|2014
0-19|0.3|0.4|0.4|Benign/Borderline|314|82835167|Male and Female|Tumors of Cranial and Spinal Nerves|2015
0-19|~|~|~|Malignant|~|82835167|Male and Female|Tumors of Cranial and Spinal Nerves|2015
0-19|0.3|0.4|0.4|Benign/Borderline|314|83018369|Male and Female|Tumors of Cranial and Spinal Nerves|2016
0-19|~|~|~|Malignant|~|83018369|Male and Female|Tumors of Cranial and Spinal Nerves|2016
0-19|0.3|0.3|0.3|Benign/Borderline|247|83117707|Male and Female|Tumors of Cranial and Spinal Nerves|2017
0-19|~|~|~|Malignant|~|83117707|Male and Female|Tumors of Cranial and Spinal Nerves|2017
0-19|0.2|0.2|0.2|Benign/Borderline|862|404367531|Male and Female|Tumors of Cranial and Spinal Nerves|2017-2021
0-19|0.0|0.0|0.0|Malignant|17|404367531|Male and Female|Tumors of Cranial and Spinal Nerves|2017-2021
0-19|0.2|0.2|0.2|Benign/Borderline|172|83111569|Male and Female|Tumors of Cranial and Spinal Nerves|2018
0-19|~|~|~|Malignant|~|83111569|Male and Female|Tumors of Cranial and Spinal Nerves|2018
0-19|0.2|0.2|0.2|Benign/Borderline|173|82986327|Male and Female|Tumors of Cranial and Spinal Nerves|2019
0-19|~|~|~|Malignant|~|82986327|Male and Female|Tumors of Cranial and Spinal Nerves|2019
0-19|0.1|0.2|0.2|Benign/Borderline|142|80749239|Male and Female|Tumors of Cranial and Spinal Nerves|2020
0-19|~|~|~|Malignant|~|80749239|Male and Female|Tumors of Cranial and Spinal Nerves|2020
0-19|0.1|0.2|0.2|Benign/Borderline|135|79740141|Male and Female|Tumors of Cranial and Spinal Nerves|2021
0-19|~|~|~|Malignant|~|79740141|Male and Female|Tumors of Cranial and Spinal Nerves|2021
0-19|0.5|0.6|0.5|Benign/Borderline|426|81754354|Male and Female|Tumors of Neuroepthelial Tissue|2004
0-19|3.0|3.3|3.2|Malignant|2572|81754354|Male and Female|Tumors of Neuroepthelial Tissue|2004
0-19|0.5|0.6|0.6|Benign/Borderline|464|82005260|Male and Female|Tumors of Neuroepthelial Tissue|2005
0-19|2.9|3.1|3.0|Malignant|2446|82005260|Male and Female|Tumors of Neuroepthelial Tissue|2005
0-19|0.5|0.6|0.6|Benign/Borderline|469|82324418|Male and Female|Tumors of Neuroepthelial Tissue|2006
0-19|3.0|3.2|3.1|Malignant|2529|82324418|Male and Female|Tumors of Neuroepthelial Tissue|2006
0-19|0.6|0.7|0.6|Benign/Borderline|504|82749431|Male and Female|Tumors of Neuroepthelial Tissue|2007
0-19|3.1|3.3|3.2|Malignant|2627|82749431|Male and Female|Tumors of Neuroepthelial Tissue|2007
0-19|0.6|0.7|0.6|Benign/Borderline|517|83118264|Male and Female|Tumors of Neuroepthelial Tissue|2008
0-19|3.1|3.4|3.2|Malignant|2681|83118264|Male and Female|Tumors of Neuroepthelial Tissue|2008
0-19|0.5|0.6|0.6|Benign/Borderline|494|83280391|Male and Female|Tumors of Neuroepthelial Tissue|2009
0-19|3.1|3.3|3.2|Malignant|2643|83280391|Male and Female|Tumors of Neuroepthelial Tissue|2009
0-19|0.6|0.7|0.6|Benign/Borderline|529|83218950|Male and Female|Tumors of Neuroepthelial Tissue|2010
0-19|3.1|3.4|3.2|Malignant|2687|83218950|Male and Female|Tumors of Neuroepthelial Tissue|2010
0-19|0.6|0.7|0.7|Benign/Borderline|564|83011324|Male and Female|Tumors of Neuroepthelial Tissue|2011
0-19|3.2|3.5|3.3|Malignant|2753|83011324|Male and Female|Tumors of Neuroepthelial Tissue|2011
0-19|0.6|0.8|0.7|Benign/Borderline|585|82811054|Male and Female|Tumors of Neuroepthelial Tissue|2012
0-19|3.1|3.3|3.2|Malignant|2653|82811054|Male and Female|Tumors of Neuroepthelial Tissue|2012
0-19|0.6|0.8|0.7|Benign/Borderline|584|82716398|Male and Female|Tumors of Neuroepthelial Tissue|2013
0-19|3.2|3.4|3.3|Malignant|2720|82716398|Male and Female|Tumors of Neuroepthelial Tissue|2013
0-19|0.6|0.7|0.7|Benign/Borderline|559|82718202|Male and Female|Tumors of Neuroepthelial Tissue|2014
0-19|3.2|3.5|3.3|Malignant|2741|82718202|Male and Female|Tumors of Neuroepthelial Tissue|2014
0-19|0.7|0.8|0.7|Benign/Borderline|593|82835167|Male and Female|Tumors of Neuroepthelial Tissue|2015
0-19|3.1|3.4|3.2|Malignant|2673|82835167|Male and Female|Tumors of Neuroepthelial Tissue|2015
0-19|0.7|0.8|0.8|Benign/Borderline|647|83018369|Male and Female|Tumors of Neuroepthelial Tissue|2016
0-19|3.0|3.3|3.2|Malignant|2608|83018369|Male and Female|Tumors of Neuroepthelial Tissue|2016
0-19|0.7|0.8|0.8|Benign/Borderline|641|83117707|Male and Female|Tumors of Neuroepthelial Tissue|2017
0-19|3.2|3.5|3.3|Malignant|2768|83117707|Male and Female|Tumors of Neuroepthelial Tissue|2017
0-19|0.8|0.8|0.8|Benign/Borderline|3271|404367531|Male and Female|Tumors of Neuroepthelial Tissue|2017-2021
0-19|2.6|2.7|2.7|Malignant|10772|404367531|Male and Female|Tumors of Neuroepthelial Tissue|2017-2021
0-19|0.9|1.0|0.9|Benign/Borderline|758|83111569|Male and Female|Tumors of Neuroepthelial Tissue|2018
0-19|2.6|2.9|2.7|Malignant|2262|83111569|Male and Female|Tumors of Neuroepthelial Tissue|2018
0-19|0.8|0.9|0.9|Benign/Borderline|718|82986327|Male and Female|Tumors of Neuroepthelial Tissue|2019
0-19|2.4|2.6|2.5|Malignant|2071|82986327|Male and Female|Tumors of Neuroepthelial Tissue|2019
0-19|0.7|0.8|0.8|Benign/Borderline|614|80749239|Male and Female|Tumors of Neuroepthelial Tissue|2020
0-19|2.3|2.5|2.4|Malignant|1924|80749239|Male and Female|Tumors of Neuroepthelial Tissue|2020
0-19|0.7|0.8|0.7|Benign/Borderline|576|79740141|Male and Female|Tumors of Neuroepthelial Tissue|2021
0-19|2.3|2.5|2.4|Malignant|1901|79740141|Male and Female|Tumors of Neuroepthelial Tissue|2021
0-19|0.6|0.7|0.7|Benign/Borderline|544|81754354|Male and Female|Tumors of Sellar Region|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Tumors of Sellar Region|2004
0-19|0.7|0.8|0.7|Benign/Borderline|624|82005260|Male and Female|Tumors of Sellar Region|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Tumors of Sellar Region|2005
0-19|0.7|0.8|0.8|Benign/Borderline|634|82324418|Male and Female|Tumors of Sellar Region|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Tumors of Sellar Region|2006
0-19|0.7|0.8|0.8|Benign/Borderline|661|82749431|Male and Female|Tumors of Sellar Region|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Tumors of Sellar Region|2007
0-19|0.8|0.9|0.8|Benign/Borderline|725|83118264|Male and Female|Tumors of Sellar Region|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of Sellar Region|2008
0-19|0.8|1.0|0.9|Benign/Borderline|759|83280391|Male and Female|Tumors of Sellar Region|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Tumors of Sellar Region|2009
0-19|0.9|1.0|0.9|Benign/Borderline|805|83218950|Male and Female|Tumors of Sellar Region|2010
0-19|~|~|~|Malignant|~|83218950|Male and Female|Tumors of Sellar Region|2010
0-19|0.9|1.0|0.9|Benign/Borderline|797|83011324|Male and Female|Tumors of Sellar Region|2011
0-19|~|~|~|Malignant|~|83011324|Male and Female|Tumors of Sellar Region|2011
0-19|1.0|1.1|1.0|Benign/Borderline|863|82811054|Male and Female|Tumors of Sellar Region|2012
0-19|~|~|~|Malignant|~|82811054|Male and Female|Tumors of Sellar Region|2012
0-19|1.0|1.1|1.0|Benign/Borderline|880|82716398|Male and Female|Tumors of Sellar Region|2013
0-19|~|~|~|Malignant|~|82716398|Male and Female|Tumors of Sellar Region|2013
0-19|1.1|1.2|1.2|Benign/Borderline|966|82718202|Male and Female|Tumors of Sellar Region|2014
0-19|~|~|~|Malignant|~|82718202|Male and Female|Tumors of Sellar Region|2014
0-19|1.0|1.2|1.1|Benign/Borderline|913|82835167|Male and Female|Tumors of Sellar Region|2015
0-19|~|~|~|Malignant|~|82835167|Male and Female|Tumors of Sellar Region|2015
0-19|1.1|1.2|1.1|Benign/Borderline|973|83018369|Male and Female|Tumors of Sellar Region|2016
0-19|~|~|~|Malignant|~|83018369|Male and Female|Tumors of Sellar Region|2016
0-19|1.2|1.3|1.2|Benign/Borderline|1063|83117707|Male and Female|Tumors of Sellar Region|2017
0-19|~|~|~|Malignant|~|83117707|Male and Female|Tumors of Sellar Region|2017
0-19|1.1|1.2|1.1|Benign/Borderline|4744|404367531|Male and Female|Tumors of Sellar Region|2017-2021
0-19|~|~|~|Malignant|~|404367531|Male and Female|Tumors of Sellar Region|2017-2021
0-19|1.1|1.2|1.2|Benign/Borderline|990|83111569|Male and Female|Tumors of Sellar Region|2018
0-19|~|~|~|Malignant|~|83111569|Male and Female|Tumors of Sellar Region|2018
0-19|1.1|1.2|1.1|Benign/Borderline|982|82986327|Male and Female|Tumors of Sellar Region|2019
0-19|~|~|~|Malignant|~|82986327|Male and Female|Tumors of Sellar Region|2019
0-19|1.0|1.1|1.0|Benign/Borderline|875|80749239|Male and Female|Tumors of Sellar Region|2020
0-19|~|~|~|Malignant|~|80749239|Male and Female|Tumors of Sellar Region|2020
0-19|1.0|1.2|1.1|Benign/Borderline|884|79740141|Male and Female|Tumors of Sellar Region|2021
0-19|~|~|~|Malignant|~|79740141|Male and Female|Tumors of Sellar Region|2021
0-19|0.2|0.2|0.2|Benign/Borderline|151|81754354|Male and Female|Tumors of the Meninges|2004
0-19|0.0|0.0|0.0|Malignant|20|81754354|Male and Female|Tumors of the Meninges|2004
0-19|0.2|0.3|0.2|Benign/Borderline|197|82005260|Male and Female|Tumors of the Meninges|2005
0-19|0.0|0.0|0.0|Malignant|20|82005260|Male and Female|Tumors of the Meninges|2005
0-19|0.2|0.2|0.2|Benign/Borderline|166|82324418|Male and Female|Tumors of the Meninges|2006
0-19|0.0|0.0|0.0|Malignant|17|82324418|Male and Female|Tumors of the Meninges|2006
0-19|0.2|0.2|0.2|Benign/Borderline|180|82749431|Male and Female|Tumors of the Meninges|2007
0-19|0.0|0.0|0.0|Malignant|17|82749431|Male and Female|Tumors of the Meninges|2007
0-19|0.2|0.2|0.2|Benign/Borderline|183|83118264|Male and Female|Tumors of the Meninges|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of the Meninges|2008
0-19|0.2|0.3|0.2|Benign/Borderline|207|83280391|Male and Female|Tumors of the Meninges|2009
0-19|0.0|0.0|0.0|Malignant|21|83280391|Male and Female|Tumors of the Meninges|2009
0-19|0.2|0.3|0.2|Benign/Borderline|196|83218950|Male and Female|Tumors of the Meninges|2010
0-19|0.0|0.0|0.0|Malignant|21|83218950|Male and Female|Tumors of the Meninges|2010
0-19|0.2|0.3|0.3|Benign/Borderline|237|83011324|Male and Female|Tumors of the Meninges|2011
0-19|0.0|0.0|0.0|Malignant|16|83011324|Male and Female|Tumors of the Meninges|2011
0-19|0.3|0.4|0.3|Benign/Borderline|266|82811054|Male and Female|Tumors of the Meninges|2012
0-19|0.0|0.0|0.0|Malignant|20|82811054|Male and Female|Tumors of the Meninges|2012
0-19|0.3|0.3|0.3|Benign/Borderline|249|82716398|Male and Female|Tumors of the Meninges|2013
0-19|0.0|0.0|0.0|Malignant|22|82716398|Male and Female|Tumors of the Meninges|2013
0-19|0.3|0.4|0.3|Benign/Borderline|264|82718202|Male and Female|Tumors of the Meninges|2014
0-19|0.0|0.0|0.0|Malignant|18|82718202|Male and Female|Tumors of the Meninges|2014
0-19|0.3|0.4|0.3|Benign/Borderline|262|82835167|Male and Female|Tumors of the Meninges|2015
0-19|0.0|0.0|0.0|Malignant|22|82835167|Male and Female|Tumors of the Meninges|2015
0-19|0.3|0.4|0.3|Benign/Borderline|269|83018369|Male and Female|Tumors of the Meninges|2016
0-19|0.0|0.0|0.0|Malignant|22|83018369|Male and Female|Tumors of the Meninges|2016
0-19|0.3|0.4|0.3|Benign/Borderline|265|83117707|Male and Female|Tumors of the Meninges|2017
0-19|0.0|0.0|0.0|Malignant|16|83117707|Male and Female|Tumors of the Meninges|2017
0-19|0.3|0.3|0.3|Benign/Borderline|1258|404367531|Male and Female|Tumors of the Meninges|2017-2021
0-19|0.0|0.0|0.0|Malignant|103|404367531|Male and Female|Tumors of the Meninges|2017-2021
0-19|0.3|0.4|0.3|Benign/Borderline|290|83111569|Male and Female|Tumors of the Meninges|2018
0-19|0.0|0.0|0.0|Malignant|17|83111569|Male and Female|Tumors of the Meninges|2018
0-19|0.2|0.3|0.3|Benign/Borderline|230|82986327|Male and Female|Tumors of the Meninges|2019
0-19|~|~|~|Malignant|~|82986327|Male and Female|Tumors of the Meninges|2019
0-19|0.3|0.3|0.3|Benign/Borderline|233|80749239|Male and Female|Tumors of the Meninges|2020
0-19|0.0|0.1|0.0|Malignant|29|80749239|Male and Female|Tumors of the Meninges|2020
0-19|0.3|0.4|0.3|Benign/Borderline|252|79740141|Male and Female|Tumors of the Meninges|2021
0-19|0.0|0.1|0.0|Malignant|28|79740141|Male and Female|Tumors of the Meninges|2021
0-19|0.1|0.2|0.1|Benign/Borderline|114|81754354|Male and Female|Unclassified Tumors|2004
0-19|0.0|0.1|0.1|Malignant|43|81754354|Male and Female|Unclassified Tumors|2004
0-19|0.2|0.2|0.2|Benign/Borderline|164|82005260|Male and Female|Unclassified Tumors|2005
0-19|0.0|0.1|0.0|Malignant|38|82005260|Male and Female|Unclassified Tumors|2005
0-19|0.2|0.3|0.2|Benign/Borderline|179|82324418|Male and Female|Unclassified Tumors|2006
0-19|0.0|0.1|0.1|Malignant|52|82324418|Male and Female|Unclassified Tumors|2006
0-19|0.2|0.3|0.2|Benign/Borderline|207|82749431|Male and Female|Unclassified Tumors|2007
0-19|0.0|0.1|0.0|Malignant|41|82749431|Male and Female|Unclassified Tumors|2007
0-19|0.2|0.3|0.3|Benign/Borderline|228|83118264|Male and Female|Unclassified Tumors|2008
0-19|0.0|0.1|0.0|Malignant|35|83118264|Male and Female|Unclassified Tumors|2008
0-19|0.3|0.4|0.3|Benign/Borderline|268|83280391|Male and Female|Unclassified Tumors|2009
0-19|0.0|0.1|0.0|Malignant|38|83280391|Male and Female|Unclassified Tumors|2009
0-19|0.3|0.4|0.3|Benign/Borderline|274|83218950|Male and Female|Unclassified Tumors|2010
0-19|0.0|0.0|0.0|Malignant|27|83218950|Male and Female|Unclassified Tumors|2010
0-19|0.3|0.4|0.3|Benign/Borderline|291|83011324|Male and Female|Unclassified Tumors|2011
0-19|0.0|0.1|0.0|Malignant|34|83011324|Male and Female|Unclassified Tumors|2011
0-19|0.3|0.4|0.3|Benign/Borderline|273|82811054|Male and Female|Unclassified Tumors|2012
0-19|0.1|0.1|0.1|Malignant|55|82811054|Male and Female|Unclassified Tumors|2012
0-19|0.3|0.4|0.3|Benign/Borderline|277|82716398|Male and Female|Unclassified Tumors|2013
0-19|0.0|0.1|0.1|Malignant|45|82716398|Male and Female|Unclassified Tumors|2013
0-19|0.3|0.4|0.3|Benign/Borderline|280|82718202|Male and Female|Unclassified Tumors|2014
0-19|0.0|0.1|0.1|Malignant|46|82718202|Male and Female|Unclassified Tumors|2014
0-19|0.3|0.4|0.3|Benign/Borderline|280|82835167|Male and Female|Unclassified Tumors|2015
0-19|0.0|0.1|0.0|Malignant|38|82835167|Male and Female|Unclassified Tumors|2015
0-19|0.3|0.4|0.3|Benign/Borderline|267|83018369|Male and Female|Unclassified Tumors|2016
0-19|0.0|0.1|0.1|Malignant|46|83018369|Male and Female|Unclassified Tumors|2016
0-19|0.3|0.3|0.3|Benign/Borderline|246|83117707|Male and Female|Unclassified Tumors|2017
0-19|0.0|0.1|0.1|Malignant|51|83117707|Male and Female|Unclassified Tumors|2017
0-19|0.3|0.3|0.3|Benign/Borderline|1097|404367531|Male and Female|Unclassified Tumors|2017-2021
0-19|0.1|0.1|0.1|Malignant|248|404367531|Male and Female|Unclassified Tumors|2017-2021
0-19|0.3|0.3|0.3|Benign/Borderline|259|83111569|Male and Female|Unclassified Tumors|2018
0-19|0.0|0.1|0.1|Malignant|47|83111569|Male and Female|Unclassified Tumors|2018
0-19|0.2|0.3|0.2|Benign/Borderline|205|82986327|Male and Female|Unclassified Tumors|2019
0-19|0.0|0.1|0.0|Malignant|37|82986327|Male and Female|Unclassified Tumors|2019
0-19|0.2|0.3|0.2|Benign/Borderline|198|80749239|Male and Female|Unclassified Tumors|2020
0-19|0.1|0.1|0.1|Malignant|55|80749239|Male and Female|Unclassified Tumors|2020
0-19|0.2|0.3|0.2|Benign/Borderline|194|79740141|Male and Female|Unclassified Tumors|2021
0-19|0.1|0.1|0.1|Malignant|59|79740141|Male and Female|Unclassified Tumors|2021
0-19|0.1|0.1|0.1|Benign/Borderline|55|81754354|Male and Female|Unique astrocytoma variants|2004
0-19|0.0|0.1|0.0|Malignant|32|81754354|Male and Female|Unique astrocytoma variants|2004
0-19|0.1|0.1|0.1|Benign/Borderline|63|82005260|Male and Female|Unique astrocytoma variants|2005
0-19|0.0|0.1|0.0|Malignant|31|82005260|Male and Female|Unique astrocytoma variants|2005
0-19|0.0|0.1|0.1|Benign/Borderline|50|82324418|Male and Female|Unique astrocytoma variants|2006
0-19|0.0|0.1|0.0|Malignant|37|82324418|Male and Female|Unique astrocytoma variants|2006
0-19|0.1|0.1|0.1|Benign/Borderline|68|82749431|Male and Female|Unique astrocytoma variants|2007
0-19|0.1|0.1|0.1|Malignant|58|82749431|Male and Female|Unique astrocytoma variants|2007
0-19|0.1|0.1|0.1|Benign/Borderline|70|83118264|Male and Female|Unique astrocytoma variants|2008
0-19|0.0|0.1|0.0|Malignant|32|83118264|Male and Female|Unique astrocytoma variants|2008
0-19|0.1|0.1|0.1|Benign/Borderline|81|83280391|Male and Female|Unique astrocytoma variants|2009
0-19|0.0|0.1|0.1|Malignant|45|83280391|Male and Female|Unique astrocytoma variants|2009
0-19|0.1|0.1|0.1|Benign/Borderline|67|83218950|Male and Female|Unique astrocytoma variants|2010
0-19|0.0|0.0|0.0|Malignant|27|83218950|Male and Female|Unique astrocytoma variants|2010
0-19|0.1|0.1|0.1|Benign/Borderline|70|83011324|Male and Female|Unique astrocytoma variants|2011
0-19|0.0|0.1|0.1|Malignant|53|83011324|Male and Female|Unique astrocytoma variants|2011
0-19|0.1|0.1|0.1|Benign/Borderline|79|82811054|Male and Female|Unique astrocytoma variants|2012
0-19|0.0|0.1|0.1|Malignant|45|82811054|Male and Female|Unique astrocytoma variants|2012
0-19|0.1|0.1|0.1|Benign/Borderline|79|82716398|Male and Female|Unique astrocytoma variants|2013
0-19|0.0|0.1|0.1|Malignant|44|82716398|Male and Female|Unique astrocytoma variants|2013
0-19|0.1|0.1|0.1|Benign/Borderline|96|82718202|Male and Female|Unique astrocytoma variants|2014
0-19|0.0|0.1|0.1|Malignant|42|82718202|Male and Female|Unique astrocytoma variants|2014
0-19|0.0|0.1|0.1|Benign/Borderline|51|82835167|Male and Female|Unique astrocytoma variants|2015
0-19|0.0|0.1|0.1|Malignant|52|82835167|Male and Female|Unique astrocytoma variants|2015
0-19|0.1|0.1|0.1|Benign/Borderline|60|83018369|Male and Female|Unique astrocytoma variants|2016
0-19|0.0|0.1|0.1|Malignant|49|83018369|Male and Female|Unique astrocytoma variants|2016
0-19|0.1|0.1|0.1|Benign/Borderline|61|83117707|Male and Female|Unique astrocytoma variants|2017
0-19|0.0|0.1|0.0|Malignant|42|83117707|Male and Female|Unique astrocytoma variants|2017
0-19|0.1|0.1|0.1|Benign/Borderline|274|404367531|Male and Female|Unique astrocytoma variants|2017-2021
0-19|0.0|0.1|0.0|Malignant|204|404367531|Male and Female|Unique astrocytoma variants|2017-2021
0-19|0.1|0.1|0.1|Benign/Borderline|65|83111569|Male and Female|Unique astrocytoma variants|2018
0-19|0.0|0.1|0.1|Malignant|47|83111569|Male and Female|Unique astrocytoma variants|2018
0-19|0.1|0.1|0.1|Benign/Borderline|62|82986327|Male and Female|Unique astrocytoma variants|2019
0-19|0.0|0.1|0.1|Malignant|44|82986327|Male and Female|Unique astrocytoma variants|2019
0-19|0.0|0.1|0.1|Benign/Borderline|43|80749239|Male and Female|Unique astrocytoma variants|2020
0-19|0.0|0.1|0.0|Malignant|37|80749239|Male and Female|Unique astrocytoma variants|2020
0-19|0.0|0.1|0.1|Benign/Borderline|44|79740141|Male and Female|Unique astrocytoma variants|2021
0-19|0.0|0.1|0.1|Malignant|42|79740141|Male and Female|Unique astrocytoma variants|2021
20+|~|~|~|Benign/Borderline|~|109112165|Female|All other|2004
20+|~|~|~|Malignant|~|109112165|Female|All other|2004
20+|0.0|0.0|0.0|Benign/Borderline|19|110320645|Female|All other|2005
20+|~|~|~|Malignant|~|110320645|Female|All other|2005
20+|0.0|0.0|0.0|Benign/Borderline|23|111567226|Female|All other|2006
20+|~|~|~|Malignant|~|111567226|Female|All other|2006
20+|0.0|0.0|0.0|Benign/Borderline|19|112783993|Female|All other|2007
20+|~|~|~|Malignant|~|112783993|Female|All other|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|All other|2008
20+|~|~|~|Malignant|~|114027722|Female|All other|2008
20+|0.0|0.0|0.0|Benign/Borderline|19|115293599|Female|All other|2009
20+|~|~|~|Malignant|~|115293599|Female|All other|2009
20+|0.0|0.0|0.0|Benign/Borderline|23|116598241|Female|All other|2010
20+|0.0|0.0|0.0|Malignant|19|116598241|Female|All other|2010
20+|~|~|~|Benign/Borderline|~|117817623|Female|All other|2011
20+|0.0|0.0|0.0|Malignant|21|117817623|Female|All other|2011
20+|0.0|0.0|0.0|Benign/Borderline|20|119004221|Female|All other|2012
20+|~|~|~|Malignant|~|119004221|Female|All other|2012
20+|~|~|~|Benign/Borderline|~|120085013|Female|All other|2013
20+|0.0|0.0|0.0|Malignant|23|120085013|Female|All other|2013
20+|0.0|0.0|0.0|Benign/Borderline|17|121202956|Female|All other|2014
20+|0.0|0.0|0.0|Malignant|22|121202956|Female|All other|2014
20+|0.0|0.0|0.0|Benign/Borderline|21|122262894|Female|All other|2015
20+|0.0|0.0|0.0|Malignant|27|122262894|Female|All other|2015
20+|0.0|0.0|0.0|Benign/Borderline|32|123298060|Female|All other|2016
20+|0.0|0.0|0.0|Malignant|26|123298060|Female|All other|2016
20+|0.0|0.0|0.0|Benign/Borderline|33|124243876|Female|All other|2017
20+|0.0|0.0|0.0|Malignant|31|124243876|Female|All other|2017
20+|0.0|0.0|0.0|Benign/Borderline|220|616718331|Female|All other|2017-2021
20+|0.1|0.1|0.1|Malignant|810|616718331|Female|All other|2017-2021
20+|0.0|0.1|0.0|Benign/Borderline|50|125090257|Female|All other|2018
20+|0.1|0.2|0.1|Malignant|173|125090257|Female|All other|2018
20+|0.0|0.0|0.0|Benign/Borderline|46|125886169|Female|All other|2019
20+|0.2|0.2|0.2|Malignant|217|125886169|Female|All other|2019
20+|0.0|0.0|0.0|Benign/Borderline|41|124127412|Female|All other|2020
20+|0.1|0.2|0.2|Malignant|205|124127412|Female|All other|2020
20+|0.0|0.1|0.0|Benign/Borderline|51|124936720|Female|All other|2021
20+|0.1|0.2|0.2|Malignant|191|124936720|Female|All other|2021
20+|~|~|~|Benign/Borderline|~|109112165|Female|Anaplastic astrocytoma|2004
20+|0.5|0.6|0.5|Malignant|566|109112165|Female|Anaplastic astrocytoma|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Anaplastic astrocytoma|2005
20+|0.4|0.5|0.5|Malignant|514|110320645|Female|Anaplastic astrocytoma|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Anaplastic astrocytoma|2006
20+|0.4|0.5|0.4|Malignant|512|111567226|Female|Anaplastic astrocytoma|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Anaplastic astrocytoma|2007
20+|0.4|0.5|0.5|Malignant|532|112783993|Female|Anaplastic astrocytoma|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Anaplastic astrocytoma|2008
20+|0.4|0.5|0.4|Malignant|504|114027722|Female|Anaplastic astrocytoma|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Anaplastic astrocytoma|2009
20+|0.4|0.5|0.4|Malignant|500|115293599|Female|Anaplastic astrocytoma|2009
20+|~|~|~|Benign/Borderline|~|116598241|Female|Anaplastic astrocytoma|2010
20+|0.4|0.5|0.5|Malignant|575|116598241|Female|Anaplastic astrocytoma|2010
20+|~|~|~|Benign/Borderline|~|117817623|Female|Anaplastic astrocytoma|2011
20+|0.4|0.5|0.5|Malignant|572|117817623|Female|Anaplastic astrocytoma|2011
20+|~|~|~|Benign/Borderline|~|119004221|Female|Anaplastic astrocytoma|2012
20+|0.4|0.5|0.5|Malignant|590|119004221|Female|Anaplastic astrocytoma|2012
20+|~|~|~|Benign/Borderline|~|120085013|Female|Anaplastic astrocytoma|2013
20+|0.5|0.6|0.5|Malignant|641|120085013|Female|Anaplastic astrocytoma|2013
20+|~|~|~|Benign/Borderline|~|121202956|Female|Anaplastic astrocytoma|2014
20+|0.5|0.5|0.5|Malignant|619|121202956|Female|Anaplastic astrocytoma|2014
20+|~|~|~|Benign/Borderline|~|122262894|Female|Anaplastic astrocytoma|2015
20+|0.5|0.6|0.6|Malignant|706|122262894|Female|Anaplastic astrocytoma|2015
20+|~|~|~|Benign/Borderline|~|123298060|Female|Anaplastic astrocytoma|2016
20+|0.5|0.5|0.5|Malignant|641|123298060|Female|Anaplastic astrocytoma|2016
20+|~|~|~|Benign/Borderline|~|124243876|Female|Anaplastic astrocytoma|2017
20+|0.5|0.6|0.5|Malignant|673|124243876|Female|Anaplastic astrocytoma|2017
20+|~|~|~|Benign/Borderline|~|616718331|Female|Anaplastic astrocytoma|2017-2021
20+|0.4|0.4|0.4|Malignant|2681|616718331|Female|Anaplastic astrocytoma|2017-2021
20+|~|~|~|Benign/Borderline|~|125090257|Female|Anaplastic astrocytoma|2018
20+|0.4|0.5|0.5|Malignant|631|125090257|Female|Anaplastic astrocytoma|2018
20+|~|~|~|Benign/Borderline|~|125886169|Female|Anaplastic astrocytoma|2019
20+|0.4|0.5|0.4|Malignant|575|125886169|Female|Anaplastic astrocytoma|2019
20+|~|~|~|Benign/Borderline|~|124127412|Female|Anaplastic astrocytoma|2020
20+|0.4|0.4|0.4|Malignant|505|124127412|Female|Anaplastic astrocytoma|2020
20+|~|~|~|Benign/Borderline|~|124936720|Female|Anaplastic astrocytoma|2021
20+|0.2|0.3|0.3|Malignant|345|124936720|Female|Anaplastic astrocytoma|2021
20+|~|~|~|Benign/Borderline|~|109112165|Female|Anaplastic oligodendroglioma|2004
20+|0.1|0.2|0.2|Malignant|186|109112165|Female|Anaplastic oligodendroglioma|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Anaplastic oligodendroglioma|2005
20+|0.1|0.2|0.1|Malignant|165|110320645|Female|Anaplastic oligodendroglioma|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Anaplastic oligodendroglioma|2006
20+|0.1|0.1|0.1|Malignant|138|111567226|Female|Anaplastic oligodendroglioma|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Anaplastic oligodendroglioma|2007
20+|0.1|0.2|0.1|Malignant|161|112783993|Female|Anaplastic oligodendroglioma|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Anaplastic oligodendroglioma|2008
20+|0.1|0.2|0.1|Malignant|170|114027722|Female|Anaplastic oligodendroglioma|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Anaplastic oligodendroglioma|2009
20+|0.1|0.1|0.1|Malignant|148|115293599|Female|Anaplastic oligodendroglioma|2009
20+|~|~|~|Benign/Borderline|~|116598241|Female|Anaplastic oligodendroglioma|2010
20+|0.1|0.1|0.1|Malignant|136|116598241|Female|Anaplastic oligodendroglioma|2010
20+|~|~|~|Benign/Borderline|~|117817623|Female|Anaplastic oligodendroglioma|2011
20+|0.1|0.2|0.1|Malignant|154|117817623|Female|Anaplastic oligodendroglioma|2011
20+|~|~|~|Benign/Borderline|~|119004221|Female|Anaplastic oligodendroglioma|2012
20+|0.1|0.2|0.1|Malignant|169|119004221|Female|Anaplastic oligodendroglioma|2012
20+|~|~|~|Benign/Borderline|~|120085013|Female|Anaplastic oligodendroglioma|2013
20+|0.1|0.2|0.1|Malignant|154|120085013|Female|Anaplastic oligodendroglioma|2013
20+|~|~|~|Benign/Borderline|~|121202956|Female|Anaplastic oligodendroglioma|2014
20+|0.1|0.2|0.1|Malignant|153|121202956|Female|Anaplastic oligodendroglioma|2014
20+|~|~|~|Benign/Borderline|~|122262894|Female|Anaplastic oligodendroglioma|2015
20+|0.1|0.2|0.1|Malignant|163|122262894|Female|Anaplastic oligodendroglioma|2015
20+|~|~|~|Benign/Borderline|~|123298060|Female|Anaplastic oligodendroglioma|2016
20+|0.1|0.2|0.1|Malignant|169|123298060|Female|Anaplastic oligodendroglioma|2016
20+|~|~|~|Benign/Borderline|~|124243876|Female|Anaplastic oligodendroglioma|2017
20+|0.1|0.2|0.2|Malignant|187|124243876|Female|Anaplastic oligodendroglioma|2017
20+|~|~|~|Benign/Borderline|~|616718331|Female|Anaplastic oligodendroglioma|2017-2021
20+|0.1|0.1|0.1|Malignant|732|616718331|Female|Anaplastic oligodendroglioma|2017-2021
20+|~|~|~|Benign/Borderline|~|125090257|Female|Anaplastic oligodendroglioma|2018
20+|0.1|0.1|0.1|Malignant|155|125090257|Female|Anaplastic oligodendroglioma|2018
20+|~|~|~|Benign/Borderline|~|125886169|Female|Anaplastic oligodendroglioma|2019
20+|0.1|0.2|0.1|Malignant|161|125886169|Female|Anaplastic oligodendroglioma|2019
20+|~|~|~|Benign/Borderline|~|124127412|Female|Anaplastic oligodendroglioma|2020
20+|0.1|0.1|0.1|Malignant|125|124127412|Female|Anaplastic oligodendroglioma|2020
20+|~|~|~|Benign/Borderline|~|124936720|Female|Anaplastic oligodendroglioma|2021
20+|0.1|0.1|0.1|Malignant|108|124936720|Female|Anaplastic oligodendroglioma|2021
20+|~|~|~|Benign/Borderline|~|109112165|Female|Astrocytoma, NOS|2004
20+|0.5|0.6|0.5|Malignant|574|109112165|Female|Astrocytoma, NOS|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Astrocytoma, NOS|2005
20+|0.5|0.5|0.5|Malignant|565|110320645|Female|Astrocytoma, NOS|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Astrocytoma, NOS|2006
20+|0.4|0.5|0.5|Malignant|546|111567226|Female|Astrocytoma, NOS|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Astrocytoma, NOS|2007
20+|0.4|0.5|0.5|Malignant|535|112783993|Female|Astrocytoma, NOS|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Astrocytoma, NOS|2008
20+|0.4|0.5|0.4|Malignant|496|114027722|Female|Astrocytoma, NOS|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Astrocytoma, NOS|2009
20+|0.4|0.5|0.4|Malignant|482|115293599|Female|Astrocytoma, NOS|2009
20+|~|~|~|Benign/Borderline|~|116598241|Female|Astrocytoma, NOS|2010
20+|0.4|0.4|0.4|Malignant|481|116598241|Female|Astrocytoma, NOS|2010
20+|~|~|~|Benign/Borderline|~|117817623|Female|Astrocytoma, NOS|2011
20+|0.4|0.4|0.4|Malignant|467|117817623|Female|Astrocytoma, NOS|2011
20+|~|~|~|Benign/Borderline|~|119004221|Female|Astrocytoma, NOS|2012
20+|0.4|0.4|0.4|Malignant|491|119004221|Female|Astrocytoma, NOS|2012
20+|~|~|~|Benign/Borderline|~|120085013|Female|Astrocytoma, NOS|2013
20+|0.3|0.4|0.4|Malignant|455|120085013|Female|Astrocytoma, NOS|2013
20+|~|~|~|Benign/Borderline|~|121202956|Female|Astrocytoma, NOS|2014
20+|0.4|0.4|0.4|Malignant|501|121202956|Female|Astrocytoma, NOS|2014
20+|~|~|~|Benign/Borderline|~|122262894|Female|Astrocytoma, NOS|2015
20+|0.4|0.5|0.4|Malignant|522|122262894|Female|Astrocytoma, NOS|2015
20+|~|~|~|Benign/Borderline|~|123298060|Female|Astrocytoma, NOS|2016
20+|0.4|0.5|0.5|Malignant|573|123298060|Female|Astrocytoma, NOS|2016
20+|~|~|~|Benign/Borderline|~|124243876|Female|Astrocytoma, NOS|2017
20+|0.4|0.5|0.4|Malignant|526|124243876|Female|Astrocytoma, NOS|2017
20+|~|~|~|Benign/Borderline|~|616718331|Female|Astrocytoma, NOS|2017-2021
20+|0.4|0.5|0.5|Malignant|2771|616718331|Female|Astrocytoma, NOS|2017-2021
20+|~|~|~|Benign/Borderline|~|125090257|Female|Astrocytoma, NOS|2018
20+|0.4|0.5|0.5|Malignant|602|125090257|Female|Astrocytoma, NOS|2018
20+|~|~|~|Benign/Borderline|~|125886169|Female|Astrocytoma, NOS|2019
20+|0.4|0.5|0.4|Malignant|545|125886169|Female|Astrocytoma, NOS|2019
20+|~|~|~|Benign/Borderline|~|124127412|Female|Astrocytoma, NOS|2020
20+|0.4|0.5|0.4|Malignant|516|124127412|Female|Astrocytoma, NOS|2020
20+|~|~|~|Benign/Borderline|~|124936720|Female|Astrocytoma, NOS|2021
20+|0.5|0.6|0.5|Malignant|617|124936720|Female|Astrocytoma, NOS|2021
20+|0.0|0.0|0.0|Benign/Borderline|39|109112165|Female|Choroid plexus|2004
20+|~|~|~|Malignant|~|109112165|Female|Choroid plexus|2004
20+|0.0|0.0|0.0|Benign/Borderline|39|110320645|Female|Choroid plexus|2005
20+|~|~|~|Malignant|~|110320645|Female|Choroid plexus|2005
20+|0.0|0.1|0.0|Benign/Borderline|42|111567226|Female|Choroid plexus|2006
20+|~|~|~|Malignant|~|111567226|Female|Choroid plexus|2006
20+|0.0|0.1|0.1|Benign/Borderline|56|112783993|Female|Choroid plexus|2007
20+|~|~|~|Malignant|~|112783993|Female|Choroid plexus|2007
20+|0.0|0.1|0.0|Benign/Borderline|49|114027722|Female|Choroid plexus|2008
20+|~|~|~|Malignant|~|114027722|Female|Choroid plexus|2008
20+|0.0|0.1|0.0|Benign/Borderline|45|115293599|Female|Choroid plexus|2009
20+|~|~|~|Malignant|~|115293599|Female|Choroid plexus|2009
20+|0.0|0.1|0.0|Benign/Borderline|49|116598241|Female|Choroid plexus|2010
20+|~|~|~|Malignant|~|116598241|Female|Choroid plexus|2010
20+|0.0|0.1|0.0|Benign/Borderline|54|117817623|Female|Choroid plexus|2011
20+|~|~|~|Malignant|~|117817623|Female|Choroid plexus|2011
20+|0.0|0.0|0.0|Benign/Borderline|42|119004221|Female|Choroid plexus|2012
20+|~|~|~|Malignant|~|119004221|Female|Choroid plexus|2012
20+|0.0|0.1|0.0|Benign/Borderline|51|120085013|Female|Choroid plexus|2013
20+|~|~|~|Malignant|~|120085013|Female|Choroid plexus|2013
20+|0.0|0.1|0.0|Benign/Borderline|48|121202956|Female|Choroid plexus|2014
20+|~|~|~|Malignant|~|121202956|Female|Choroid plexus|2014
20+|0.0|0.1|0.0|Benign/Borderline|48|122262894|Female|Choroid plexus|2015
20+|~|~|~|Malignant|~|122262894|Female|Choroid plexus|2015
20+|0.0|0.0|0.0|Benign/Borderline|42|123298060|Female|Choroid plexus|2016
20+|~|~|~|Malignant|~|123298060|Female|Choroid plexus|2016
20+|0.0|0.0|0.0|Benign/Borderline|43|124243876|Female|Choroid plexus|2017
20+|~|~|~|Malignant|~|124243876|Female|Choroid plexus|2017
20+|0.0|0.0|0.0|Benign/Borderline|240|616718331|Female|Choroid plexus|2017-2021
20+|~|~|~|Malignant|~|616718331|Female|Choroid plexus|2017-2021
20+|0.0|0.1|0.0|Benign/Borderline|59|125090257|Female|Choroid plexus|2018
20+|~|~|~|Malignant|~|125090257|Female|Choroid plexus|2018
20+|0.0|0.1|0.0|Benign/Borderline|52|125886169|Female|Choroid plexus|2019
20+|~|~|~|Malignant|~|125886169|Female|Choroid plexus|2019
20+|0.0|0.1|0.0|Benign/Borderline|44|124127412|Female|Choroid plexus|2020
20+|~|~|~|Malignant|~|124127412|Female|Choroid plexus|2020
20+|0.0|0.0|0.0|Benign/Borderline|43|124936720|Female|Choroid plexus|2021
20+|~|~|~|Malignant|~|124936720|Female|Choroid plexus|2021
20+|0.2|0.2|0.2|Benign/Borderline|208|109112165|Female|Craniopharyngioma|2004
20+|~|~|~|Malignant|~|109112165|Female|Craniopharyngioma|2004
20+|0.1|0.2|0.2|Benign/Borderline|186|110320645|Female|Craniopharyngioma|2005
20+|~|~|~|Malignant|~|110320645|Female|Craniopharyngioma|2005
20+|0.2|0.2|0.2|Benign/Borderline|207|111567226|Female|Craniopharyngioma|2006
20+|~|~|~|Malignant|~|111567226|Female|Craniopharyngioma|2006
20+|0.2|0.2|0.2|Benign/Borderline|222|112783993|Female|Craniopharyngioma|2007
20+|~|~|~|Malignant|~|112783993|Female|Craniopharyngioma|2007
20+|0.2|0.2|0.2|Benign/Borderline|227|114027722|Female|Craniopharyngioma|2008
20+|~|~|~|Malignant|~|114027722|Female|Craniopharyngioma|2008
20+|0.2|0.2|0.2|Benign/Borderline|231|115293599|Female|Craniopharyngioma|2009
20+|~|~|~|Malignant|~|115293599|Female|Craniopharyngioma|2009
20+|0.2|0.2|0.2|Benign/Borderline|241|116598241|Female|Craniopharyngioma|2010
20+|~|~|~|Malignant|~|116598241|Female|Craniopharyngioma|2010
20+|0.2|0.2|0.2|Benign/Borderline|222|117817623|Female|Craniopharyngioma|2011
20+|~|~|~|Malignant|~|117817623|Female|Craniopharyngioma|2011
20+|0.2|0.2|0.2|Benign/Borderline|228|119004221|Female|Craniopharyngioma|2012
20+|~|~|~|Malignant|~|119004221|Female|Craniopharyngioma|2012
20+|0.2|0.2|0.2|Benign/Borderline|247|120085013|Female|Craniopharyngioma|2013
20+|~|~|~|Malignant|~|120085013|Female|Craniopharyngioma|2013
20+|0.2|0.2|0.2|Benign/Borderline|225|121202956|Female|Craniopharyngioma|2014
20+|~|~|~|Malignant|~|121202956|Female|Craniopharyngioma|2014
20+|0.2|0.2|0.2|Benign/Borderline|241|122262894|Female|Craniopharyngioma|2015
20+|~|~|~|Malignant|~|122262894|Female|Craniopharyngioma|2015
20+|0.2|0.2|0.2|Benign/Borderline|231|123298060|Female|Craniopharyngioma|2016
20+|~|~|~|Malignant|~|123298060|Female|Craniopharyngioma|2016
20+|0.2|0.2|0.2|Benign/Borderline|247|124243876|Female|Craniopharyngioma|2017
20+|~|~|~|Malignant|~|124243876|Female|Craniopharyngioma|2017
20+|0.2|0.2|0.2|Benign/Borderline|1128|616718331|Female|Craniopharyngioma|2017-2021
20+|~|~|~|Malignant|~|616718331|Female|Craniopharyngioma|2017-2021
20+|0.2|0.2|0.2|Benign/Borderline|246|125090257|Female|Craniopharyngioma|2018
20+|~|~|~|Malignant|~|125090257|Female|Craniopharyngioma|2018
20+|0.1|0.2|0.2|Benign/Borderline|234|125886169|Female|Craniopharyngioma|2019
20+|~|~|~|Malignant|~|125886169|Female|Craniopharyngioma|2019
20+|0.1|0.2|0.2|Benign/Borderline|208|124127412|Female|Craniopharyngioma|2020
20+|~|~|~|Malignant|~|124127412|Female|Craniopharyngioma|2020
20+|0.1|0.2|0.2|Benign/Borderline|203|124936720|Female|Craniopharyngioma|2021
20+|~|~|~|Malignant|~|124936720|Female|Craniopharyngioma|2021
20+|~|~|~|Benign/Borderline|~|109112165|Female|Diffuse astrocytoma|2004
20+|0.1|0.1|0.1|Malignant|114|109112165|Female|Diffuse astrocytoma|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Diffuse astrocytoma|2005
20+|0.1|0.1|0.1|Malignant|132|110320645|Female|Diffuse astrocytoma|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Diffuse astrocytoma|2006
20+|0.1|0.1|0.1|Malignant|94|111567226|Female|Diffuse astrocytoma|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Diffuse astrocytoma|2007
20+|0.1|0.1|0.1|Malignant|133|112783993|Female|Diffuse astrocytoma|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Diffuse astrocytoma|2008
20+|0.1|0.1|0.1|Malignant|130|114027722|Female|Diffuse astrocytoma|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Diffuse astrocytoma|2009
20+|0.1|0.2|0.1|Malignant|161|115293599|Female|Diffuse astrocytoma|2009
20+|~|~|~|Benign/Borderline|~|116598241|Female|Diffuse astrocytoma|2010
20+|0.1|0.2|0.1|Malignant|164|116598241|Female|Diffuse astrocytoma|2010
20+|~|~|~|Benign/Borderline|~|117817623|Female|Diffuse astrocytoma|2011
20+|0.1|0.1|0.1|Malignant|114|117817623|Female|Diffuse astrocytoma|2011
20+|~|~|~|Benign/Borderline|~|119004221|Female|Diffuse astrocytoma|2012
20+|0.1|0.1|0.1|Malignant|94|119004221|Female|Diffuse astrocytoma|2012
20+|~|~|~|Benign/Borderline|~|120085013|Female|Diffuse astrocytoma|2013
20+|0.0|0.1|0.1|Malignant|71|120085013|Female|Diffuse astrocytoma|2013
20+|~|~|~|Benign/Borderline|~|121202956|Female|Diffuse astrocytoma|2014
20+|0.0|0.1|0.0|Malignant|63|121202956|Female|Diffuse astrocytoma|2014
20+|~|~|~|Benign/Borderline|~|122262894|Female|Diffuse astrocytoma|2015
20+|0.0|0.0|0.0|Malignant|35|122262894|Female|Diffuse astrocytoma|2015
20+|~|~|~|Benign/Borderline|~|123298060|Female|Diffuse astrocytoma|2016
20+|~|~|~|Malignant|~|123298060|Female|Diffuse astrocytoma|2016
20+|~|~|~|Benign/Borderline|~|124243876|Female|Diffuse astrocytoma|2017
20+|~|~|~|Malignant|~|124243876|Female|Diffuse astrocytoma|2017
20+|~|~|~|Benign/Borderline|~|616718331|Female|Diffuse astrocytoma|2017-2021
20+|0.0|0.0|0.0|Malignant|33|616718331|Female|Diffuse astrocytoma|2017-2021
20+|~|~|~|Benign/Borderline|~|125090257|Female|Diffuse astrocytoma|2018
20+|~|~|~|Malignant|~|125090257|Female|Diffuse astrocytoma|2018
20+|~|~|~|Benign/Borderline|~|125886169|Female|Diffuse astrocytoma|2019
20+|~|~|~|Malignant|~|125886169|Female|Diffuse astrocytoma|2019
20+|~|~|~|Benign/Borderline|~|124127412|Female|Diffuse astrocytoma|2020
20+|~|~|~|Malignant|~|124127412|Female|Diffuse astrocytoma|2020
20+|~|~|~|Benign/Borderline|~|124936720|Female|Diffuse astrocytoma|2021
20+|~|~|~|Malignant|~|124936720|Female|Diffuse astrocytoma|2021
20+|~|~|~|Benign/Borderline|~|109112165|Female|Embryonal/primitive/medulloblastoma|2004
20+|0.1|0.1|0.1|Malignant|69|109112165|Female|Embryonal/primitive/medulloblastoma|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Embryonal/primitive/medulloblastoma|2005
20+|0.1|0.1|0.1|Malignant|83|110320645|Female|Embryonal/primitive/medulloblastoma|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Embryonal/primitive/medulloblastoma|2006
20+|0.1|0.1|0.1|Malignant|74|111567226|Female|Embryonal/primitive/medulloblastoma|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Embryonal/primitive/medulloblastoma|2007
20+|0.1|0.1|0.1|Malignant|93|112783993|Female|Embryonal/primitive/medulloblastoma|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Embryonal/primitive/medulloblastoma|2008
20+|0.1|0.1|0.1|Malignant|90|114027722|Female|Embryonal/primitive/medulloblastoma|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Embryonal/primitive/medulloblastoma|2009
20+|0.1|0.1|0.1|Malignant|102|115293599|Female|Embryonal/primitive/medulloblastoma|2009
20+|~|~|~|Benign/Borderline|~|116598241|Female|Embryonal/primitive/medulloblastoma|2010
20+|0.1|0.1|0.1|Malignant|73|116598241|Female|Embryonal/primitive/medulloblastoma|2010
20+|~|~|~|Benign/Borderline|~|117817623|Female|Embryonal/primitive/medulloblastoma|2011
20+|0.0|0.1|0.1|Malignant|69|117817623|Female|Embryonal/primitive/medulloblastoma|2011
20+|~|~|~|Benign/Borderline|~|119004221|Female|Embryonal/primitive/medulloblastoma|2012
20+|0.1|0.1|0.1|Malignant|81|119004221|Female|Embryonal/primitive/medulloblastoma|2012
20+|~|~|~|Benign/Borderline|~|120085013|Female|Embryonal/primitive/medulloblastoma|2013
20+|0.1|0.1|0.1|Malignant|92|120085013|Female|Embryonal/primitive/medulloblastoma|2013
20+|~|~|~|Benign/Borderline|~|121202956|Female|Embryonal/primitive/medulloblastoma|2014
20+|0.1|0.1|0.1|Malignant|74|121202956|Female|Embryonal/primitive/medulloblastoma|2014
20+|~|~|~|Benign/Borderline|~|122262894|Female|Embryonal/primitive/medulloblastoma|2015
20+|0.0|0.1|0.1|Malignant|68|122262894|Female|Embryonal/primitive/medulloblastoma|2015
20+|~|~|~|Benign/Borderline|~|123298060|Female|Embryonal/primitive/medulloblastoma|2016
20+|0.0|0.1|0.1|Malignant|63|123298060|Female|Embryonal/primitive/medulloblastoma|2016
20+|~|~|~|Benign/Borderline|~|124243876|Female|Embryonal/primitive/medulloblastoma|2017
20+|0.0|0.1|0.1|Malignant|62|124243876|Female|Embryonal/primitive/medulloblastoma|2017
20+|~|~|~|Benign/Borderline|~|616718331|Female|Embryonal/primitive/medulloblastoma|2017-2021
20+|0.0|0.1|0.1|Malignant|294|616718331|Female|Embryonal/primitive/medulloblastoma|2017-2021
20+|~|~|~|Benign/Borderline|~|125090257|Female|Embryonal/primitive/medulloblastoma|2018
20+|0.0|0.1|0.0|Malignant|57|125090257|Female|Embryonal/primitive/medulloblastoma|2018
20+|~|~|~|Benign/Borderline|~|125886169|Female|Embryonal/primitive/medulloblastoma|2019
20+|0.0|0.1|0.1|Malignant|60|125886169|Female|Embryonal/primitive/medulloblastoma|2019
20+|~|~|~|Benign/Borderline|~|124127412|Female|Embryonal/primitive/medulloblastoma|2020
20+|0.0|0.1|0.1|Malignant|55|124127412|Female|Embryonal/primitive/medulloblastoma|2020
20+|~|~|~|Benign/Borderline|~|124936720|Female|Embryonal/primitive/medulloblastoma|2021
20+|0.0|0.1|0.1|Malignant|60|124936720|Female|Embryonal/primitive/medulloblastoma|2021
20+|0.1|0.1|0.1|Benign/Borderline|107|109112165|Female|Ependymoma variants|2004
20+|~|~|~|Malignant|~|109112165|Female|Ependymoma variants|2004
20+|0.1|0.1|0.1|Benign/Borderline|117|110320645|Female|Ependymoma variants|2005
20+|~|~|~|Malignant|~|110320645|Female|Ependymoma variants|2005
20+|0.1|0.2|0.1|Benign/Borderline|149|111567226|Female|Ependymoma variants|2006
20+|~|~|~|Malignant|~|111567226|Female|Ependymoma variants|2006
20+|0.1|0.1|0.1|Benign/Borderline|114|112783993|Female|Ependymoma variants|2007
20+|~|~|~|Malignant|~|112783993|Female|Ependymoma variants|2007
20+|0.1|0.1|0.1|Benign/Borderline|110|114027722|Female|Ependymoma variants|2008
20+|~|~|~|Malignant|~|114027722|Female|Ependymoma variants|2008
20+|0.1|0.1|0.1|Benign/Borderline|113|115293599|Female|Ependymoma variants|2009
20+|~|~|~|Malignant|~|115293599|Female|Ependymoma variants|2009
20+|0.1|0.1|0.1|Benign/Borderline|124|116598241|Female|Ependymoma variants|2010
20+|~|~|~|Malignant|~|116598241|Female|Ependymoma variants|2010
20+|0.1|0.1|0.1|Benign/Borderline|122|117817623|Female|Ependymoma variants|2011
20+|~|~|~|Malignant|~|117817623|Female|Ependymoma variants|2011
20+|0.1|0.1|0.1|Benign/Borderline|129|119004221|Female|Ependymoma variants|2012
20+|~|~|~|Malignant|~|119004221|Female|Ependymoma variants|2012
20+|0.1|0.1|0.1|Benign/Borderline|117|120085013|Female|Ependymoma variants|2013
20+|~|~|~|Malignant|~|120085013|Female|Ependymoma variants|2013
20+|0.1|0.1|0.1|Benign/Borderline|131|121202956|Female|Ependymoma variants|2014
20+|~|~|~|Malignant|~|121202956|Female|Ependymoma variants|2014
20+|0.1|0.1|0.1|Benign/Borderline|136|122262894|Female|Ependymoma variants|2015
20+|~|~|~|Malignant|~|122262894|Female|Ependymoma variants|2015
20+|0.1|0.1|0.1|Benign/Borderline|125|123298060|Female|Ependymoma variants|2016
20+|~|~|~|Malignant|~|123298060|Female|Ependymoma variants|2016
20+|0.1|0.1|0.1|Benign/Borderline|119|124243876|Female|Ependymoma variants|2017
20+|~|~|~|Malignant|~|124243876|Female|Ependymoma variants|2017
20+|0.1|0.1|0.1|Benign/Borderline|570|616718331|Female|Ependymoma variants|2017-2021
20+|~|~|~|Malignant|~|616718331|Female|Ependymoma variants|2017-2021
20+|0.1|0.1|0.1|Benign/Borderline|114|125090257|Female|Ependymoma variants|2018
20+|~|~|~|Malignant|~|125090257|Female|Ependymoma variants|2018
20+|0.1|0.1|0.1|Benign/Borderline|106|125886169|Female|Ependymoma variants|2019
20+|~|~|~|Malignant|~|125886169|Female|Ependymoma variants|2019
20+|0.1|0.1|0.1|Benign/Borderline|118|124127412|Female|Ependymoma variants|2020
20+|~|~|~|Malignant|~|124127412|Female|Ependymoma variants|2020
20+|0.1|0.1|0.1|Benign/Borderline|123|124936720|Female|Ependymoma variants|2021
20+|~|~|~|Malignant|~|124936720|Female|Ependymoma variants|2021
20+|~|~|~|Benign/Borderline|~|109112165|Female|Ependymoma/anaplastic ependymoma|2004
20+|0.2|0.3|0.3|Malignant|294|109112165|Female|Ependymoma/anaplastic ependymoma|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Ependymoma/anaplastic ependymoma|2005
20+|0.2|0.3|0.3|Malignant|305|110320645|Female|Ependymoma/anaplastic ependymoma|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Ependymoma/anaplastic ependymoma|2006
20+|0.2|0.3|0.3|Malignant|294|111567226|Female|Ependymoma/anaplastic ependymoma|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Ependymoma/anaplastic ependymoma|2007
20+|0.2|0.3|0.3|Malignant|299|112783993|Female|Ependymoma/anaplastic ependymoma|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Ependymoma/anaplastic ependymoma|2008
20+|0.2|0.3|0.3|Malignant|316|114027722|Female|Ependymoma/anaplastic ependymoma|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Ependymoma/anaplastic ependymoma|2009
20+|0.3|0.3|0.3|Malignant|346|115293599|Female|Ependymoma/anaplastic ependymoma|2009
20+|~|~|~|Benign/Borderline|~|116598241|Female|Ependymoma/anaplastic ependymoma|2010
20+|0.2|0.3|0.3|Malignant|297|116598241|Female|Ependymoma/anaplastic ependymoma|2010
20+|~|~|~|Benign/Borderline|~|117817623|Female|Ependymoma/anaplastic ependymoma|2011
20+|0.2|0.3|0.3|Malignant|300|117817623|Female|Ependymoma/anaplastic ependymoma|2011
20+|~|~|~|Benign/Borderline|~|119004221|Female|Ependymoma/anaplastic ependymoma|2012
20+|0.2|0.3|0.3|Malignant|305|119004221|Female|Ependymoma/anaplastic ependymoma|2012
20+|~|~|~|Benign/Borderline|~|120085013|Female|Ependymoma/anaplastic ependymoma|2013
20+|0.2|0.3|0.2|Malignant|278|120085013|Female|Ependymoma/anaplastic ependymoma|2013
20+|~|~|~|Benign/Borderline|~|121202956|Female|Ependymoma/anaplastic ependymoma|2014
20+|0.2|0.2|0.2|Malignant|246|121202956|Female|Ependymoma/anaplastic ependymoma|2014
20+|~|~|~|Benign/Borderline|~|122262894|Female|Ependymoma/anaplastic ependymoma|2015
20+|0.2|0.3|0.2|Malignant|278|122262894|Female|Ependymoma/anaplastic ependymoma|2015
20+|~|~|~|Benign/Borderline|~|123298060|Female|Ependymoma/anaplastic ependymoma|2016
20+|0.2|0.3|0.2|Malignant|277|123298060|Female|Ependymoma/anaplastic ependymoma|2016
20+|~|~|~|Benign/Borderline|~|124243876|Female|Ependymoma/anaplastic ependymoma|2017
20+|0.2|0.3|0.2|Malignant|292|124243876|Female|Ependymoma/anaplastic ependymoma|2017
20+|0.0|0.0|0.0|Benign/Borderline|59|616718331|Female|Ependymoma/anaplastic ependymoma|2017-2021
20+|0.2|0.2|0.2|Malignant|1262|616718331|Female|Ependymoma/anaplastic ependymoma|2017-2021
20+|~|~|~|Benign/Borderline|~|125090257|Female|Ependymoma/anaplastic ependymoma|2018
20+|0.2|0.2|0.2|Malignant|240|125090257|Female|Ependymoma/anaplastic ependymoma|2018
20+|~|~|~|Benign/Borderline|~|125886169|Female|Ependymoma/anaplastic ependymoma|2019
20+|0.2|0.2|0.2|Malignant|256|125886169|Female|Ependymoma/anaplastic ependymoma|2019
20+|~|~|~|Benign/Borderline|~|124127412|Female|Ependymoma/anaplastic ependymoma|2020
20+|0.2|0.2|0.2|Malignant|246|124127412|Female|Ependymoma/anaplastic ependymoma|2020
20+|~|~|~|Benign/Borderline|~|124936720|Female|Ependymoma/anaplastic ependymoma|2021
20+|0.2|0.2|0.2|Malignant|244|124936720|Female|Ependymoma/anaplastic ependymoma|2021
20+|0.0|0.0|0.0|Benign/Borderline|18|109112165|Female|Germ Cell Tumors|2004
20+|~|~|~|Malignant|~|109112165|Female|Germ Cell Tumors|2004
20+|0.0|0.0|0.0|Benign/Borderline|36|110320645|Female|Germ Cell Tumors|2005
20+|~|~|~|Malignant|~|110320645|Female|Germ Cell Tumors|2005
20+|0.0|0.0|0.0|Benign/Borderline|36|111567226|Female|Germ Cell Tumors|2006
20+|~|~|~|Malignant|~|111567226|Female|Germ Cell Tumors|2006
20+|0.0|0.0|0.0|Benign/Borderline|37|112783993|Female|Germ Cell Tumors|2007
20+|~|~|~|Malignant|~|112783993|Female|Germ Cell Tumors|2007
20+|0.0|0.0|0.0|Benign/Borderline|33|114027722|Female|Germ Cell Tumors|2008
20+|~|~|~|Malignant|~|114027722|Female|Germ Cell Tumors|2008
20+|0.0|0.1|0.0|Benign/Borderline|43|115293599|Female|Germ Cell Tumors|2009
20+|~|~|~|Malignant|~|115293599|Female|Germ Cell Tumors|2009
20+|0.0|0.0|0.0|Benign/Borderline|32|116598241|Female|Germ Cell Tumors|2010
20+|~|~|~|Malignant|~|116598241|Female|Germ Cell Tumors|2010
20+|0.0|0.0|0.0|Benign/Borderline|40|117817623|Female|Germ Cell Tumors|2011
20+|~|~|~|Malignant|~|117817623|Female|Germ Cell Tumors|2011
20+|0.0|0.0|0.0|Benign/Borderline|33|119004221|Female|Germ Cell Tumors|2012
20+|~|~|~|Malignant|~|119004221|Female|Germ Cell Tumors|2012
20+|0.0|0.0|0.0|Benign/Borderline|27|120085013|Female|Germ Cell Tumors|2013
20+|~|~|~|Malignant|~|120085013|Female|Germ Cell Tumors|2013
20+|0.0|0.0|0.0|Benign/Borderline|32|121202956|Female|Germ Cell Tumors|2014
20+|~|~|~|Malignant|~|121202956|Female|Germ Cell Tumors|2014
20+|0.0|0.0|0.0|Benign/Borderline|33|122262894|Female|Germ Cell Tumors|2015
20+|~|~|~|Malignant|~|122262894|Female|Germ Cell Tumors|2015
20+|0.0|0.0|0.0|Benign/Borderline|33|123298060|Female|Germ Cell Tumors|2016
20+|~|~|~|Malignant|~|123298060|Female|Germ Cell Tumors|2016
20+|0.0|0.0|0.0|Benign/Borderline|25|124243876|Female|Germ Cell Tumors|2017
20+|~|~|~|Malignant|~|124243876|Female|Germ Cell Tumors|2017
20+|0.0|0.0|0.0|Benign/Borderline|134|616718331|Female|Germ Cell Tumors|2017-2021
20+|0.0|0.0|0.0|Malignant|34|616718331|Female|Germ Cell Tumors|2017-2021
20+|0.0|0.0|0.0|Benign/Borderline|20|125090257|Female|Germ Cell Tumors|2018
20+|~|~|~|Malignant|~|125090257|Female|Germ Cell Tumors|2018
20+|0.0|0.0|0.0|Benign/Borderline|42|125886169|Female|Germ Cell Tumors|2019
20+|~|~|~|Malignant|~|125886169|Female|Germ Cell Tumors|2019
20+|0.0|0.0|0.0|Benign/Borderline|23|124127412|Female|Germ Cell Tumors|2020
20+|~|~|~|Malignant|~|124127412|Female|Germ Cell Tumors|2020
20+|0.0|0.0|0.0|Benign/Borderline|26|124936720|Female|Germ Cell Tumors|2021
20+|~|~|~|Malignant|~|124936720|Female|Germ Cell Tumors|2021
20+|~|~|~|Benign/Borderline|~|109112165|Female|Glioblastoma|2004
20+|3.4|3.6|3.5|Malignant|4108|109112165|Female|Glioblastoma|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Glioblastoma|2005
20+|3.4|3.6|3.5|Malignant|4161|110320645|Female|Glioblastoma|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Glioblastoma|2006
20+|3.4|3.7|3.6|Malignant|4284|111567226|Female|Glioblastoma|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Glioblastoma|2007
20+|3.5|3.7|3.6|Malignant|4374|112783993|Female|Glioblastoma|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Glioblastoma|2008
20+|3.4|3.6|3.5|Malignant|4403|114027722|Female|Glioblastoma|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Glioblastoma|2009
20+|3.4|3.6|3.5|Malignant|4491|115293599|Female|Glioblastoma|2009
20+|~|~|~|Benign/Borderline|~|116598241|Female|Glioblastoma|2010
20+|3.4|3.6|3.5|Malignant|4616|116598241|Female|Glioblastoma|2010
20+|~|~|~|Benign/Borderline|~|117817623|Female|Glioblastoma|2011
20+|3.4|3.6|3.5|Malignant|4582|117817623|Female|Glioblastoma|2011
20+|~|~|~|Benign/Borderline|~|119004221|Female|Glioblastoma|2012
20+|3.5|3.7|3.6|Malignant|4856|119004221|Female|Glioblastoma|2012
20+|~|~|~|Benign/Borderline|~|120085013|Female|Glioblastoma|2013
20+|3.4|3.7|3.5|Malignant|4907|120085013|Female|Glioblastoma|2013
20+|~|~|~|Benign/Borderline|~|121202956|Female|Glioblastoma|2014
20+|3.3|3.5|3.4|Malignant|4800|121202956|Female|Glioblastoma|2014
20+|~|~|~|Benign/Borderline|~|122262894|Female|Glioblastoma|2015
20+|3.5|3.7|3.6|Malignant|5144|122262894|Female|Glioblastoma|2015
20+|~|~|~|Benign/Borderline|~|123298060|Female|Glioblastoma|2016
20+|3.5|3.7|3.6|Malignant|5220|123298060|Female|Glioblastoma|2016
20+|~|~|~|Benign/Borderline|~|124243876|Female|Glioblastoma|2017
20+|3.4|3.6|3.5|Malignant|5242|124243876|Female|Glioblastoma|2017
20+|~|~|~|Benign/Borderline|~|616718331|Female|Glioblastoma|2017-2021
20+|3.4|3.5|3.5|Malignant|26223|616718331|Female|Glioblastoma|2017-2021
20+|~|~|~|Benign/Borderline|~|125090257|Female|Glioblastoma|2018
20+|3.4|3.6|3.5|Malignant|5278|125090257|Female|Glioblastoma|2018
20+|~|~|~|Benign/Borderline|~|125886169|Female|Glioblastoma|2019
20+|3.4|3.6|3.5|Malignant|5306|125886169|Female|Glioblastoma|2019
20+|~|~|~|Benign/Borderline|~|124127412|Female|Glioblastoma|2020
20+|3.5|3.6|3.6|Malignant|5460|124127412|Female|Glioblastoma|2020
20+|~|~|~|Benign/Borderline|~|124936720|Female|Glioblastoma|2021
20+|3.3|3.5|3.4|Malignant|5294|124936720|Female|Glioblastoma|2021
20+|~|~|~|Benign/Borderline|~|109112165|Female|Glioma malignant, NOS|2004
20+|0.3|0.4|0.4|Malignant|426|109112165|Female|Glioma malignant, NOS|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Glioma malignant, NOS|2005
20+|0.3|0.4|0.3|Malignant|399|110320645|Female|Glioma malignant, NOS|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Glioma malignant, NOS|2006
20+|0.3|0.4|0.3|Malignant|397|111567226|Female|Glioma malignant, NOS|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Glioma malignant, NOS|2007
20+|0.3|0.4|0.3|Malignant|414|112783993|Female|Glioma malignant, NOS|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Glioma malignant, NOS|2008
20+|0.3|0.4|0.4|Malignant|450|114027722|Female|Glioma malignant, NOS|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Glioma malignant, NOS|2009
20+|0.4|0.5|0.4|Malignant|520|115293599|Female|Glioma malignant, NOS|2009
20+|~|~|~|Benign/Borderline|~|116598241|Female|Glioma malignant, NOS|2010
20+|0.3|0.4|0.3|Malignant|412|116598241|Female|Glioma malignant, NOS|2010
20+|~|~|~|Benign/Borderline|~|117817623|Female|Glioma malignant, NOS|2011
20+|0.3|0.4|0.4|Malignant|449|117817623|Female|Glioma malignant, NOS|2011
20+|0.0|0.0|0.0|Benign/Borderline|17|119004221|Female|Glioma malignant, NOS|2012
20+|0.3|0.4|0.3|Malignant|441|119004221|Female|Glioma malignant, NOS|2012
20+|0.0|0.0|0.0|Benign/Borderline|18|120085013|Female|Glioma malignant, NOS|2013
20+|0.3|0.4|0.4|Malignant|475|120085013|Female|Glioma malignant, NOS|2013
20+|0.0|0.0|0.0|Benign/Borderline|26|121202956|Female|Glioma malignant, NOS|2014
20+|0.3|0.4|0.3|Malignant|455|121202956|Female|Glioma malignant, NOS|2014
20+|0.0|0.0|0.0|Benign/Borderline|30|122262894|Female|Glioma malignant, NOS|2015
20+|0.4|0.4|0.4|Malignant|526|122262894|Female|Glioma malignant, NOS|2015
20+|0.0|0.0|0.0|Benign/Borderline|23|123298060|Female|Glioma malignant, NOS|2016
20+|0.4|0.4|0.4|Malignant|533|123298060|Female|Glioma malignant, NOS|2016
20+|0.0|0.0|0.0|Benign/Borderline|33|124243876|Female|Glioma malignant, NOS|2017
20+|0.4|0.5|0.4|Malignant|561|124243876|Female|Glioma malignant, NOS|2017
20+|0.0|0.0|0.0|Benign/Borderline|106|616718331|Female|Glioma malignant, NOS|2017-2021
20+|0.4|0.4|0.4|Malignant|2492|616718331|Female|Glioma malignant, NOS|2017-2021
20+|0.0|0.0|0.0|Benign/Borderline|18|125090257|Female|Glioma malignant, NOS|2018
20+|0.3|0.4|0.4|Malignant|509|125090257|Female|Glioma malignant, NOS|2018
20+|0.0|0.0|0.0|Benign/Borderline|20|125886169|Female|Glioma malignant, NOS|2019
20+|0.3|0.4|0.4|Malignant|491|125886169|Female|Glioma malignant, NOS|2019
20+|0.0|0.0|0.0|Benign/Borderline|17|124127412|Female|Glioma malignant, NOS|2020
20+|0.3|0.4|0.4|Malignant|482|124127412|Female|Glioma malignant, NOS|2020
20+|0.0|0.0|0.0|Benign/Borderline|18|124936720|Female|Glioma malignant, NOS|2021
20+|0.3|0.4|0.4|Malignant|482|124936720|Female|Glioma malignant, NOS|2021
20+|0.2|0.2|0.2|Benign/Borderline|208|109112165|Female|Hemangioblastoma|2004
20+|~|~|~|Malignant|~|109112165|Female|Hemangioblastoma|2004
20+|0.2|0.2|0.2|Benign/Borderline|234|110320645|Female|Hemangioblastoma|2005
20+|~|~|~|Malignant|~|110320645|Female|Hemangioblastoma|2005
20+|0.2|0.2|0.2|Benign/Borderline|222|111567226|Female|Hemangioblastoma|2006
20+|~|~|~|Malignant|~|111567226|Female|Hemangioblastoma|2006
20+|0.2|0.2|0.2|Benign/Borderline|218|112783993|Female|Hemangioblastoma|2007
20+|~|~|~|Malignant|~|112783993|Female|Hemangioblastoma|2007
20+|0.2|0.2|0.2|Benign/Borderline|243|114027722|Female|Hemangioblastoma|2008
20+|~|~|~|Malignant|~|114027722|Female|Hemangioblastoma|2008
20+|0.2|0.2|0.2|Benign/Borderline|239|115293599|Female|Hemangioblastoma|2009
20+|~|~|~|Malignant|~|115293599|Female|Hemangioblastoma|2009
20+|0.2|0.2|0.2|Benign/Borderline|238|116598241|Female|Hemangioblastoma|2010
20+|~|~|~|Malignant|~|116598241|Female|Hemangioblastoma|2010
20+|0.2|0.2|0.2|Benign/Borderline|252|117817623|Female|Hemangioblastoma|2011
20+|~|~|~|Malignant|~|117817623|Female|Hemangioblastoma|2011
20+|0.2|0.3|0.2|Benign/Borderline|264|119004221|Female|Hemangioblastoma|2012
20+|~|~|~|Malignant|~|119004221|Female|Hemangioblastoma|2012
20+|0.2|0.2|0.2|Benign/Borderline|235|120085013|Female|Hemangioblastoma|2013
20+|~|~|~|Malignant|~|120085013|Female|Hemangioblastoma|2013
20+|0.2|0.2|0.2|Benign/Borderline|220|121202956|Female|Hemangioblastoma|2014
20+|~|~|~|Malignant|~|121202956|Female|Hemangioblastoma|2014
20+|0.2|0.2|0.2|Benign/Borderline|250|122262894|Female|Hemangioblastoma|2015
20+|~|~|~|Malignant|~|122262894|Female|Hemangioblastoma|2015
20+|0.2|0.2|0.2|Benign/Borderline|277|123298060|Female|Hemangioblastoma|2016
20+|~|~|~|Malignant|~|123298060|Female|Hemangioblastoma|2016
20+|0.2|0.2|0.2|Benign/Borderline|229|124243876|Female|Hemangioblastoma|2017
20+|~|~|~|Malignant|~|124243876|Female|Hemangioblastoma|2017
20+|0.2|0.2|0.2|Benign/Borderline|1178|616718331|Female|Hemangioblastoma|2017-2021
20+|~|~|~|Malignant|~|616718331|Female|Hemangioblastoma|2017-2021
20+|0.2|0.2|0.2|Benign/Borderline|220|125090257|Female|Hemangioblastoma|2018
20+|~|~|~|Malignant|~|125090257|Female|Hemangioblastoma|2018
20+|0.2|0.3|0.2|Benign/Borderline|282|125886169|Female|Hemangioblastoma|2019
20+|~|~|~|Malignant|~|125886169|Female|Hemangioblastoma|2019
20+|0.2|0.2|0.2|Benign/Borderline|236|124127412|Female|Hemangioblastoma|2020
20+|~|~|~|Malignant|~|124127412|Female|Hemangioblastoma|2020
20+|0.2|0.2|0.2|Benign/Borderline|229|124936720|Female|Hemangioblastoma|2021
20+|~|~|~|Malignant|~|124936720|Female|Hemangioblastoma|2021
20+|0.2|0.3|0.2|Benign/Borderline|247|109112165|Female|Hemangioma|2004
20+|~|~|~|Malignant|~|109112165|Female|Hemangioma|2004
20+|0.2|0.3|0.3|Benign/Borderline|292|110320645|Female|Hemangioma|2005
20+|~|~|~|Malignant|~|110320645|Female|Hemangioma|2005
20+|0.3|0.3|0.3|Benign/Borderline|324|111567226|Female|Hemangioma|2006
20+|~|~|~|Malignant|~|111567226|Female|Hemangioma|2006
20+|0.3|0.4|0.3|Benign/Borderline|378|112783993|Female|Hemangioma|2007
20+|~|~|~|Malignant|~|112783993|Female|Hemangioma|2007
20+|0.4|0.5|0.4|Benign/Borderline|485|114027722|Female|Hemangioma|2008
20+|~|~|~|Malignant|~|114027722|Female|Hemangioma|2008
20+|0.4|0.5|0.5|Benign/Borderline|537|115293599|Female|Hemangioma|2009
20+|~|~|~|Malignant|~|115293599|Female|Hemangioma|2009
20+|0.5|0.6|0.6|Benign/Borderline|676|116598241|Female|Hemangioma|2010
20+|~|~|~|Malignant|~|116598241|Female|Hemangioma|2010
20+|0.6|0.7|0.6|Benign/Borderline|727|117817623|Female|Hemangioma|2011
20+|~|~|~|Malignant|~|117817623|Female|Hemangioma|2011
20+|0.6|0.7|0.6|Benign/Borderline|738|119004221|Female|Hemangioma|2012
20+|~|~|~|Malignant|~|119004221|Female|Hemangioma|2012
20+|0.6|0.7|0.6|Benign/Borderline|755|120085013|Female|Hemangioma|2013
20+|~|~|~|Malignant|~|120085013|Female|Hemangioma|2013
20+|0.5|0.6|0.6|Benign/Borderline|694|121202956|Female|Hemangioma|2014
20+|~|~|~|Malignant|~|121202956|Female|Hemangioma|2014
20+|0.4|0.5|0.5|Benign/Borderline|613|122262894|Female|Hemangioma|2015
20+|~|~|~|Malignant|~|122262894|Female|Hemangioma|2015
20+|0.4|0.5|0.5|Benign/Borderline|595|123298060|Female|Hemangioma|2016
20+|~|~|~|Malignant|~|123298060|Female|Hemangioma|2016
20+|0.4|0.5|0.4|Benign/Borderline|556|124243876|Female|Hemangioma|2017
20+|~|~|~|Malignant|~|124243876|Female|Hemangioma|2017
20+|0.4|0.4|0.4|Benign/Borderline|2769|616718331|Female|Hemangioma|2017-2021
20+|~|~|~|Malignant|~|616718331|Female|Hemangioma|2017-2021
20+|0.4|0.5|0.4|Benign/Borderline|576|125090257|Female|Hemangioma|2018
20+|~|~|~|Malignant|~|125090257|Female|Hemangioma|2018
20+|0.4|0.5|0.4|Benign/Borderline|556|125886169|Female|Hemangioma|2019
20+|~|~|~|Malignant|~|125886169|Female|Hemangioma|2019
20+|0.4|0.5|0.5|Benign/Borderline|601|124127412|Female|Hemangioma|2020
20+|~|~|~|Malignant|~|124127412|Female|Hemangioma|2020
20+|0.3|0.4|0.4|Benign/Borderline|496|124936720|Female|Hemangioma|2021
20+|~|~|~|Malignant|~|124936720|Female|Hemangioma|2021
20+|~|~|~|Benign/Borderline|~|109112165|Female|Local Extensions from Regional Tumors|2004
20+|0.0|0.0|0.0|Malignant|24|109112165|Female|Local Extensions from Regional Tumors|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Local Extensions from Regional Tumors|2005
20+|0.0|0.0|0.0|Malignant|23|110320645|Female|Local Extensions from Regional Tumors|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Local Extensions from Regional Tumors|2006
20+|0.0|0.0|0.0|Malignant|18|111567226|Female|Local Extensions from Regional Tumors|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Local Extensions from Regional Tumors|2007
20+|0.0|0.0|0.0|Malignant|25|112783993|Female|Local Extensions from Regional Tumors|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Local Extensions from Regional Tumors|2008
20+|0.0|0.0|0.0|Malignant|21|114027722|Female|Local Extensions from Regional Tumors|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Local Extensions from Regional Tumors|2009
20+|0.0|0.0|0.0|Malignant|25|115293599|Female|Local Extensions from Regional Tumors|2009
20+|~|~|~|Benign/Borderline|~|116598241|Female|Local Extensions from Regional Tumors|2010
20+|0.0|0.0|0.0|Malignant|22|116598241|Female|Local Extensions from Regional Tumors|2010
20+|~|~|~|Benign/Borderline|~|117817623|Female|Local Extensions from Regional Tumors|2011
20+|0.0|0.0|0.0|Malignant|21|117817623|Female|Local Extensions from Regional Tumors|2011
20+|~|~|~|Benign/Borderline|~|119004221|Female|Local Extensions from Regional Tumors|2012
20+|0.0|0.0|0.0|Malignant|20|119004221|Female|Local Extensions from Regional Tumors|2012
20+|~|~|~|Benign/Borderline|~|120085013|Female|Local Extensions from Regional Tumors|2013
20+|0.0|0.0|0.0|Malignant|16|120085013|Female|Local Extensions from Regional Tumors|2013
20+|~|~|~|Benign/Borderline|~|121202956|Female|Local Extensions from Regional Tumors|2014
20+|0.0|0.0|0.0|Malignant|26|121202956|Female|Local Extensions from Regional Tumors|2014
20+|~|~|~|Benign/Borderline|~|122262894|Female|Local Extensions from Regional Tumors|2015
20+|0.0|0.0|0.0|Malignant|18|122262894|Female|Local Extensions from Regional Tumors|2015
20+|~|~|~|Benign/Borderline|~|123298060|Female|Local Extensions from Regional Tumors|2016
20+|~|~|~|Malignant|~|123298060|Female|Local Extensions from Regional Tumors|2016
20+|~|~|~|Benign/Borderline|~|124243876|Female|Local Extensions from Regional Tumors|2017
20+|~|~|~|Malignant|~|124243876|Female|Local Extensions from Regional Tumors|2017
20+|~|~|~|Benign/Borderline|~|616718331|Female|Local Extensions from Regional Tumors|2017-2021
20+|0.0|0.0|0.0|Malignant|60|616718331|Female|Local Extensions from Regional Tumors|2017-2021
20+|~|~|~|Benign/Borderline|~|125090257|Female|Local Extensions from Regional Tumors|2018
20+|~|~|~|Malignant|~|125090257|Female|Local Extensions from Regional Tumors|2018
20+|~|~|~|Benign/Borderline|~|125886169|Female|Local Extensions from Regional Tumors|2019
20+|~|~|~|Malignant|~|125886169|Female|Local Extensions from Regional Tumors|2019
20+|~|~|~|Benign/Borderline|~|124127412|Female|Local Extensions from Regional Tumors|2020
20+|~|~|~|Malignant|~|124127412|Female|Local Extensions from Regional Tumors|2020
20+|~|~|~|Benign/Borderline|~|124936720|Female|Local Extensions from Regional Tumors|2021
20+|~|~|~|Malignant|~|124936720|Female|Local Extensions from Regional Tumors|2021
20+|~|~|~|Benign/Borderline|~|109112165|Female|Lymphomas and Hematopoietic Neoplasms|2004
20+|0.5|0.6|0.5|Malignant|591|109112165|Female|Lymphomas and Hematopoietic Neoplasms|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Lymphomas and Hematopoietic Neoplasms|2005
20+|0.5|0.6|0.6|Malignant|665|110320645|Female|Lymphomas and Hematopoietic Neoplasms|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Lymphomas and Hematopoietic Neoplasms|2006
20+|0.5|0.6|0.6|Malignant|674|111567226|Female|Lymphomas and Hematopoietic Neoplasms|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Lymphomas and Hematopoietic Neoplasms|2007
20+|0.5|0.6|0.5|Malignant|641|112783993|Female|Lymphomas and Hematopoietic Neoplasms|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Lymphomas and Hematopoietic Neoplasms|2008
20+|0.5|0.6|0.6|Malignant|705|114027722|Female|Lymphomas and Hematopoietic Neoplasms|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Lymphomas and Hematopoietic Neoplasms|2009
20+|0.5|0.6|0.5|Malignant|665|115293599|Female|Lymphomas and Hematopoietic Neoplasms|2009
20+|~|~|~|Benign/Borderline|~|116598241|Female|Lymphomas and Hematopoietic Neoplasms|2010
20+|0.5|0.6|0.6|Malignant|743|116598241|Female|Lymphomas and Hematopoietic Neoplasms|2010
20+|~|~|~|Benign/Borderline|~|117817623|Female|Lymphomas and Hematopoietic Neoplasms|2011
20+|0.5|0.6|0.5|Malignant|712|117817623|Female|Lymphomas and Hematopoietic Neoplasms|2011
20+|~|~|~|Benign/Borderline|~|119004221|Female|Lymphomas and Hematopoietic Neoplasms|2012
20+|0.5|0.6|0.5|Malignant|702|119004221|Female|Lymphomas and Hematopoietic Neoplasms|2012
20+|~|~|~|Benign/Borderline|~|120085013|Female|Lymphomas and Hematopoietic Neoplasms|2013
20+|0.5|0.6|0.6|Malignant|742|120085013|Female|Lymphomas and Hematopoietic Neoplasms|2013
20+|~|~|~|Benign/Borderline|~|121202956|Female|Lymphomas and Hematopoietic Neoplasms|2014
20+|0.6|0.6|0.6|Malignant|814|121202956|Female|Lymphomas and Hematopoietic Neoplasms|2014
20+|~|~|~|Benign/Borderline|~|122262894|Female|Lymphomas and Hematopoietic Neoplasms|2015
20+|0.5|0.6|0.5|Malignant|763|122262894|Female|Lymphomas and Hematopoietic Neoplasms|2015
20+|~|~|~|Benign/Borderline|~|123298060|Female|Lymphomas and Hematopoietic Neoplasms|2016
20+|0.5|0.6|0.6|Malignant|839|123298060|Female|Lymphomas and Hematopoietic Neoplasms|2016
20+|~|~|~|Benign/Borderline|~|124243876|Female|Lymphomas and Hematopoietic Neoplasms|2017
20+|0.5|0.6|0.6|Malignant|832|124243876|Female|Lymphomas and Hematopoietic Neoplasms|2017
20+|~|~|~|Benign/Borderline|~|616718331|Female|Lymphomas and Hematopoietic Neoplasms|2017-2021
20+|0.5|0.6|0.5|Malignant|4010|616718331|Female|Lymphomas and Hematopoietic Neoplasms|2017-2021
20+|~|~|~|Benign/Borderline|~|125090257|Female|Lymphomas and Hematopoietic Neoplasms|2018
20+|0.5|0.6|0.6|Malignant|824|125090257|Female|Lymphomas and Hematopoietic Neoplasms|2018
20+|~|~|~|Benign/Borderline|~|125886169|Female|Lymphomas and Hematopoietic Neoplasms|2019
20+|0.5|0.6|0.5|Malignant|795|125886169|Female|Lymphomas and Hematopoietic Neoplasms|2019
20+|~|~|~|Benign/Borderline|~|124127412|Female|Lymphomas and Hematopoietic Neoplasms|2020
20+|0.5|0.6|0.5|Malignant|829|124127412|Female|Lymphomas and Hematopoietic Neoplasms|2020
20+|~|~|~|Benign/Borderline|~|124936720|Female|Lymphomas and Hematopoietic Neoplasms|2021
20+|0.5|0.5|0.5|Malignant|778|124936720|Female|Lymphomas and Hematopoietic Neoplasms|2021
20+|12.2|12.6|12.4|Benign/Borderline|14413|109112165|Female|Meningioma|2004
20+|0.2|0.3|0.2|Malignant|275|109112165|Female|Meningioma|2004
20+|13.7|14.1|13.9|Benign/Borderline|16467|110320645|Female|Meningioma|2005
20+|0.2|0.3|0.2|Malignant|281|110320645|Female|Meningioma|2005
20+|14.4|14.8|14.6|Benign/Borderline|17556|111567226|Female|Meningioma|2006
20+|0.2|0.2|0.2|Malignant|252|111567226|Female|Meningioma|2006
20+|15.0|15.4|15.2|Benign/Borderline|18579|112783993|Female|Meningioma|2007
20+|0.2|0.2|0.2|Malignant|267|112783993|Female|Meningioma|2007
20+|15.8|16.2|16.0|Benign/Borderline|19917|114027722|Female|Meningioma|2008
20+|0.2|0.2|0.2|Malignant|218|114027722|Female|Meningioma|2008
20+|16.9|17.3|17.1|Benign/Borderline|21627|115293599|Female|Meningioma|2009
20+|0.1|0.2|0.2|Malignant|208|115293599|Female|Meningioma|2009
20+|16.4|16.8|16.6|Benign/Borderline|21300|116598241|Female|Meningioma|2010
20+|0.1|0.2|0.2|Malignant|210|116598241|Female|Meningioma|2010
20+|16.6|17.0|16.8|Benign/Borderline|21808|117817623|Female|Meningioma|2011
20+|0.1|0.2|0.1|Malignant|186|117817623|Female|Meningioma|2011
20+|16.9|17.4|17.1|Benign/Borderline|22656|119004221|Female|Meningioma|2012
20+|0.1|0.2|0.2|Malignant|204|119004221|Female|Meningioma|2012
20+|17.1|17.6|17.4|Benign/Borderline|23258|120085013|Female|Meningioma|2013
20+|0.1|0.2|0.2|Malignant|225|120085013|Female|Meningioma|2013
20+|17.6|18.0|17.8|Benign/Borderline|24323|121202956|Female|Meningioma|2014
20+|0.1|0.2|0.2|Malignant|221|121202956|Female|Meningioma|2014
20+|18.2|18.7|18.5|Benign/Borderline|25584|122262894|Female|Meningioma|2015
20+|0.1|0.2|0.1|Malignant|201|122262894|Female|Meningioma|2015
20+|18.7|19.2|18.9|Benign/Borderline|26542|123298060|Female|Meningioma|2016
20+|0.1|0.1|0.1|Malignant|175|123298060|Female|Meningioma|2016
20+|19.2|19.7|19.4|Benign/Borderline|27745|124243876|Female|Meningioma|2017
20+|0.1|0.1|0.1|Malignant|182|124243876|Female|Meningioma|2017
20+|19.3|19.5|19.4|Benign/Borderline|139922|616718331|Female|Meningioma|2017-2021
20+|0.1|0.1|0.1|Malignant|872|616718331|Female|Meningioma|2017-2021
20+|19.3|19.7|19.5|Benign/Borderline|28297|125090257|Female|Meningioma|2018
20+|0.1|0.2|0.1|Malignant|182|125090257|Female|Meningioma|2018
20+|20.1|20.6|20.3|Benign/Borderline|29924|125886169|Female|Meningioma|2019
20+|0.1|0.1|0.1|Malignant|160|125886169|Female|Meningioma|2019
20+|18.0|18.5|18.2|Benign/Borderline|26615|124127412|Female|Meningioma|2020
20+|0.1|0.1|0.1|Malignant|161|124127412|Female|Meningioma|2020
20+|19.1|19.5|19.3|Benign/Borderline|28631|124936720|Female|Meningioma|2021
20+|0.1|0.1|0.1|Malignant|190|124936720|Female|Meningioma|2021
20+|~|~|~|Benign/Borderline|~|109112165|Female|Mixed glioma|2004
20+|0.2|0.2|0.2|Malignant|198|109112165|Female|Mixed glioma|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Mixed glioma|2005
20+|0.2|0.2|0.2|Malignant|236|110320645|Female|Mixed glioma|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Mixed glioma|2006
20+|0.2|0.3|0.2|Malignant|273|111567226|Female|Mixed glioma|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Mixed glioma|2007
20+|0.2|0.2|0.2|Malignant|239|112783993|Female|Mixed glioma|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Mixed glioma|2008
20+|0.2|0.3|0.2|Malignant|263|114027722|Female|Mixed glioma|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Mixed glioma|2009
20+|0.2|0.3|0.3|Malignant|288|115293599|Female|Mixed glioma|2009
20+|~|~|~|Benign/Borderline|~|116598241|Female|Mixed glioma|2010
20+|0.2|0.3|0.2|Malignant|272|116598241|Female|Mixed glioma|2010
20+|~|~|~|Benign/Borderline|~|117817623|Female|Mixed glioma|2011
20+|0.2|0.3|0.2|Malignant|274|117817623|Female|Mixed glioma|2011
20+|~|~|~|Benign/Borderline|~|119004221|Female|Mixed glioma|2012
20+|0.2|0.2|0.2|Malignant|242|119004221|Female|Mixed glioma|2012
20+|~|~|~|Benign/Borderline|~|120085013|Female|Mixed glioma|2013
20+|0.2|0.2|0.2|Malignant|248|120085013|Female|Mixed glioma|2013
20+|~|~|~|Benign/Borderline|~|121202956|Female|Mixed glioma|2014
20+|0.1|0.2|0.2|Malignant|200|121202956|Female|Mixed glioma|2014
20+|~|~|~|Benign/Borderline|~|122262894|Female|Mixed glioma|2015
20+|0.1|0.1|0.1|Malignant|131|122262894|Female|Mixed glioma|2015
20+|~|~|~|Benign/Borderline|~|123298060|Female|Mixed glioma|2016
20+|0.0|0.0|0.0|Malignant|42|123298060|Female|Mixed glioma|2016
20+|~|~|~|Benign/Borderline|~|124243876|Female|Mixed glioma|2017
20+|0.0|0.0|0.0|Malignant|31|124243876|Female|Mixed glioma|2017
20+|~|~|~|Benign/Borderline|~|616718331|Female|Mixed glioma|2017-2021
20+|0.0|0.0|0.0|Malignant|62|616718331|Female|Mixed glioma|2017-2021
20+|~|~|~|Benign/Borderline|~|125090257|Female|Mixed glioma|2018
20+|~|~|~|Malignant|~|125090257|Female|Mixed glioma|2018
20+|~|~|~|Benign/Borderline|~|125886169|Female|Mixed glioma|2019
20+|~|~|~|Malignant|~|125886169|Female|Mixed glioma|2019
20+|~|~|~|Benign/Borderline|~|124127412|Female|Mixed glioma|2020
20+|~|~|~|Malignant|~|124127412|Female|Mixed glioma|2020
20+|~|~|~|Benign/Borderline|~|124936720|Female|Mixed glioma|2021
20+|~|~|~|Malignant|~|124936720|Female|Mixed glioma|2021
20+|0.5|0.6|0.6|Benign/Borderline|692|109112165|Female|Neoplasm, unspecified|2004
20+|0.5|0.6|0.6|Malignant|685|109112165|Female|Neoplasm, unspecified|2004
20+|0.7|0.8|0.7|Benign/Borderline|863|110320645|Female|Neoplasm, unspecified|2005
20+|0.5|0.6|0.6|Malignant|715|110320645|Female|Neoplasm, unspecified|2005
20+|0.6|0.7|0.7|Benign/Borderline|805|111567226|Female|Neoplasm, unspecified|2006
20+|0.5|0.6|0.6|Malignant|721|111567226|Female|Neoplasm, unspecified|2006
20+|0.6|0.7|0.7|Benign/Borderline|845|112783993|Female|Neoplasm, unspecified|2007
20+|0.5|0.5|0.5|Malignant|650|112783993|Female|Neoplasm, unspecified|2007
20+|0.6|0.7|0.7|Benign/Borderline|834|114027722|Female|Neoplasm, unspecified|2008
20+|0.5|0.6|0.6|Malignant|751|114027722|Female|Neoplasm, unspecified|2008
20+|0.7|0.8|0.7|Benign/Borderline|928|115293599|Female|Neoplasm, unspecified|2009
20+|0.5|0.6|0.6|Malignant|782|115293599|Female|Neoplasm, unspecified|2009
20+|0.6|0.7|0.7|Benign/Borderline|830|116598241|Female|Neoplasm, unspecified|2010
20+|0.4|0.5|0.5|Malignant|643|116598241|Female|Neoplasm, unspecified|2010
20+|0.6|0.7|0.7|Benign/Borderline|854|117817623|Female|Neoplasm, unspecified|2011
20+|0.4|0.5|0.5|Malignant|650|117817623|Female|Neoplasm, unspecified|2011
20+|0.6|0.7|0.7|Benign/Borderline|883|119004221|Female|Neoplasm, unspecified|2012
20+|0.4|0.5|0.5|Malignant|656|119004221|Female|Neoplasm, unspecified|2012
20+|0.6|0.6|0.6|Benign/Borderline|799|120085013|Female|Neoplasm, unspecified|2013
20+|0.4|0.5|0.5|Malignant|667|120085013|Female|Neoplasm, unspecified|2013
20+|0.6|0.7|0.7|Benign/Borderline|898|121202956|Female|Neoplasm, unspecified|2014
20+|0.5|0.5|0.5|Malignant|746|121202956|Female|Neoplasm, unspecified|2014
20+|0.6|0.7|0.6|Benign/Borderline|877|122262894|Female|Neoplasm, unspecified|2015
20+|0.5|0.5|0.5|Malignant|741|122262894|Female|Neoplasm, unspecified|2015
20+|0.5|0.6|0.6|Benign/Borderline|813|123298060|Female|Neoplasm, unspecified|2016
20+|0.4|0.4|0.4|Malignant|627|123298060|Female|Neoplasm, unspecified|2016
20+|0.5|0.6|0.6|Benign/Borderline|778|124243876|Female|Neoplasm, unspecified|2017
20+|0.4|0.5|0.4|Malignant|688|124243876|Female|Neoplasm, unspecified|2017
20+|0.5|0.5|0.5|Benign/Borderline|3354|616718331|Female|Neoplasm, unspecified|2017-2021
20+|0.4|0.5|0.4|Malignant|3460|616718331|Female|Neoplasm, unspecified|2017-2021
20+|0.5|0.6|0.5|Benign/Borderline|743|125090257|Female|Neoplasm, unspecified|2018
20+|0.4|0.5|0.4|Malignant|690|125090257|Female|Neoplasm, unspecified|2018
20+|0.4|0.5|0.4|Benign/Borderline|638|125886169|Female|Neoplasm, unspecified|2019
20+|0.4|0.5|0.5|Malignant|719|125886169|Female|Neoplasm, unspecified|2019
20+|0.4|0.5|0.5|Benign/Borderline|627|124127412|Female|Neoplasm, unspecified|2020
20+|0.5|0.5|0.5|Malignant|763|124127412|Female|Neoplasm, unspecified|2020
20+|0.4|0.5|0.4|Benign/Borderline|594|124936720|Female|Neoplasm, unspecified|2021
20+|0.4|0.4|0.4|Malignant|635|124936720|Female|Neoplasm, unspecified|2021
20+|2.2|2.4|2.3|Benign/Borderline|2603|109112165|Female|Nerve sheath, benign and malignant|2004
20+|0.0|0.0|0.0|Malignant|19|109112165|Female|Nerve sheath, benign and malignant|2004
20+|2.4|2.6|2.5|Benign/Borderline|2870|110320645|Female|Nerve sheath, benign and malignant|2005
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Nerve sheath, benign and malignant|2005
20+|2.5|2.7|2.6|Benign/Borderline|3000|111567226|Female|Nerve sheath, benign and malignant|2006
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Nerve sheath, benign and malignant|2006
20+|2.5|2.7|2.6|Benign/Borderline|3027|112783993|Female|Nerve sheath, benign and malignant|2007
20+|0.0|0.0|0.0|Malignant|39|112783993|Female|Nerve sheath, benign and malignant|2007
20+|2.6|2.7|2.6|Benign/Borderline|3162|114027722|Female|Nerve sheath, benign and malignant|2008
20+|0.0|0.0|0.0|Malignant|26|114027722|Female|Nerve sheath, benign and malignant|2008
20+|2.6|2.8|2.7|Benign/Borderline|3289|115293599|Female|Nerve sheath, benign and malignant|2009
20+|0.0|0.0|0.0|Malignant|16|115293599|Female|Nerve sheath, benign and malignant|2009
20+|2.4|2.6|2.5|Benign/Borderline|3117|116598241|Female|Nerve sheath, benign and malignant|2010
20+|0.0|0.0|0.0|Malignant|22|116598241|Female|Nerve sheath, benign and malignant|2010
20+|2.6|2.8|2.7|Benign/Borderline|3366|117817623|Female|Nerve sheath, benign and malignant|2011
20+|0.0|0.0|0.0|Malignant|21|117817623|Female|Nerve sheath, benign and malignant|2011
20+|2.7|2.9|2.8|Benign/Borderline|3581|119004221|Female|Nerve sheath, benign and malignant|2012
20+|0.0|0.0|0.0|Malignant|27|119004221|Female|Nerve sheath, benign and malignant|2012
20+|2.9|3.1|3.0|Benign/Borderline|3780|120085013|Female|Nerve sheath, benign and malignant|2013
20+|0.0|0.0|0.0|Malignant|23|120085013|Female|Nerve sheath, benign and malignant|2013
20+|2.9|3.1|3.0|Benign/Borderline|3916|121202956|Female|Nerve sheath, benign and malignant|2014
20+|0.0|0.0|0.0|Malignant|16|121202956|Female|Nerve sheath, benign and malignant|2014
20+|3.0|3.2|3.1|Benign/Borderline|4061|122262894|Female|Nerve sheath, benign and malignant|2015
20+|0.0|0.0|0.0|Malignant|23|122262894|Female|Nerve sheath, benign and malignant|2015
20+|2.9|3.1|3.0|Benign/Borderline|4043|123298060|Female|Nerve sheath, benign and malignant|2016
20+|0.0|0.0|0.0|Malignant|28|123298060|Female|Nerve sheath, benign and malignant|2016
20+|2.9|3.1|3.0|Benign/Borderline|3991|124243876|Female|Nerve sheath, benign and malignant|2017
20+|0.0|0.0|0.0|Malignant|18|124243876|Female|Nerve sheath, benign and malignant|2017
20+|2.8|2.8|2.8|Benign/Borderline|18893|616718331|Female|Nerve sheath, benign and malignant|2017-2021
20+|0.0|0.0|0.0|Malignant|95|616718331|Female|Nerve sheath, benign and malignant|2017-2021
20+|2.8|3.0|2.9|Benign/Borderline|3974|125090257|Female|Nerve sheath, benign and malignant|2018
20+|~|~|~|Malignant|~|125090257|Female|Nerve sheath, benign and malignant|2018
20+|2.8|3.0|2.9|Benign/Borderline|4032|125886169|Female|Nerve sheath, benign and malignant|2019
20+|0.0|0.0|0.0|Malignant|19|125886169|Female|Nerve sheath, benign and malignant|2019
20+|2.4|2.5|2.5|Benign/Borderline|3324|124127412|Female|Nerve sheath, benign and malignant|2020
20+|0.0|0.0|0.0|Malignant|16|124127412|Female|Nerve sheath, benign and malignant|2020
20+|2.7|2.9|2.8|Benign/Borderline|3781|124936720|Female|Nerve sheath, benign and malignant|2021
20+|0.0|0.0|0.0|Malignant|28|124936720|Female|Nerve sheath, benign and malignant|2021
20+|~|~|~|Benign/Borderline|~|109112165|Female|Neuroepithelial|2004
20+|0.0|0.0|0.0|Malignant|19|109112165|Female|Neuroepithelial|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Neuroepithelial|2005
20+|0.0|0.0|0.0|Malignant|23|110320645|Female|Neuroepithelial|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Neuroepithelial|2006
20+|0.0|0.0|0.0|Malignant|17|111567226|Female|Neuroepithelial|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Neuroepithelial|2007
20+|0.0|0.0|0.0|Malignant|20|112783993|Female|Neuroepithelial|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Neuroepithelial|2008
20+|0.0|0.0|0.0|Malignant|27|114027722|Female|Neuroepithelial|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Neuroepithelial|2009
20+|0.0|0.0|0.0|Malignant|21|115293599|Female|Neuroepithelial|2009
20+|~|~|~|Benign/Borderline|~|116598241|Female|Neuroepithelial|2010
20+|0.0|0.0|0.0|Malignant|26|116598241|Female|Neuroepithelial|2010
20+|~|~|~|Benign/Borderline|~|117817623|Female|Neuroepithelial|2011
20+|0.0|0.0|0.0|Malignant|23|117817623|Female|Neuroepithelial|2011
20+|~|~|~|Benign/Borderline|~|119004221|Female|Neuroepithelial|2012
20+|0.0|0.0|0.0|Malignant|28|119004221|Female|Neuroepithelial|2012
20+|~|~|~|Benign/Borderline|~|120085013|Female|Neuroepithelial|2013
20+|0.0|0.0|0.0|Malignant|21|120085013|Female|Neuroepithelial|2013
20+|~|~|~|Benign/Borderline|~|121202956|Female|Neuroepithelial|2014
20+|0.0|0.0|0.0|Malignant|22|121202956|Female|Neuroepithelial|2014
20+|~|~|~|Benign/Borderline|~|122262894|Female|Neuroepithelial|2015
20+|0.0|0.0|0.0|Malignant|39|122262894|Female|Neuroepithelial|2015
20+|~|~|~|Benign/Borderline|~|123298060|Female|Neuroepithelial|2016
20+|0.0|0.0|0.0|Malignant|22|123298060|Female|Neuroepithelial|2016
20+|~|~|~|Benign/Borderline|~|124243876|Female|Neuroepithelial|2017
20+|~|~|~|Malignant|~|124243876|Female|Neuroepithelial|2017
20+|0.0|0.0|0.0|Benign/Borderline|27|616718331|Female|Neuroepithelial|2017-2021
20+|0.0|0.0|0.0|Malignant|64|616718331|Female|Neuroepithelial|2017-2021
20+|~|~|~|Benign/Borderline|~|125090257|Female|Neuroepithelial|2018
20+|~|~|~|Malignant|~|125090257|Female|Neuroepithelial|2018
20+|~|~|~|Benign/Borderline|~|125886169|Female|Neuroepithelial|2019
20+|0.0|0.0|0.0|Malignant|16|125886169|Female|Neuroepithelial|2019
20+|~|~|~|Benign/Borderline|~|124127412|Female|Neuroepithelial|2020
20+|~|~|~|Malignant|~|124127412|Female|Neuroepithelial|2020
20+|~|~|~|Benign/Borderline|~|124936720|Female|Neuroepithelial|2021
20+|~|~|~|Malignant|~|124936720|Female|Neuroepithelial|2021
20+|0.1|0.2|0.1|Benign/Borderline|154|109112165|Female|Neuronal/glial, neuronal|2004
20+|~|~|~|Malignant|~|109112165|Female|Neuronal/glial, neuronal|2004
20+|0.1|0.2|0.2|Benign/Borderline|186|110320645|Female|Neuronal/glial, neuronal|2005
20+|0.0|0.0|0.0|Malignant|18|110320645|Female|Neuronal/glial, neuronal|2005
20+|0.2|0.2|0.2|Benign/Borderline|187|111567226|Female|Neuronal/glial, neuronal|2006
20+|0.0|0.0|0.0|Malignant|18|111567226|Female|Neuronal/glial, neuronal|2006
20+|0.2|0.2|0.2|Benign/Borderline|206|112783993|Female|Neuronal/glial, neuronal|2007
20+|0.0|0.0|0.0|Malignant|23|112783993|Female|Neuronal/glial, neuronal|2007
20+|0.2|0.2|0.2|Benign/Borderline|204|114027722|Female|Neuronal/glial, neuronal|2008
20+|0.0|0.0|0.0|Malignant|24|114027722|Female|Neuronal/glial, neuronal|2008
20+|0.2|0.2|0.2|Benign/Borderline|223|115293599|Female|Neuronal/glial, neuronal|2009
20+|0.0|0.0|0.0|Malignant|21|115293599|Female|Neuronal/glial, neuronal|2009
20+|0.2|0.3|0.2|Benign/Borderline|248|116598241|Female|Neuronal/glial, neuronal|2010
20+|0.0|0.0|0.0|Malignant|18|116598241|Female|Neuronal/glial, neuronal|2010
20+|0.2|0.2|0.2|Benign/Borderline|242|117817623|Female|Neuronal/glial, neuronal|2011
20+|0.0|0.0|0.0|Malignant|18|117817623|Female|Neuronal/glial, neuronal|2011
20+|0.2|0.2|0.2|Benign/Borderline|215|119004221|Female|Neuronal/glial, neuronal|2012
20+|0.0|0.0|0.0|Malignant|22|119004221|Female|Neuronal/glial, neuronal|2012
20+|0.1|0.2|0.2|Benign/Borderline|184|120085013|Female|Neuronal/glial, neuronal|2013
20+|~|~|~|Malignant|~|120085013|Female|Neuronal/glial, neuronal|2013
20+|0.2|0.2|0.2|Benign/Borderline|241|121202956|Female|Neuronal/glial, neuronal|2014
20+|~|~|~|Malignant|~|121202956|Female|Neuronal/glial, neuronal|2014
20+|0.2|0.2|0.2|Benign/Borderline|233|122262894|Female|Neuronal/glial, neuronal|2015
20+|~|~|~|Malignant|~|122262894|Female|Neuronal/glial, neuronal|2015
20+|0.2|0.2|0.2|Benign/Borderline|247|123298060|Female|Neuronal/glial, neuronal|2016
20+|0.0|0.0|0.0|Malignant|29|123298060|Female|Neuronal/glial, neuronal|2016
20+|0.2|0.3|0.2|Benign/Borderline|273|124243876|Female|Neuronal/glial, neuronal|2017
20+|0.0|0.0|0.0|Malignant|22|124243876|Female|Neuronal/glial, neuronal|2017
20+|0.2|0.2|0.2|Benign/Borderline|1159|616718331|Female|Neuronal/glial, neuronal|2017-2021
20+|0.0|0.0|0.0|Malignant|76|616718331|Female|Neuronal/glial, neuronal|2017-2021
20+|0.2|0.2|0.2|Benign/Borderline|216|125090257|Female|Neuronal/glial, neuronal|2018
20+|~|~|~|Malignant|~|125090257|Female|Neuronal/glial, neuronal|2018
20+|0.2|0.2|0.2|Benign/Borderline|243|125886169|Female|Neuronal/glial, neuronal|2019
20+|0.0|0.0|0.0|Malignant|17|125886169|Female|Neuronal/glial, neuronal|2019
20+|0.2|0.2|0.2|Benign/Borderline|220|124127412|Female|Neuronal/glial, neuronal|2020
20+|~|~|~|Malignant|~|124127412|Female|Neuronal/glial, neuronal|2020
20+|0.2|0.2|0.2|Benign/Borderline|224|124936720|Female|Neuronal/glial, neuronal|2021
20+|0.0|0.0|0.0|Malignant|16|124936720|Female|Neuronal/glial, neuronal|2021
20+|~|~|~|Benign/Borderline|~|109112165|Female|Oligodendroglioma|2004
20+|0.3|0.4|0.3|Malignant|355|109112165|Female|Oligodendroglioma|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Oligodendroglioma|2005
20+|0.3|0.4|0.3|Malignant|366|110320645|Female|Oligodendroglioma|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Oligodendroglioma|2006
20+|0.3|0.4|0.4|Malignant|385|111567226|Female|Oligodendroglioma|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Oligodendroglioma|2007
20+|0.3|0.4|0.3|Malignant|374|112783993|Female|Oligodendroglioma|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Oligodendroglioma|2008
20+|0.3|0.4|0.3|Malignant|372|114027722|Female|Oligodendroglioma|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Oligodendroglioma|2009
20+|0.3|0.4|0.3|Malignant|371|115293599|Female|Oligodendroglioma|2009
20+|~|~|~|Benign/Borderline|~|116598241|Female|Oligodendroglioma|2010
20+|0.3|0.3|0.3|Malignant|339|116598241|Female|Oligodendroglioma|2010
20+|~|~|~|Benign/Borderline|~|117817623|Female|Oligodendroglioma|2011
20+|0.3|0.3|0.3|Malignant|322|117817623|Female|Oligodendroglioma|2011
20+|~|~|~|Benign/Borderline|~|119004221|Female|Oligodendroglioma|2012
20+|0.2|0.3|0.3|Malignant|307|119004221|Female|Oligodendroglioma|2012
20+|~|~|~|Benign/Borderline|~|120085013|Female|Oligodendroglioma|2013
20+|0.3|0.3|0.3|Malignant|357|120085013|Female|Oligodendroglioma|2013
20+|~|~|~|Benign/Borderline|~|121202956|Female|Oligodendroglioma|2014
20+|0.2|0.3|0.3|Malignant|308|121202956|Female|Oligodendroglioma|2014
20+|~|~|~|Benign/Borderline|~|122262894|Female|Oligodendroglioma|2015
20+|0.2|0.3|0.3|Malignant|317|122262894|Female|Oligodendroglioma|2015
20+|~|~|~|Benign/Borderline|~|123298060|Female|Oligodendroglioma|2016
20+|0.3|0.3|0.3|Malignant|347|123298060|Female|Oligodendroglioma|2016
20+|~|~|~|Benign/Borderline|~|124243876|Female|Oligodendroglioma|2017
20+|0.3|0.3|0.3|Malignant|324|124243876|Female|Oligodendroglioma|2017
20+|~|~|~|Benign/Borderline|~|616718331|Female|Oligodendroglioma|2017-2021
20+|0.2|0.3|0.3|Malignant|1482|616718331|Female|Oligodendroglioma|2017-2021
20+|~|~|~|Benign/Borderline|~|125090257|Female|Oligodendroglioma|2018
20+|0.2|0.3|0.3|Malignant|311|125090257|Female|Oligodendroglioma|2018
20+|~|~|~|Benign/Borderline|~|125886169|Female|Oligodendroglioma|2019
20+|0.2|0.3|0.3|Malignant|316|125886169|Female|Oligodendroglioma|2019
20+|~|~|~|Benign/Borderline|~|124127412|Female|Oligodendroglioma|2020
20+|0.2|0.3|0.2|Malignant|252|124127412|Female|Oligodendroglioma|2020
20+|~|~|~|Benign/Borderline|~|124936720|Female|Oligodendroglioma|2021
20+|0.2|0.3|0.3|Malignant|302|124936720|Female|Oligodendroglioma|2021
20+|0.0|0.1|0.1|Benign/Borderline|69|109112165|Female|Other mesenchymal|2004
20+|0.0|0.0|0.0|Malignant|27|109112165|Female|Other mesenchymal|2004
20+|0.1|0.1|0.1|Benign/Borderline|83|110320645|Female|Other mesenchymal|2005
20+|0.0|0.0|0.0|Malignant|28|110320645|Female|Other mesenchymal|2005
20+|0.1|0.1|0.1|Benign/Borderline|89|111567226|Female|Other mesenchymal|2006
20+|0.0|0.0|0.0|Malignant|28|111567226|Female|Other mesenchymal|2006
20+|0.1|0.1|0.1|Benign/Borderline|84|112783993|Female|Other mesenchymal|2007
20+|0.0|0.0|0.0|Malignant|38|112783993|Female|Other mesenchymal|2007
20+|0.1|0.1|0.1|Benign/Borderline|106|114027722|Female|Other mesenchymal|2008
20+|0.0|0.1|0.0|Malignant|53|114027722|Female|Other mesenchymal|2008
20+|0.1|0.1|0.1|Benign/Borderline|98|115293599|Female|Other mesenchymal|2009
20+|0.0|0.0|0.0|Malignant|29|115293599|Female|Other mesenchymal|2009
20+|0.1|0.1|0.1|Benign/Borderline|98|116598241|Female|Other mesenchymal|2010
20+|0.0|0.0|0.0|Malignant|37|116598241|Female|Other mesenchymal|2010
20+|0.1|0.1|0.1|Benign/Borderline|96|117817623|Female|Other mesenchymal|2011
20+|0.0|0.0|0.0|Malignant|31|117817623|Female|Other mesenchymal|2011
20+|0.1|0.1|0.1|Benign/Borderline|108|119004221|Female|Other mesenchymal|2012
20+|0.0|0.0|0.0|Malignant|40|119004221|Female|Other mesenchymal|2012
20+|0.1|0.1|0.1|Benign/Borderline|109|120085013|Female|Other mesenchymal|2013
20+|0.0|0.0|0.0|Malignant|40|120085013|Female|Other mesenchymal|2013
20+|0.1|0.1|0.1|Benign/Borderline|98|121202956|Female|Other mesenchymal|2014
20+|0.0|0.0|0.0|Malignant|35|121202956|Female|Other mesenchymal|2014
20+|0.1|0.1|0.1|Benign/Borderline|96|122262894|Female|Other mesenchymal|2015
20+|0.0|0.0|0.0|Malignant|42|122262894|Female|Other mesenchymal|2015
20+|0.0|0.1|0.1|Benign/Borderline|82|123298060|Female|Other mesenchymal|2016
20+|0.0|0.0|0.0|Malignant|42|123298060|Female|Other mesenchymal|2016
20+|0.1|0.1|0.1|Benign/Borderline|115|124243876|Female|Other mesenchymal|2017
20+|0.0|0.1|0.0|Malignant|66|124243876|Female|Other mesenchymal|2017
20+|0.1|0.1|0.1|Benign/Borderline|431|616718331|Female|Other mesenchymal|2017-2021
20+|0.0|0.0|0.0|Malignant|278|616718331|Female|Other mesenchymal|2017-2021
20+|0.1|0.1|0.1|Benign/Borderline|95|125090257|Female|Other mesenchymal|2018
20+|0.0|0.0|0.0|Malignant|47|125090257|Female|Other mesenchymal|2018
20+|0.1|0.1|0.1|Benign/Borderline|81|125886169|Female|Other mesenchymal|2019
20+|0.0|0.1|0.0|Malignant|51|125886169|Female|Other mesenchymal|2019
20+|0.0|0.1|0.0|Benign/Borderline|61|124127412|Female|Other mesenchymal|2020
20+|0.0|0.1|0.1|Malignant|63|124127412|Female|Other mesenchymal|2020
20+|0.0|0.1|0.1|Benign/Borderline|86|124936720|Female|Other mesenchymal|2021
20+|0.0|0.1|0.0|Malignant|52|124936720|Female|Other mesenchymal|2021
20+|~|~|~|Benign/Borderline|~|109112165|Female|Pilocytic astrocytoma|2004
20+|0.1|0.1|0.1|Malignant|128|109112165|Female|Pilocytic astrocytoma|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Pilocytic astrocytoma|2005
20+|0.1|0.2|0.1|Malignant|151|110320645|Female|Pilocytic astrocytoma|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Pilocytic astrocytoma|2006
20+|0.1|0.2|0.1|Malignant|150|111567226|Female|Pilocytic astrocytoma|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Pilocytic astrocytoma|2007
20+|0.1|0.2|0.2|Malignant|166|112783993|Female|Pilocytic astrocytoma|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Pilocytic astrocytoma|2008
20+|0.1|0.2|0.1|Malignant|146|114027722|Female|Pilocytic astrocytoma|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Pilocytic astrocytoma|2009
20+|0.1|0.1|0.1|Malignant|135|115293599|Female|Pilocytic astrocytoma|2009
20+|~|~|~|Benign/Borderline|~|116598241|Female|Pilocytic astrocytoma|2010
20+|0.1|0.2|0.2|Malignant|170|116598241|Female|Pilocytic astrocytoma|2010
20+|~|~|~|Benign/Borderline|~|117817623|Female|Pilocytic astrocytoma|2011
20+|0.1|0.2|0.1|Malignant|163|117817623|Female|Pilocytic astrocytoma|2011
20+|~|~|~|Benign/Borderline|~|119004221|Female|Pilocytic astrocytoma|2012
20+|0.1|0.1|0.1|Malignant|127|119004221|Female|Pilocytic astrocytoma|2012
20+|~|~|~|Benign/Borderline|~|120085013|Female|Pilocytic astrocytoma|2013
20+|0.1|0.2|0.1|Malignant|160|120085013|Female|Pilocytic astrocytoma|2013
20+|~|~|~|Benign/Borderline|~|121202956|Female|Pilocytic astrocytoma|2014
20+|0.1|0.2|0.1|Malignant|148|121202956|Female|Pilocytic astrocytoma|2014
20+|~|~|~|Benign/Borderline|~|122262894|Female|Pilocytic astrocytoma|2015
20+|0.1|0.2|0.1|Malignant|151|122262894|Female|Pilocytic astrocytoma|2015
20+|~|~|~|Benign/Borderline|~|123298060|Female|Pilocytic astrocytoma|2016
20+|0.1|0.1|0.1|Malignant|138|123298060|Female|Pilocytic astrocytoma|2016
20+|~|~|~|Benign/Borderline|~|124243876|Female|Pilocytic astrocytoma|2017
20+|0.1|0.1|0.1|Malignant|132|124243876|Female|Pilocytic astrocytoma|2017
20+|0.0|0.0|0.0|Benign/Borderline|48|616718331|Female|Pilocytic astrocytoma|2017-2021
20+|0.1|0.1|0.1|Malignant|627|616718331|Female|Pilocytic astrocytoma|2017-2021
20+|~|~|~|Benign/Borderline|~|125090257|Female|Pilocytic astrocytoma|2018
20+|0.1|0.1|0.1|Malignant|127|125090257|Female|Pilocytic astrocytoma|2018
20+|0.0|0.0|0.0|Benign/Borderline|16|125886169|Female|Pilocytic astrocytoma|2019
20+|0.1|0.1|0.1|Malignant|129|125886169|Female|Pilocytic astrocytoma|2019
20+|~|~|~|Benign/Borderline|~|124127412|Female|Pilocytic astrocytoma|2020
20+|0.1|0.1|0.1|Malignant|119|124127412|Female|Pilocytic astrocytoma|2020
20+|~|~|~|Benign/Borderline|~|124936720|Female|Pilocytic astrocytoma|2021
20+|0.1|0.1|0.1|Malignant|126|124936720|Female|Pilocytic astrocytoma|2021
20+|0.0|0.0|0.0|Benign/Borderline|20|109112165|Female|Pineal parenchymal|2004
20+|0.0|0.0|0.0|Malignant|16|109112165|Female|Pineal parenchymal|2004
20+|0.0|0.0|0.0|Benign/Borderline|35|110320645|Female|Pineal parenchymal|2005
20+|~|~|~|Malignant|~|110320645|Female|Pineal parenchymal|2005
20+|0.0|0.0|0.0|Benign/Borderline|29|111567226|Female|Pineal parenchymal|2006
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Pineal parenchymal|2006
20+|0.0|0.0|0.0|Benign/Borderline|32|112783993|Female|Pineal parenchymal|2007
20+|0.0|0.0|0.0|Malignant|28|112783993|Female|Pineal parenchymal|2007
20+|0.0|0.1|0.0|Benign/Borderline|46|114027722|Female|Pineal parenchymal|2008
20+|0.0|0.0|0.0|Malignant|21|114027722|Female|Pineal parenchymal|2008
20+|0.0|0.0|0.0|Benign/Borderline|32|115293599|Female|Pineal parenchymal|2009
20+|0.0|0.0|0.0|Malignant|29|115293599|Female|Pineal parenchymal|2009
20+|0.0|0.1|0.0|Benign/Borderline|43|116598241|Female|Pineal parenchymal|2010
20+|0.0|0.0|0.0|Malignant|23|116598241|Female|Pineal parenchymal|2010
20+|0.0|0.1|0.0|Benign/Borderline|48|117817623|Female|Pineal parenchymal|2011
20+|0.0|0.0|0.0|Malignant|26|117817623|Female|Pineal parenchymal|2011
20+|0.0|0.0|0.0|Benign/Borderline|38|119004221|Female|Pineal parenchymal|2012
20+|0.0|0.0|0.0|Malignant|21|119004221|Female|Pineal parenchymal|2012
20+|0.0|0.1|0.0|Benign/Borderline|54|120085013|Female|Pineal parenchymal|2013
20+|0.0|0.0|0.0|Malignant|34|120085013|Female|Pineal parenchymal|2013
20+|0.0|0.1|0.0|Benign/Borderline|44|121202956|Female|Pineal parenchymal|2014
20+|0.0|0.0|0.0|Malignant|19|121202956|Female|Pineal parenchymal|2014
20+|0.0|0.1|0.0|Benign/Borderline|53|122262894|Female|Pineal parenchymal|2015
20+|0.0|0.0|0.0|Malignant|31|122262894|Female|Pineal parenchymal|2015
20+|0.0|0.0|0.0|Benign/Borderline|38|123298060|Female|Pineal parenchymal|2016
20+|0.0|0.0|0.0|Malignant|30|123298060|Female|Pineal parenchymal|2016
20+|0.0|0.0|0.0|Benign/Borderline|39|124243876|Female|Pineal parenchymal|2017
20+|0.0|0.0|0.0|Malignant|25|124243876|Female|Pineal parenchymal|2017
20+|0.0|0.0|0.0|Benign/Borderline|158|616718331|Female|Pineal parenchymal|2017-2021
20+|0.0|0.0|0.0|Malignant|122|616718331|Female|Pineal parenchymal|2017-2021
20+|0.0|0.0|0.0|Benign/Borderline|36|125090257|Female|Pineal parenchymal|2018
20+|0.0|0.0|0.0|Malignant|22|125090257|Female|Pineal parenchymal|2018
20+|0.0|0.0|0.0|Benign/Borderline|30|125886169|Female|Pineal parenchymal|2019
20+|0.0|0.0|0.0|Malignant|30|125886169|Female|Pineal parenchymal|2019
20+|0.0|0.0|0.0|Benign/Borderline|27|124127412|Female|Pineal parenchymal|2020
20+|0.0|0.0|0.0|Malignant|22|124127412|Female|Pineal parenchymal|2020
20+|0.0|0.0|0.0|Benign/Borderline|26|124936720|Female|Pineal parenchymal|2021
20+|0.0|0.0|0.0|Malignant|23|124936720|Female|Pineal parenchymal|2021
20+|3.8|4.1|3.9|Benign/Borderline|4265|109112165|Female|Pituitary|2004
20+|0.0|0.0|0.0|Malignant|25|109112165|Female|Pituitary|2004
20+|4.4|4.7|4.5|Benign/Borderline|4966|110320645|Female|Pituitary|2005
20+|0.0|0.0|0.0|Malignant|24|110320645|Female|Pituitary|2005
20+|4.8|5.1|4.9|Benign/Borderline|5468|111567226|Female|Pituitary|2006
20+|~|~|~|Malignant|~|111567226|Female|Pituitary|2006
20+|5.0|5.2|5.1|Benign/Borderline|5680|112783993|Female|Pituitary|2007
20+|~|~|~|Malignant|~|112783993|Female|Pituitary|2007
20+|5.3|5.6|5.5|Benign/Borderline|6155|114027722|Female|Pituitary|2008
20+|~|~|~|Malignant|~|114027722|Female|Pituitary|2008
20+|5.8|6.1|6.0|Benign/Borderline|6781|115293599|Female|Pituitary|2009
20+|0.0|0.0|0.0|Malignant|17|115293599|Female|Pituitary|2009
20+|5.8|6.1|6.0|Benign/Borderline|6847|116598241|Female|Pituitary|2010
20+|0.0|0.0|0.0|Malignant|18|116598241|Female|Pituitary|2010
20+|6.0|6.3|6.1|Benign/Borderline|7057|117817623|Female|Pituitary|2011
20+|~|~|~|Malignant|~|117817623|Female|Pituitary|2011
20+|6.4|6.7|6.6|Benign/Borderline|7610|119004221|Female|Pituitary|2012
20+|0.0|0.0|0.0|Malignant|16|119004221|Female|Pituitary|2012
20+|6.2|6.5|6.4|Benign/Borderline|7545|120085013|Female|Pituitary|2013
20+|~|~|~|Malignant|~|120085013|Female|Pituitary|2013
20+|6.5|6.8|6.6|Benign/Borderline|7799|121202956|Female|Pituitary|2014
20+|~|~|~|Malignant|~|121202956|Female|Pituitary|2014
20+|6.8|7.1|6.9|Benign/Borderline|8244|122262894|Female|Pituitary|2015
20+|~|~|~|Malignant|~|122262894|Female|Pituitary|2015
20+|6.9|7.2|7.0|Benign/Borderline|8441|123298060|Female|Pituitary|2016
20+|~|~|~|Malignant|~|123298060|Female|Pituitary|2016
20+|7.2|7.5|7.4|Benign/Borderline|8917|124243876|Female|Pituitary|2017
20+|~|~|~|Malignant|~|124243876|Female|Pituitary|2017
20+|7.0|7.1|7.0|Benign/Borderline|42361|616718331|Female|Pituitary|2017-2021
20+|0.0|0.0|0.0|Malignant|41|616718331|Female|Pituitary|2017-2021
20+|7.2|7.5|7.3|Benign/Borderline|8942|125090257|Female|Pituitary|2018
20+|~|~|~|Malignant|~|125090257|Female|Pituitary|2018
20+|7.1|7.5|7.3|Benign/Borderline|8992|125886169|Female|Pituitary|2019
20+|~|~|~|Malignant|~|125886169|Female|Pituitary|2019
20+|6.2|6.5|6.3|Benign/Borderline|7692|124127412|Female|Pituitary|2020
20+|~|~|~|Malignant|~|124127412|Female|Pituitary|2020
20+|6.5|6.8|6.7|Benign/Borderline|8138|124936720|Female|Pituitary|2021
20+|0.0|0.0|0.0|Malignant|16|124936720|Female|Pituitary|2021
20+|20.0|20.6|20.3|Benign/Borderline|23113|109112165|Female|Total|2004
20+|7.5|7.8|7.6|Malignant|8754|109112165|Female|Total|2004
20+|22.6|23.2|22.9|Benign/Borderline|26448|110320645|Female|Total|2005
20+|7.5|7.8|7.7|Malignant|8936|110320645|Female|Total|2005
20+|23.8|24.3|24.1|Benign/Borderline|28203|111567226|Female|Total|2006
20+|7.5|7.8|7.6|Malignant|8991|111567226|Female|Total|2006
20+|24.6|25.1|24.8|Benign/Borderline|29565|112783993|Female|Total|2007
20+|7.4|7.8|7.6|Malignant|9092|112783993|Female|Total|2007
20+|25.9|26.5|26.2|Benign/Borderline|31664|114027722|Female|Total|2008
20+|7.4|7.8|7.6|Malignant|9254|114027722|Female|Total|2008
20+|27.7|28.3|28.0|Benign/Borderline|34292|115293599|Female|Total|2009
20+|7.4|7.7|7.6|Malignant|9412|115293599|Female|Total|2009
20+|27.0|27.6|27.3|Benign/Borderline|33939|116598241|Female|Total|2010
20+|7.2|7.5|7.4|Malignant|9338|116598241|Female|Total|2010
20+|27.6|28.2|27.9|Benign/Borderline|35002|117817623|Female|Total|2011
20+|7.1|7.4|7.2|Malignant|9217|117817623|Female|Total|2011
20+|28.5|29.1|28.8|Benign/Borderline|36658|119004221|Female|Total|2012
20+|7.2|7.5|7.3|Malignant|9493|119004221|Female|Total|2012
20+|28.6|29.2|28.9|Benign/Borderline|37293|120085013|Female|Total|2013
20+|7.2|7.5|7.3|Malignant|9683|120085013|Female|Total|2013
20+|29.4|30.0|29.7|Benign/Borderline|38818|121202956|Female|Total|2014
20+|7.0|7.3|7.1|Malignant|9560|121202956|Female|Total|2014
20+|30.3|31.0|30.6|Benign/Borderline|40635|122262894|Female|Total|2015
20+|7.2|7.5|7.4|Malignant|9973|122262894|Female|Total|2015
20+|30.8|31.4|31.1|Benign/Borderline|41674|123298060|Female|Total|2016
20+|7.0|7.3|7.1|Malignant|9895|123298060|Female|Total|2016
20+|31.4|32.1|31.7|Benign/Borderline|43239|124243876|Female|Total|2017
20+|7.0|7.2|7.1|Malignant|9962|124243876|Female|Total|2017
20+|31.0|31.2|31.1|Benign/Borderline|213138|616718331|Female|Total|2017-2021
20+|6.7|6.8|6.8|Malignant|47962|616718331|Female|Total|2017-2021
20+|31.3|32.0|31.6|Benign/Borderline|43705|125090257|Female|Total|2018
20+|6.7|7.0|6.9|Malignant|9805|125090257|Female|Total|2018
20+|32.1|32.7|32.4|Benign/Borderline|45400|125886169|Female|Total|2019
20+|6.6|6.9|6.7|Malignant|9729|125886169|Female|Total|2019
20+|28.5|29.1|28.8|Benign/Borderline|39951|124127412|Female|Total|2020
20+|6.6|6.8|6.7|Malignant|9703|124127412|Female|Total|2020
20+|30.1|30.7|30.4|Benign/Borderline|42773|124936720|Female|Total|2021
20+|6.3|6.6|6.5|Malignant|9383|124936720|Female|Total|2021
20+|2.2|2.4|2.3|Benign/Borderline|2603|109112165|Female|Tumors of Cranial and Spinal Nerves|2004
20+|0.0|0.0|0.0|Malignant|19|109112165|Female|Tumors of Cranial and Spinal Nerves|2004
20+|2.4|2.6|2.5|Benign/Borderline|2873|110320645|Female|Tumors of Cranial and Spinal Nerves|2005
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Tumors of Cranial and Spinal Nerves|2005
20+|2.5|2.7|2.6|Benign/Borderline|3001|111567226|Female|Tumors of Cranial and Spinal Nerves|2006
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Tumors of Cranial and Spinal Nerves|2006
20+|2.5|2.7|2.6|Benign/Borderline|3028|112783993|Female|Tumors of Cranial and Spinal Nerves|2007
20+|0.0|0.0|0.0|Malignant|39|112783993|Female|Tumors of Cranial and Spinal Nerves|2007
20+|2.6|2.7|2.6|Benign/Borderline|3164|114027722|Female|Tumors of Cranial and Spinal Nerves|2008
20+|0.0|0.0|0.0|Malignant|26|114027722|Female|Tumors of Cranial and Spinal Nerves|2008
20+|2.6|2.8|2.7|Benign/Borderline|3292|115293599|Female|Tumors of Cranial and Spinal Nerves|2009
20+|0.0|0.0|0.0|Malignant|16|115293599|Female|Tumors of Cranial and Spinal Nerves|2009
20+|2.4|2.6|2.5|Benign/Borderline|3120|116598241|Female|Tumors of Cranial and Spinal Nerves|2010
20+|0.0|0.0|0.0|Malignant|22|116598241|Female|Tumors of Cranial and Spinal Nerves|2010
20+|2.6|2.8|2.7|Benign/Borderline|3368|117817623|Female|Tumors of Cranial and Spinal Nerves|2011
20+|0.0|0.0|0.0|Malignant|21|117817623|Female|Tumors of Cranial and Spinal Nerves|2011
20+|2.7|2.9|2.8|Benign/Borderline|3581|119004221|Female|Tumors of Cranial and Spinal Nerves|2012
20+|0.0|0.0|0.0|Malignant|27|119004221|Female|Tumors of Cranial and Spinal Nerves|2012
20+|2.9|3.1|3.0|Benign/Borderline|3781|120085013|Female|Tumors of Cranial and Spinal Nerves|2013
20+|0.0|0.0|0.0|Malignant|23|120085013|Female|Tumors of Cranial and Spinal Nerves|2013
20+|2.9|3.1|3.0|Benign/Borderline|3922|121202956|Female|Tumors of Cranial and Spinal Nerves|2014
20+|0.0|0.0|0.0|Malignant|16|121202956|Female|Tumors of Cranial and Spinal Nerves|2014
20+|3.0|3.2|3.1|Benign/Borderline|4064|122262894|Female|Tumors of Cranial and Spinal Nerves|2015
20+|0.0|0.0|0.0|Malignant|23|122262894|Female|Tumors of Cranial and Spinal Nerves|2015
20+|3.0|3.1|3.0|Benign/Borderline|4049|123298060|Female|Tumors of Cranial and Spinal Nerves|2016
20+|0.0|0.0|0.0|Malignant|28|123298060|Female|Tumors of Cranial and Spinal Nerves|2016
20+|2.9|3.1|3.0|Benign/Borderline|3992|124243876|Female|Tumors of Cranial and Spinal Nerves|2017
20+|0.0|0.0|0.0|Malignant|18|124243876|Female|Tumors of Cranial and Spinal Nerves|2017
20+|2.8|2.8|2.8|Benign/Borderline|18899|616718331|Female|Tumors of Cranial and Spinal Nerves|2017-2021
20+|0.0|0.0|0.0|Malignant|95|616718331|Female|Tumors of Cranial and Spinal Nerves|2017-2021
20+|2.8|3.0|2.9|Benign/Borderline|3977|125090257|Female|Tumors of Cranial and Spinal Nerves|2018
20+|~|~|~|Malignant|~|125090257|Female|Tumors of Cranial and Spinal Nerves|2018
20+|2.8|3.0|2.9|Benign/Borderline|4032|125886169|Female|Tumors of Cranial and Spinal Nerves|2019
20+|0.0|0.0|0.0|Malignant|19|125886169|Female|Tumors of Cranial and Spinal Nerves|2019
20+|2.4|2.5|2.5|Benign/Borderline|3325|124127412|Female|Tumors of Cranial and Spinal Nerves|2020
20+|0.0|0.0|0.0|Malignant|16|124127412|Female|Tumors of Cranial and Spinal Nerves|2020
20+|2.7|2.9|2.8|Benign/Borderline|3782|124936720|Female|Tumors of Cranial and Spinal Nerves|2021
20+|0.0|0.0|0.0|Malignant|28|124936720|Female|Tumors of Cranial and Spinal Nerves|2021
20+|0.3|0.4|0.4|Benign/Borderline|385|109112165|Female|Tumors of Neuroepthelial Tissue|2004
20+|6.1|6.4|6.2|Malignant|7088|109112165|Female|Tumors of Neuroepthelial Tissue|2004
20+|0.4|0.4|0.4|Benign/Borderline|442|110320645|Female|Tumors of Neuroepthelial Tissue|2005
20+|6.1|6.3|6.2|Malignant|7162|110320645|Female|Tumors of Neuroepthelial Tissue|2005
20+|0.4|0.5|0.5|Benign/Borderline|487|111567226|Female|Tumors of Neuroepthelial Tissue|2006
20+|6.0|6.3|6.2|Malignant|7238|111567226|Female|Tumors of Neuroepthelial Tissue|2006
20+|0.4|0.5|0.4|Benign/Borderline|489|112783993|Female|Tumors of Neuroepthelial Tissue|2007
20+|6.1|6.4|6.2|Malignant|7414|112783993|Female|Tumors of Neuroepthelial Tissue|2007
20+|0.4|0.5|0.4|Benign/Borderline|494|114027722|Female|Tumors of Neuroepthelial Tissue|2008
20+|6.0|6.3|6.2|Malignant|7441|114027722|Female|Tumors of Neuroepthelial Tissue|2008
20+|0.4|0.5|0.5|Benign/Borderline|513|115293599|Female|Tumors of Neuroepthelial Tissue|2009
20+|6.1|6.4|6.2|Malignant|7652|115293599|Female|Tumors of Neuroepthelial Tissue|2009
20+|0.4|0.5|0.5|Benign/Borderline|553|116598241|Female|Tumors of Neuroepthelial Tissue|2010
20+|6.0|6.2|6.1|Malignant|7627|116598241|Female|Tumors of Neuroepthelial Tissue|2010
20+|0.5|0.5|0.5|Benign/Borderline|574|117817623|Female|Tumors of Neuroepthelial Tissue|2011
20+|5.8|6.1|6.0|Malignant|7568|117817623|Female|Tumors of Neuroepthelial Tissue|2011
20+|0.4|0.5|0.5|Benign/Borderline|552|119004221|Female|Tumors of Neuroepthelial Tissue|2012
20+|5.9|6.2|6.1|Malignant|7813|119004221|Female|Tumors of Neuroepthelial Tissue|2012
20+|0.4|0.5|0.5|Benign/Borderline|533|120085013|Female|Tumors of Neuroepthelial Tissue|2013
20+|5.9|6.2|6.1|Malignant|7940|120085013|Female|Tumors of Neuroepthelial Tissue|2013
20+|0.5|0.6|0.5|Benign/Borderline|606|121202956|Female|Tumors of Neuroepthelial Tissue|2014
20+|5.6|5.9|5.8|Malignant|7667|121202956|Female|Tumors of Neuroepthelial Tissue|2014
20+|0.5|0.6|0.5|Benign/Borderline|629|122262894|Female|Tumors of Neuroepthelial Tissue|2015
20+|5.9|6.2|6.1|Malignant|8153|122262894|Female|Tumors of Neuroepthelial Tissue|2015
20+|0.5|0.6|0.5|Benign/Borderline|608|123298060|Female|Tumors of Neuroepthelial Tissue|2016
20+|5.8|6.1|5.9|Malignant|8137|123298060|Female|Tumors of Neuroepthelial Tissue|2016
20+|0.5|0.6|0.5|Benign/Borderline|631|124243876|Female|Tumors of Neuroepthelial Tissue|2017
20+|5.7|6.0|5.9|Malignant|8141|124243876|Female|Tumors of Neuroepthelial Tissue|2017
20+|0.5|0.5|0.5|Benign/Borderline|2944|616718331|Female|Tumors of Neuroepthelial Tissue|2017-2021
20+|5.5|5.6|5.6|Malignant|39071|616718331|Female|Tumors of Neuroepthelial Tissue|2017-2021
20+|0.4|0.5|0.5|Benign/Borderline|582|125090257|Female|Tumors of Neuroepthelial Tissue|2018
20+|5.5|5.8|5.7|Malignant|8013|125090257|Female|Tumors of Neuroepthelial Tissue|2018
20+|0.5|0.5|0.5|Benign/Borderline|617|125886169|Female|Tumors of Neuroepthelial Tissue|2019
20+|5.4|5.7|5.6|Malignant|7947|125886169|Female|Tumors of Neuroepthelial Tissue|2019
20+|0.4|0.5|0.5|Benign/Borderline|562|124127412|Female|Tumors of Neuroepthelial Tissue|2020
20+|5.3|5.6|5.5|Malignant|7841|124127412|Female|Tumors of Neuroepthelial Tissue|2020
20+|0.4|0.5|0.5|Benign/Borderline|584|124936720|Female|Tumors of Neuroepthelial Tissue|2021
20+|5.2|5.4|5.3|Malignant|7657|124936720|Female|Tumors of Neuroepthelial Tissue|2021
20+|4.0|4.2|4.1|Benign/Borderline|4473|109112165|Female|Tumors of Sellar Region|2004
20+|0.0|0.0|0.0|Malignant|25|109112165|Female|Tumors of Sellar Region|2004
20+|4.6|4.8|4.7|Benign/Borderline|5152|110320645|Female|Tumors of Sellar Region|2005
20+|0.0|0.0|0.0|Malignant|25|110320645|Female|Tumors of Sellar Region|2005
20+|5.0|5.3|5.1|Benign/Borderline|5675|111567226|Female|Tumors of Sellar Region|2006
20+|~|~|~|Malignant|~|111567226|Female|Tumors of Sellar Region|2006
20+|5.2|5.4|5.3|Benign/Borderline|5902|112783993|Female|Tumors of Sellar Region|2007
20+|~|~|~|Malignant|~|112783993|Female|Tumors of Sellar Region|2007
20+|5.5|5.8|5.7|Benign/Borderline|6382|114027722|Female|Tumors of Sellar Region|2008
20+|~|~|~|Malignant|~|114027722|Female|Tumors of Sellar Region|2008
20+|6.0|6.3|6.2|Benign/Borderline|7012|115293599|Female|Tumors of Sellar Region|2009
20+|0.0|0.0|0.0|Malignant|18|115293599|Female|Tumors of Sellar Region|2009
20+|6.0|6.3|6.2|Benign/Borderline|7088|116598241|Female|Tumors of Sellar Region|2010
20+|0.0|0.0|0.0|Malignant|18|116598241|Female|Tumors of Sellar Region|2010
20+|6.2|6.5|6.3|Benign/Borderline|7279|117817623|Female|Tumors of Sellar Region|2011
20+|~|~|~|Malignant|~|117817623|Female|Tumors of Sellar Region|2011
20+|6.6|6.9|6.7|Benign/Borderline|7838|119004221|Female|Tumors of Sellar Region|2012
20+|0.0|0.0|0.0|Malignant|16|119004221|Female|Tumors of Sellar Region|2012
20+|6.4|6.7|6.6|Benign/Borderline|7792|120085013|Female|Tumors of Sellar Region|2013
20+|0.0|0.0|0.0|Malignant|16|120085013|Female|Tumors of Sellar Region|2013
20+|6.6|7.0|6.8|Benign/Borderline|8024|121202956|Female|Tumors of Sellar Region|2014
20+|~|~|~|Malignant|~|121202956|Female|Tumors of Sellar Region|2014
20+|7.0|7.3|7.1|Benign/Borderline|8485|122262894|Female|Tumors of Sellar Region|2015
20+|~|~|~|Malignant|~|122262894|Female|Tumors of Sellar Region|2015
20+|7.0|7.4|7.2|Benign/Borderline|8672|123298060|Female|Tumors of Sellar Region|2016
20+|~|~|~|Malignant|~|123298060|Female|Tumors of Sellar Region|2016
20+|7.4|7.7|7.5|Benign/Borderline|9164|124243876|Female|Tumors of Sellar Region|2017
20+|~|~|~|Malignant|~|124243876|Female|Tumors of Sellar Region|2017
20+|7.1|7.3|7.2|Benign/Borderline|43489|616718331|Female|Tumors of Sellar Region|2017-2021
20+|0.0|0.0|0.0|Malignant|43|616718331|Female|Tumors of Sellar Region|2017-2021
20+|7.4|7.7|7.5|Benign/Borderline|9188|125090257|Female|Tumors of Sellar Region|2018
20+|~|~|~|Malignant|~|125090257|Female|Tumors of Sellar Region|2018
20+|7.3|7.6|7.5|Benign/Borderline|9226|125886169|Female|Tumors of Sellar Region|2019
20+|~|~|~|Malignant|~|125886169|Female|Tumors of Sellar Region|2019
20+|6.4|6.6|6.5|Benign/Borderline|7900|124127412|Female|Tumors of Sellar Region|2020
20+|~|~|~|Malignant|~|124127412|Female|Tumors of Sellar Region|2020
20+|6.7|7.0|6.8|Benign/Borderline|8341|124936720|Female|Tumors of Sellar Region|2021
20+|0.0|0.0|0.0|Malignant|17|124936720|Female|Tumors of Sellar Region|2021
20+|12.5|12.9|12.7|Benign/Borderline|14690|109112165|Female|Tumors of the Meninges|2004
20+|0.2|0.3|0.3|Malignant|302|109112165|Female|Tumors of the Meninges|2004
20+|14.0|14.4|14.2|Benign/Borderline|16784|110320645|Female|Tumors of the Meninges|2005
20+|0.2|0.3|0.3|Malignant|309|110320645|Female|Tumors of the Meninges|2005
20+|14.7|15.1|14.9|Benign/Borderline|17867|111567226|Female|Tumors of the Meninges|2006
20+|0.2|0.3|0.2|Malignant|283|111567226|Female|Tumors of the Meninges|2006
20+|15.3|15.7|15.5|Benign/Borderline|18881|112783993|Female|Tumors of the Meninges|2007
20+|0.2|0.3|0.3|Malignant|307|112783993|Female|Tumors of the Meninges|2007
20+|16.1|16.5|16.3|Benign/Borderline|20266|114027722|Female|Tumors of the Meninges|2008
20+|0.2|0.3|0.2|Malignant|272|114027722|Female|Tumors of the Meninges|2008
20+|17.2|17.6|17.4|Benign/Borderline|21964|115293599|Female|Tumors of the Meninges|2009
20+|0.2|0.2|0.2|Malignant|239|115293599|Female|Tumors of the Meninges|2009
20+|16.6|17.1|16.9|Benign/Borderline|21636|116598241|Female|Tumors of the Meninges|2010
20+|0.2|0.2|0.2|Malignant|247|116598241|Female|Tumors of the Meninges|2010
20+|16.8|17.3|17.1|Benign/Borderline|22156|117817623|Female|Tumors of the Meninges|2011
20+|0.1|0.2|0.2|Malignant|217|117817623|Female|Tumors of the Meninges|2011
20+|17.2|17.7|17.4|Benign/Borderline|23028|119004221|Female|Tumors of the Meninges|2012
20+|0.2|0.2|0.2|Malignant|244|119004221|Female|Tumors of the Meninges|2012
20+|17.4|17.9|17.7|Benign/Borderline|23602|120085013|Female|Tumors of the Meninges|2013
20+|0.2|0.2|0.2|Malignant|269|120085013|Female|Tumors of the Meninges|2013
20+|17.8|18.3|18.1|Benign/Borderline|24641|121202956|Female|Tumors of the Meninges|2014
20+|0.2|0.2|0.2|Malignant|261|121202956|Female|Tumors of the Meninges|2014
20+|18.5|19.0|18.7|Benign/Borderline|25930|122262894|Female|Tumors of the Meninges|2015
20+|0.2|0.2|0.2|Malignant|247|122262894|Female|Tumors of the Meninges|2015
20+|19.0|19.5|19.2|Benign/Borderline|26901|123298060|Female|Tumors of the Meninges|2016
20+|0.1|0.2|0.2|Malignant|220|123298060|Female|Tumors of the Meninges|2016
20+|19.5|19.9|19.7|Benign/Borderline|28089|124243876|Female|Tumors of the Meninges|2017
20+|0.2|0.2|0.2|Malignant|250|124243876|Female|Tumors of the Meninges|2017
20+|19.6|19.8|19.7|Benign/Borderline|141531|616718331|Female|Tumors of the Meninges|2017-2021
20+|0.2|0.2|0.2|Malignant|1157|616718331|Female|Tumors of the Meninges|2017-2021
20+|19.5|20.0|19.8|Benign/Borderline|28612|125090257|Female|Tumors of the Meninges|2018
20+|0.1|0.2|0.2|Malignant|232|125090257|Female|Tumors of the Meninges|2018
20+|20.4|20.9|20.6|Benign/Borderline|30287|125886169|Female|Tumors of the Meninges|2019
20+|0.1|0.2|0.1|Malignant|212|125886169|Female|Tumors of the Meninges|2019
20+|18.2|18.7|18.5|Benign/Borderline|26912|124127412|Female|Tumors of the Meninges|2020
20+|0.1|0.2|0.2|Malignant|224|124127412|Female|Tumors of the Meninges|2020
20+|19.3|19.8|19.5|Benign/Borderline|28946|124936720|Female|Tumors of the Meninges|2021
20+|0.1|0.2|0.2|Malignant|243|124936720|Female|Tumors of the Meninges|2021
20+|0.8|0.9|0.8|Benign/Borderline|943|109112165|Female|Unclassified Tumors|2004
20+|0.5|0.6|0.6|Malignant|691|109112165|Female|Unclassified Tumors|2004
20+|0.9|1.1|1.0|Benign/Borderline|1159|110320645|Female|Unclassified Tumors|2005
20+|0.5|0.6|0.6|Malignant|719|110320645|Female|Unclassified Tumors|2005
20+|0.9|1.0|1.0|Benign/Borderline|1137|111567226|Female|Unclassified Tumors|2006
20+|0.5|0.6|0.6|Malignant|726|111567226|Female|Unclassified Tumors|2006
20+|1.0|1.1|1.0|Benign/Borderline|1227|112783993|Female|Unclassified Tumors|2007
20+|0.5|0.5|0.5|Malignant|652|112783993|Female|Unclassified Tumors|2007
20+|1.0|1.2|1.1|Benign/Borderline|1324|114027722|Female|Unclassified Tumors|2008
20+|0.5|0.6|0.6|Malignant|766|114027722|Female|Unclassified Tumors|2008
20+|1.1|1.3|1.2|Benign/Borderline|1466|115293599|Female|Unclassified Tumors|2009
20+|0.5|0.6|0.6|Malignant|789|115293599|Female|Unclassified Tumors|2009
20+|1.2|1.3|1.2|Benign/Borderline|1509|116598241|Female|Unclassified Tumors|2010
20+|0.4|0.5|0.5|Malignant|651|116598241|Female|Unclassified Tumors|2010
20+|1.2|1.4|1.3|Benign/Borderline|1585|117817623|Female|Unclassified Tumors|2011
20+|0.4|0.5|0.5|Malignant|656|117817623|Female|Unclassified Tumors|2011
20+|1.2|1.3|1.3|Benign/Borderline|1622|119004221|Female|Unclassified Tumors|2012
20+|0.4|0.5|0.5|Malignant|661|119004221|Female|Unclassified Tumors|2012
20+|1.2|1.3|1.2|Benign/Borderline|1558|120085013|Female|Unclassified Tumors|2013
20+|0.4|0.5|0.5|Malignant|671|120085013|Female|Unclassified Tumors|2013
20+|1.2|1.3|1.2|Benign/Borderline|1593|121202956|Female|Unclassified Tumors|2014
20+|0.5|0.5|0.5|Malignant|754|121202956|Female|Unclassified Tumors|2014
20+|1.1|1.2|1.1|Benign/Borderline|1493|122262894|Female|Unclassified Tumors|2015
20+|0.5|0.5|0.5|Malignant|749|122262894|Female|Unclassified Tumors|2015
20+|1.0|1.1|1.1|Benign/Borderline|1410|123298060|Female|Unclassified Tumors|2016
20+|0.4|0.5|0.4|Malignant|633|123298060|Female|Unclassified Tumors|2016
20+|0.9|1.1|1.0|Benign/Borderline|1336|124243876|Female|Unclassified Tumors|2017
20+|0.4|0.5|0.4|Malignant|696|124243876|Female|Unclassified Tumors|2017
20+|0.9|0.9|0.9|Benign/Borderline|6132|616718331|Female|Unclassified Tumors|2017-2021
20+|0.4|0.5|0.5|Malignant|3492|616718331|Female|Unclassified Tumors|2017-2021
20+|0.9|1.0|1.0|Benign/Borderline|1324|125090257|Female|Unclassified Tumors|2018
20+|0.4|0.5|0.5|Malignant|700|125090257|Female|Unclassified Tumors|2018
20+|0.8|0.9|0.9|Benign/Borderline|1196|125886169|Female|Unclassified Tumors|2019
20+|0.4|0.5|0.5|Malignant|724|125886169|Female|Unclassified Tumors|2019
20+|0.9|1.0|0.9|Benign/Borderline|1228|124127412|Female|Unclassified Tumors|2020
20+|0.5|0.5|0.5|Malignant|767|124127412|Female|Unclassified Tumors|2020
20+|0.7|0.8|0.8|Benign/Borderline|1090|124936720|Female|Unclassified Tumors|2021
20+|0.4|0.4|0.4|Malignant|642|124936720|Female|Unclassified Tumors|2021
20+|0.0|0.1|0.0|Benign/Borderline|54|109112165|Female|Unique astrocytoma variants|2004
20+|0.0|0.0|0.0|Malignant|18|109112165|Female|Unique astrocytoma variants|2004
20+|0.0|0.1|0.0|Benign/Borderline|43|110320645|Female|Unique astrocytoma variants|2005
20+|0.0|0.0|0.0|Malignant|23|110320645|Female|Unique astrocytoma variants|2005
20+|0.0|0.1|0.0|Benign/Borderline|50|111567226|Female|Unique astrocytoma variants|2006
20+|0.0|0.0|0.0|Malignant|24|111567226|Female|Unique astrocytoma variants|2006
20+|0.0|0.1|0.1|Benign/Borderline|63|112783993|Female|Unique astrocytoma variants|2007
20+|0.0|0.0|0.0|Malignant|20|112783993|Female|Unique astrocytoma variants|2007
20+|0.0|0.1|0.1|Benign/Borderline|62|114027722|Female|Unique astrocytoma variants|2008
20+|0.0|0.0|0.0|Malignant|22|114027722|Female|Unique astrocytoma variants|2008
20+|0.1|0.1|0.1|Benign/Borderline|76|115293599|Female|Unique astrocytoma variants|2009
20+|0.0|0.0|0.0|Malignant|29|115293599|Female|Unique astrocytoma variants|2009
20+|0.0|0.1|0.1|Benign/Borderline|73|116598241|Female|Unique astrocytoma variants|2010
20+|0.0|0.0|0.0|Malignant|20|116598241|Female|Unique astrocytoma variants|2010
20+|0.1|0.1|0.1|Benign/Borderline|81|117817623|Female|Unique astrocytoma variants|2011
20+|0.0|0.0|0.0|Malignant|31|117817623|Female|Unique astrocytoma variants|2011
20+|0.1|0.1|0.1|Benign/Borderline|104|119004221|Female|Unique astrocytoma variants|2012
20+|0.0|0.0|0.0|Malignant|32|119004221|Female|Unique astrocytoma variants|2012
20+|0.1|0.1|0.1|Benign/Borderline|100|120085013|Female|Unique astrocytoma variants|2013
20+|0.0|0.0|0.0|Malignant|30|120085013|Female|Unique astrocytoma variants|2013
20+|0.1|0.1|0.1|Benign/Borderline|102|121202956|Female|Unique astrocytoma variants|2014
20+|0.0|0.0|0.0|Malignant|39|121202956|Female|Unique astrocytoma variants|2014
20+|0.1|0.1|0.1|Benign/Borderline|112|122262894|Female|Unique astrocytoma variants|2015
20+|0.0|0.0|0.0|Malignant|24|122262894|Female|Unique astrocytoma variants|2015
20+|0.1|0.1|0.1|Benign/Borderline|119|123298060|Female|Unique astrocytoma variants|2016
20+|0.0|0.0|0.0|Malignant|37|123298060|Female|Unique astrocytoma variants|2016
20+|0.1|0.1|0.1|Benign/Borderline|104|124243876|Female|Unique astrocytoma variants|2017
20+|0.0|0.0|0.0|Malignant|30|124243876|Female|Unique astrocytoma variants|2017
20+|0.1|0.1|0.1|Benign/Borderline|559|616718331|Female|Unique astrocytoma variants|2017-2021
20+|0.0|0.0|0.0|Malignant|129|616718331|Female|Unique astrocytoma variants|2017-2021
20+|0.1|0.1|0.1|Benign/Borderline|111|125090257|Female|Unique astrocytoma variants|2018
20+|0.0|0.0|0.0|Malignant|33|125090257|Female|Unique astrocytoma variants|2018
20+|0.1|0.1|0.1|Benign/Borderline|128|125886169|Female|Unique astrocytoma variants|2019
20+|0.0|0.0|0.0|Malignant|28|125886169|Female|Unique astrocytoma variants|2019
20+|0.1|0.1|0.1|Benign/Borderline|101|124127412|Female|Unique astrocytoma variants|2020
20+|0.0|0.0|0.0|Malignant|23|124127412|Female|Unique astrocytoma variants|2020
20+|0.1|0.1|0.1|Benign/Borderline|118|124936720|Female|Unique astrocytoma variants|2021
20+|0.0|0.0|0.0|Malignant|18|124936720|Female|Unique astrocytoma variants|2021
20+|~|~|~|Benign/Borderline|~|101938779|Male|All other|2004
20+|~|~|~|Malignant|~|101938779|Male|All other|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|All other|2005
20+|~|~|~|Malignant|~|103190694|Male|All other|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|All other|2006
20+|~|~|~|Malignant|~|104488268|Male|All other|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|All other|2007
20+|~|~|~|Malignant|~|105697783|Male|All other|2007
20+|0.0|0.0|0.0|Benign/Borderline|22|106947980|Male|All other|2008
20+|~|~|~|Malignant|~|106947980|Male|All other|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|All other|2009
20+|~|~|~|Malignant|~|108197539|Male|All other|2009
20+|~|~|~|Benign/Borderline|~|109565056|Male|All other|2010
20+|~|~|~|Malignant|~|109565056|Male|All other|2010
20+|0.0|0.0|0.0|Benign/Borderline|17|111031677|Male|All other|2011
20+|0.0|0.0|0.0|Malignant|23|111031677|Male|All other|2011
20+|~|~|~|Benign/Borderline|~|112556171|Male|All other|2012
20+|0.0|0.0|0.0|Malignant|20|112556171|Male|All other|2012
20+|0.0|0.0|0.0|Benign/Borderline|19|113963637|Male|All other|2013
20+|0.0|0.0|0.0|Malignant|28|113963637|Male|All other|2013
20+|~|~|~|Benign/Borderline|~|115373558|Male|All other|2014
20+|0.0|0.0|0.0|Malignant|27|115373558|Male|All other|2014
20+|0.0|0.0|0.0|Benign/Borderline|26|116752460|Male|All other|2015
20+|0.0|0.0|0.0|Malignant|26|116752460|Male|All other|2015
20+|0.0|0.1|0.0|Benign/Borderline|49|118061478|Male|All other|2016
20+|0.0|0.0|0.0|Malignant|27|118061478|Male|All other|2016
20+|0.0|0.1|0.0|Benign/Borderline|42|119249602|Male|All other|2017
20+|0.0|0.0|0.0|Malignant|25|119249602|Male|All other|2017
20+|0.0|0.0|0.0|Benign/Borderline|213|594041481|Male|All other|2017-2021
20+|0.2|0.2|0.2|Malignant|1073|594041481|Male|All other|2017-2021
20+|0.0|0.1|0.0|Benign/Borderline|44|120324107|Male|All other|2018
20+|0.2|0.2|0.2|Malignant|225|120324107|Male|All other|2018
20+|0.0|0.0|0.0|Benign/Borderline|41|121349512|Male|All other|2019
20+|0.2|0.3|0.2|Malignant|292|121349512|Male|All other|2019
20+|0.0|0.0|0.0|Benign/Borderline|40|119846062|Male|All other|2020
20+|0.2|0.3|0.2|Malignant|293|119846062|Male|All other|2020
20+|0.0|0.1|0.0|Benign/Borderline|49|120541161|Male|All other|2021
20+|0.2|0.2|0.2|Malignant|252|120541161|Male|All other|2021
20+|~|~|~|Benign/Borderline|~|101938779|Male|Anaplastic astrocytoma|2004
20+|0.6|0.7|0.7|Malignant|677|101938779|Male|Anaplastic astrocytoma|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Anaplastic astrocytoma|2005
20+|0.6|0.7|0.7|Malignant|701|103190694|Male|Anaplastic astrocytoma|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Anaplastic astrocytoma|2006
20+|0.6|0.7|0.7|Malignant|702|104488268|Male|Anaplastic astrocytoma|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Anaplastic astrocytoma|2007
20+|0.6|0.7|0.6|Malignant|674|105697783|Male|Anaplastic astrocytoma|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Anaplastic astrocytoma|2008
20+|0.6|0.7|0.7|Malignant|709|106947980|Male|Anaplastic astrocytoma|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Anaplastic astrocytoma|2009
20+|0.6|0.7|0.7|Malignant|716|108197539|Male|Anaplastic astrocytoma|2009
20+|~|~|~|Benign/Borderline|~|109565056|Male|Anaplastic astrocytoma|2010
20+|0.6|0.7|0.7|Malignant|711|109565056|Male|Anaplastic astrocytoma|2010
20+|~|~|~|Benign/Borderline|~|111031677|Male|Anaplastic astrocytoma|2011
20+|0.6|0.7|0.6|Malignant|710|111031677|Male|Anaplastic astrocytoma|2011
20+|~|~|~|Benign/Borderline|~|112556171|Male|Anaplastic astrocytoma|2012
20+|0.6|0.7|0.7|Malignant|748|112556171|Male|Anaplastic astrocytoma|2012
20+|~|~|~|Benign/Borderline|~|113963637|Male|Anaplastic astrocytoma|2013
20+|0.6|0.7|0.7|Malignant|801|113963637|Male|Anaplastic astrocytoma|2013
20+|~|~|~|Benign/Borderline|~|115373558|Male|Anaplastic astrocytoma|2014
20+|0.6|0.7|0.7|Malignant|799|115373558|Male|Anaplastic astrocytoma|2014
20+|~|~|~|Benign/Borderline|~|116752460|Male|Anaplastic astrocytoma|2015
20+|0.6|0.7|0.7|Malignant|784|116752460|Male|Anaplastic astrocytoma|2015
20+|~|~|~|Benign/Borderline|~|118061478|Male|Anaplastic astrocytoma|2016
20+|0.6|0.7|0.7|Malignant|836|118061478|Male|Anaplastic astrocytoma|2016
20+|~|~|~|Benign/Borderline|~|119249602|Male|Anaplastic astrocytoma|2017
20+|0.6|0.7|0.7|Malignant|788|119249602|Male|Anaplastic astrocytoma|2017
20+|~|~|~|Benign/Borderline|~|594041481|Male|Anaplastic astrocytoma|2017-2021
20+|0.5|0.6|0.6|Malignant|3364|594041481|Male|Anaplastic astrocytoma|2017-2021
20+|~|~|~|Benign/Borderline|~|120324107|Male|Anaplastic astrocytoma|2018
20+|0.6|0.7|0.7|Malignant|812|120324107|Male|Anaplastic astrocytoma|2018
20+|~|~|~|Benign/Borderline|~|121349512|Male|Anaplastic astrocytoma|2019
20+|0.5|0.6|0.6|Malignant|720|121349512|Male|Anaplastic astrocytoma|2019
20+|~|~|~|Benign/Borderline|~|119846062|Male|Anaplastic astrocytoma|2020
20+|0.5|0.6|0.5|Malignant|644|119846062|Male|Anaplastic astrocytoma|2020
20+|~|~|~|Benign/Borderline|~|120541161|Male|Anaplastic astrocytoma|2021
20+|0.3|0.4|0.4|Malignant|447|120541161|Male|Anaplastic astrocytoma|2021
20+|~|~|~|Benign/Borderline|~|101938779|Male|Anaplastic oligodendroglioma|2004
20+|0.2|0.2|0.2|Malignant|213|101938779|Male|Anaplastic oligodendroglioma|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Anaplastic oligodendroglioma|2005
20+|0.2|0.2|0.2|Malignant|213|103190694|Male|Anaplastic oligodendroglioma|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Anaplastic oligodendroglioma|2006
20+|0.2|0.2|0.2|Malignant|215|104488268|Male|Anaplastic oligodendroglioma|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Anaplastic oligodendroglioma|2007
20+|0.2|0.2|0.2|Malignant|190|105697783|Male|Anaplastic oligodendroglioma|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Anaplastic oligodendroglioma|2008
20+|0.2|0.2|0.2|Malignant|190|106947980|Male|Anaplastic oligodendroglioma|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Anaplastic oligodendroglioma|2009
20+|0.2|0.2|0.2|Malignant|192|108197539|Male|Anaplastic oligodendroglioma|2009
20+|~|~|~|Benign/Borderline|~|109565056|Male|Anaplastic oligodendroglioma|2010
20+|0.2|0.2|0.2|Malignant|194|109565056|Male|Anaplastic oligodendroglioma|2010
20+|~|~|~|Benign/Borderline|~|111031677|Male|Anaplastic oligodendroglioma|2011
20+|0.1|0.2|0.2|Malignant|189|111031677|Male|Anaplastic oligodendroglioma|2011
20+|~|~|~|Benign/Borderline|~|112556171|Male|Anaplastic oligodendroglioma|2012
20+|0.1|0.2|0.2|Malignant|190|112556171|Male|Anaplastic oligodendroglioma|2012
20+|~|~|~|Benign/Borderline|~|113963637|Male|Anaplastic oligodendroglioma|2013
20+|0.2|0.2|0.2|Malignant|223|113963637|Male|Anaplastic oligodendroglioma|2013
20+|~|~|~|Benign/Borderline|~|115373558|Male|Anaplastic oligodendroglioma|2014
20+|0.2|0.2|0.2|Malignant|209|115373558|Male|Anaplastic oligodendroglioma|2014
20+|~|~|~|Benign/Borderline|~|116752460|Male|Anaplastic oligodendroglioma|2015
20+|0.1|0.2|0.2|Malignant|193|116752460|Male|Anaplastic oligodendroglioma|2015
20+|~|~|~|Benign/Borderline|~|118061478|Male|Anaplastic oligodendroglioma|2016
20+|0.2|0.2|0.2|Malignant|202|118061478|Male|Anaplastic oligodendroglioma|2016
20+|~|~|~|Benign/Borderline|~|119249602|Male|Anaplastic oligodendroglioma|2017
20+|0.2|0.2|0.2|Malignant|236|119249602|Male|Anaplastic oligodendroglioma|2017
20+|~|~|~|Benign/Borderline|~|594041481|Male|Anaplastic oligodendroglioma|2017-2021
20+|0.2|0.2|0.2|Malignant|984|594041481|Male|Anaplastic oligodendroglioma|2017-2021
20+|~|~|~|Benign/Borderline|~|120324107|Male|Anaplastic oligodendroglioma|2018
20+|0.1|0.2|0.2|Malignant|189|120324107|Male|Anaplastic oligodendroglioma|2018
20+|~|~|~|Benign/Borderline|~|121349512|Male|Anaplastic oligodendroglioma|2019
20+|0.2|0.2|0.2|Malignant|220|121349512|Male|Anaplastic oligodendroglioma|2019
20+|~|~|~|Benign/Borderline|~|119846062|Male|Anaplastic oligodendroglioma|2020
20+|0.1|0.2|0.2|Malignant|193|119846062|Male|Anaplastic oligodendroglioma|2020
20+|~|~|~|Benign/Borderline|~|120541161|Male|Anaplastic oligodendroglioma|2021
20+|0.1|0.2|0.1|Malignant|153|120541161|Male|Anaplastic oligodendroglioma|2021
20+|~|~|~|Benign/Borderline|~|101938779|Male|Astrocytoma, NOS|2004
20+|0.6|0.7|0.6|Malignant|635|101938779|Male|Astrocytoma, NOS|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Astrocytoma, NOS|2005
20+|0.6|0.7|0.6|Malignant|636|103190694|Male|Astrocytoma, NOS|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Astrocytoma, NOS|2006
20+|0.6|0.7|0.6|Malignant|645|104488268|Male|Astrocytoma, NOS|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Astrocytoma, NOS|2007
20+|0.6|0.7|0.6|Malignant|629|105697783|Male|Astrocytoma, NOS|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Astrocytoma, NOS|2008
20+|0.5|0.6|0.6|Malignant|629|106947980|Male|Astrocytoma, NOS|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Astrocytoma, NOS|2009
20+|0.5|0.6|0.5|Malignant|577|108197539|Male|Astrocytoma, NOS|2009
20+|~|~|~|Benign/Borderline|~|109565056|Male|Astrocytoma, NOS|2010
20+|0.5|0.6|0.6|Malignant|622|109565056|Male|Astrocytoma, NOS|2010
20+|~|~|~|Benign/Borderline|~|111031677|Male|Astrocytoma, NOS|2011
20+|0.5|0.6|0.5|Malignant|585|111031677|Male|Astrocytoma, NOS|2011
20+|~|~|~|Benign/Borderline|~|112556171|Male|Astrocytoma, NOS|2012
20+|0.5|0.5|0.5|Malignant|565|112556171|Male|Astrocytoma, NOS|2012
20+|~|~|~|Benign/Borderline|~|113963637|Male|Astrocytoma, NOS|2013
20+|0.5|0.5|0.5|Malignant|572|113963637|Male|Astrocytoma, NOS|2013
20+|~|~|~|Benign/Borderline|~|115373558|Male|Astrocytoma, NOS|2014
20+|0.5|0.6|0.5|Malignant|604|115373558|Male|Astrocytoma, NOS|2014
20+|~|~|~|Benign/Borderline|~|116752460|Male|Astrocytoma, NOS|2015
20+|0.6|0.6|0.6|Malignant|698|116752460|Male|Astrocytoma, NOS|2015
20+|~|~|~|Benign/Borderline|~|118061478|Male|Astrocytoma, NOS|2016
20+|0.5|0.6|0.6|Malignant|703|118061478|Male|Astrocytoma, NOS|2016
20+|~|~|~|Benign/Borderline|~|119249602|Male|Astrocytoma, NOS|2017
20+|0.5|0.6|0.6|Malignant|706|119249602|Male|Astrocytoma, NOS|2017
20+|~|~|~|Benign/Borderline|~|594041481|Male|Astrocytoma, NOS|2017-2021
20+|0.6|0.6|0.6|Malignant|3585|594041481|Male|Astrocytoma, NOS|2017-2021
20+|~|~|~|Benign/Borderline|~|120324107|Male|Astrocytoma, NOS|2018
20+|0.5|0.6|0.6|Malignant|705|120324107|Male|Astrocytoma, NOS|2018
20+|~|~|~|Benign/Borderline|~|121349512|Male|Astrocytoma, NOS|2019
20+|0.5|0.6|0.6|Malignant|710|121349512|Male|Astrocytoma, NOS|2019
20+|~|~|~|Benign/Borderline|~|119846062|Male|Astrocytoma, NOS|2020
20+|0.5|0.6|0.6|Malignant|697|119846062|Male|Astrocytoma, NOS|2020
20+|~|~|~|Benign/Borderline|~|120541161|Male|Astrocytoma, NOS|2021
20+|0.6|0.7|0.7|Malignant|813|120541161|Male|Astrocytoma, NOS|2021
20+|0.0|0.0|0.0|Benign/Borderline|26|101938779|Male|Choroid plexus|2004
20+|~|~|~|Malignant|~|101938779|Male|Choroid plexus|2004
20+|0.0|0.1|0.0|Benign/Borderline|37|103190694|Male|Choroid plexus|2005
20+|~|~|~|Malignant|~|103190694|Male|Choroid plexus|2005
20+|0.0|0.0|0.0|Benign/Borderline|26|104488268|Male|Choroid plexus|2006
20+|~|~|~|Malignant|~|104488268|Male|Choroid plexus|2006
20+|0.0|0.0|0.0|Benign/Borderline|35|105697783|Male|Choroid plexus|2007
20+|~|~|~|Malignant|~|105697783|Male|Choroid plexus|2007
20+|0.0|0.0|0.0|Benign/Borderline|28|106947980|Male|Choroid plexus|2008
20+|~|~|~|Malignant|~|106947980|Male|Choroid plexus|2008
20+|0.0|0.0|0.0|Benign/Borderline|28|108197539|Male|Choroid plexus|2009
20+|~|~|~|Malignant|~|108197539|Male|Choroid plexus|2009
20+|0.0|0.0|0.0|Benign/Borderline|36|109565056|Male|Choroid plexus|2010
20+|~|~|~|Malignant|~|109565056|Male|Choroid plexus|2010
20+|0.0|0.0|0.0|Benign/Borderline|32|111031677|Male|Choroid plexus|2011
20+|~|~|~|Malignant|~|111031677|Male|Choroid plexus|2011
20+|0.0|0.0|0.0|Benign/Borderline|36|112556171|Male|Choroid plexus|2012
20+|~|~|~|Malignant|~|112556171|Male|Choroid plexus|2012
20+|0.0|0.0|0.0|Benign/Borderline|31|113963637|Male|Choroid plexus|2013
20+|~|~|~|Malignant|~|113963637|Male|Choroid plexus|2013
20+|0.0|0.0|0.0|Benign/Borderline|41|115373558|Male|Choroid plexus|2014
20+|~|~|~|Malignant|~|115373558|Male|Choroid plexus|2014
20+|0.0|0.0|0.0|Benign/Borderline|38|116752460|Male|Choroid plexus|2015
20+|~|~|~|Malignant|~|116752460|Male|Choroid plexus|2015
20+|0.0|0.0|0.0|Benign/Borderline|31|118061478|Male|Choroid plexus|2016
20+|~|~|~|Malignant|~|118061478|Male|Choroid plexus|2016
20+|0.0|0.1|0.0|Benign/Borderline|52|119249602|Male|Choroid plexus|2017
20+|~|~|~|Malignant|~|119249602|Male|Choroid plexus|2017
20+|0.0|0.0|0.0|Benign/Borderline|170|594041481|Male|Choroid plexus|2017-2021
20+|0.0|0.0|0.0|Malignant|17|594041481|Male|Choroid plexus|2017-2021
20+|0.0|0.0|0.0|Benign/Borderline|24|120324107|Male|Choroid plexus|2018
20+|~|~|~|Malignant|~|120324107|Male|Choroid plexus|2018
20+|0.0|0.0|0.0|Benign/Borderline|33|121349512|Male|Choroid plexus|2019
20+|~|~|~|Malignant|~|121349512|Male|Choroid plexus|2019
20+|0.0|0.0|0.0|Benign/Borderline|27|119846062|Male|Choroid plexus|2020
20+|~|~|~|Malignant|~|119846062|Male|Choroid plexus|2020
20+|0.0|0.0|0.0|Benign/Borderline|35|120541161|Male|Choroid plexus|2021
20+|~|~|~|Malignant|~|120541161|Male|Choroid plexus|2021
20+|0.2|0.2|0.2|Benign/Borderline|188|101938779|Male|Craniopharyngioma|2004
20+|~|~|~|Malignant|~|101938779|Male|Craniopharyngioma|2004
20+|0.2|0.3|0.2|Benign/Borderline|234|103190694|Male|Craniopharyngioma|2005
20+|~|~|~|Malignant|~|103190694|Male|Craniopharyngioma|2005
20+|0.2|0.2|0.2|Benign/Borderline|193|104488268|Male|Craniopharyngioma|2006
20+|~|~|~|Malignant|~|104488268|Male|Craniopharyngioma|2006
20+|0.2|0.2|0.2|Benign/Borderline|202|105697783|Male|Craniopharyngioma|2007
20+|~|~|~|Malignant|~|105697783|Male|Craniopharyngioma|2007
20+|0.2|0.2|0.2|Benign/Borderline|199|106947980|Male|Craniopharyngioma|2008
20+|~|~|~|Malignant|~|106947980|Male|Craniopharyngioma|2008
20+|0.2|0.2|0.2|Benign/Borderline|201|108197539|Male|Craniopharyngioma|2009
20+|~|~|~|Malignant|~|108197539|Male|Craniopharyngioma|2009
20+|0.2|0.2|0.2|Benign/Borderline|202|109565056|Male|Craniopharyngioma|2010
20+|~|~|~|Malignant|~|109565056|Male|Craniopharyngioma|2010
20+|0.1|0.2|0.2|Benign/Borderline|197|111031677|Male|Craniopharyngioma|2011
20+|~|~|~|Malignant|~|111031677|Male|Craniopharyngioma|2011
20+|0.2|0.2|0.2|Benign/Borderline|217|112556171|Male|Craniopharyngioma|2012
20+|~|~|~|Malignant|~|112556171|Male|Craniopharyngioma|2012
20+|0.2|0.2|0.2|Benign/Borderline|236|113963637|Male|Craniopharyngioma|2013
20+|~|~|~|Malignant|~|113963637|Male|Craniopharyngioma|2013
20+|0.2|0.2|0.2|Benign/Borderline|213|115373558|Male|Craniopharyngioma|2014
20+|~|~|~|Malignant|~|115373558|Male|Craniopharyngioma|2014
20+|0.2|0.2|0.2|Benign/Borderline|227|116752460|Male|Craniopharyngioma|2015
20+|~|~|~|Malignant|~|116752460|Male|Craniopharyngioma|2015
20+|0.2|0.2|0.2|Benign/Borderline|250|118061478|Male|Craniopharyngioma|2016
20+|~|~|~|Malignant|~|118061478|Male|Craniopharyngioma|2016
20+|0.2|0.2|0.2|Benign/Borderline|246|119249602|Male|Craniopharyngioma|2017
20+|~|~|~|Malignant|~|119249602|Male|Craniopharyngioma|2017
20+|0.2|0.2|0.2|Benign/Borderline|1160|594041481|Male|Craniopharyngioma|2017-2021
20+|~|~|~|Malignant|~|594041481|Male|Craniopharyngioma|2017-2021
20+|0.2|0.2|0.2|Benign/Borderline|229|120324107|Male|Craniopharyngioma|2018
20+|~|~|~|Malignant|~|120324107|Male|Craniopharyngioma|2018
20+|0.2|0.2|0.2|Benign/Borderline|245|121349512|Male|Craniopharyngioma|2019
20+|~|~|~|Malignant|~|121349512|Male|Craniopharyngioma|2019
20+|0.2|0.2|0.2|Benign/Borderline|229|119846062|Male|Craniopharyngioma|2020
20+|~|~|~|Malignant|~|119846062|Male|Craniopharyngioma|2020
20+|0.2|0.2|0.2|Benign/Borderline|220|120541161|Male|Craniopharyngioma|2021
20+|~|~|~|Malignant|~|120541161|Male|Craniopharyngioma|2021
20+|~|~|~|Benign/Borderline|~|101938779|Male|Diffuse astrocytoma|2004
20+|0.1|0.2|0.1|Malignant|146|101938779|Male|Diffuse astrocytoma|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Diffuse astrocytoma|2005
20+|0.1|0.2|0.1|Malignant|149|103190694|Male|Diffuse astrocytoma|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Diffuse astrocytoma|2006
20+|0.2|0.2|0.2|Malignant|200|104488268|Male|Diffuse astrocytoma|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Diffuse astrocytoma|2007
20+|0.2|0.2|0.2|Malignant|185|105697783|Male|Diffuse astrocytoma|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Diffuse astrocytoma|2008
20+|0.2|0.2|0.2|Malignant|210|106947980|Male|Diffuse astrocytoma|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Diffuse astrocytoma|2009
20+|0.2|0.2|0.2|Malignant|207|108197539|Male|Diffuse astrocytoma|2009
20+|~|~|~|Benign/Borderline|~|109565056|Male|Diffuse astrocytoma|2010
20+|0.1|0.2|0.2|Malignant|186|109565056|Male|Diffuse astrocytoma|2010
20+|~|~|~|Benign/Borderline|~|111031677|Male|Diffuse astrocytoma|2011
20+|0.1|0.1|0.1|Malignant|136|111031677|Male|Diffuse astrocytoma|2011
20+|~|~|~|Benign/Borderline|~|112556171|Male|Diffuse astrocytoma|2012
20+|0.1|0.1|0.1|Malignant|113|112556171|Male|Diffuse astrocytoma|2012
20+|~|~|~|Benign/Borderline|~|113963637|Male|Diffuse astrocytoma|2013
20+|0.1|0.1|0.1|Malignant|103|113963637|Male|Diffuse astrocytoma|2013
20+|~|~|~|Benign/Borderline|~|115373558|Male|Diffuse astrocytoma|2014
20+|0.0|0.1|0.1|Malignant|69|115373558|Male|Diffuse astrocytoma|2014
20+|~|~|~|Benign/Borderline|~|116752460|Male|Diffuse astrocytoma|2015
20+|0.0|0.1|0.0|Malignant|49|116752460|Male|Diffuse astrocytoma|2015
20+|~|~|~|Benign/Borderline|~|118061478|Male|Diffuse astrocytoma|2016
20+|0.0|0.0|0.0|Malignant|23|118061478|Male|Diffuse astrocytoma|2016
20+|~|~|~|Benign/Borderline|~|119249602|Male|Diffuse astrocytoma|2017
20+|~|~|~|Malignant|~|119249602|Male|Diffuse astrocytoma|2017
20+|~|~|~|Benign/Borderline|~|594041481|Male|Diffuse astrocytoma|2017-2021
20+|0.0|0.0|0.0|Malignant|42|594041481|Male|Diffuse astrocytoma|2017-2021
20+|~|~|~|Benign/Borderline|~|120324107|Male|Diffuse astrocytoma|2018
20+|~|~|~|Malignant|~|120324107|Male|Diffuse astrocytoma|2018
20+|~|~|~|Benign/Borderline|~|121349512|Male|Diffuse astrocytoma|2019
20+|~|~|~|Malignant|~|121349512|Male|Diffuse astrocytoma|2019
20+|~|~|~|Benign/Borderline|~|119846062|Male|Diffuse astrocytoma|2020
20+|~|~|~|Malignant|~|119846062|Male|Diffuse astrocytoma|2020
20+|~|~|~|Benign/Borderline|~|120541161|Male|Diffuse astrocytoma|2021
20+|~|~|~|Malignant|~|120541161|Male|Diffuse astrocytoma|2021
20+|~|~|~|Benign/Borderline|~|101938779|Male|Embryonal/primitive/medulloblastoma|2004
20+|0.1|0.1|0.1|Malignant|97|101938779|Male|Embryonal/primitive/medulloblastoma|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Embryonal/primitive/medulloblastoma|2005
20+|0.1|0.1|0.1|Malignant|105|103190694|Male|Embryonal/primitive/medulloblastoma|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Embryonal/primitive/medulloblastoma|2006
20+|0.1|0.1|0.1|Malignant|97|104488268|Male|Embryonal/primitive/medulloblastoma|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Embryonal/primitive/medulloblastoma|2007
20+|0.1|0.1|0.1|Malignant|124|105697783|Male|Embryonal/primitive/medulloblastoma|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Embryonal/primitive/medulloblastoma|2008
20+|0.1|0.1|0.1|Malignant|124|106947980|Male|Embryonal/primitive/medulloblastoma|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Embryonal/primitive/medulloblastoma|2009
20+|0.1|0.1|0.1|Malignant|132|108197539|Male|Embryonal/primitive/medulloblastoma|2009
20+|~|~|~|Benign/Borderline|~|109565056|Male|Embryonal/primitive/medulloblastoma|2010
20+|0.1|0.1|0.1|Malignant|126|109565056|Male|Embryonal/primitive/medulloblastoma|2010
20+|~|~|~|Benign/Borderline|~|111031677|Male|Embryonal/primitive/medulloblastoma|2011
20+|0.1|0.1|0.1|Malignant|115|111031677|Male|Embryonal/primitive/medulloblastoma|2011
20+|~|~|~|Benign/Borderline|~|112556171|Male|Embryonal/primitive/medulloblastoma|2012
20+|0.1|0.1|0.1|Malignant|93|112556171|Male|Embryonal/primitive/medulloblastoma|2012
20+|~|~|~|Benign/Borderline|~|113963637|Male|Embryonal/primitive/medulloblastoma|2013
20+|0.1|0.1|0.1|Malignant|97|113963637|Male|Embryonal/primitive/medulloblastoma|2013
20+|~|~|~|Benign/Borderline|~|115373558|Male|Embryonal/primitive/medulloblastoma|2014
20+|0.1|0.1|0.1|Malignant|107|115373558|Male|Embryonal/primitive/medulloblastoma|2014
20+|~|~|~|Benign/Borderline|~|116752460|Male|Embryonal/primitive/medulloblastoma|2015
20+|0.1|0.1|0.1|Malignant|101|116752460|Male|Embryonal/primitive/medulloblastoma|2015
20+|~|~|~|Benign/Borderline|~|118061478|Male|Embryonal/primitive/medulloblastoma|2016
20+|0.1|0.1|0.1|Malignant|119|118061478|Male|Embryonal/primitive/medulloblastoma|2016
20+|~|~|~|Benign/Borderline|~|119249602|Male|Embryonal/primitive/medulloblastoma|2017
20+|0.1|0.1|0.1|Malignant|99|119249602|Male|Embryonal/primitive/medulloblastoma|2017
20+|~|~|~|Benign/Borderline|~|594041481|Male|Embryonal/primitive/medulloblastoma|2017-2021
20+|0.1|0.1|0.1|Malignant|401|594041481|Male|Embryonal/primitive/medulloblastoma|2017-2021
20+|~|~|~|Benign/Borderline|~|120324107|Male|Embryonal/primitive/medulloblastoma|2018
20+|0.1|0.1|0.1|Malignant|85|120324107|Male|Embryonal/primitive/medulloblastoma|2018
20+|~|~|~|Benign/Borderline|~|121349512|Male|Embryonal/primitive/medulloblastoma|2019
20+|0.1|0.1|0.1|Malignant|81|121349512|Male|Embryonal/primitive/medulloblastoma|2019
20+|~|~|~|Benign/Borderline|~|119846062|Male|Embryonal/primitive/medulloblastoma|2020
20+|0.0|0.1|0.1|Malignant|66|119846062|Male|Embryonal/primitive/medulloblastoma|2020
20+|~|~|~|Benign/Borderline|~|120541161|Male|Embryonal/primitive/medulloblastoma|2021
20+|0.1|0.1|0.1|Malignant|75|120541161|Male|Embryonal/primitive/medulloblastoma|2021
20+|0.1|0.2|0.1|Benign/Borderline|142|101938779|Male|Ependymoma variants|2004
20+|~|~|~|Malignant|~|101938779|Male|Ependymoma variants|2004
20+|0.1|0.2|0.1|Benign/Borderline|151|103190694|Male|Ependymoma variants|2005
20+|~|~|~|Malignant|~|103190694|Male|Ependymoma variants|2005
20+|0.1|0.2|0.2|Benign/Borderline|163|104488268|Male|Ependymoma variants|2006
20+|~|~|~|Malignant|~|104488268|Male|Ependymoma variants|2006
20+|0.1|0.1|0.1|Benign/Borderline|137|105697783|Male|Ependymoma variants|2007
20+|~|~|~|Malignant|~|105697783|Male|Ependymoma variants|2007
20+|0.1|0.2|0.1|Benign/Borderline|146|106947980|Male|Ependymoma variants|2008
20+|~|~|~|Malignant|~|106947980|Male|Ependymoma variants|2008
20+|0.1|0.2|0.1|Benign/Borderline|149|108197539|Male|Ependymoma variants|2009
20+|~|~|~|Malignant|~|108197539|Male|Ependymoma variants|2009
20+|0.1|0.2|0.1|Benign/Borderline|155|109565056|Male|Ependymoma variants|2010
20+|~|~|~|Malignant|~|109565056|Male|Ependymoma variants|2010
20+|0.1|0.2|0.1|Benign/Borderline|151|111031677|Male|Ependymoma variants|2011
20+|~|~|~|Malignant|~|111031677|Male|Ependymoma variants|2011
20+|0.1|0.2|0.1|Benign/Borderline|164|112556171|Male|Ependymoma variants|2012
20+|~|~|~|Malignant|~|112556171|Male|Ependymoma variants|2012
20+|0.1|0.2|0.1|Benign/Borderline|161|113963637|Male|Ependymoma variants|2013
20+|~|~|~|Malignant|~|113963637|Male|Ependymoma variants|2013
20+|0.1|0.2|0.1|Benign/Borderline|170|115373558|Male|Ependymoma variants|2014
20+|~|~|~|Malignant|~|115373558|Male|Ependymoma variants|2014
20+|0.1|0.2|0.1|Benign/Borderline|161|116752460|Male|Ependymoma variants|2015
20+|~|~|~|Malignant|~|116752460|Male|Ependymoma variants|2015
20+|0.1|0.2|0.1|Benign/Borderline|173|118061478|Male|Ependymoma variants|2016
20+|~|~|~|Malignant|~|118061478|Male|Ependymoma variants|2016
20+|0.1|0.2|0.1|Benign/Borderline|163|119249602|Male|Ependymoma variants|2017
20+|~|~|~|Malignant|~|119249602|Male|Ependymoma variants|2017
20+|0.1|0.1|0.1|Benign/Borderline|703|594041481|Male|Ependymoma variants|2017-2021
20+|~|~|~|Malignant|~|594041481|Male|Ependymoma variants|2017-2021
20+|0.1|0.1|0.1|Benign/Borderline|140|120324107|Male|Ependymoma variants|2018
20+|~|~|~|Malignant|~|120324107|Male|Ependymoma variants|2018
20+|0.1|0.1|0.1|Benign/Borderline|137|121349512|Male|Ependymoma variants|2019
20+|~|~|~|Malignant|~|121349512|Male|Ependymoma variants|2019
20+|0.1|0.1|0.1|Benign/Borderline|139|119846062|Male|Ependymoma variants|2020
20+|~|~|~|Malignant|~|119846062|Male|Ependymoma variants|2020
20+|0.1|0.1|0.1|Benign/Borderline|137|120541161|Male|Ependymoma variants|2021
20+|~|~|~|Malignant|~|120541161|Male|Ependymoma variants|2021
20+|~|~|~|Benign/Borderline|~|101938779|Male|Ependymoma/anaplastic ependymoma|2004
20+|0.3|0.3|0.3|Malignant|305|101938779|Male|Ependymoma/anaplastic ependymoma|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Ependymoma/anaplastic ependymoma|2005
20+|0.3|0.3|0.3|Malignant|302|103190694|Male|Ependymoma/anaplastic ependymoma|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Ependymoma/anaplastic ependymoma|2006
20+|0.2|0.3|0.3|Malignant|292|104488268|Male|Ependymoma/anaplastic ependymoma|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Ependymoma/anaplastic ependymoma|2007
20+|0.2|0.3|0.3|Malignant|288|105697783|Male|Ependymoma/anaplastic ependymoma|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Ependymoma/anaplastic ependymoma|2008
20+|0.3|0.3|0.3|Malignant|323|106947980|Male|Ependymoma/anaplastic ependymoma|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Ependymoma/anaplastic ependymoma|2009
20+|0.3|0.3|0.3|Malignant|341|108197539|Male|Ependymoma/anaplastic ependymoma|2009
20+|~|~|~|Benign/Borderline|~|109565056|Male|Ependymoma/anaplastic ependymoma|2010
20+|0.3|0.3|0.3|Malignant|331|109565056|Male|Ependymoma/anaplastic ependymoma|2010
20+|~|~|~|Benign/Borderline|~|111031677|Male|Ependymoma/anaplastic ependymoma|2011
20+|0.2|0.3|0.3|Malignant|298|111031677|Male|Ependymoma/anaplastic ependymoma|2011
20+|~|~|~|Benign/Borderline|~|112556171|Male|Ependymoma/anaplastic ependymoma|2012
20+|0.3|0.3|0.3|Malignant|328|112556171|Male|Ependymoma/anaplastic ependymoma|2012
20+|~|~|~|Benign/Borderline|~|113963637|Male|Ependymoma/anaplastic ependymoma|2013
20+|0.2|0.3|0.3|Malignant|304|113963637|Male|Ependymoma/anaplastic ependymoma|2013
20+|0.0|0.0|0.0|Benign/Borderline|22|115373558|Male|Ependymoma/anaplastic ependymoma|2014
20+|0.2|0.3|0.3|Malignant|321|115373558|Male|Ependymoma/anaplastic ependymoma|2014
20+|~|~|~|Benign/Borderline|~|116752460|Male|Ependymoma/anaplastic ependymoma|2015
20+|0.2|0.3|0.3|Malignant|310|116752460|Male|Ependymoma/anaplastic ependymoma|2015
20+|~|~|~|Benign/Borderline|~|118061478|Male|Ependymoma/anaplastic ependymoma|2016
20+|0.2|0.3|0.3|Malignant|330|118061478|Male|Ependymoma/anaplastic ependymoma|2016
20+|~|~|~|Benign/Borderline|~|119249602|Male|Ependymoma/anaplastic ependymoma|2017
20+|0.2|0.3|0.2|Malignant|302|119249602|Male|Ependymoma/anaplastic ependymoma|2017
20+|0.0|0.0|0.0|Benign/Borderline|46|594041481|Male|Ependymoma/anaplastic ependymoma|2017-2021
20+|0.2|0.2|0.2|Malignant|1398|594041481|Male|Ependymoma/anaplastic ependymoma|2017-2021
20+|~|~|~|Benign/Borderline|~|120324107|Male|Ependymoma/anaplastic ependymoma|2018
20+|0.2|0.3|0.3|Malignant|309|120324107|Male|Ependymoma/anaplastic ependymoma|2018
20+|~|~|~|Benign/Borderline|~|121349512|Male|Ependymoma/anaplastic ependymoma|2019
20+|0.2|0.3|0.2|Malignant|279|121349512|Male|Ependymoma/anaplastic ependymoma|2019
20+|~|~|~|Benign/Borderline|~|119846062|Male|Ependymoma/anaplastic ependymoma|2020
20+|0.2|0.2|0.2|Malignant|270|119846062|Male|Ependymoma/anaplastic ependymoma|2020
20+|~|~|~|Benign/Borderline|~|120541161|Male|Ependymoma/anaplastic ependymoma|2021
20+|0.2|0.2|0.2|Malignant|252|120541161|Male|Ependymoma/anaplastic ependymoma|2021
20+|0.0|0.0|0.0|Benign/Borderline|22|101938779|Male|Germ Cell Tumors|2004
20+|0.0|0.1|0.0|Malignant|40|101938779|Male|Germ Cell Tumors|2004
20+|0.0|0.0|0.0|Benign/Borderline|33|103190694|Male|Germ Cell Tumors|2005
20+|0.0|0.1|0.0|Malignant|54|103190694|Male|Germ Cell Tumors|2005
20+|0.0|0.0|0.0|Benign/Borderline|29|104488268|Male|Germ Cell Tumors|2006
20+|0.0|0.1|0.0|Malignant|47|104488268|Male|Germ Cell Tumors|2006
20+|0.0|0.0|0.0|Benign/Borderline|35|105697783|Male|Germ Cell Tumors|2007
20+|0.1|0.1|0.1|Malignant|76|105697783|Male|Germ Cell Tumors|2007
20+|0.0|0.0|0.0|Benign/Borderline|34|106947980|Male|Germ Cell Tumors|2008
20+|0.0|0.1|0.0|Malignant|53|106947980|Male|Germ Cell Tumors|2008
20+|0.0|0.0|0.0|Benign/Borderline|36|108197539|Male|Germ Cell Tumors|2009
20+|0.0|0.0|0.0|Malignant|36|108197539|Male|Germ Cell Tumors|2009
20+|0.0|0.0|0.0|Benign/Borderline|28|109565056|Male|Germ Cell Tumors|2010
20+|0.0|0.1|0.1|Malignant|56|109565056|Male|Germ Cell Tumors|2010
20+|0.0|0.0|0.0|Benign/Borderline|24|111031677|Male|Germ Cell Tumors|2011
20+|0.0|0.1|0.1|Malignant|60|111031677|Male|Germ Cell Tumors|2011
20+|0.0|0.0|0.0|Benign/Borderline|33|112556171|Male|Germ Cell Tumors|2012
20+|0.0|0.0|0.0|Malignant|42|112556171|Male|Germ Cell Tumors|2012
20+|0.0|0.0|0.0|Benign/Borderline|26|113963637|Male|Germ Cell Tumors|2013
20+|0.0|0.1|0.0|Malignant|46|113963637|Male|Germ Cell Tumors|2013
20+|0.0|0.0|0.0|Benign/Borderline|28|115373558|Male|Germ Cell Tumors|2014
20+|0.0|0.1|0.1|Malignant|62|115373558|Male|Germ Cell Tumors|2014
20+|0.0|0.0|0.0|Benign/Borderline|29|116752460|Male|Germ Cell Tumors|2015
20+|0.0|0.1|0.0|Malignant|55|116752460|Male|Germ Cell Tumors|2015
20+|0.0|0.0|0.0|Benign/Borderline|33|118061478|Male|Germ Cell Tumors|2016
20+|0.0|0.1|0.1|Malignant|67|118061478|Male|Germ Cell Tumors|2016
20+|0.0|0.0|0.0|Benign/Borderline|31|119249602|Male|Germ Cell Tumors|2017
20+|0.0|0.1|0.1|Malignant|61|119249602|Male|Germ Cell Tumors|2017
20+|0.0|0.0|0.0|Benign/Borderline|118|594041481|Male|Germ Cell Tumors|2017-2021
20+|0.0|0.1|0.0|Malignant|285|594041481|Male|Germ Cell Tumors|2017-2021
20+|0.0|0.0|0.0|Benign/Borderline|22|120324107|Male|Germ Cell Tumors|2018
20+|0.0|0.1|0.0|Malignant|60|120324107|Male|Germ Cell Tumors|2018
20+|0.0|0.0|0.0|Benign/Borderline|29|121349512|Male|Germ Cell Tumors|2019
20+|0.0|0.1|0.1|Malignant|63|121349512|Male|Germ Cell Tumors|2019
20+|0.0|0.0|0.0|Benign/Borderline|22|119846062|Male|Germ Cell Tumors|2020
20+|0.0|0.1|0.0|Malignant|44|119846062|Male|Germ Cell Tumors|2020
20+|~|~|~|Benign/Borderline|~|120541161|Male|Germ Cell Tumors|2021
20+|0.0|0.1|0.1|Malignant|62|120541161|Male|Germ Cell Tumors|2021
20+|~|~|~|Benign/Borderline|~|101938779|Male|Glioblastoma|2004
20+|5.5|5.8|5.6|Malignant|5481|101938779|Male|Glioblastoma|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Glioblastoma|2005
20+|5.5|5.8|5.6|Malignant|5540|103190694|Male|Glioblastoma|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Glioblastoma|2006
20+|5.3|5.6|5.4|Malignant|5501|104488268|Male|Glioblastoma|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Glioblastoma|2007
20+|5.4|5.7|5.6|Malignant|5815|105697783|Male|Glioblastoma|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Glioblastoma|2008
20+|5.5|5.8|5.7|Malignant|6010|106947980|Male|Glioblastoma|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Glioblastoma|2009
20+|5.4|5.7|5.6|Malignant|6006|108197539|Male|Glioblastoma|2009
20+|~|~|~|Benign/Borderline|~|109565056|Male|Glioblastoma|2010
20+|5.4|5.6|5.5|Malignant|6121|109565056|Male|Glioblastoma|2010
20+|~|~|~|Benign/Borderline|~|111031677|Male|Glioblastoma|2011
20+|5.4|5.7|5.5|Malignant|6302|111031677|Male|Glioblastoma|2011
20+|~|~|~|Benign/Borderline|~|112556171|Male|Glioblastoma|2012
20+|5.4|5.7|5.6|Malignant|6507|112556171|Male|Glioblastoma|2012
20+|~|~|~|Benign/Borderline|~|113963637|Male|Glioblastoma|2013
20+|5.4|5.7|5.6|Malignant|6639|113963637|Male|Glioblastoma|2013
20+|~|~|~|Benign/Borderline|~|115373558|Male|Glioblastoma|2014
20+|5.5|5.7|5.6|Malignant|6809|115373558|Male|Glioblastoma|2014
20+|~|~|~|Benign/Borderline|~|116752460|Male|Glioblastoma|2015
20+|5.4|5.7|5.5|Malignant|6902|116752460|Male|Glioblastoma|2015
20+|~|~|~|Benign/Borderline|~|118061478|Male|Glioblastoma|2016
20+|5.5|5.8|5.7|Malignant|7216|118061478|Male|Glioblastoma|2016
20+|~|~|~|Benign/Borderline|~|119249602|Male|Glioblastoma|2017
20+|5.5|5.8|5.7|Malignant|7369|119249602|Male|Glioblastoma|2017
20+|~|~|~|Benign/Borderline|~|594041481|Male|Glioblastoma|2017-2021
20+|5.5|5.6|5.5|Malignant|36609|594041481|Male|Glioblastoma|2017-2021
20+|~|~|~|Benign/Borderline|~|120324107|Male|Glioblastoma|2018
20+|5.5|5.7|5.6|Malignant|7445|120324107|Male|Glioblastoma|2018
20+|~|~|~|Benign/Borderline|~|121349512|Male|Glioblastoma|2019
20+|5.5|5.7|5.6|Malignant|7543|121349512|Male|Glioblastoma|2019
20+|~|~|~|Benign/Borderline|~|119846062|Male|Glioblastoma|2020
20+|5.4|5.6|5.5|Malignant|7418|119846062|Male|Glioblastoma|2020
20+|~|~|~|Benign/Borderline|~|120541161|Male|Glioblastoma|2021
20+|5.2|5.4|5.3|Malignant|7292|120541161|Male|Glioblastoma|2021
20+|~|~|~|Benign/Borderline|~|101938779|Male|Glioma malignant, NOS|2004
20+|0.4|0.5|0.4|Malignant|426|101938779|Male|Glioma malignant, NOS|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Glioma malignant, NOS|2005
20+|0.4|0.5|0.5|Malignant|444|103190694|Male|Glioma malignant, NOS|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Glioma malignant, NOS|2006
20+|0.4|0.5|0.4|Malignant|442|104488268|Male|Glioma malignant, NOS|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Glioma malignant, NOS|2007
20+|0.4|0.5|0.5|Malignant|463|105697783|Male|Glioma malignant, NOS|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Glioma malignant, NOS|2008
20+|0.4|0.5|0.5|Malignant|481|106947980|Male|Glioma malignant, NOS|2008
20+|0.0|0.0|0.0|Benign/Borderline|16|108197539|Male|Glioma malignant, NOS|2009
20+|0.4|0.5|0.4|Malignant|462|108197539|Male|Glioma malignant, NOS|2009
20+|0.0|0.0|0.0|Benign/Borderline|16|109565056|Male|Glioma malignant, NOS|2010
20+|0.3|0.4|0.4|Malignant|406|109565056|Male|Glioma malignant, NOS|2010
20+|0.0|0.0|0.0|Benign/Borderline|17|111031677|Male|Glioma malignant, NOS|2011
20+|0.4|0.5|0.5|Malignant|500|111031677|Male|Glioma malignant, NOS|2011
20+|~|~|~|Benign/Borderline|~|112556171|Male|Glioma malignant, NOS|2012
20+|0.4|0.5|0.5|Malignant|488|112556171|Male|Glioma malignant, NOS|2012
20+|~|~|~|Benign/Borderline|~|113963637|Male|Glioma malignant, NOS|2013
20+|0.4|0.5|0.4|Malignant|466|113963637|Male|Glioma malignant, NOS|2013
20+|~|~|~|Benign/Borderline|~|115373558|Male|Glioma malignant, NOS|2014
20+|0.4|0.5|0.4|Malignant|505|115373558|Male|Glioma malignant, NOS|2014
20+|0.0|0.0|0.0|Benign/Borderline|22|116752460|Male|Glioma malignant, NOS|2015
20+|0.4|0.5|0.4|Malignant|481|116752460|Male|Glioma malignant, NOS|2015
20+|0.0|0.0|0.0|Benign/Borderline|30|118061478|Male|Glioma malignant, NOS|2016
20+|0.4|0.5|0.5|Malignant|547|118061478|Male|Glioma malignant, NOS|2016
20+|0.0|0.0|0.0|Benign/Borderline|18|119249602|Male|Glioma malignant, NOS|2017
20+|0.5|0.6|0.5|Malignant|608|119249602|Male|Glioma malignant, NOS|2017
20+|0.0|0.0|0.0|Benign/Borderline|82|594041481|Male|Glioma malignant, NOS|2017-2021
20+|0.5|0.5|0.5|Malignant|2804|594041481|Male|Glioma malignant, NOS|2017-2021
20+|0.0|0.0|0.0|Benign/Borderline|21|120324107|Male|Glioma malignant, NOS|2018
20+|0.4|0.5|0.5|Malignant|577|120324107|Male|Glioma malignant, NOS|2018
20+|0.0|0.0|0.0|Benign/Borderline|21|121349512|Male|Glioma malignant, NOS|2019
20+|0.4|0.5|0.5|Malignant|550|121349512|Male|Glioma malignant, NOS|2019
20+|~|~|~|Benign/Borderline|~|119846062|Male|Glioma malignant, NOS|2020
20+|0.4|0.5|0.5|Malignant|558|119846062|Male|Glioma malignant, NOS|2020
20+|~|~|~|Benign/Borderline|~|120541161|Male|Glioma malignant, NOS|2021
20+|0.4|0.5|0.4|Malignant|551|120541161|Male|Glioma malignant, NOS|2021
20+|0.2|0.3|0.2|Benign/Borderline|253|101938779|Male|Hemangioblastoma|2004
20+|~|~|~|Malignant|~|101938779|Male|Hemangioblastoma|2004
20+|0.2|0.3|0.3|Benign/Borderline|288|103190694|Male|Hemangioblastoma|2005
20+|~|~|~|Malignant|~|103190694|Male|Hemangioblastoma|2005
20+|0.2|0.3|0.3|Benign/Borderline|279|104488268|Male|Hemangioblastoma|2006
20+|~|~|~|Malignant|~|104488268|Male|Hemangioblastoma|2006
20+|0.2|0.3|0.2|Benign/Borderline|255|105697783|Male|Hemangioblastoma|2007
20+|~|~|~|Malignant|~|105697783|Male|Hemangioblastoma|2007
20+|0.2|0.3|0.3|Benign/Borderline|294|106947980|Male|Hemangioblastoma|2008
20+|~|~|~|Malignant|~|106947980|Male|Hemangioblastoma|2008
20+|0.2|0.3|0.3|Benign/Borderline|276|108197539|Male|Hemangioblastoma|2009
20+|~|~|~|Malignant|~|108197539|Male|Hemangioblastoma|2009
20+|0.2|0.3|0.3|Benign/Borderline|306|109565056|Male|Hemangioblastoma|2010
20+|~|~|~|Malignant|~|109565056|Male|Hemangioblastoma|2010
20+|0.2|0.3|0.3|Benign/Borderline|280|111031677|Male|Hemangioblastoma|2011
20+|~|~|~|Malignant|~|111031677|Male|Hemangioblastoma|2011
20+|0.2|0.3|0.3|Benign/Borderline|286|112556171|Male|Hemangioblastoma|2012
20+|~|~|~|Malignant|~|112556171|Male|Hemangioblastoma|2012
20+|0.2|0.3|0.2|Benign/Borderline|278|113963637|Male|Hemangioblastoma|2013
20+|~|~|~|Malignant|~|113963637|Male|Hemangioblastoma|2013
20+|0.2|0.3|0.2|Benign/Borderline|281|115373558|Male|Hemangioblastoma|2014
20+|~|~|~|Malignant|~|115373558|Male|Hemangioblastoma|2014
20+|0.2|0.3|0.2|Benign/Borderline|300|116752460|Male|Hemangioblastoma|2015
20+|~|~|~|Malignant|~|116752460|Male|Hemangioblastoma|2015
20+|0.2|0.3|0.2|Benign/Borderline|292|118061478|Male|Hemangioblastoma|2016
20+|~|~|~|Malignant|~|118061478|Male|Hemangioblastoma|2016
20+|0.2|0.3|0.3|Benign/Borderline|338|119249602|Male|Hemangioblastoma|2017
20+|~|~|~|Malignant|~|119249602|Male|Hemangioblastoma|2017
20+|0.2|0.3|0.2|Benign/Borderline|1479|594041481|Male|Hemangioblastoma|2017-2021
20+|~|~|~|Malignant|~|594041481|Male|Hemangioblastoma|2017-2021
20+|0.2|0.3|0.2|Benign/Borderline|306|120324107|Male|Hemangioblastoma|2018
20+|~|~|~|Malignant|~|120324107|Male|Hemangioblastoma|2018
20+|0.2|0.3|0.2|Benign/Borderline|281|121349512|Male|Hemangioblastoma|2019
20+|~|~|~|Malignant|~|121349512|Male|Hemangioblastoma|2019
20+|0.2|0.3|0.2|Benign/Borderline|298|119846062|Male|Hemangioblastoma|2020
20+|~|~|~|Malignant|~|119846062|Male|Hemangioblastoma|2020
20+|0.2|0.3|0.2|Benign/Borderline|281|120541161|Male|Hemangioblastoma|2021
20+|~|~|~|Malignant|~|120541161|Male|Hemangioblastoma|2021
20+|0.1|0.2|0.1|Benign/Borderline|140|101938779|Male|Hemangioma|2004
20+|~|~|~|Malignant|~|101938779|Male|Hemangioma|2004
20+|0.2|0.2|0.2|Benign/Borderline|205|103190694|Male|Hemangioma|2005
20+|~|~|~|Malignant|~|103190694|Male|Hemangioma|2005
20+|0.2|0.3|0.2|Benign/Borderline|237|104488268|Male|Hemangioma|2006
20+|~|~|~|Malignant|~|104488268|Male|Hemangioma|2006
20+|0.2|0.3|0.3|Benign/Borderline|271|105697783|Male|Hemangioma|2007
20+|~|~|~|Malignant|~|105697783|Male|Hemangioma|2007
20+|0.3|0.4|0.3|Benign/Borderline|332|106947980|Male|Hemangioma|2008
20+|~|~|~|Malignant|~|106947980|Male|Hemangioma|2008
20+|0.4|0.5|0.4|Benign/Borderline|445|108197539|Male|Hemangioma|2009
20+|~|~|~|Malignant|~|108197539|Male|Hemangioma|2009
20+|0.4|0.5|0.4|Benign/Borderline|457|109565056|Male|Hemangioma|2010
20+|~|~|~|Malignant|~|109565056|Male|Hemangioma|2010
20+|0.4|0.5|0.5|Benign/Borderline|518|111031677|Male|Hemangioma|2011
20+|~|~|~|Malignant|~|111031677|Male|Hemangioma|2011
20+|0.4|0.5|0.5|Benign/Borderline|515|112556171|Male|Hemangioma|2012
20+|~|~|~|Malignant|~|112556171|Male|Hemangioma|2012
20+|0.4|0.5|0.4|Benign/Borderline|515|113963637|Male|Hemangioma|2013
20+|~|~|~|Malignant|~|113963637|Male|Hemangioma|2013
20+|0.4|0.5|0.4|Benign/Borderline|516|115373558|Male|Hemangioma|2014
20+|~|~|~|Malignant|~|115373558|Male|Hemangioma|2014
20+|0.4|0.4|0.4|Benign/Borderline|470|116752460|Male|Hemangioma|2015
20+|~|~|~|Malignant|~|116752460|Male|Hemangioma|2015
20+|0.3|0.4|0.4|Benign/Borderline|427|118061478|Male|Hemangioma|2016
20+|~|~|~|Malignant|~|118061478|Male|Hemangioma|2016
20+|0.3|0.4|0.4|Benign/Borderline|456|119249602|Male|Hemangioma|2017
20+|~|~|~|Malignant|~|119249602|Male|Hemangioma|2017
20+|0.4|0.4|0.4|Benign/Borderline|2267|594041481|Male|Hemangioma|2017-2021
20+|~|~|~|Malignant|~|594041481|Male|Hemangioma|2017-2021
20+|0.3|0.4|0.4|Benign/Borderline|468|120324107|Male|Hemangioma|2018
20+|~|~|~|Malignant|~|120324107|Male|Hemangioma|2018
20+|0.3|0.4|0.4|Benign/Borderline|476|121349512|Male|Hemangioma|2019
20+|~|~|~|Malignant|~|121349512|Male|Hemangioma|2019
20+|0.3|0.4|0.4|Benign/Borderline|443|119846062|Male|Hemangioma|2020
20+|~|~|~|Malignant|~|119846062|Male|Hemangioma|2020
20+|0.3|0.4|0.3|Benign/Borderline|443|120541161|Male|Hemangioma|2021
20+|~|~|~|Malignant|~|120541161|Male|Hemangioma|2021
20+|~|~|~|Benign/Borderline|~|101938779|Male|Local Extensions from Regional Tumors|2004
20+|0.0|0.0|0.0|Malignant|25|101938779|Male|Local Extensions from Regional Tumors|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Local Extensions from Regional Tumors|2005
20+|0.0|0.0|0.0|Malignant|22|103190694|Male|Local Extensions from Regional Tumors|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Local Extensions from Regional Tumors|2006
20+|0.0|0.0|0.0|Malignant|35|104488268|Male|Local Extensions from Regional Tumors|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Local Extensions from Regional Tumors|2007
20+|0.0|0.0|0.0|Malignant|23|105697783|Male|Local Extensions from Regional Tumors|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Local Extensions from Regional Tumors|2008
20+|0.0|0.0|0.0|Malignant|30|106947980|Male|Local Extensions from Regional Tumors|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Local Extensions from Regional Tumors|2009
20+|0.0|0.0|0.0|Malignant|30|108197539|Male|Local Extensions from Regional Tumors|2009
20+|~|~|~|Benign/Borderline|~|109565056|Male|Local Extensions from Regional Tumors|2010
20+|0.0|0.0|0.0|Malignant|30|109565056|Male|Local Extensions from Regional Tumors|2010
20+|~|~|~|Benign/Borderline|~|111031677|Male|Local Extensions from Regional Tumors|2011
20+|0.0|0.0|0.0|Malignant|23|111031677|Male|Local Extensions from Regional Tumors|2011
20+|~|~|~|Benign/Borderline|~|112556171|Male|Local Extensions from Regional Tumors|2012
20+|0.0|0.0|0.0|Malignant|27|112556171|Male|Local Extensions from Regional Tumors|2012
20+|~|~|~|Benign/Borderline|~|113963637|Male|Local Extensions from Regional Tumors|2013
20+|0.0|0.0|0.0|Malignant|30|113963637|Male|Local Extensions from Regional Tumors|2013
20+|~|~|~|Benign/Borderline|~|115373558|Male|Local Extensions from Regional Tumors|2014
20+|0.0|0.0|0.0|Malignant|24|115373558|Male|Local Extensions from Regional Tumors|2014
20+|~|~|~|Benign/Borderline|~|116752460|Male|Local Extensions from Regional Tumors|2015
20+|0.0|0.0|0.0|Malignant|23|116752460|Male|Local Extensions from Regional Tumors|2015
20+|~|~|~|Benign/Borderline|~|118061478|Male|Local Extensions from Regional Tumors|2016
20+|0.0|0.0|0.0|Malignant|26|118061478|Male|Local Extensions from Regional Tumors|2016
20+|~|~|~|Benign/Borderline|~|119249602|Male|Local Extensions from Regional Tumors|2017
20+|0.0|0.0|0.0|Malignant|24|119249602|Male|Local Extensions from Regional Tumors|2017
20+|~|~|~|Benign/Borderline|~|594041481|Male|Local Extensions from Regional Tumors|2017-2021
20+|0.0|0.0|0.0|Malignant|95|594041481|Male|Local Extensions from Regional Tumors|2017-2021
20+|~|~|~|Benign/Borderline|~|120324107|Male|Local Extensions from Regional Tumors|2018
20+|0.0|0.0|0.0|Malignant|18|120324107|Male|Local Extensions from Regional Tumors|2018
20+|~|~|~|Benign/Borderline|~|121349512|Male|Local Extensions from Regional Tumors|2019
20+|0.0|0.0|0.0|Malignant|20|121349512|Male|Local Extensions from Regional Tumors|2019
20+|~|~|~|Benign/Borderline|~|119846062|Male|Local Extensions from Regional Tumors|2020
20+|~|~|~|Malignant|~|119846062|Male|Local Extensions from Regional Tumors|2020
20+|~|~|~|Benign/Borderline|~|120541161|Male|Local Extensions from Regional Tumors|2021
20+|0.0|0.0|0.0|Malignant|20|120541161|Male|Local Extensions from Regional Tumors|2021
20+|~|~|~|Benign/Borderline|~|101938779|Male|Lymphomas and Hematopoietic Neoplasms|2004
20+|0.7|0.8|0.8|Malignant|749|101938779|Male|Lymphomas and Hematopoietic Neoplasms|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Lymphomas and Hematopoietic Neoplasms|2005
20+|0.7|0.8|0.8|Malignant|775|103190694|Male|Lymphomas and Hematopoietic Neoplasms|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Lymphomas and Hematopoietic Neoplasms|2006
20+|0.7|0.8|0.8|Malignant|762|104488268|Male|Lymphomas and Hematopoietic Neoplasms|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Lymphomas and Hematopoietic Neoplasms|2007
20+|0.7|0.8|0.7|Malignant|734|105697783|Male|Lymphomas and Hematopoietic Neoplasms|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Lymphomas and Hematopoietic Neoplasms|2008
20+|0.7|0.8|0.8|Malignant|772|106947980|Male|Lymphomas and Hematopoietic Neoplasms|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Lymphomas and Hematopoietic Neoplasms|2009
20+|0.7|0.8|0.7|Malignant|754|108197539|Male|Lymphomas and Hematopoietic Neoplasms|2009
20+|~|~|~|Benign/Borderline|~|109565056|Male|Lymphomas and Hematopoietic Neoplasms|2010
20+|0.6|0.7|0.7|Malignant|755|109565056|Male|Lymphomas and Hematopoietic Neoplasms|2010
20+|~|~|~|Benign/Borderline|~|111031677|Male|Lymphomas and Hematopoietic Neoplasms|2011
20+|0.7|0.8|0.7|Malignant|806|111031677|Male|Lymphomas and Hematopoietic Neoplasms|2011
20+|~|~|~|Benign/Borderline|~|112556171|Male|Lymphomas and Hematopoietic Neoplasms|2012
20+|0.6|0.7|0.7|Malignant|754|112556171|Male|Lymphomas and Hematopoietic Neoplasms|2012
20+|~|~|~|Benign/Borderline|~|113963637|Male|Lymphomas and Hematopoietic Neoplasms|2013
20+|0.6|0.7|0.6|Malignant|727|113963637|Male|Lymphomas and Hematopoietic Neoplasms|2013
20+|~|~|~|Benign/Borderline|~|115373558|Male|Lymphomas and Hematopoietic Neoplasms|2014
20+|0.6|0.7|0.7|Malignant|822|115373558|Male|Lymphomas and Hematopoietic Neoplasms|2014
20+|~|~|~|Benign/Borderline|~|116752460|Male|Lymphomas and Hematopoietic Neoplasms|2015
20+|0.6|0.7|0.7|Malignant|822|116752460|Male|Lymphomas and Hematopoietic Neoplasms|2015
20+|~|~|~|Benign/Borderline|~|118061478|Male|Lymphomas and Hematopoietic Neoplasms|2016
20+|0.6|0.7|0.7|Malignant|821|118061478|Male|Lymphomas and Hematopoietic Neoplasms|2016
20+|~|~|~|Benign/Borderline|~|119249602|Male|Lymphomas and Hematopoietic Neoplasms|2017
20+|0.7|0.8|0.7|Malignant|887|119249602|Male|Lymphomas and Hematopoietic Neoplasms|2017
20+|~|~|~|Benign/Borderline|~|594041481|Male|Lymphomas and Hematopoietic Neoplasms|2017-2021
20+|0.6|0.7|0.6|Malignant|4172|594041481|Male|Lymphomas and Hematopoietic Neoplasms|2017-2021
20+|~|~|~|Benign/Borderline|~|120324107|Male|Lymphomas and Hematopoietic Neoplasms|2018
20+|0.6|0.7|0.7|Malignant|848|120324107|Male|Lymphomas and Hematopoietic Neoplasms|2018
20+|~|~|~|Benign/Borderline|~|121349512|Male|Lymphomas and Hematopoietic Neoplasms|2019
20+|0.6|0.7|0.6|Malignant|838|121349512|Male|Lymphomas and Hematopoietic Neoplasms|2019
20+|~|~|~|Benign/Borderline|~|119846062|Male|Lymphomas and Hematopoietic Neoplasms|2020
20+|0.6|0.7|0.6|Malignant|815|119846062|Male|Lymphomas and Hematopoietic Neoplasms|2020
20+|~|~|~|Benign/Borderline|~|120541161|Male|Lymphomas and Hematopoietic Neoplasms|2021
20+|0.6|0.7|0.6|Malignant|829|120541161|Male|Lymphomas and Hematopoietic Neoplasms|2021
20+|5.1|5.4|5.3|Benign/Borderline|4948|101938779|Male|Meningioma|2004
20+|0.2|0.2|0.2|Malignant|175|101938779|Male|Meningioma|2004
20+|5.6|5.9|5.8|Benign/Borderline|5513|103190694|Male|Meningioma|2005
20+|0.1|0.2|0.2|Malignant|153|103190694|Male|Meningioma|2005
20+|5.9|6.3|6.1|Benign/Borderline|5928|104488268|Male|Meningioma|2006
20+|0.1|0.2|0.2|Malignant|155|104488268|Male|Meningioma|2006
20+|6.1|6.4|6.2|Benign/Borderline|6187|105697783|Male|Meningioma|2007
20+|0.1|0.2|0.2|Malignant|175|105697783|Male|Meningioma|2007
20+|6.6|6.9|6.7|Benign/Borderline|6826|106947980|Male|Meningioma|2008
20+|0.1|0.2|0.1|Malignant|148|106947980|Male|Meningioma|2008
20+|7.0|7.3|7.1|Benign/Borderline|7339|108197539|Male|Meningioma|2009
20+|0.1|0.2|0.1|Malignant|150|108197539|Male|Meningioma|2009
20+|6.9|7.2|7.0|Benign/Borderline|7384|109565056|Male|Meningioma|2010
20+|0.1|0.1|0.1|Malignant|121|109565056|Male|Meningioma|2010
20+|6.9|7.2|7.1|Benign/Borderline|7628|111031677|Male|Meningioma|2011
20+|0.1|0.2|0.1|Malignant|141|111031677|Male|Meningioma|2011
20+|7.0|7.3|7.1|Benign/Borderline|7863|112556171|Male|Meningioma|2012
20+|0.1|0.2|0.1|Malignant|155|112556171|Male|Meningioma|2012
20+|7.3|7.6|7.5|Benign/Borderline|8380|113963637|Male|Meningioma|2013
20+|0.1|0.2|0.1|Malignant|158|113963637|Male|Meningioma|2013
20+|7.3|7.6|7.5|Benign/Borderline|8573|115373558|Male|Meningioma|2014
20+|0.1|0.2|0.1|Malignant|168|115373558|Male|Meningioma|2014
20+|7.6|8.0|7.8|Benign/Borderline|9186|116752460|Male|Meningioma|2015
20+|0.1|0.1|0.1|Malignant|149|116752460|Male|Meningioma|2015
20+|7.8|8.1|7.9|Benign/Borderline|9489|118061478|Male|Meningioma|2016
20+|0.1|0.1|0.1|Malignant|162|118061478|Male|Meningioma|2016
20+|8.1|8.4|8.2|Benign/Borderline|10087|119249602|Male|Meningioma|2017
20+|0.1|0.1|0.1|Malignant|152|119249602|Male|Meningioma|2017
20+|8.2|8.4|8.3|Benign/Borderline|51710|594041481|Male|Meningioma|2017-2021
20+|0.1|0.1|0.1|Malignant|719|594041481|Male|Meningioma|2017-2021
20+|8.1|8.4|8.3|Benign/Borderline|10324|120324107|Male|Meningioma|2018
20+|0.1|0.1|0.1|Malignant|140|120324107|Male|Meningioma|2018
20+|8.6|8.9|8.7|Benign/Borderline|11082|121349512|Male|Meningioma|2019
20+|0.1|0.1|0.1|Malignant|147|121349512|Male|Meningioma|2019
20+|7.9|8.2|8.0|Benign/Borderline|10173|119846062|Male|Meningioma|2020
20+|0.1|0.1|0.1|Malignant|135|119846062|Male|Meningioma|2020
20+|8.0|8.3|8.2|Benign/Borderline|10516|120541161|Male|Meningioma|2021
20+|0.1|0.1|0.1|Malignant|157|120541161|Male|Meningioma|2021
20+|~|~|~|Benign/Borderline|~|101938779|Male|Mixed glioma|2004
20+|0.3|0.3|0.3|Malignant|295|101938779|Male|Mixed glioma|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Mixed glioma|2005
20+|0.3|0.4|0.3|Malignant|329|103190694|Male|Mixed glioma|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Mixed glioma|2006
20+|0.3|0.4|0.4|Malignant|367|104488268|Male|Mixed glioma|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Mixed glioma|2007
20+|0.3|0.4|0.3|Malignant|352|105697783|Male|Mixed glioma|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Mixed glioma|2008
20+|0.3|0.4|0.3|Malignant|340|106947980|Male|Mixed glioma|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Mixed glioma|2009
20+|0.3|0.4|0.4|Malignant|390|108197539|Male|Mixed glioma|2009
20+|~|~|~|Benign/Borderline|~|109565056|Male|Mixed glioma|2010
20+|0.3|0.4|0.3|Malignant|341|109565056|Male|Mixed glioma|2010
20+|~|~|~|Benign/Borderline|~|111031677|Male|Mixed glioma|2011
20+|0.3|0.4|0.3|Malignant|367|111031677|Male|Mixed glioma|2011
20+|~|~|~|Benign/Borderline|~|112556171|Male|Mixed glioma|2012
20+|0.3|0.3|0.3|Malignant|332|112556171|Male|Mixed glioma|2012
20+|~|~|~|Benign/Borderline|~|113963637|Male|Mixed glioma|2013
20+|0.3|0.4|0.3|Malignant|373|113963637|Male|Mixed glioma|2013
20+|~|~|~|Benign/Borderline|~|115373558|Male|Mixed glioma|2014
20+|0.2|0.3|0.2|Malignant|269|115373558|Male|Mixed glioma|2014
20+|~|~|~|Benign/Borderline|~|116752460|Male|Mixed glioma|2015
20+|0.1|0.1|0.1|Malignant|144|116752460|Male|Mixed glioma|2015
20+|~|~|~|Benign/Borderline|~|118061478|Male|Mixed glioma|2016
20+|0.0|0.1|0.1|Malignant|63|118061478|Male|Mixed glioma|2016
20+|~|~|~|Benign/Borderline|~|119249602|Male|Mixed glioma|2017
20+|0.0|0.0|0.0|Malignant|29|119249602|Male|Mixed glioma|2017
20+|~|~|~|Benign/Borderline|~|594041481|Male|Mixed glioma|2017-2021
20+|0.0|0.0|0.0|Malignant|62|594041481|Male|Mixed glioma|2017-2021
20+|~|~|~|Benign/Borderline|~|120324107|Male|Mixed glioma|2018
20+|~|~|~|Malignant|~|120324107|Male|Mixed glioma|2018
20+|~|~|~|Benign/Borderline|~|121349512|Male|Mixed glioma|2019
20+|~|~|~|Malignant|~|121349512|Male|Mixed glioma|2019
20+|~|~|~|Benign/Borderline|~|119846062|Male|Mixed glioma|2020
20+|~|~|~|Malignant|~|119846062|Male|Mixed glioma|2020
20+|~|~|~|Benign/Borderline|~|120541161|Male|Mixed glioma|2021
20+|~|~|~|Malignant|~|120541161|Male|Mixed glioma|2021
20+|0.5|0.6|0.6|Benign/Borderline|502|101938779|Male|Neoplasm, unspecified|2004
20+|0.6|0.7|0.7|Malignant|586|101938779|Male|Neoplasm, unspecified|2004
20+|0.6|0.7|0.7|Benign/Borderline|634|103190694|Male|Neoplasm, unspecified|2005
20+|0.6|0.7|0.7|Malignant|602|103190694|Male|Neoplasm, unspecified|2005
20+|0.6|0.7|0.6|Benign/Borderline|624|104488268|Male|Neoplasm, unspecified|2006
20+|0.6|0.7|0.6|Malignant|564|104488268|Male|Neoplasm, unspecified|2006
20+|0.6|0.7|0.6|Benign/Borderline|586|105697783|Male|Neoplasm, unspecified|2007
20+|0.6|0.7|0.6|Malignant|565|105697783|Male|Neoplasm, unspecified|2007
20+|0.6|0.7|0.6|Benign/Borderline|619|106947980|Male|Neoplasm, unspecified|2008
20+|0.6|0.7|0.7|Malignant|615|106947980|Male|Neoplasm, unspecified|2008
20+|0.6|0.7|0.6|Benign/Borderline|617|108197539|Male|Neoplasm, unspecified|2009
20+|0.6|0.7|0.6|Malignant|632|108197539|Male|Neoplasm, unspecified|2009
20+|0.6|0.7|0.7|Benign/Borderline|677|109565056|Male|Neoplasm, unspecified|2010
20+|0.6|0.7|0.6|Malignant|601|109565056|Male|Neoplasm, unspecified|2010
20+|0.6|0.6|0.6|Benign/Borderline|639|111031677|Male|Neoplasm, unspecified|2011
20+|0.6|0.6|0.6|Malignant|612|111031677|Male|Neoplasm, unspecified|2011
20+|0.6|0.7|0.7|Benign/Borderline|710|112556171|Male|Neoplasm, unspecified|2012
20+|0.5|0.6|0.6|Malignant|619|112556171|Male|Neoplasm, unspecified|2012
20+|0.6|0.7|0.6|Benign/Borderline|694|113963637|Male|Neoplasm, unspecified|2013
20+|0.5|0.6|0.6|Malignant|610|113963637|Male|Neoplasm, unspecified|2013
20+|0.5|0.6|0.6|Benign/Borderline|649|115373558|Male|Neoplasm, unspecified|2014
20+|0.6|0.7|0.6|Malignant|667|115373558|Male|Neoplasm, unspecified|2014
20+|0.5|0.6|0.6|Benign/Borderline|649|116752460|Male|Neoplasm, unspecified|2015
20+|0.5|0.6|0.6|Malignant|632|116752460|Male|Neoplasm, unspecified|2015
20+|0.5|0.6|0.5|Benign/Borderline|607|118061478|Male|Neoplasm, unspecified|2016
20+|0.5|0.6|0.6|Malignant|636|118061478|Male|Neoplasm, unspecified|2016
20+|0.4|0.5|0.5|Benign/Borderline|572|119249602|Male|Neoplasm, unspecified|2017
20+|0.5|0.5|0.5|Malignant|582|119249602|Male|Neoplasm, unspecified|2017
20+|0.4|0.5|0.4|Benign/Borderline|2647|594041481|Male|Neoplasm, unspecified|2017-2021
20+|0.5|0.6|0.6|Malignant|3300|594041481|Male|Neoplasm, unspecified|2017-2021
20+|0.4|0.5|0.5|Benign/Borderline|549|120324107|Male|Neoplasm, unspecified|2018
20+|0.5|0.6|0.6|Malignant|664|120324107|Male|Neoplasm, unspecified|2018
20+|0.4|0.4|0.4|Benign/Borderline|491|121349512|Male|Neoplasm, unspecified|2019
20+|0.5|0.6|0.6|Malignant|720|121349512|Male|Neoplasm, unspecified|2019
20+|0.4|0.5|0.4|Benign/Borderline|535|119846062|Male|Neoplasm, unspecified|2020
20+|0.5|0.6|0.6|Malignant|711|119846062|Male|Neoplasm, unspecified|2020
20+|0.4|0.5|0.4|Benign/Borderline|524|120541161|Male|Neoplasm, unspecified|2021
20+|0.5|0.6|0.5|Malignant|659|120541161|Male|Neoplasm, unspecified|2021
20+|2.2|2.4|2.3|Benign/Borderline|2356|101938779|Male|Nerve sheath, benign and malignant|2004
20+|0.0|0.0|0.0|Malignant|27|101938779|Male|Nerve sheath, benign and malignant|2004
20+|2.5|2.7|2.6|Benign/Borderline|2713|103190694|Male|Nerve sheath, benign and malignant|2005
20+|0.0|0.0|0.0|Malignant|31|103190694|Male|Nerve sheath, benign and malignant|2005
20+|2.4|2.6|2.5|Benign/Borderline|2689|104488268|Male|Nerve sheath, benign and malignant|2006
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Nerve sheath, benign and malignant|2006
20+|2.5|2.7|2.6|Benign/Borderline|2772|105697783|Male|Nerve sheath, benign and malignant|2007
20+|0.0|0.0|0.0|Malignant|20|105697783|Male|Nerve sheath, benign and malignant|2007
20+|2.4|2.6|2.5|Benign/Borderline|2757|106947980|Male|Nerve sheath, benign and malignant|2008
20+|0.0|0.0|0.0|Malignant|25|106947980|Male|Nerve sheath, benign and malignant|2008
20+|2.6|2.7|2.6|Benign/Borderline|2931|108197539|Male|Nerve sheath, benign and malignant|2009
20+|0.0|0.0|0.0|Malignant|21|108197539|Male|Nerve sheath, benign and malignant|2009
20+|2.5|2.7|2.6|Benign/Borderline|2976|109565056|Male|Nerve sheath, benign and malignant|2010
20+|0.0|0.0|0.0|Malignant|22|109565056|Male|Nerve sheath, benign and malignant|2010
20+|2.6|2.8|2.7|Benign/Borderline|3086|111031677|Male|Nerve sheath, benign and malignant|2011
20+|0.0|0.0|0.0|Malignant|17|111031677|Male|Nerve sheath, benign and malignant|2011
20+|2.7|2.9|2.8|Benign/Borderline|3275|112556171|Male|Nerve sheath, benign and malignant|2012
20+|0.0|0.0|0.0|Malignant|24|112556171|Male|Nerve sheath, benign and malignant|2012
20+|2.7|2.9|2.8|Benign/Borderline|3389|113963637|Male|Nerve sheath, benign and malignant|2013
20+|0.0|0.0|0.0|Malignant|21|113963637|Male|Nerve sheath, benign and malignant|2013
20+|2.9|3.1|3.0|Benign/Borderline|3657|115373558|Male|Nerve sheath, benign and malignant|2014
20+|0.0|0.0|0.0|Malignant|21|115373558|Male|Nerve sheath, benign and malignant|2014
20+|2.9|3.1|3.0|Benign/Borderline|3653|116752460|Male|Nerve sheath, benign and malignant|2015
20+|0.0|0.0|0.0|Malignant|16|116752460|Male|Nerve sheath, benign and malignant|2015
20+|2.8|3.0|2.9|Benign/Borderline|3615|118061478|Male|Nerve sheath, benign and malignant|2016
20+|0.0|0.0|0.0|Malignant|25|118061478|Male|Nerve sheath, benign and malignant|2016
20+|2.8|3.0|2.9|Benign/Borderline|3713|119249602|Male|Nerve sheath, benign and malignant|2017
20+|0.0|0.0|0.0|Malignant|25|119249602|Male|Nerve sheath, benign and malignant|2017
20+|2.7|2.8|2.7|Benign/Borderline|17421|594041481|Male|Nerve sheath, benign and malignant|2017-2021
20+|0.0|0.0|0.0|Malignant|96|594041481|Male|Nerve sheath, benign and malignant|2017-2021
20+|2.8|3.0|2.9|Benign/Borderline|3716|120324107|Male|Nerve sheath, benign and malignant|2018
20+|~|~|~|Malignant|~|120324107|Male|Nerve sheath, benign and malignant|2018
20+|2.8|3.0|2.9|Benign/Borderline|3722|121349512|Male|Nerve sheath, benign and malignant|2019
20+|0.0|0.0|0.0|Malignant|18|121349512|Male|Nerve sheath, benign and malignant|2019
20+|2.3|2.5|2.4|Benign/Borderline|3123|119846062|Male|Nerve sheath, benign and malignant|2020
20+|0.0|0.0|0.0|Malignant|23|119846062|Male|Nerve sheath, benign and malignant|2020
20+|2.5|2.7|2.6|Benign/Borderline|3320|120541161|Male|Nerve sheath, benign and malignant|2021
20+|0.0|0.0|0.0|Malignant|16|120541161|Male|Nerve sheath, benign and malignant|2021
20+|~|~|~|Benign/Borderline|~|101938779|Male|Neuroepithelial|2004
20+|0.0|0.0|0.0|Malignant|29|101938779|Male|Neuroepithelial|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Neuroepithelial|2005
20+|0.0|0.0|0.0|Malignant|18|103190694|Male|Neuroepithelial|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Neuroepithelial|2006
20+|0.0|0.0|0.0|Malignant|25|104488268|Male|Neuroepithelial|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Neuroepithelial|2007
20+|0.0|0.0|0.0|Malignant|31|105697783|Male|Neuroepithelial|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Neuroepithelial|2008
20+|0.0|0.0|0.0|Malignant|18|106947980|Male|Neuroepithelial|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Neuroepithelial|2009
20+|0.0|0.0|0.0|Malignant|24|108197539|Male|Neuroepithelial|2009
20+|~|~|~|Benign/Borderline|~|109565056|Male|Neuroepithelial|2010
20+|0.0|0.0|0.0|Malignant|26|109565056|Male|Neuroepithelial|2010
20+|~|~|~|Benign/Borderline|~|111031677|Male|Neuroepithelial|2011
20+|0.0|0.0|0.0|Malignant|27|111031677|Male|Neuroepithelial|2011
20+|~|~|~|Benign/Borderline|~|112556171|Male|Neuroepithelial|2012
20+|0.0|0.0|0.0|Malignant|27|112556171|Male|Neuroepithelial|2012
20+|~|~|~|Benign/Borderline|~|113963637|Male|Neuroepithelial|2013
20+|0.0|0.0|0.0|Malignant|27|113963637|Male|Neuroepithelial|2013
20+|~|~|~|Benign/Borderline|~|115373558|Male|Neuroepithelial|2014
20+|0.0|0.0|0.0|Malignant|35|115373558|Male|Neuroepithelial|2014
20+|~|~|~|Benign/Borderline|~|116752460|Male|Neuroepithelial|2015
20+|0.0|0.0|0.0|Malignant|33|116752460|Male|Neuroepithelial|2015
20+|~|~|~|Benign/Borderline|~|118061478|Male|Neuroepithelial|2016
20+|0.0|0.0|0.0|Malignant|25|118061478|Male|Neuroepithelial|2016
20+|~|~|~|Benign/Borderline|~|119249602|Male|Neuroepithelial|2017
20+|0.0|0.0|0.0|Malignant|19|119249602|Male|Neuroepithelial|2017
20+|0.0|0.0|0.0|Benign/Borderline|21|594041481|Male|Neuroepithelial|2017-2021
20+|0.0|0.0|0.0|Malignant|62|594041481|Male|Neuroepithelial|2017-2021
20+|~|~|~|Benign/Borderline|~|120324107|Male|Neuroepithelial|2018
20+|~|~|~|Malignant|~|120324107|Male|Neuroepithelial|2018
20+|~|~|~|Benign/Borderline|~|121349512|Male|Neuroepithelial|2019
20+|~|~|~|Malignant|~|121349512|Male|Neuroepithelial|2019
20+|~|~|~|Benign/Borderline|~|119846062|Male|Neuroepithelial|2020
20+|~|~|~|Malignant|~|119846062|Male|Neuroepithelial|2020
20+|~|~|~|Benign/Borderline|~|120541161|Male|Neuroepithelial|2021
20+|~|~|~|Malignant|~|120541161|Male|Neuroepithelial|2021
20+|0.1|0.2|0.2|Benign/Borderline|163|101938779|Male|Neuronal/glial, neuronal|2004
20+|0.0|0.0|0.0|Malignant|22|101938779|Male|Neuronal/glial, neuronal|2004
20+|0.2|0.2|0.2|Benign/Borderline|192|103190694|Male|Neuronal/glial, neuronal|2005
20+|0.0|0.0|0.0|Malignant|35|103190694|Male|Neuronal/glial, neuronal|2005
20+|0.2|0.2|0.2|Benign/Borderline|203|104488268|Male|Neuronal/glial, neuronal|2006
20+|0.0|0.0|0.0|Malignant|25|104488268|Male|Neuronal/glial, neuronal|2006
20+|0.1|0.2|0.2|Benign/Borderline|186|105697783|Male|Neuronal/glial, neuronal|2007
20+|0.0|0.0|0.0|Malignant|23|105697783|Male|Neuronal/glial, neuronal|2007
20+|0.2|0.2|0.2|Benign/Borderline|217|106947980|Male|Neuronal/glial, neuronal|2008
20+|0.0|0.0|0.0|Malignant|23|106947980|Male|Neuronal/glial, neuronal|2008
20+|0.2|0.2|0.2|Benign/Borderline|219|108197539|Male|Neuronal/glial, neuronal|2009
20+|0.0|0.0|0.0|Malignant|21|108197539|Male|Neuronal/glial, neuronal|2009
20+|0.2|0.2|0.2|Benign/Borderline|234|109565056|Male|Neuronal/glial, neuronal|2010
20+|~|~|~|Malignant|~|109565056|Male|Neuronal/glial, neuronal|2010
20+|0.1|0.2|0.2|Benign/Borderline|191|111031677|Male|Neuronal/glial, neuronal|2011
20+|0.0|0.0|0.0|Malignant|22|111031677|Male|Neuronal/glial, neuronal|2011
20+|0.2|0.2|0.2|Benign/Borderline|209|112556171|Male|Neuronal/glial, neuronal|2012
20+|0.0|0.0|0.0|Malignant|22|112556171|Male|Neuronal/glial, neuronal|2012
20+|0.2|0.2|0.2|Benign/Borderline|216|113963637|Male|Neuronal/glial, neuronal|2013
20+|0.0|0.0|0.0|Malignant|18|113963637|Male|Neuronal/glial, neuronal|2013
20+|0.2|0.2|0.2|Benign/Borderline|225|115373558|Male|Neuronal/glial, neuronal|2014
20+|0.0|0.0|0.0|Malignant|20|115373558|Male|Neuronal/glial, neuronal|2014
20+|0.2|0.3|0.2|Benign/Borderline|267|116752460|Male|Neuronal/glial, neuronal|2015
20+|0.0|0.0|0.0|Malignant|17|116752460|Male|Neuronal/glial, neuronal|2015
20+|0.2|0.2|0.2|Benign/Borderline|246|118061478|Male|Neuronal/glial, neuronal|2016
20+|0.0|0.0|0.0|Malignant|19|118061478|Male|Neuronal/glial, neuronal|2016
20+|0.2|0.2|0.2|Benign/Borderline|251|119249602|Male|Neuronal/glial, neuronal|2017
20+|~|~|~|Malignant|~|119249602|Male|Neuronal/glial, neuronal|2017
20+|0.2|0.2|0.2|Benign/Borderline|1197|594041481|Male|Neuronal/glial, neuronal|2017-2021
20+|0.0|0.0|0.0|Malignant|79|594041481|Male|Neuronal/glial, neuronal|2017-2021
20+|0.2|0.2|0.2|Benign/Borderline|253|120324107|Male|Neuronal/glial, neuronal|2018
20+|~|~|~|Malignant|~|120324107|Male|Neuronal/glial, neuronal|2018
20+|0.2|0.2|0.2|Benign/Borderline|255|121349512|Male|Neuronal/glial, neuronal|2019
20+|0.0|0.0|0.0|Malignant|17|121349512|Male|Neuronal/glial, neuronal|2019
20+|0.2|0.2|0.2|Benign/Borderline|212|119846062|Male|Neuronal/glial, neuronal|2020
20+|~|~|~|Malignant|~|119846062|Male|Neuronal/glial, neuronal|2020
20+|0.2|0.2|0.2|Benign/Borderline|237|120541161|Male|Neuronal/glial, neuronal|2021
20+|0.0|0.0|0.0|Malignant|25|120541161|Male|Neuronal/glial, neuronal|2021
20+|~|~|~|Benign/Borderline|~|101938779|Male|Oligodendroglioma|2004
20+|0.4|0.5|0.5|Malignant|477|101938779|Male|Oligodendroglioma|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Oligodendroglioma|2005
20+|0.4|0.5|0.4|Malignant|444|103190694|Male|Oligodendroglioma|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Oligodendroglioma|2006
20+|0.4|0.5|0.5|Malignant|481|104488268|Male|Oligodendroglioma|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Oligodendroglioma|2007
20+|0.4|0.5|0.4|Malignant|443|105697783|Male|Oligodendroglioma|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Oligodendroglioma|2008
20+|0.4|0.4|0.4|Malignant|419|106947980|Male|Oligodendroglioma|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Oligodendroglioma|2009
20+|0.4|0.5|0.5|Malignant|480|108197539|Male|Oligodendroglioma|2009
20+|~|~|~|Benign/Borderline|~|109565056|Male|Oligodendroglioma|2010
20+|0.4|0.5|0.4|Malignant|478|109565056|Male|Oligodendroglioma|2010
20+|~|~|~|Benign/Borderline|~|111031677|Male|Oligodendroglioma|2011
20+|0.4|0.5|0.4|Malignant|447|111031677|Male|Oligodendroglioma|2011
20+|~|~|~|Benign/Borderline|~|112556171|Male|Oligodendroglioma|2012
20+|0.3|0.4|0.3|Malignant|377|112556171|Male|Oligodendroglioma|2012
20+|~|~|~|Benign/Borderline|~|113963637|Male|Oligodendroglioma|2013
20+|0.3|0.4|0.3|Malignant|368|113963637|Male|Oligodendroglioma|2013
20+|~|~|~|Benign/Borderline|~|115373558|Male|Oligodendroglioma|2014
20+|0.3|0.4|0.4|Malignant|420|115373558|Male|Oligodendroglioma|2014
20+|~|~|~|Benign/Borderline|~|116752460|Male|Oligodendroglioma|2015
20+|0.3|0.4|0.4|Malignant|406|116752460|Male|Oligodendroglioma|2015
20+|~|~|~|Benign/Borderline|~|118061478|Male|Oligodendroglioma|2016
20+|0.3|0.4|0.4|Malignant|405|118061478|Male|Oligodendroglioma|2016
20+|~|~|~|Benign/Borderline|~|119249602|Male|Oligodendroglioma|2017
20+|0.3|0.4|0.4|Malignant|408|119249602|Male|Oligodendroglioma|2017
20+|~|~|~|Benign/Borderline|~|594041481|Male|Oligodendroglioma|2017-2021
20+|0.3|0.4|0.3|Malignant|1930|594041481|Male|Oligodendroglioma|2017-2021
20+|~|~|~|Benign/Borderline|~|120324107|Male|Oligodendroglioma|2018
20+|0.3|0.3|0.3|Malignant|355|120324107|Male|Oligodendroglioma|2018
20+|~|~|~|Benign/Borderline|~|121349512|Male|Oligodendroglioma|2019
20+|0.3|0.4|0.4|Malignant|424|121349512|Male|Oligodendroglioma|2019
20+|~|~|~|Benign/Borderline|~|119846062|Male|Oligodendroglioma|2020
20+|0.3|0.4|0.3|Malignant|358|119846062|Male|Oligodendroglioma|2020
20+|~|~|~|Benign/Borderline|~|120541161|Male|Oligodendroglioma|2021
20+|0.3|0.4|0.3|Malignant|401|120541161|Male|Oligodendroglioma|2021
20+|0.1|0.1|0.1|Benign/Borderline|83|101938779|Male|Other mesenchymal|2004
20+|0.0|0.0|0.0|Malignant|31|101938779|Male|Other mesenchymal|2004
20+|0.1|0.1|0.1|Benign/Borderline|74|103190694|Male|Other mesenchymal|2005
20+|0.0|0.1|0.0|Malignant|37|103190694|Male|Other mesenchymal|2005
20+|0.1|0.1|0.1|Benign/Borderline|69|104488268|Male|Other mesenchymal|2006
20+|0.0|0.0|0.0|Malignant|29|104488268|Male|Other mesenchymal|2006
20+|0.1|0.1|0.1|Benign/Borderline|82|105697783|Male|Other mesenchymal|2007
20+|0.0|0.1|0.0|Malignant|41|105697783|Male|Other mesenchymal|2007
20+|0.1|0.1|0.1|Benign/Borderline|105|106947980|Male|Other mesenchymal|2008
20+|0.0|0.1|0.0|Malignant|48|106947980|Male|Other mesenchymal|2008
20+|0.1|0.1|0.1|Benign/Borderline|103|108197539|Male|Other mesenchymal|2009
20+|0.0|0.1|0.0|Malignant|50|108197539|Male|Other mesenchymal|2009
20+|0.1|0.1|0.1|Benign/Borderline|80|109565056|Male|Other mesenchymal|2010
20+|0.0|0.0|0.0|Malignant|35|109565056|Male|Other mesenchymal|2010
20+|0.0|0.1|0.1|Benign/Borderline|68|111031677|Male|Other mesenchymal|2011
20+|0.0|0.1|0.0|Malignant|46|111031677|Male|Other mesenchymal|2011
20+|0.1|0.1|0.1|Benign/Borderline|93|112556171|Male|Other mesenchymal|2012
20+|0.0|0.0|0.0|Malignant|31|112556171|Male|Other mesenchymal|2012
20+|0.1|0.1|0.1|Benign/Borderline|74|113963637|Male|Other mesenchymal|2013
20+|0.0|0.1|0.0|Malignant|45|113963637|Male|Other mesenchymal|2013
20+|0.1|0.1|0.1|Benign/Borderline|89|115373558|Male|Other mesenchymal|2014
20+|0.0|0.1|0.0|Malignant|48|115373558|Male|Other mesenchymal|2014
20+|0.1|0.1|0.1|Benign/Borderline|108|116752460|Male|Other mesenchymal|2015
20+|0.0|0.1|0.0|Malignant|49|116752460|Male|Other mesenchymal|2015
20+|0.1|0.1|0.1|Benign/Borderline|83|118061478|Male|Other mesenchymal|2016
20+|0.0|0.0|0.0|Malignant|44|118061478|Male|Other mesenchymal|2016
20+|0.1|0.1|0.1|Benign/Borderline|84|119249602|Male|Other mesenchymal|2017
20+|0.0|0.1|0.0|Malignant|52|119249602|Male|Other mesenchymal|2017
20+|0.1|0.1|0.1|Benign/Borderline|375|594041481|Male|Other mesenchymal|2017-2021
20+|0.0|0.0|0.0|Malignant|265|594041481|Male|Other mesenchymal|2017-2021
20+|0.1|0.1|0.1|Benign/Borderline|85|120324107|Male|Other mesenchymal|2018
20+|0.0|0.1|0.0|Malignant|60|120324107|Male|Other mesenchymal|2018
20+|0.0|0.1|0.1|Benign/Borderline|76|121349512|Male|Other mesenchymal|2019
20+|0.0|0.1|0.0|Malignant|46|121349512|Male|Other mesenchymal|2019
20+|0.0|0.1|0.0|Benign/Borderline|58|119846062|Male|Other mesenchymal|2020
20+|0.0|0.1|0.0|Malignant|56|119846062|Male|Other mesenchymal|2020
20+|0.1|0.1|0.1|Benign/Borderline|78|120541161|Male|Other mesenchymal|2021
20+|0.0|0.1|0.0|Malignant|52|120541161|Male|Other mesenchymal|2021
20+|~|~|~|Benign/Borderline|~|101938779|Male|Pilocytic astrocytoma|2004
20+|0.1|0.2|0.1|Malignant|151|101938779|Male|Pilocytic astrocytoma|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Pilocytic astrocytoma|2005
20+|0.1|0.2|0.2|Malignant|159|103190694|Male|Pilocytic astrocytoma|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Pilocytic astrocytoma|2006
20+|0.1|0.2|0.1|Malignant|157|104488268|Male|Pilocytic astrocytoma|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Pilocytic astrocytoma|2007
20+|0.1|0.2|0.1|Malignant|142|105697783|Male|Pilocytic astrocytoma|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Pilocytic astrocytoma|2008
20+|0.1|0.2|0.1|Malignant|145|106947980|Male|Pilocytic astrocytoma|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Pilocytic astrocytoma|2009
20+|0.1|0.2|0.1|Malignant|138|108197539|Male|Pilocytic astrocytoma|2009
20+|~|~|~|Benign/Borderline|~|109565056|Male|Pilocytic astrocytoma|2010
20+|0.1|0.2|0.1|Malignant|164|109565056|Male|Pilocytic astrocytoma|2010
20+|~|~|~|Benign/Borderline|~|111031677|Male|Pilocytic astrocytoma|2011
20+|0.1|0.2|0.2|Malignant|175|111031677|Male|Pilocytic astrocytoma|2011
20+|~|~|~|Benign/Borderline|~|112556171|Male|Pilocytic astrocytoma|2012
20+|0.1|0.2|0.1|Malignant|147|112556171|Male|Pilocytic astrocytoma|2012
20+|~|~|~|Benign/Borderline|~|113963637|Male|Pilocytic astrocytoma|2013
20+|0.1|0.2|0.1|Malignant|148|113963637|Male|Pilocytic astrocytoma|2013
20+|~|~|~|Benign/Borderline|~|115373558|Male|Pilocytic astrocytoma|2014
20+|0.1|0.2|0.1|Malignant|152|115373558|Male|Pilocytic astrocytoma|2014
20+|~|~|~|Benign/Borderline|~|116752460|Male|Pilocytic astrocytoma|2015
20+|0.1|0.2|0.1|Malignant|149|116752460|Male|Pilocytic astrocytoma|2015
20+|~|~|~|Benign/Borderline|~|118061478|Male|Pilocytic astrocytoma|2016
20+|0.1|0.2|0.1|Malignant|163|118061478|Male|Pilocytic astrocytoma|2016
20+|~|~|~|Benign/Borderline|~|119249602|Male|Pilocytic astrocytoma|2017
20+|0.1|0.1|0.1|Malignant|143|119249602|Male|Pilocytic astrocytoma|2017
20+|0.0|0.0|0.0|Benign/Borderline|24|594041481|Male|Pilocytic astrocytoma|2017-2021
20+|0.1|0.1|0.1|Malignant|713|594041481|Male|Pilocytic astrocytoma|2017-2021
20+|~|~|~|Benign/Borderline|~|120324107|Male|Pilocytic astrocytoma|2018
20+|0.1|0.2|0.1|Malignant|154|120324107|Male|Pilocytic astrocytoma|2018
20+|~|~|~|Benign/Borderline|~|121349512|Male|Pilocytic astrocytoma|2019
20+|0.1|0.2|0.1|Malignant|163|121349512|Male|Pilocytic astrocytoma|2019
20+|~|~|~|Benign/Borderline|~|119846062|Male|Pilocytic astrocytoma|2020
20+|0.1|0.1|0.1|Malignant|138|119846062|Male|Pilocytic astrocytoma|2020
20+|~|~|~|Benign/Borderline|~|120541161|Male|Pilocytic astrocytoma|2021
20+|0.1|0.1|0.1|Malignant|128|120541161|Male|Pilocytic astrocytoma|2021
20+|~|~|~|Benign/Borderline|~|101938779|Male|Pineal parenchymal|2004
20+|~|~|~|Malignant|~|101938779|Male|Pineal parenchymal|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Pineal parenchymal|2005
20+|0.0|0.0|0.0|Malignant|18|103190694|Male|Pineal parenchymal|2005
20+|0.0|0.0|0.0|Benign/Borderline|18|104488268|Male|Pineal parenchymal|2006
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Pineal parenchymal|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Pineal parenchymal|2007
20+|0.0|0.0|0.0|Malignant|16|105697783|Male|Pineal parenchymal|2007
20+|0.0|0.0|0.0|Benign/Borderline|24|106947980|Male|Pineal parenchymal|2008
20+|0.0|0.0|0.0|Malignant|22|106947980|Male|Pineal parenchymal|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Pineal parenchymal|2009
20+|0.0|0.0|0.0|Malignant|18|108197539|Male|Pineal parenchymal|2009
20+|~|~|~|Benign/Borderline|~|109565056|Male|Pineal parenchymal|2010
20+|0.0|0.0|0.0|Malignant|18|109565056|Male|Pineal parenchymal|2010
20+|0.0|0.0|0.0|Benign/Borderline|16|111031677|Male|Pineal parenchymal|2011
20+|0.0|0.0|0.0|Malignant|18|111031677|Male|Pineal parenchymal|2011
20+|0.0|0.0|0.0|Benign/Borderline|25|112556171|Male|Pineal parenchymal|2012
20+|0.0|0.0|0.0|Malignant|20|112556171|Male|Pineal parenchymal|2012
20+|~|~|~|Benign/Borderline|~|113963637|Male|Pineal parenchymal|2013
20+|0.0|0.0|0.0|Malignant|36|113963637|Male|Pineal parenchymal|2013
20+|0.0|0.0|0.0|Benign/Borderline|22|115373558|Male|Pineal parenchymal|2014
20+|~|~|~|Malignant|~|115373558|Male|Pineal parenchymal|2014
20+|~|~|~|Benign/Borderline|~|116752460|Male|Pineal parenchymal|2015
20+|0.0|0.0|0.0|Malignant|28|116752460|Male|Pineal parenchymal|2015
20+|0.0|0.0|0.0|Benign/Borderline|26|118061478|Male|Pineal parenchymal|2016
20+|0.0|0.0|0.0|Malignant|34|118061478|Male|Pineal parenchymal|2016
20+|0.0|0.0|0.0|Benign/Borderline|17|119249602|Male|Pineal parenchymal|2017
20+|0.0|0.0|0.0|Malignant|28|119249602|Male|Pineal parenchymal|2017
20+|0.0|0.0|0.0|Benign/Borderline|84|594041481|Male|Pineal parenchymal|2017-2021
20+|0.0|0.0|0.0|Malignant|118|594041481|Male|Pineal parenchymal|2017-2021
20+|0.0|0.0|0.0|Benign/Borderline|24|120324107|Male|Pineal parenchymal|2018
20+|0.0|0.0|0.0|Malignant|20|120324107|Male|Pineal parenchymal|2018
20+|~|~|~|Benign/Borderline|~|121349512|Male|Pineal parenchymal|2019
20+|0.0|0.0|0.0|Malignant|18|121349512|Male|Pineal parenchymal|2019
20+|0.0|0.0|0.0|Benign/Borderline|17|119846062|Male|Pineal parenchymal|2020
20+|0.0|0.0|0.0|Malignant|24|119846062|Male|Pineal parenchymal|2020
20+|~|~|~|Benign/Borderline|~|120541161|Male|Pineal parenchymal|2021
20+|0.0|0.0|0.0|Malignant|28|120541161|Male|Pineal parenchymal|2021
20+|3.4|3.6|3.5|Benign/Borderline|3507|101938779|Male|Pituitary|2004
20+|0.0|0.0|0.0|Malignant|18|101938779|Male|Pituitary|2004
20+|3.7|4.0|3.8|Benign/Borderline|3868|103190694|Male|Pituitary|2005
20+|~|~|~|Malignant|~|103190694|Male|Pituitary|2005
20+|3.9|4.2|4.0|Benign/Borderline|4149|104488268|Male|Pituitary|2006
20+|0.0|0.0|0.0|Malignant|17|104488268|Male|Pituitary|2006
20+|4.2|4.5|4.3|Benign/Borderline|4556|105697783|Male|Pituitary|2007
20+|0.0|0.0|0.0|Malignant|25|105697783|Male|Pituitary|2007
20+|4.5|4.8|4.7|Benign/Borderline|4965|106947980|Male|Pituitary|2008
20+|~|~|~|Malignant|~|106947980|Male|Pituitary|2008
20+|4.8|5.0|4.9|Benign/Borderline|5320|108197539|Male|Pituitary|2009
20+|~|~|~|Malignant|~|108197539|Male|Pituitary|2009
20+|4.9|5.2|5.0|Benign/Borderline|5554|109565056|Male|Pituitary|2010
20+|0.0|0.0|0.0|Malignant|16|109565056|Male|Pituitary|2010
20+|5.0|5.2|5.1|Benign/Borderline|5711|111031677|Male|Pituitary|2011
20+|0.0|0.0|0.0|Malignant|21|111031677|Male|Pituitary|2011
20+|5.3|5.6|5.5|Benign/Borderline|6230|112556171|Male|Pituitary|2012
20+|0.0|0.0|0.0|Malignant|18|112556171|Male|Pituitary|2012
20+|5.3|5.6|5.5|Benign/Borderline|6323|113963637|Male|Pituitary|2013
20+|0.0|0.0|0.0|Malignant|26|113963637|Male|Pituitary|2013
20+|5.3|5.6|5.5|Benign/Borderline|6455|115373558|Male|Pituitary|2014
20+|0.0|0.0|0.0|Malignant|20|115373558|Male|Pituitary|2014
20+|5.5|5.8|5.6|Benign/Borderline|6727|116752460|Male|Pituitary|2015
20+|~|~|~|Malignant|~|116752460|Male|Pituitary|2015
20+|5.5|5.8|5.7|Benign/Borderline|6878|118061478|Male|Pituitary|2016
20+|~|~|~|Malignant|~|118061478|Male|Pituitary|2016
20+|5.6|5.9|5.8|Benign/Borderline|7141|119249602|Male|Pituitary|2017
20+|0.0|0.0|0.0|Malignant|16|119249602|Male|Pituitary|2017
20+|5.4|5.5|5.5|Benign/Borderline|33995|594041481|Male|Pituitary|2017-2021
20+|0.0|0.0|0.0|Malignant|67|594041481|Male|Pituitary|2017-2021
20+|5.6|5.8|5.7|Benign/Borderline|7149|120324107|Male|Pituitary|2018
20+|0.0|0.0|0.0|Malignant|18|120324107|Male|Pituitary|2018
20+|5.6|5.8|5.7|Benign/Borderline|7258|121349512|Male|Pituitary|2019
20+|~|~|~|Malignant|~|121349512|Male|Pituitary|2019
20+|4.7|5.0|4.9|Benign/Borderline|6126|119846062|Male|Pituitary|2020
20+|~|~|~|Malignant|~|119846062|Male|Pituitary|2020
20+|5.1|5.4|5.2|Benign/Borderline|6676|120541161|Male|Pituitary|2021
20+|~|~|~|Malignant|~|120541161|Male|Pituitary|2021
20+|12.5|13.0|12.8|Benign/Borderline|12457|101938779|Male|Total|2004
20+|10.7|11.1|10.9|Malignant|10655|101938779|Male|Total|2004
20+|14.0|14.5|14.2|Benign/Borderline|14094|103190694|Male|Total|2005
20+|10.7|11.1|10.9|Malignant|10817|103190694|Male|Total|2005
20+|14.4|14.9|14.6|Benign/Borderline|14768|104488268|Male|Total|2006
20+|10.5|10.9|10.7|Malignant|10840|104488268|Male|Total|2006
20+|14.8|15.3|15.1|Benign/Borderline|15478|105697783|Male|Total|2007
20+|10.5|10.9|10.7|Malignant|11083|105697783|Male|Total|2007
20+|15.8|16.2|16.0|Benign/Borderline|16728|106947980|Male|Total|2008
20+|10.6|11.0|10.8|Malignant|11394|106947980|Male|Total|2008
20+|16.6|17.1|16.8|Benign/Borderline|17875|108197539|Male|Total|2009
20+|10.5|10.9|10.7|Malignant|11435|108197539|Male|Total|2009
20+|16.7|17.2|16.9|Benign/Borderline|18319|109565056|Male|Total|2010
20+|10.2|10.6|10.4|Malignant|11420|109565056|Male|Total|2010
20+|16.7|17.2|17.0|Benign/Borderline|18772|111031677|Male|Total|2011
20+|10.2|10.6|10.4|Malignant|11674|111031677|Male|Total|2011
20+|17.4|17.9|17.6|Benign/Borderline|19865|112556171|Male|Total|2012
20+|10.0|10.4|10.2|Malignant|11674|112556171|Male|Total|2012
20+|17.7|18.2|17.9|Benign/Borderline|20543|113963637|Male|Total|2013
20+|10.0|10.4|10.2|Malignant|11896|113963637|Male|Total|2013
20+|17.9|18.4|18.1|Benign/Borderline|21154|115373558|Male|Total|2014
20+|10.1|10.5|10.3|Malignant|12229|115373558|Male|Total|2014
20+|18.3|18.8|18.5|Benign/Borderline|22062|116752460|Male|Total|2015
20+|9.8|10.2|10.0|Malignant|12101|116752460|Male|Total|2015
20+|18.3|18.8|18.6|Benign/Borderline|22412|118061478|Male|Total|2016
20+|9.9|10.3|10.1|Malignant|12532|118061478|Male|Total|2016
20+|18.7|19.2|19.0|Benign/Borderline|23408|119249602|Male|Total|2017
20+|9.9|10.2|10.0|Malignant|12619|119249602|Male|Total|2017
20+|18.3|18.5|18.4|Benign/Borderline|114672|594041481|Male|Total|2017-2021
20+|9.6|9.7|9.6|Malignant|61419|594041481|Male|Total|2017-2021
20+|18.5|19.0|18.8|Benign/Borderline|23569|120324107|Male|Total|2018
20+|9.7|10.0|9.8|Malignant|12578|120324107|Male|Total|2018
20+|18.9|19.4|19.2|Benign/Borderline|24389|121349512|Male|Total|2019
20+|9.6|9.9|9.7|Malignant|12653|121349512|Male|Total|2019
20+|16.9|17.4|17.1|Benign/Borderline|21673|119846062|Male|Total|2020
20+|9.3|9.6|9.4|Malignant|12281|119846062|Male|Total|2020
20+|17.6|18.0|17.8|Benign/Borderline|22753|120541161|Male|Total|2021
20+|9.0|9.4|9.2|Malignant|12039|120541161|Male|Total|2021
20+|2.2|2.4|2.3|Benign/Borderline|2356|101938779|Male|Tumors of Cranial and Spinal Nerves|2004
20+|0.0|0.0|0.0|Malignant|27|101938779|Male|Tumors of Cranial and Spinal Nerves|2004
20+|2.5|2.7|2.6|Benign/Borderline|2713|103190694|Male|Tumors of Cranial and Spinal Nerves|2005
20+|0.0|0.0|0.0|Malignant|31|103190694|Male|Tumors of Cranial and Spinal Nerves|2005
20+|2.4|2.6|2.5|Benign/Borderline|2690|104488268|Male|Tumors of Cranial and Spinal Nerves|2006
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Tumors of Cranial and Spinal Nerves|2006
20+|2.5|2.7|2.6|Benign/Borderline|2773|105697783|Male|Tumors of Cranial and Spinal Nerves|2007
20+|0.0|0.0|0.0|Malignant|20|105697783|Male|Tumors of Cranial and Spinal Nerves|2007
20+|2.4|2.6|2.5|Benign/Borderline|2759|106947980|Male|Tumors of Cranial and Spinal Nerves|2008
20+|0.0|0.0|0.0|Malignant|25|106947980|Male|Tumors of Cranial and Spinal Nerves|2008
20+|2.6|2.8|2.7|Benign/Borderline|2935|108197539|Male|Tumors of Cranial and Spinal Nerves|2009
20+|0.0|0.0|0.0|Malignant|21|108197539|Male|Tumors of Cranial and Spinal Nerves|2009
20+|2.5|2.7|2.6|Benign/Borderline|2977|109565056|Male|Tumors of Cranial and Spinal Nerves|2010
20+|0.0|0.0|0.0|Malignant|22|109565056|Male|Tumors of Cranial and Spinal Nerves|2010
20+|2.6|2.8|2.7|Benign/Borderline|3089|111031677|Male|Tumors of Cranial and Spinal Nerves|2011
20+|0.0|0.0|0.0|Malignant|17|111031677|Male|Tumors of Cranial and Spinal Nerves|2011
20+|2.7|2.9|2.8|Benign/Borderline|3277|112556171|Male|Tumors of Cranial and Spinal Nerves|2012
20+|0.0|0.0|0.0|Malignant|24|112556171|Male|Tumors of Cranial and Spinal Nerves|2012
20+|2.7|2.9|2.8|Benign/Borderline|3393|113963637|Male|Tumors of Cranial and Spinal Nerves|2013
20+|0.0|0.0|0.0|Malignant|21|113963637|Male|Tumors of Cranial and Spinal Nerves|2013
20+|2.9|3.1|3.0|Benign/Borderline|3660|115373558|Male|Tumors of Cranial and Spinal Nerves|2014
20+|0.0|0.0|0.0|Malignant|21|115373558|Male|Tumors of Cranial and Spinal Nerves|2014
20+|2.9|3.1|3.0|Benign/Borderline|3661|116752460|Male|Tumors of Cranial and Spinal Nerves|2015
20+|0.0|0.0|0.0|Malignant|16|116752460|Male|Tumors of Cranial and Spinal Nerves|2015
20+|2.8|3.0|2.9|Benign/Borderline|3619|118061478|Male|Tumors of Cranial and Spinal Nerves|2016
20+|0.0|0.0|0.0|Malignant|25|118061478|Male|Tumors of Cranial and Spinal Nerves|2016
20+|2.8|3.0|2.9|Benign/Borderline|3717|119249602|Male|Tumors of Cranial and Spinal Nerves|2017
20+|0.0|0.0|0.0|Malignant|25|119249602|Male|Tumors of Cranial and Spinal Nerves|2017
20+|2.7|2.8|2.7|Benign/Borderline|17438|594041481|Male|Tumors of Cranial and Spinal Nerves|2017-2021
20+|0.0|0.0|0.0|Malignant|96|594041481|Male|Tumors of Cranial and Spinal Nerves|2017-2021
20+|2.8|3.0|2.9|Benign/Borderline|3719|120324107|Male|Tumors of Cranial and Spinal Nerves|2018
20+|~|~|~|Malignant|~|120324107|Male|Tumors of Cranial and Spinal Nerves|2018
20+|2.8|3.0|2.9|Benign/Borderline|3727|121349512|Male|Tumors of Cranial and Spinal Nerves|2019
20+|0.0|0.0|0.0|Malignant|18|121349512|Male|Tumors of Cranial and Spinal Nerves|2019
20+|2.3|2.5|2.4|Benign/Borderline|3125|119846062|Male|Tumors of Cranial and Spinal Nerves|2020
20+|0.0|0.0|0.0|Malignant|23|119846062|Male|Tumors of Cranial and Spinal Nerves|2020
20+|2.5|2.7|2.6|Benign/Borderline|3324|120541161|Male|Tumors of Cranial and Spinal Nerves|2021
20+|0.0|0.0|0.0|Malignant|16|120541161|Male|Tumors of Cranial and Spinal Nerves|2021
20+|0.4|0.5|0.4|Benign/Borderline|454|101938779|Male|Tumors of Neuroepthelial Tissue|2004
20+|8.9|9.3|9.1|Malignant|8996|101938779|Male|Tumors of Neuroepthelial Tissue|2004
20+|0.5|0.6|0.5|Benign/Borderline|531|103190694|Male|Tumors of Neuroepthelial Tissue|2005
20+|8.9|9.3|9.1|Malignant|9116|103190694|Male|Tumors of Neuroepthelial Tissue|2005
20+|0.5|0.6|0.5|Benign/Borderline|566|104488268|Male|Tumors of Neuroepthelial Tissue|2006
20+|8.8|9.2|9.0|Malignant|9198|104488268|Male|Tumors of Neuroepthelial Tissue|2006
20+|0.4|0.5|0.5|Benign/Borderline|527|105697783|Male|Tumors of Neuroepthelial Tissue|2007
20+|8.8|9.2|9.0|Malignant|9410|105697783|Male|Tumors of Neuroepthelial Tissue|2007
20+|0.5|0.6|0.5|Benign/Borderline|590|106947980|Male|Tumors of Neuroepthelial Tissue|2008
20+|8.9|9.3|9.1|Malignant|9683|106947980|Male|Tumors of Neuroepthelial Tissue|2008
20+|0.5|0.6|0.6|Benign/Borderline|600|108197539|Male|Tumors of Neuroepthelial Tissue|2009
20+|8.9|9.2|9.0|Malignant|9745|108197539|Male|Tumors of Neuroepthelial Tissue|2009
20+|0.6|0.6|0.6|Benign/Borderline|651|109565056|Male|Tumors of Neuroepthelial Tissue|2010
20+|8.7|9.0|8.9|Malignant|9770|109565056|Male|Tumors of Neuroepthelial Tissue|2010
20+|0.5|0.6|0.6|Benign/Borderline|616|111031677|Male|Tumors of Neuroepthelial Tissue|2011
20+|8.6|9.0|8.8|Malignant|9931|111031677|Male|Tumors of Neuroepthelial Tissue|2011
20+|0.5|0.6|0.6|Benign/Borderline|641|112556171|Male|Tumors of Neuroepthelial Tissue|2012
20+|8.5|8.9|8.7|Malignant|9992|112556171|Male|Tumors of Neuroepthelial Tissue|2012
20+|0.5|0.6|0.5|Benign/Borderline|619|113963637|Male|Tumors of Neuroepthelial Tissue|2013
20+|8.6|8.9|8.7|Malignant|10223|113963637|Male|Tumors of Neuroepthelial Tissue|2013
20+|0.5|0.6|0.6|Benign/Borderline|687|115373558|Male|Tumors of Neuroepthelial Tissue|2014
20+|8.5|8.9|8.7|Malignant|10380|115373558|Male|Tumors of Neuroepthelial Tissue|2014
20+|0.6|0.6|0.6|Benign/Borderline|703|116752460|Male|Tumors of Neuroepthelial Tissue|2015
20+|8.3|8.7|8.5|Malignant|10331|116752460|Male|Tumors of Neuroepthelial Tissue|2015
20+|0.6|0.7|0.6|Benign/Borderline|732|118061478|Male|Tumors of Neuroepthelial Tissue|2016
20+|8.5|8.8|8.6|Malignant|10719|118061478|Male|Tumors of Neuroepthelial Tissue|2016
20+|0.6|0.7|0.6|Benign/Borderline|728|119249602|Male|Tumors of Neuroepthelial Tissue|2017
20+|8.4|8.7|8.6|Malignant|10808|119249602|Male|Tumors of Neuroepthelial Tissue|2017
20+|0.6|0.6|0.6|Benign/Borderline|3462|594041481|Male|Tumors of Neuroepthelial Tissue|2017-2021
20+|8.1|8.3|8.2|Malignant|52347|594041481|Male|Tumors of Neuroepthelial Tissue|2017-2021
20+|0.5|0.6|0.6|Benign/Borderline|711|120324107|Male|Tumors of Neuroepthelial Tissue|2018
20+|8.2|8.5|8.4|Malignant|10733|120324107|Male|Tumors of Neuroepthelial Tissue|2018
20+|0.6|0.6|0.6|Benign/Borderline|723|121349512|Male|Tumors of Neuroepthelial Tissue|2019
20+|8.1|8.4|8.3|Malignant|10783|121349512|Male|Tumors of Neuroepthelial Tissue|2019
20+|0.5|0.6|0.5|Benign/Borderline|660|119846062|Male|Tumors of Neuroepthelial Tissue|2020
20+|7.8|8.2|8.0|Malignant|10455|119846062|Male|Tumors of Neuroepthelial Tissue|2020
20+|0.5|0.6|0.6|Benign/Borderline|676|120541161|Male|Tumors of Neuroepthelial Tissue|2021
20+|7.6|7.9|7.8|Malignant|10216|120541161|Male|Tumors of Neuroepthelial Tissue|2021
20+|3.6|3.8|3.7|Benign/Borderline|3695|101938779|Male|Tumors of Sellar Region|2004
20+|0.0|0.0|0.0|Malignant|18|101938779|Male|Tumors of Sellar Region|2004
20+|3.9|4.2|4.1|Benign/Borderline|4102|103190694|Male|Tumors of Sellar Region|2005
20+|~|~|~|Malignant|~|103190694|Male|Tumors of Sellar Region|2005
20+|4.1|4.3|4.2|Benign/Borderline|4342|104488268|Male|Tumors of Sellar Region|2006
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Tumors of Sellar Region|2006
20+|4.4|4.7|4.5|Benign/Borderline|4758|105697783|Male|Tumors of Sellar Region|2007
20+|0.0|0.0|0.0|Malignant|25|105697783|Male|Tumors of Sellar Region|2007
20+|4.7|5.0|4.9|Benign/Borderline|5164|106947980|Male|Tumors of Sellar Region|2008
20+|~|~|~|Malignant|~|106947980|Male|Tumors of Sellar Region|2008
20+|5.0|5.2|5.1|Benign/Borderline|5521|108197539|Male|Tumors of Sellar Region|2009
20+|~|~|~|Malignant|~|108197539|Male|Tumors of Sellar Region|2009
20+|5.1|5.4|5.2|Benign/Borderline|5756|109565056|Male|Tumors of Sellar Region|2010
20+|0.0|0.0|0.0|Malignant|16|109565056|Male|Tumors of Sellar Region|2010
20+|5.1|5.4|5.3|Benign/Borderline|5908|111031677|Male|Tumors of Sellar Region|2011
20+|0.0|0.0|0.0|Malignant|22|111031677|Male|Tumors of Sellar Region|2011
20+|5.5|5.8|5.7|Benign/Borderline|6447|112556171|Male|Tumors of Sellar Region|2012
20+|0.0|0.0|0.0|Malignant|18|112556171|Male|Tumors of Sellar Region|2012
20+|5.5|5.8|5.7|Benign/Borderline|6559|113963637|Male|Tumors of Sellar Region|2013
20+|0.0|0.0|0.0|Malignant|26|113963637|Male|Tumors of Sellar Region|2013
20+|5.5|5.8|5.7|Benign/Borderline|6668|115373558|Male|Tumors of Sellar Region|2014
20+|0.0|0.0|0.0|Malignant|23|115373558|Male|Tumors of Sellar Region|2014
20+|5.7|5.9|5.8|Benign/Borderline|6954|116752460|Male|Tumors of Sellar Region|2015
20+|~|~|~|Malignant|~|116752460|Male|Tumors of Sellar Region|2015
20+|5.7|6.0|5.9|Benign/Borderline|7128|118061478|Male|Tumors of Sellar Region|2016
20+|~|~|~|Malignant|~|118061478|Male|Tumors of Sellar Region|2016
20+|5.8|6.1|6.0|Benign/Borderline|7387|119249602|Male|Tumors of Sellar Region|2017
20+|0.0|0.0|0.0|Malignant|16|119249602|Male|Tumors of Sellar Region|2017
20+|5.6|5.7|5.7|Benign/Borderline|35155|594041481|Male|Tumors of Sellar Region|2017-2021
20+|0.0|0.0|0.0|Malignant|68|594041481|Male|Tumors of Sellar Region|2017-2021
20+|5.7|6.0|5.9|Benign/Borderline|7378|120324107|Male|Tumors of Sellar Region|2018
20+|0.0|0.0|0.0|Malignant|18|120324107|Male|Tumors of Sellar Region|2018
20+|5.8|6.0|5.9|Benign/Borderline|7503|121349512|Male|Tumors of Sellar Region|2019
20+|~|~|~|Malignant|~|121349512|Male|Tumors of Sellar Region|2019
20+|4.9|5.2|5.0|Benign/Borderline|6355|119846062|Male|Tumors of Sellar Region|2020
20+|~|~|~|Malignant|~|119846062|Male|Tumors of Sellar Region|2020
20+|5.3|5.6|5.4|Benign/Borderline|6896|120541161|Male|Tumors of Sellar Region|2021
20+|~|~|~|Malignant|~|120541161|Male|Tumors of Sellar Region|2021
20+|5.4|5.7|5.6|Benign/Borderline|5284|101938779|Male|Tumors of the Meninges|2004
20+|0.2|0.2|0.2|Malignant|207|101938779|Male|Tumors of the Meninges|2004
20+|6.0|6.3|6.1|Benign/Borderline|5875|103190694|Male|Tumors of the Meninges|2005
20+|0.2|0.2|0.2|Malignant|193|103190694|Male|Tumors of the Meninges|2005
20+|6.3|6.6|6.4|Benign/Borderline|6276|104488268|Male|Tumors of the Meninges|2006
20+|0.2|0.2|0.2|Malignant|187|104488268|Male|Tumors of the Meninges|2006
20+|6.4|6.7|6.6|Benign/Borderline|6524|105697783|Male|Tumors of the Meninges|2007
20+|0.2|0.2|0.2|Malignant|221|105697783|Male|Tumors of the Meninges|2007
20+|6.9|7.3|7.1|Benign/Borderline|7225|106947980|Male|Tumors of the Meninges|2008
20+|0.2|0.2|0.2|Malignant|201|106947980|Male|Tumors of the Meninges|2008
20+|7.3|7.7|7.5|Benign/Borderline|7718|108197539|Male|Tumors of the Meninges|2009
20+|0.2|0.2|0.2|Malignant|201|108197539|Male|Tumors of the Meninges|2009
20+|7.2|7.5|7.4|Benign/Borderline|7770|109565056|Male|Tumors of the Meninges|2010
20+|0.1|0.2|0.1|Malignant|158|109565056|Male|Tumors of the Meninges|2010
20+|7.2|7.6|7.4|Benign/Borderline|7976|111031677|Male|Tumors of the Meninges|2011
20+|0.1|0.2|0.2|Malignant|188|111031677|Male|Tumors of the Meninges|2011
20+|7.3|7.6|7.5|Benign/Borderline|8242|112556171|Male|Tumors of the Meninges|2012
20+|0.1|0.2|0.2|Malignant|186|112556171|Male|Tumors of the Meninges|2012
20+|7.6|7.9|7.8|Benign/Borderline|8732|113963637|Male|Tumors of the Meninges|2013
20+|0.2|0.2|0.2|Malignant|203|113963637|Male|Tumors of the Meninges|2013
20+|7.6|7.9|7.8|Benign/Borderline|8943|115373558|Male|Tumors of the Meninges|2014
20+|0.2|0.2|0.2|Malignant|218|115373558|Male|Tumors of the Meninges|2014
20+|8.0|8.3|8.1|Benign/Borderline|9594|116752460|Male|Tumors of the Meninges|2015
20+|0.1|0.2|0.2|Malignant|199|116752460|Male|Tumors of the Meninges|2015
20+|8.1|8.4|8.2|Benign/Borderline|9864|118061478|Male|Tumors of the Meninges|2016
20+|0.1|0.2|0.2|Malignant|211|118061478|Male|Tumors of the Meninges|2016
20+|8.4|8.8|8.6|Benign/Borderline|10509|119249602|Male|Tumors of the Meninges|2017
20+|0.1|0.2|0.2|Malignant|208|119249602|Male|Tumors of the Meninges|2017
20+|8.5|8.7|8.6|Benign/Borderline|53564|594041481|Male|Tumors of the Meninges|2017-2021
20+|0.2|0.2|0.2|Malignant|997|594041481|Male|Tumors of the Meninges|2017-2021
20+|8.4|8.7|8.6|Benign/Borderline|10715|120324107|Male|Tumors of the Meninges|2018
20+|0.1|0.2|0.2|Malignant|205|120324107|Male|Tumors of the Meninges|2018
20+|8.8|9.2|9.0|Benign/Borderline|11439|121349512|Male|Tumors of the Meninges|2019
20+|0.1|0.2|0.2|Malignant|194|121349512|Male|Tumors of the Meninges|2019
20+|8.1|8.5|8.3|Benign/Borderline|10529|119846062|Male|Tumors of the Meninges|2020
20+|0.1|0.2|0.1|Malignant|193|119846062|Male|Tumors of the Meninges|2020
20+|8.3|8.6|8.4|Benign/Borderline|10875|120541161|Male|Tumors of the Meninges|2021
20+|0.1|0.2|0.2|Malignant|210|120541161|Male|Tumors of the Meninges|2021
20+|0.6|0.7|0.7|Benign/Borderline|644|101938779|Male|Unclassified Tumors|2004
20+|0.6|0.7|0.7|Malignant|593|101938779|Male|Unclassified Tumors|2004
20+|0.8|0.9|0.9|Benign/Borderline|840|103190694|Male|Unclassified Tumors|2005
20+|0.6|0.7|0.7|Malignant|611|103190694|Male|Unclassified Tumors|2005
20+|0.8|0.9|0.9|Benign/Borderline|863|104488268|Male|Unclassified Tumors|2006
20+|0.6|0.7|0.6|Malignant|575|104488268|Male|Unclassified Tumors|2006
20+|0.8|0.9|0.9|Benign/Borderline|859|105697783|Male|Unclassified Tumors|2007
20+|0.6|0.7|0.6|Malignant|574|105697783|Male|Unclassified Tumors|2007
20+|0.9|1.0|0.9|Benign/Borderline|955|106947980|Male|Unclassified Tumors|2008
20+|0.6|0.7|0.7|Malignant|625|106947980|Male|Unclassified Tumors|2008
20+|1.0|1.1|1.0|Benign/Borderline|1064|108197539|Male|Unclassified Tumors|2009
20+|0.6|0.7|0.7|Malignant|641|108197539|Male|Unclassified Tumors|2009
20+|1.0|1.1|1.1|Benign/Borderline|1136|109565056|Male|Unclassified Tumors|2010
20+|0.6|0.7|0.6|Malignant|613|109565056|Male|Unclassified Tumors|2010
20+|1.0|1.1|1.1|Benign/Borderline|1158|111031677|Male|Unclassified Tumors|2011
20+|0.6|0.7|0.6|Malignant|627|111031677|Male|Unclassified Tumors|2011
20+|1.1|1.2|1.1|Benign/Borderline|1225|112556171|Male|Unclassified Tumors|2012
20+|0.6|0.7|0.6|Malignant|631|112556171|Male|Unclassified Tumors|2012
20+|1.0|1.1|1.1|Benign/Borderline|1212|113963637|Male|Unclassified Tumors|2013
20+|0.5|0.6|0.6|Malignant|620|113963637|Male|Unclassified Tumors|2013
20+|1.0|1.1|1.0|Benign/Borderline|1167|115373558|Male|Unclassified Tumors|2014
20+|0.6|0.7|0.6|Malignant|679|115373558|Male|Unclassified Tumors|2014
20+|0.9|1.0|1.0|Benign/Borderline|1120|116752460|Male|Unclassified Tumors|2015
20+|0.5|0.6|0.6|Malignant|640|116752460|Male|Unclassified Tumors|2015
20+|0.8|1.0|0.9|Benign/Borderline|1035|118061478|Male|Unclassified Tumors|2016
20+|0.5|0.6|0.6|Malignant|649|118061478|Male|Unclassified Tumors|2016
20+|0.8|0.9|0.9|Benign/Borderline|1032|119249602|Male|Unclassified Tumors|2017
20+|0.5|0.5|0.5|Malignant|590|119249602|Male|Unclassified Tumors|2017
20+|0.8|0.8|0.8|Benign/Borderline|4925|594041481|Male|Unclassified Tumors|2017-2021
20+|0.5|0.6|0.6|Malignant|3359|594041481|Male|Unclassified Tumors|2017-2021
20+|0.8|0.9|0.8|Benign/Borderline|1020|120324107|Male|Unclassified Tumors|2018
20+|0.5|0.6|0.6|Malignant|681|120324107|Male|Unclassified Tumors|2018
20+|0.7|0.8|0.8|Benign/Borderline|968|121349512|Male|Unclassified Tumors|2019
20+|0.6|0.6|0.6|Malignant|732|121349512|Male|Unclassified Tumors|2019
20+|0.7|0.8|0.8|Benign/Borderline|980|119846062|Male|Unclassified Tumors|2020
20+|0.6|0.6|0.6|Malignant|723|119846062|Male|Unclassified Tumors|2020
20+|0.7|0.8|0.8|Benign/Borderline|968|120541161|Male|Unclassified Tumors|2021
20+|0.5|0.6|0.5|Malignant|671|120541161|Male|Unclassified Tumors|2021
20+|0.1|0.1|0.1|Benign/Borderline|100|101938779|Male|Unique astrocytoma variants|2004
20+|0.0|0.0|0.0|Malignant|18|101938779|Male|Unique astrocytoma variants|2004
20+|0.1|0.1|0.1|Benign/Borderline|116|103190694|Male|Unique astrocytoma variants|2005
20+|0.0|0.0|0.0|Malignant|17|103190694|Male|Unique astrocytoma variants|2005
20+|0.1|0.2|0.1|Benign/Borderline|140|104488268|Male|Unique astrocytoma variants|2006
20+|0.0|0.0|0.0|Malignant|25|104488268|Male|Unique astrocytoma variants|2006
20+|0.1|0.1|0.1|Benign/Borderline|125|105697783|Male|Unique astrocytoma variants|2007
20+|0.0|0.0|0.0|Malignant|30|105697783|Male|Unique astrocytoma variants|2007
20+|0.1|0.2|0.1|Benign/Borderline|152|106947980|Male|Unique astrocytoma variants|2008
20+|0.0|0.0|0.0|Malignant|36|106947980|Male|Unique astrocytoma variants|2008
20+|0.1|0.2|0.1|Benign/Borderline|163|108197539|Male|Unique astrocytoma variants|2009
20+|0.0|0.0|0.0|Malignant|37|108197539|Male|Unique astrocytoma variants|2009
20+|0.1|0.2|0.2|Benign/Borderline|185|109565056|Male|Unique astrocytoma variants|2010
20+|0.0|0.0|0.0|Malignant|26|109565056|Male|Unique astrocytoma variants|2010
20+|0.1|0.2|0.2|Benign/Borderline|194|111031677|Male|Unique astrocytoma variants|2011
20+|0.0|0.0|0.0|Malignant|32|111031677|Male|Unique astrocytoma variants|2011
20+|0.1|0.2|0.2|Benign/Borderline|181|112556171|Male|Unique astrocytoma variants|2012
20+|0.0|0.0|0.0|Malignant|27|112556171|Male|Unique astrocytoma variants|2012
20+|0.1|0.2|0.1|Benign/Borderline|174|113963637|Male|Unique astrocytoma variants|2013
20+|0.0|0.0|0.0|Malignant|39|113963637|Male|Unique astrocytoma variants|2013
20+|0.1|0.2|0.2|Benign/Borderline|183|115373558|Male|Unique astrocytoma variants|2014
20+|0.0|0.0|0.0|Malignant|40|115373558|Male|Unique astrocytoma variants|2014
20+|0.1|0.2|0.2|Benign/Borderline|180|116752460|Male|Unique astrocytoma variants|2015
20+|0.0|0.0|0.0|Malignant|28|116752460|Male|Unique astrocytoma variants|2015
20+|0.1|0.2|0.2|Benign/Borderline|205|118061478|Male|Unique astrocytoma variants|2016
20+|0.0|0.0|0.0|Malignant|31|118061478|Male|Unique astrocytoma variants|2016
20+|0.1|0.2|0.2|Benign/Borderline|210|119249602|Male|Unique astrocytoma variants|2017
20+|0.0|0.0|0.0|Malignant|43|119249602|Male|Unique astrocytoma variants|2017
20+|0.2|0.2|0.2|Benign/Borderline|1117|594041481|Male|Unique astrocytoma variants|2017-2021
20+|0.0|0.0|0.0|Malignant|169|594041481|Male|Unique astrocytoma variants|2017-2021
20+|0.2|0.2|0.2|Benign/Borderline|230|120324107|Male|Unique astrocytoma variants|2018
20+|0.0|0.0|0.0|Malignant|32|120324107|Male|Unique astrocytoma variants|2018
20+|0.2|0.2|0.2|Benign/Borderline|239|121349512|Male|Unique astrocytoma variants|2019
20+|0.0|0.0|0.0|Malignant|29|121349512|Male|Unique astrocytoma variants|2019
20+|0.2|0.2|0.2|Benign/Borderline|227|119846062|Male|Unique astrocytoma variants|2020
20+|0.0|0.0|0.0|Malignant|36|119846062|Male|Unique astrocytoma variants|2020
20+|0.2|0.2|0.2|Benign/Borderline|222|120541161|Male|Unique astrocytoma variants|2021
20+|0.0|0.0|0.0|Malignant|29|120541161|Male|Unique astrocytoma variants|2021
20+|0.0|0.0|0.0|Benign/Borderline|25|211050944|Male and Female|All other|2004
20+|~|~|~|Malignant|~|211050944|Male and Female|All other|2004
20+|0.0|0.0|0.0|Benign/Borderline|31|213511339|Male and Female|All other|2005
20+|~|~|~|Malignant|~|213511339|Male and Female|All other|2005
20+|0.0|0.0|0.0|Benign/Borderline|38|216055494|Male and Female|All other|2006
20+|~|~|~|Malignant|~|216055494|Male and Female|All other|2006
20+|0.0|0.0|0.0|Benign/Borderline|32|218481776|Male and Female|All other|2007
20+|~|~|~|Malignant|~|218481776|Male and Female|All other|2007
20+|0.0|0.0|0.0|Benign/Borderline|36|220975702|Male and Female|All other|2008
20+|~|~|~|Malignant|~|220975702|Male and Female|All other|2008
20+|0.0|0.0|0.0|Benign/Borderline|30|223491138|Male and Female|All other|2009
20+|~|~|~|Malignant|~|223491138|Male and Female|All other|2009
20+|0.0|0.0|0.0|Benign/Borderline|33|226163297|Male and Female|All other|2010
20+|0.0|0.0|0.0|Malignant|33|226163297|Male and Female|All other|2010
20+|0.0|0.0|0.0|Benign/Borderline|31|228849300|Male and Female|All other|2011
20+|0.0|0.0|0.0|Malignant|44|228849300|Male and Female|All other|2011
20+|0.0|0.0|0.0|Benign/Borderline|33|231560392|Male and Female|All other|2012
20+|0.0|0.0|0.0|Malignant|35|231560392|Male and Female|All other|2012
20+|0.0|0.0|0.0|Benign/Borderline|34|234048650|Male and Female|All other|2013
20+|0.0|0.0|0.0|Malignant|51|234048650|Male and Female|All other|2013
20+|0.0|0.0|0.0|Benign/Borderline|30|236576514|Male and Female|All other|2014
20+|0.0|0.0|0.0|Malignant|49|236576514|Male and Female|All other|2014
20+|0.0|0.0|0.0|Benign/Borderline|47|239015354|Male and Female|All other|2015
20+|0.0|0.0|0.0|Malignant|53|239015354|Male and Female|All other|2015
20+|0.0|0.0|0.0|Benign/Borderline|81|241359538|Male and Female|All other|2016
20+|0.0|0.0|0.0|Malignant|53|241359538|Male and Female|All other|2016
20+|0.0|0.0|0.0|Benign/Borderline|75|243493478|Male and Female|All other|2017
20+|0.0|0.0|0.0|Malignant|56|243493478|Male and Female|All other|2017
20+|0.0|0.0|0.0|Benign/Borderline|433|1210759812|Male and Female|All other|2017-2021
20+|0.1|0.2|0.2|Malignant|1883|1210759812|Male and Female|All other|2017-2021
20+|0.0|0.0|0.0|Benign/Borderline|94|245414364|Male and Female|All other|2018
20+|0.1|0.2|0.2|Malignant|398|245414364|Male and Female|All other|2018
20+|0.0|0.0|0.0|Benign/Borderline|87|247235681|Male and Female|All other|2019
20+|0.2|0.2|0.2|Malignant|509|247235681|Male and Female|All other|2019
20+|0.0|0.0|0.0|Benign/Borderline|81|243973474|Male and Female|All other|2020
20+|0.2|0.2|0.2|Malignant|498|243973474|Male and Female|All other|2020
20+|0.0|0.0|0.0|Benign/Borderline|100|245477881|Male and Female|All other|2021
20+|0.2|0.2|0.2|Malignant|443|245477881|Male and Female|All other|2021
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Anaplastic astrocytoma|2004
20+|0.6|0.6|0.6|Malignant|1243|211050944|Male and Female|Anaplastic astrocytoma|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Anaplastic astrocytoma|2005
20+|0.5|0.6|0.6|Malignant|1215|213511339|Male and Female|Anaplastic astrocytoma|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Anaplastic astrocytoma|2006
20+|0.5|0.6|0.6|Malignant|1214|216055494|Male and Female|Anaplastic astrocytoma|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Anaplastic astrocytoma|2007
20+|0.5|0.6|0.5|Malignant|1206|218481776|Male and Female|Anaplastic astrocytoma|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Anaplastic astrocytoma|2008
20+|0.5|0.6|0.5|Malignant|1213|220975702|Male and Female|Anaplastic astrocytoma|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Anaplastic astrocytoma|2009
20+|0.5|0.6|0.5|Malignant|1216|223491138|Male and Female|Anaplastic astrocytoma|2009
20+|~|~|~|Benign/Borderline|~|226163297|Male and Female|Anaplastic astrocytoma|2010
20+|0.5|0.6|0.6|Malignant|1286|226163297|Male and Female|Anaplastic astrocytoma|2010
20+|~|~|~|Benign/Borderline|~|228849300|Male and Female|Anaplastic astrocytoma|2011
20+|0.5|0.6|0.5|Malignant|1282|228849300|Male and Female|Anaplastic astrocytoma|2011
20+|~|~|~|Benign/Borderline|~|231560392|Male and Female|Anaplastic astrocytoma|2012
20+|0.5|0.6|0.6|Malignant|1338|231560392|Male and Female|Anaplastic astrocytoma|2012
20+|~|~|~|Benign/Borderline|~|234048650|Male and Female|Anaplastic astrocytoma|2013
20+|0.6|0.6|0.6|Malignant|1442|234048650|Male and Female|Anaplastic astrocytoma|2013
20+|~|~|~|Benign/Borderline|~|236576514|Male and Female|Anaplastic astrocytoma|2014
20+|0.6|0.6|0.6|Malignant|1418|236576514|Male and Female|Anaplastic astrocytoma|2014
20+|~|~|~|Benign/Borderline|~|239015354|Male and Female|Anaplastic astrocytoma|2015
20+|0.6|0.6|0.6|Malignant|1490|239015354|Male and Female|Anaplastic astrocytoma|2015
20+|~|~|~|Benign/Borderline|~|241359538|Male and Female|Anaplastic astrocytoma|2016
20+|0.6|0.6|0.6|Malignant|1477|241359538|Male and Female|Anaplastic astrocytoma|2016
20+|~|~|~|Benign/Borderline|~|243493478|Male and Female|Anaplastic astrocytoma|2017
20+|0.6|0.6|0.6|Malignant|1461|243493478|Male and Female|Anaplastic astrocytoma|2017
20+|~|~|~|Benign/Borderline|~|1210759812|Male and Female|Anaplastic astrocytoma|2017-2021
20+|0.5|0.5|0.5|Malignant|6045|1210759812|Male and Female|Anaplastic astrocytoma|2017-2021
20+|~|~|~|Benign/Borderline|~|245414364|Male and Female|Anaplastic astrocytoma|2018
20+|0.5|0.6|0.6|Malignant|1443|245414364|Male and Female|Anaplastic astrocytoma|2018
20+|~|~|~|Benign/Borderline|~|247235681|Male and Female|Anaplastic astrocytoma|2019
20+|0.5|0.5|0.5|Malignant|1295|247235681|Male and Female|Anaplastic astrocytoma|2019
20+|~|~|~|Benign/Borderline|~|243973474|Male and Female|Anaplastic astrocytoma|2020
20+|0.4|0.5|0.5|Malignant|1149|243973474|Male and Female|Anaplastic astrocytoma|2020
20+|~|~|~|Benign/Borderline|~|245477881|Male and Female|Anaplastic astrocytoma|2021
20+|0.3|0.4|0.3|Malignant|792|245477881|Male and Female|Anaplastic astrocytoma|2021
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Anaplastic oligodendroglioma|2004
20+|0.2|0.2|0.2|Malignant|399|211050944|Male and Female|Anaplastic oligodendroglioma|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Anaplastic oligodendroglioma|2005
20+|0.2|0.2|0.2|Malignant|378|213511339|Male and Female|Anaplastic oligodendroglioma|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Anaplastic oligodendroglioma|2006
20+|0.1|0.2|0.2|Malignant|353|216055494|Male and Female|Anaplastic oligodendroglioma|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Anaplastic oligodendroglioma|2007
20+|0.1|0.2|0.2|Malignant|351|218481776|Male and Female|Anaplastic oligodendroglioma|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Anaplastic oligodendroglioma|2008
20+|0.1|0.2|0.2|Malignant|360|220975702|Male and Female|Anaplastic oligodendroglioma|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Anaplastic oligodendroglioma|2009
20+|0.1|0.2|0.2|Malignant|340|223491138|Male and Female|Anaplastic oligodendroglioma|2009
20+|~|~|~|Benign/Borderline|~|226163297|Male and Female|Anaplastic oligodendroglioma|2010
20+|0.1|0.2|0.1|Malignant|330|226163297|Male and Female|Anaplastic oligodendroglioma|2010
20+|~|~|~|Benign/Borderline|~|228849300|Male and Female|Anaplastic oligodendroglioma|2011
20+|0.1|0.2|0.1|Malignant|343|228849300|Male and Female|Anaplastic oligodendroglioma|2011
20+|~|~|~|Benign/Borderline|~|231560392|Male and Female|Anaplastic oligodendroglioma|2012
20+|0.1|0.2|0.2|Malignant|359|231560392|Male and Female|Anaplastic oligodendroglioma|2012
20+|~|~|~|Benign/Borderline|~|234048650|Male and Female|Anaplastic oligodendroglioma|2013
20+|0.1|0.2|0.2|Malignant|377|234048650|Male and Female|Anaplastic oligodendroglioma|2013
20+|~|~|~|Benign/Borderline|~|236576514|Male and Female|Anaplastic oligodendroglioma|2014
20+|0.1|0.2|0.2|Malignant|362|236576514|Male and Female|Anaplastic oligodendroglioma|2014
20+|~|~|~|Benign/Borderline|~|239015354|Male and Female|Anaplastic oligodendroglioma|2015
20+|0.1|0.2|0.1|Malignant|356|239015354|Male and Female|Anaplastic oligodendroglioma|2015
20+|~|~|~|Benign/Borderline|~|241359538|Male and Female|Anaplastic oligodendroglioma|2016
20+|0.1|0.2|0.2|Malignant|371|241359538|Male and Female|Anaplastic oligodendroglioma|2016
20+|~|~|~|Benign/Borderline|~|243493478|Male and Female|Anaplastic oligodendroglioma|2017
20+|0.2|0.2|0.2|Malignant|423|243493478|Male and Female|Anaplastic oligodendroglioma|2017
20+|~|~|~|Benign/Borderline|~|1210759812|Male and Female|Anaplastic oligodendroglioma|2017-2021
20+|0.1|0.2|0.1|Malignant|1716|1210759812|Male and Female|Anaplastic oligodendroglioma|2017-2021
20+|~|~|~|Benign/Borderline|~|245414364|Male and Female|Anaplastic oligodendroglioma|2018
20+|0.1|0.2|0.1|Malignant|344|245414364|Male and Female|Anaplastic oligodendroglioma|2018
20+|~|~|~|Benign/Borderline|~|247235681|Male and Female|Anaplastic oligodendroglioma|2019
20+|0.1|0.2|0.2|Malignant|381|247235681|Male and Female|Anaplastic oligodendroglioma|2019
20+|~|~|~|Benign/Borderline|~|243973474|Male and Female|Anaplastic oligodendroglioma|2020
20+|0.1|0.1|0.1|Malignant|318|243973474|Male and Female|Anaplastic oligodendroglioma|2020
20+|~|~|~|Benign/Borderline|~|245477881|Male and Female|Anaplastic oligodendroglioma|2021
20+|0.1|0.1|0.1|Malignant|261|245477881|Male and Female|Anaplastic oligodendroglioma|2021
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Astrocytoma, NOS|2004
20+|0.5|0.6|0.6|Malignant|1209|211050944|Male and Female|Astrocytoma, NOS|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Astrocytoma, NOS|2005
20+|0.5|0.6|0.6|Malignant|1201|213511339|Male and Female|Astrocytoma, NOS|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Astrocytoma, NOS|2006
20+|0.5|0.6|0.6|Malignant|1191|216055494|Male and Female|Astrocytoma, NOS|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Astrocytoma, NOS|2007
20+|0.5|0.6|0.5|Malignant|1164|218481776|Male and Female|Astrocytoma, NOS|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Astrocytoma, NOS|2008
20+|0.5|0.5|0.5|Malignant|1125|220975702|Male and Female|Astrocytoma, NOS|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Astrocytoma, NOS|2009
20+|0.4|0.5|0.5|Malignant|1059|223491138|Male and Female|Astrocytoma, NOS|2009
20+|~|~|~|Benign/Borderline|~|226163297|Male and Female|Astrocytoma, NOS|2010
20+|0.5|0.5|0.5|Malignant|1103|226163297|Male and Female|Astrocytoma, NOS|2010
20+|~|~|~|Benign/Borderline|~|228849300|Male and Female|Astrocytoma, NOS|2011
20+|0.4|0.5|0.5|Malignant|1052|228849300|Male and Female|Astrocytoma, NOS|2011
20+|~|~|~|Benign/Borderline|~|231560392|Male and Female|Astrocytoma, NOS|2012
20+|0.4|0.5|0.5|Malignant|1056|231560392|Male and Female|Astrocytoma, NOS|2012
20+|~|~|~|Benign/Borderline|~|234048650|Male and Female|Astrocytoma, NOS|2013
20+|0.4|0.5|0.4|Malignant|1027|234048650|Male and Female|Astrocytoma, NOS|2013
20+|~|~|~|Benign/Borderline|~|236576514|Male and Female|Astrocytoma, NOS|2014
20+|0.4|0.5|0.5|Malignant|1105|236576514|Male and Female|Astrocytoma, NOS|2014
20+|~|~|~|Benign/Borderline|~|239015354|Male and Female|Astrocytoma, NOS|2015
20+|0.5|0.5|0.5|Malignant|1220|239015354|Male and Female|Astrocytoma, NOS|2015
20+|~|~|~|Benign/Borderline|~|241359538|Male and Female|Astrocytoma, NOS|2016
20+|0.5|0.6|0.5|Malignant|1276|241359538|Male and Female|Astrocytoma, NOS|2016
20+|~|~|~|Benign/Borderline|~|243493478|Male and Female|Astrocytoma, NOS|2017
20+|0.5|0.5|0.5|Malignant|1232|243493478|Male and Female|Astrocytoma, NOS|2017
20+|~|~|~|Benign/Borderline|~|1210759812|Male and Female|Astrocytoma, NOS|2017-2021
20+|0.5|0.5|0.5|Malignant|6356|1210759812|Male and Female|Astrocytoma, NOS|2017-2021
20+|~|~|~|Benign/Borderline|~|245414364|Male and Female|Astrocytoma, NOS|2018
20+|0.5|0.6|0.5|Malignant|1307|245414364|Male and Female|Astrocytoma, NOS|2018
20+|~|~|~|Benign/Borderline|~|247235681|Male and Female|Astrocytoma, NOS|2019
20+|0.5|0.5|0.5|Malignant|1255|247235681|Male and Female|Astrocytoma, NOS|2019
20+|~|~|~|Benign/Borderline|~|243973474|Male and Female|Astrocytoma, NOS|2020
20+|0.5|0.5|0.5|Malignant|1213|243973474|Male and Female|Astrocytoma, NOS|2020
20+|~|~|~|Benign/Borderline|~|245477881|Male and Female|Astrocytoma, NOS|2021
20+|0.6|0.6|0.6|Malignant|1430|245477881|Male and Female|Astrocytoma, NOS|2021
20+|0.0|0.0|0.0|Benign/Borderline|65|211050944|Male and Female|Choroid plexus|2004
20+|~|~|~|Malignant|~|211050944|Male and Female|Choroid plexus|2004
20+|0.0|0.0|0.0|Benign/Borderline|76|213511339|Male and Female|Choroid plexus|2005
20+|~|~|~|Malignant|~|213511339|Male and Female|Choroid plexus|2005
20+|0.0|0.0|0.0|Benign/Borderline|68|216055494|Male and Female|Choroid plexus|2006
20+|~|~|~|Malignant|~|216055494|Male and Female|Choroid plexus|2006
20+|0.0|0.1|0.0|Benign/Borderline|91|218481776|Male and Female|Choroid plexus|2007
20+|~|~|~|Malignant|~|218481776|Male and Female|Choroid plexus|2007
20+|0.0|0.0|0.0|Benign/Borderline|77|220975702|Male and Female|Choroid plexus|2008
20+|~|~|~|Malignant|~|220975702|Male and Female|Choroid plexus|2008
20+|0.0|0.0|0.0|Benign/Borderline|73|223491138|Male and Female|Choroid plexus|2009
20+|~|~|~|Malignant|~|223491138|Male and Female|Choroid plexus|2009
20+|0.0|0.0|0.0|Benign/Borderline|85|226163297|Male and Female|Choroid plexus|2010
20+|~|~|~|Malignant|~|226163297|Male and Female|Choroid plexus|2010
20+|0.0|0.0|0.0|Benign/Borderline|86|228849300|Male and Female|Choroid plexus|2011
20+|~|~|~|Malignant|~|228849300|Male and Female|Choroid plexus|2011
20+|0.0|0.0|0.0|Benign/Borderline|78|231560392|Male and Female|Choroid plexus|2012
20+|~|~|~|Malignant|~|231560392|Male and Female|Choroid plexus|2012
20+|0.0|0.0|0.0|Benign/Borderline|82|234048650|Male and Female|Choroid plexus|2013
20+|~|~|~|Malignant|~|234048650|Male and Female|Choroid plexus|2013
20+|0.0|0.0|0.0|Benign/Borderline|89|236576514|Male and Female|Choroid plexus|2014
20+|~|~|~|Malignant|~|236576514|Male and Female|Choroid plexus|2014
20+|0.0|0.0|0.0|Benign/Borderline|86|239015354|Male and Female|Choroid plexus|2015
20+|~|~|~|Malignant|~|239015354|Male and Female|Choroid plexus|2015
20+|0.0|0.0|0.0|Benign/Borderline|73|241359538|Male and Female|Choroid plexus|2016
20+|~|~|~|Malignant|~|241359538|Male and Female|Choroid plexus|2016
20+|0.0|0.0|0.0|Benign/Borderline|95|243493478|Male and Female|Choroid plexus|2017
20+|~|~|~|Malignant|~|243493478|Male and Female|Choroid plexus|2017
20+|0.0|0.0|0.0|Benign/Borderline|410|1210759812|Male and Female|Choroid plexus|2017-2021
20+|0.0|0.0|0.0|Malignant|31|1210759812|Male and Female|Choroid plexus|2017-2021
20+|0.0|0.0|0.0|Benign/Borderline|83|245414364|Male and Female|Choroid plexus|2018
20+|~|~|~|Malignant|~|245414364|Male and Female|Choroid plexus|2018
20+|0.0|0.0|0.0|Benign/Borderline|85|247235681|Male and Female|Choroid plexus|2019
20+|~|~|~|Malignant|~|247235681|Male and Female|Choroid plexus|2019
20+|0.0|0.0|0.0|Benign/Borderline|71|243973474|Male and Female|Choroid plexus|2020
20+|~|~|~|Malignant|~|243973474|Male and Female|Choroid plexus|2020
20+|0.0|0.0|0.0|Benign/Borderline|78|245477881|Male and Female|Choroid plexus|2021
20+|~|~|~|Malignant|~|245477881|Male and Female|Choroid plexus|2021
20+|0.2|0.2|0.2|Benign/Borderline|396|211050944|Male and Female|Craniopharyngioma|2004
20+|~|~|~|Malignant|~|211050944|Male and Female|Craniopharyngioma|2004
20+|0.2|0.2|0.2|Benign/Borderline|420|213511339|Male and Female|Craniopharyngioma|2005
20+|~|~|~|Malignant|~|213511339|Male and Female|Craniopharyngioma|2005
20+|0.2|0.2|0.2|Benign/Borderline|400|216055494|Male and Female|Craniopharyngioma|2006
20+|~|~|~|Malignant|~|216055494|Male and Female|Craniopharyngioma|2006
20+|0.2|0.2|0.2|Benign/Borderline|424|218481776|Male and Female|Craniopharyngioma|2007
20+|~|~|~|Malignant|~|218481776|Male and Female|Craniopharyngioma|2007
20+|0.2|0.2|0.2|Benign/Borderline|426|220975702|Male and Female|Craniopharyngioma|2008
20+|~|~|~|Malignant|~|220975702|Male and Female|Craniopharyngioma|2008
20+|0.2|0.2|0.2|Benign/Borderline|432|223491138|Male and Female|Craniopharyngioma|2009
20+|~|~|~|Malignant|~|223491138|Male and Female|Craniopharyngioma|2009
20+|0.2|0.2|0.2|Benign/Borderline|443|226163297|Male and Female|Craniopharyngioma|2010
20+|~|~|~|Malignant|~|226163297|Male and Female|Craniopharyngioma|2010
20+|0.2|0.2|0.2|Benign/Borderline|419|228849300|Male and Female|Craniopharyngioma|2011
20+|~|~|~|Malignant|~|228849300|Male and Female|Craniopharyngioma|2011
20+|0.2|0.2|0.2|Benign/Borderline|445|231560392|Male and Female|Craniopharyngioma|2012
20+|~|~|~|Malignant|~|231560392|Male and Female|Craniopharyngioma|2012
20+|0.2|0.2|0.2|Benign/Borderline|483|234048650|Male and Female|Craniopharyngioma|2013
20+|~|~|~|Malignant|~|234048650|Male and Female|Craniopharyngioma|2013
20+|0.2|0.2|0.2|Benign/Borderline|438|236576514|Male and Female|Craniopharyngioma|2014
20+|~|~|~|Malignant|~|236576514|Male and Female|Craniopharyngioma|2014
20+|0.2|0.2|0.2|Benign/Borderline|468|239015354|Male and Female|Craniopharyngioma|2015
20+|~|~|~|Malignant|~|239015354|Male and Female|Craniopharyngioma|2015
20+|0.2|0.2|0.2|Benign/Borderline|481|241359538|Male and Female|Craniopharyngioma|2016
20+|~|~|~|Malignant|~|241359538|Male and Female|Craniopharyngioma|2016
20+|0.2|0.2|0.2|Benign/Borderline|493|243493478|Male and Female|Craniopharyngioma|2017
20+|~|~|~|Malignant|~|243493478|Male and Female|Craniopharyngioma|2017
20+|0.2|0.2|0.2|Benign/Borderline|2288|1210759812|Male and Female|Craniopharyngioma|2017-2021
20+|~|~|~|Malignant|~|1210759812|Male and Female|Craniopharyngioma|2017-2021
20+|0.2|0.2|0.2|Benign/Borderline|475|245414364|Male and Female|Craniopharyngioma|2018
20+|~|~|~|Malignant|~|245414364|Male and Female|Craniopharyngioma|2018
20+|0.2|0.2|0.2|Benign/Borderline|479|247235681|Male and Female|Craniopharyngioma|2019
20+|~|~|~|Malignant|~|247235681|Male and Female|Craniopharyngioma|2019
20+|0.2|0.2|0.2|Benign/Borderline|437|243973474|Male and Female|Craniopharyngioma|2020
20+|~|~|~|Malignant|~|243973474|Male and Female|Craniopharyngioma|2020
20+|0.2|0.2|0.2|Benign/Borderline|423|245477881|Male and Female|Craniopharyngioma|2021
20+|~|~|~|Malignant|~|245477881|Male and Female|Craniopharyngioma|2021
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Diffuse astrocytoma|2004
20+|0.1|0.1|0.1|Malignant|260|211050944|Male and Female|Diffuse astrocytoma|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Diffuse astrocytoma|2005
20+|0.1|0.1|0.1|Malignant|281|213511339|Male and Female|Diffuse astrocytoma|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Diffuse astrocytoma|2006
20+|0.1|0.2|0.1|Malignant|294|216055494|Male and Female|Diffuse astrocytoma|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Diffuse astrocytoma|2007
20+|0.1|0.2|0.1|Malignant|318|218481776|Male and Female|Diffuse astrocytoma|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Diffuse astrocytoma|2008
20+|0.1|0.2|0.2|Malignant|340|220975702|Male and Female|Diffuse astrocytoma|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Diffuse astrocytoma|2009
20+|0.1|0.2|0.2|Malignant|368|223491138|Male and Female|Diffuse astrocytoma|2009
20+|~|~|~|Benign/Borderline|~|226163297|Male and Female|Diffuse astrocytoma|2010
20+|0.1|0.2|0.2|Malignant|350|226163297|Male and Female|Diffuse astrocytoma|2010
20+|~|~|~|Benign/Borderline|~|228849300|Male and Female|Diffuse astrocytoma|2011
20+|0.1|0.1|0.1|Malignant|250|228849300|Male and Female|Diffuse astrocytoma|2011
20+|~|~|~|Benign/Borderline|~|231560392|Male and Female|Diffuse astrocytoma|2012
20+|0.1|0.1|0.1|Malignant|207|231560392|Male and Female|Diffuse astrocytoma|2012
20+|~|~|~|Benign/Borderline|~|234048650|Male and Female|Diffuse astrocytoma|2013
20+|0.1|0.1|0.1|Malignant|174|234048650|Male and Female|Diffuse astrocytoma|2013
20+|~|~|~|Benign/Borderline|~|236576514|Male and Female|Diffuse astrocytoma|2014
20+|0.0|0.1|0.1|Malignant|132|236576514|Male and Female|Diffuse astrocytoma|2014
20+|~|~|~|Benign/Borderline|~|239015354|Male and Female|Diffuse astrocytoma|2015
20+|0.0|0.0|0.0|Malignant|84|239015354|Male and Female|Diffuse astrocytoma|2015
20+|~|~|~|Benign/Borderline|~|241359538|Male and Female|Diffuse astrocytoma|2016
20+|0.0|0.0|0.0|Malignant|35|241359538|Male and Female|Diffuse astrocytoma|2016
20+|~|~|~|Benign/Borderline|~|243493478|Male and Female|Diffuse astrocytoma|2017
20+|0.0|0.0|0.0|Malignant|24|243493478|Male and Female|Diffuse astrocytoma|2017
20+|~|~|~|Benign/Borderline|~|1210759812|Male and Female|Diffuse astrocytoma|2017-2021
20+|0.0|0.0|0.0|Malignant|75|1210759812|Male and Female|Diffuse astrocytoma|2017-2021
20+|~|~|~|Benign/Borderline|~|245414364|Male and Female|Diffuse astrocytoma|2018
20+|0.0|0.0|0.0|Malignant|23|245414364|Male and Female|Diffuse astrocytoma|2018
20+|~|~|~|Benign/Borderline|~|247235681|Male and Female|Diffuse astrocytoma|2019
20+|~|~|~|Malignant|~|247235681|Male and Female|Diffuse astrocytoma|2019
20+|~|~|~|Benign/Borderline|~|243973474|Male and Female|Diffuse astrocytoma|2020
20+|~|~|~|Malignant|~|243973474|Male and Female|Diffuse astrocytoma|2020
20+|~|~|~|Benign/Borderline|~|245477881|Male and Female|Diffuse astrocytoma|2021
20+|~|~|~|Malignant|~|245477881|Male and Female|Diffuse astrocytoma|2021
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Embryonal/primitive/medulloblastoma|2004
20+|0.1|0.1|0.1|Malignant|166|211050944|Male and Female|Embryonal/primitive/medulloblastoma|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Embryonal/primitive/medulloblastoma|2005
20+|0.1|0.1|0.1|Malignant|188|213511339|Male and Female|Embryonal/primitive/medulloblastoma|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Embryonal/primitive/medulloblastoma|2006
20+|0.1|0.1|0.1|Malignant|171|216055494|Male and Female|Embryonal/primitive/medulloblastoma|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Embryonal/primitive/medulloblastoma|2007
20+|0.1|0.1|0.1|Malignant|217|218481776|Male and Female|Embryonal/primitive/medulloblastoma|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Embryonal/primitive/medulloblastoma|2008
20+|0.1|0.1|0.1|Malignant|214|220975702|Male and Female|Embryonal/primitive/medulloblastoma|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Embryonal/primitive/medulloblastoma|2009
20+|0.1|0.1|0.1|Malignant|234|223491138|Male and Female|Embryonal/primitive/medulloblastoma|2009
20+|~|~|~|Benign/Borderline|~|226163297|Male and Female|Embryonal/primitive/medulloblastoma|2010
20+|0.1|0.1|0.1|Malignant|199|226163297|Male and Female|Embryonal/primitive/medulloblastoma|2010
20+|~|~|~|Benign/Borderline|~|228849300|Male and Female|Embryonal/primitive/medulloblastoma|2011
20+|0.1|0.1|0.1|Malignant|184|228849300|Male and Female|Embryonal/primitive/medulloblastoma|2011
20+|~|~|~|Benign/Borderline|~|231560392|Male and Female|Embryonal/primitive/medulloblastoma|2012
20+|0.1|0.1|0.1|Malignant|174|231560392|Male and Female|Embryonal/primitive/medulloblastoma|2012
20+|~|~|~|Benign/Borderline|~|234048650|Male and Female|Embryonal/primitive/medulloblastoma|2013
20+|0.1|0.1|0.1|Malignant|189|234048650|Male and Female|Embryonal/primitive/medulloblastoma|2013
20+|~|~|~|Benign/Borderline|~|236576514|Male and Female|Embryonal/primitive/medulloblastoma|2014
20+|0.1|0.1|0.1|Malignant|181|236576514|Male and Female|Embryonal/primitive/medulloblastoma|2014
20+|~|~|~|Benign/Borderline|~|239015354|Male and Female|Embryonal/primitive/medulloblastoma|2015
20+|0.1|0.1|0.1|Malignant|169|239015354|Male and Female|Embryonal/primitive/medulloblastoma|2015
20+|~|~|~|Benign/Borderline|~|241359538|Male and Female|Embryonal/primitive/medulloblastoma|2016
20+|0.1|0.1|0.1|Malignant|182|241359538|Male and Female|Embryonal/primitive/medulloblastoma|2016
20+|~|~|~|Benign/Borderline|~|243493478|Male and Female|Embryonal/primitive/medulloblastoma|2017
20+|0.1|0.1|0.1|Malignant|161|243493478|Male and Female|Embryonal/primitive/medulloblastoma|2017
20+|~|~|~|Benign/Borderline|~|1210759812|Male and Female|Embryonal/primitive/medulloblastoma|2017-2021
20+|0.1|0.1|0.1|Malignant|695|1210759812|Male and Female|Embryonal/primitive/medulloblastoma|2017-2021
20+|~|~|~|Benign/Borderline|~|245414364|Male and Female|Embryonal/primitive/medulloblastoma|2018
20+|0.1|0.1|0.1|Malignant|142|245414364|Male and Female|Embryonal/primitive/medulloblastoma|2018
20+|~|~|~|Benign/Borderline|~|247235681|Male and Female|Embryonal/primitive/medulloblastoma|2019
20+|0.1|0.1|0.1|Malignant|141|247235681|Male and Female|Embryonal/primitive/medulloblastoma|2019
20+|~|~|~|Benign/Borderline|~|243973474|Male and Female|Embryonal/primitive/medulloblastoma|2020
20+|0.0|0.1|0.1|Malignant|121|243973474|Male and Female|Embryonal/primitive/medulloblastoma|2020
20+|~|~|~|Benign/Borderline|~|245477881|Male and Female|Embryonal/primitive/medulloblastoma|2021
20+|0.0|0.1|0.1|Malignant|135|245477881|Male and Female|Embryonal/primitive/medulloblastoma|2021
20+|0.1|0.1|0.1|Benign/Borderline|249|211050944|Male and Female|Ependymoma variants|2004
20+|~|~|~|Malignant|~|211050944|Male and Female|Ependymoma variants|2004
20+|0.1|0.1|0.1|Benign/Borderline|268|213511339|Male and Female|Ependymoma variants|2005
20+|~|~|~|Malignant|~|213511339|Male and Female|Ependymoma variants|2005
20+|0.1|0.2|0.1|Benign/Borderline|312|216055494|Male and Female|Ependymoma variants|2006
20+|~|~|~|Malignant|~|216055494|Male and Female|Ependymoma variants|2006
20+|0.1|0.1|0.1|Benign/Borderline|251|218481776|Male and Female|Ependymoma variants|2007
20+|~|~|~|Malignant|~|218481776|Male and Female|Ependymoma variants|2007
20+|0.1|0.1|0.1|Benign/Borderline|256|220975702|Male and Female|Ependymoma variants|2008
20+|~|~|~|Malignant|~|220975702|Male and Female|Ependymoma variants|2008
20+|0.1|0.1|0.1|Benign/Borderline|262|223491138|Male and Female|Ependymoma variants|2009
20+|~|~|~|Malignant|~|223491138|Male and Female|Ependymoma variants|2009
20+|0.1|0.1|0.1|Benign/Borderline|279|226163297|Male and Female|Ependymoma variants|2010
20+|~|~|~|Malignant|~|226163297|Male and Female|Ependymoma variants|2010
20+|0.1|0.1|0.1|Benign/Borderline|273|228849300|Male and Female|Ependymoma variants|2011
20+|~|~|~|Malignant|~|228849300|Male and Female|Ependymoma variants|2011
20+|0.1|0.1|0.1|Benign/Borderline|293|231560392|Male and Female|Ependymoma variants|2012
20+|~|~|~|Malignant|~|231560392|Male and Female|Ependymoma variants|2012
20+|0.1|0.1|0.1|Benign/Borderline|278|234048650|Male and Female|Ependymoma variants|2013
20+|~|~|~|Malignant|~|234048650|Male and Female|Ependymoma variants|2013
20+|0.1|0.1|0.1|Benign/Borderline|301|236576514|Male and Female|Ependymoma variants|2014
20+|~|~|~|Malignant|~|236576514|Male and Female|Ependymoma variants|2014
20+|0.1|0.1|0.1|Benign/Borderline|297|239015354|Male and Female|Ependymoma variants|2015
20+|~|~|~|Malignant|~|239015354|Male and Female|Ependymoma variants|2015
20+|0.1|0.1|0.1|Benign/Borderline|298|241359538|Male and Female|Ependymoma variants|2016
20+|~|~|~|Malignant|~|241359538|Male and Female|Ependymoma variants|2016
20+|0.1|0.1|0.1|Benign/Borderline|282|243493478|Male and Female|Ependymoma variants|2017
20+|~|~|~|Malignant|~|243493478|Male and Female|Ependymoma variants|2017
20+|0.1|0.1|0.1|Benign/Borderline|1273|1210759812|Male and Female|Ependymoma variants|2017-2021
20+|0.0|0.0|0.0|Malignant|17|1210759812|Male and Female|Ependymoma variants|2017-2021
20+|0.1|0.1|0.1|Benign/Borderline|254|245414364|Male and Female|Ependymoma variants|2018
20+|~|~|~|Malignant|~|245414364|Male and Female|Ependymoma variants|2018
20+|0.1|0.1|0.1|Benign/Borderline|243|247235681|Male and Female|Ependymoma variants|2019
20+|~|~|~|Malignant|~|247235681|Male and Female|Ependymoma variants|2019
20+|0.1|0.1|0.1|Benign/Borderline|257|243973474|Male and Female|Ependymoma variants|2020
20+|~|~|~|Malignant|~|243973474|Male and Female|Ependymoma variants|2020
20+|0.1|0.1|0.1|Benign/Borderline|260|245477881|Male and Female|Ependymoma variants|2021
20+|~|~|~|Malignant|~|245477881|Male and Female|Ependymoma variants|2021
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Ependymoma/anaplastic ependymoma|2004
20+|0.3|0.3|0.3|Malignant|599|211050944|Male and Female|Ependymoma/anaplastic ependymoma|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Ependymoma/anaplastic ependymoma|2005
20+|0.3|0.3|0.3|Malignant|607|213511339|Male and Female|Ependymoma/anaplastic ependymoma|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Ependymoma/anaplastic ependymoma|2006
20+|0.2|0.3|0.3|Malignant|586|216055494|Male and Female|Ependymoma/anaplastic ependymoma|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Ependymoma/anaplastic ependymoma|2007
20+|0.2|0.3|0.3|Malignant|587|218481776|Male and Female|Ependymoma/anaplastic ependymoma|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Ependymoma/anaplastic ependymoma|2008
20+|0.3|0.3|0.3|Malignant|639|220975702|Male and Female|Ependymoma/anaplastic ependymoma|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Ependymoma/anaplastic ependymoma|2009
20+|0.3|0.3|0.3|Malignant|687|223491138|Male and Female|Ependymoma/anaplastic ependymoma|2009
20+|0.0|0.0|0.0|Benign/Borderline|17|226163297|Male and Female|Ependymoma/anaplastic ependymoma|2010
20+|0.3|0.3|0.3|Malignant|628|226163297|Male and Female|Ependymoma/anaplastic ependymoma|2010
20+|0.0|0.0|0.0|Benign/Borderline|17|228849300|Male and Female|Ependymoma/anaplastic ependymoma|2011
20+|0.2|0.3|0.3|Malignant|598|228849300|Male and Female|Ependymoma/anaplastic ependymoma|2011
20+|~|~|~|Benign/Borderline|~|231560392|Male and Female|Ependymoma/anaplastic ependymoma|2012
20+|0.2|0.3|0.3|Malignant|633|231560392|Male and Female|Ependymoma/anaplastic ependymoma|2012
20+|~|~|~|Benign/Borderline|~|234048650|Male and Female|Ependymoma/anaplastic ependymoma|2013
20+|0.2|0.3|0.2|Malignant|582|234048650|Male and Female|Ependymoma/anaplastic ependymoma|2013
20+|0.0|0.0|0.0|Benign/Borderline|29|236576514|Male and Female|Ependymoma/anaplastic ependymoma|2014
20+|0.2|0.3|0.2|Malignant|567|236576514|Male and Female|Ependymoma/anaplastic ependymoma|2014
20+|0.0|0.0|0.0|Benign/Borderline|27|239015354|Male and Female|Ependymoma/anaplastic ependymoma|2015
20+|0.2|0.3|0.2|Malignant|588|239015354|Male and Female|Ependymoma/anaplastic ependymoma|2015
20+|0.0|0.0|0.0|Benign/Borderline|21|241359538|Male and Female|Ependymoma/anaplastic ependymoma|2016
20+|0.2|0.3|0.3|Malignant|607|241359538|Male and Female|Ependymoma/anaplastic ependymoma|2016
20+|0.0|0.0|0.0|Benign/Borderline|25|243493478|Male and Female|Ependymoma/anaplastic ependymoma|2017
20+|0.2|0.3|0.2|Malignant|594|243493478|Male and Female|Ependymoma/anaplastic ependymoma|2017
20+|0.0|0.0|0.0|Benign/Borderline|105|1210759812|Male and Female|Ependymoma/anaplastic ependymoma|2017-2021
20+|0.2|0.2|0.2|Malignant|2660|1210759812|Male and Female|Ependymoma/anaplastic ependymoma|2017-2021
20+|0.0|0.0|0.0|Benign/Borderline|18|245414364|Male and Female|Ependymoma/anaplastic ependymoma|2018
20+|0.2|0.2|0.2|Malignant|549|245414364|Male and Female|Ependymoma/anaplastic ependymoma|2018
20+|0.0|0.0|0.0|Benign/Borderline|19|247235681|Male and Female|Ependymoma/anaplastic ependymoma|2019
20+|0.2|0.2|0.2|Malignant|535|247235681|Male and Female|Ependymoma/anaplastic ependymoma|2019
20+|0.0|0.0|0.0|Benign/Borderline|27|243973474|Male and Female|Ependymoma/anaplastic ependymoma|2020
20+|0.2|0.2|0.2|Malignant|516|243973474|Male and Female|Ependymoma/anaplastic ependymoma|2020
20+|0.0|0.0|0.0|Benign/Borderline|17|245477881|Male and Female|Ependymoma/anaplastic ependymoma|2021
20+|0.2|0.2|0.2|Malignant|496|245477881|Male and Female|Ependymoma/anaplastic ependymoma|2021
20+|0.0|0.0|0.0|Benign/Borderline|40|211050944|Male and Female|Germ Cell Tumors|2004
20+|0.0|0.0|0.0|Malignant|54|211050944|Male and Female|Germ Cell Tumors|2004
20+|0.0|0.0|0.0|Benign/Borderline|69|213511339|Male and Female|Germ Cell Tumors|2005
20+|0.0|0.0|0.0|Malignant|65|213511339|Male and Female|Germ Cell Tumors|2005
20+|0.0|0.0|0.0|Benign/Borderline|65|216055494|Male and Female|Germ Cell Tumors|2006
20+|0.0|0.0|0.0|Malignant|62|216055494|Male and Female|Germ Cell Tumors|2006
20+|0.0|0.0|0.0|Benign/Borderline|72|218481776|Male and Female|Germ Cell Tumors|2007
20+|0.0|0.0|0.0|Malignant|81|218481776|Male and Female|Germ Cell Tumors|2007
20+|0.0|0.0|0.0|Benign/Borderline|67|220975702|Male and Female|Germ Cell Tumors|2008
20+|0.0|0.0|0.0|Malignant|64|220975702|Male and Female|Germ Cell Tumors|2008
20+|0.0|0.0|0.0|Benign/Borderline|79|223491138|Male and Female|Germ Cell Tumors|2009
20+|0.0|0.0|0.0|Malignant|44|223491138|Male and Female|Germ Cell Tumors|2009
20+|0.0|0.0|0.0|Benign/Borderline|60|226163297|Male and Female|Germ Cell Tumors|2010
20+|0.0|0.0|0.0|Malignant|64|226163297|Male and Female|Germ Cell Tumors|2010
20+|0.0|0.0|0.0|Benign/Borderline|64|228849300|Male and Female|Germ Cell Tumors|2011
20+|0.0|0.0|0.0|Malignant|69|228849300|Male and Female|Germ Cell Tumors|2011
20+|0.0|0.0|0.0|Benign/Borderline|66|231560392|Male and Female|Germ Cell Tumors|2012
20+|0.0|0.0|0.0|Malignant|52|231560392|Male and Female|Germ Cell Tumors|2012
20+|0.0|0.0|0.0|Benign/Borderline|53|234048650|Male and Female|Germ Cell Tumors|2013
20+|0.0|0.0|0.0|Malignant|52|234048650|Male and Female|Germ Cell Tumors|2013
20+|0.0|0.0|0.0|Benign/Borderline|60|236576514|Male and Female|Germ Cell Tumors|2014
20+|0.0|0.0|0.0|Malignant|69|236576514|Male and Female|Germ Cell Tumors|2014
20+|0.0|0.0|0.0|Benign/Borderline|62|239015354|Male and Female|Germ Cell Tumors|2015
20+|0.0|0.0|0.0|Malignant|60|239015354|Male and Female|Germ Cell Tumors|2015
20+|0.0|0.0|0.0|Benign/Borderline|66|241359538|Male and Female|Germ Cell Tumors|2016
20+|0.0|0.0|0.0|Malignant|78|241359538|Male and Female|Germ Cell Tumors|2016
20+|0.0|0.0|0.0|Benign/Borderline|56|243493478|Male and Female|Germ Cell Tumors|2017
20+|0.0|0.0|0.0|Malignant|66|243493478|Male and Female|Germ Cell Tumors|2017
20+|0.0|0.0|0.0|Benign/Borderline|252|1210759812|Male and Female|Germ Cell Tumors|2017-2021
20+|0.0|0.0|0.0|Malignant|319|1210759812|Male and Female|Germ Cell Tumors|2017-2021
20+|0.0|0.0|0.0|Benign/Borderline|42|245414364|Male and Female|Germ Cell Tumors|2018
20+|0.0|0.0|0.0|Malignant|65|245414364|Male and Female|Germ Cell Tumors|2018
20+|0.0|0.0|0.0|Benign/Borderline|71|247235681|Male and Female|Germ Cell Tumors|2019
20+|0.0|0.0|0.0|Malignant|74|247235681|Male and Female|Germ Cell Tumors|2019
20+|0.0|0.0|0.0|Benign/Borderline|45|243973474|Male and Female|Germ Cell Tumors|2020
20+|0.0|0.0|0.0|Malignant|51|243973474|Male and Female|Germ Cell Tumors|2020
20+|0.0|0.0|0.0|Benign/Borderline|40|245477881|Male and Female|Germ Cell Tumors|2021
20+|0.0|0.0|0.0|Malignant|68|245477881|Male and Female|Germ Cell Tumors|2021
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Glioblastoma|2004
20+|4.4|4.6|4.5|Malignant|9589|211050944|Male and Female|Glioblastoma|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Glioblastoma|2005
20+|4.4|4.5|4.5|Malignant|9701|213511339|Male and Female|Glioblastoma|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Glioblastoma|2006
20+|4.3|4.5|4.4|Malignant|9785|216055494|Male and Female|Glioblastoma|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Glioblastoma|2007
20+|4.4|4.6|4.5|Malignant|10189|218481776|Male and Female|Glioblastoma|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Glioblastoma|2008
20+|4.4|4.6|4.5|Malignant|10413|220975702|Male and Female|Glioblastoma|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Glioblastoma|2009
20+|4.4|4.5|4.4|Malignant|10497|223491138|Male and Female|Glioblastoma|2009
20+|~|~|~|Benign/Borderline|~|226163297|Male and Female|Glioblastoma|2010
20+|4.4|4.5|4.4|Malignant|10737|226163297|Male and Female|Glioblastoma|2010
20+|~|~|~|Benign/Borderline|~|228849300|Male and Female|Glioblastoma|2011
20+|4.3|4.5|4.4|Malignant|10884|228849300|Male and Female|Glioblastoma|2011
20+|~|~|~|Benign/Borderline|~|231560392|Male and Female|Glioblastoma|2012
20+|4.4|4.6|4.5|Malignant|11363|231560392|Male and Female|Glioblastoma|2012
20+|~|~|~|Benign/Borderline|~|234048650|Male and Female|Glioblastoma|2013
20+|4.4|4.6|4.5|Malignant|11546|234048650|Male and Female|Glioblastoma|2013
20+|~|~|~|Benign/Borderline|~|236576514|Male and Female|Glioblastoma|2014
20+|4.3|4.5|4.4|Malignant|11609|236576514|Male and Female|Glioblastoma|2014
20+|~|~|~|Benign/Borderline|~|239015354|Male and Female|Glioblastoma|2015
20+|4.4|4.6|4.5|Malignant|12046|239015354|Male and Female|Glioblastoma|2015
20+|~|~|~|Benign/Borderline|~|241359538|Male and Female|Glioblastoma|2016
20+|4.5|4.6|4.5|Malignant|12436|241359538|Male and Female|Glioblastoma|2016
20+|~|~|~|Benign/Borderline|~|243493478|Male and Female|Glioblastoma|2017
20+|4.4|4.6|4.5|Malignant|12611|243493478|Male and Female|Glioblastoma|2017
20+|0.0|0.0|0.0|Benign/Borderline|17|1210759812|Male and Female|Glioblastoma|2017-2021
20+|4.4|4.5|4.4|Malignant|62832|1210759812|Male and Female|Glioblastoma|2017-2021
20+|~|~|~|Benign/Borderline|~|245414364|Male and Female|Glioblastoma|2018
20+|4.4|4.6|4.5|Malignant|12723|245414364|Male and Female|Glioblastoma|2018
20+|~|~|~|Benign/Borderline|~|247235681|Male and Female|Glioblastoma|2019
20+|4.4|4.5|4.5|Malignant|12849|247235681|Male and Female|Glioblastoma|2019
20+|~|~|~|Benign/Borderline|~|243973474|Male and Female|Glioblastoma|2020
20+|4.4|4.5|4.5|Malignant|12878|243973474|Male and Female|Glioblastoma|2020
20+|~|~|~|Benign/Borderline|~|245477881|Male and Female|Glioblastoma|2021
20+|4.2|4.4|4.3|Malignant|12586|245477881|Male and Female|Glioblastoma|2021
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Glioma malignant, NOS|2004
20+|0.4|0.4|0.4|Malignant|852|211050944|Male and Female|Glioma malignant, NOS|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Glioma malignant, NOS|2005
20+|0.4|0.4|0.4|Malignant|843|213511339|Male and Female|Glioma malignant, NOS|2005
20+|0.0|0.0|0.0|Benign/Borderline|19|216055494|Male and Female|Glioma malignant, NOS|2006
20+|0.4|0.4|0.4|Malignant|839|216055494|Male and Female|Glioma malignant, NOS|2006
20+|0.0|0.0|0.0|Benign/Borderline|16|218481776|Male and Female|Glioma malignant, NOS|2007
20+|0.4|0.4|0.4|Malignant|877|218481776|Male and Female|Glioma malignant, NOS|2007
20+|0.0|0.0|0.0|Benign/Borderline|23|220975702|Male and Female|Glioma malignant, NOS|2008
20+|0.4|0.4|0.4|Malignant|931|220975702|Male and Female|Glioma malignant, NOS|2008
20+|0.0|0.0|0.0|Benign/Borderline|28|223491138|Male and Female|Glioma malignant, NOS|2009
20+|0.4|0.5|0.4|Malignant|982|223491138|Male and Female|Glioma malignant, NOS|2009
20+|0.0|0.0|0.0|Benign/Borderline|22|226163297|Male and Female|Glioma malignant, NOS|2010
20+|0.3|0.4|0.4|Malignant|818|226163297|Male and Female|Glioma malignant, NOS|2010
20+|0.0|0.0|0.0|Benign/Borderline|30|228849300|Male and Female|Glioma malignant, NOS|2011
20+|0.4|0.4|0.4|Malignant|949|228849300|Male and Female|Glioma malignant, NOS|2011
20+|0.0|0.0|0.0|Benign/Borderline|31|231560392|Male and Female|Glioma malignant, NOS|2012
20+|0.4|0.4|0.4|Malignant|929|231560392|Male and Female|Glioma malignant, NOS|2012
20+|0.0|0.0|0.0|Benign/Borderline|30|234048650|Male and Female|Glioma malignant, NOS|2013
20+|0.4|0.4|0.4|Malignant|941|234048650|Male and Female|Glioma malignant, NOS|2013
20+|0.0|0.0|0.0|Benign/Borderline|41|236576514|Male and Female|Glioma malignant, NOS|2014
20+|0.4|0.4|0.4|Malignant|960|236576514|Male and Female|Glioma malignant, NOS|2014
20+|0.0|0.0|0.0|Benign/Borderline|52|239015354|Male and Female|Glioma malignant, NOS|2015
20+|0.4|0.4|0.4|Malignant|1007|239015354|Male and Female|Glioma malignant, NOS|2015
20+|0.0|0.0|0.0|Benign/Borderline|53|241359538|Male and Female|Glioma malignant, NOS|2016
20+|0.4|0.5|0.4|Malignant|1080|241359538|Male and Female|Glioma malignant, NOS|2016
20+|0.0|0.0|0.0|Benign/Borderline|51|243493478|Male and Female|Glioma malignant, NOS|2017
20+|0.4|0.5|0.5|Malignant|1169|243493478|Male and Female|Glioma malignant, NOS|2017
20+|0.0|0.0|0.0|Benign/Borderline|188|1210759812|Male and Female|Glioma malignant, NOS|2017-2021
20+|0.4|0.4|0.4|Malignant|5296|1210759812|Male and Female|Glioma malignant, NOS|2017-2021
20+|0.0|0.0|0.0|Benign/Borderline|39|245414364|Male and Female|Glioma malignant, NOS|2018
20+|0.4|0.4|0.4|Malignant|1086|245414364|Male and Female|Glioma malignant, NOS|2018
20+|0.0|0.0|0.0|Benign/Borderline|41|247235681|Male and Female|Glioma malignant, NOS|2019
20+|0.4|0.4|0.4|Malignant|1041|247235681|Male and Female|Glioma malignant, NOS|2019
20+|0.0|0.0|0.0|Benign/Borderline|28|243973474|Male and Female|Glioma malignant, NOS|2020
20+|0.4|0.4|0.4|Malignant|1040|243973474|Male and Female|Glioma malignant, NOS|2020
20+|0.0|0.0|0.0|Benign/Borderline|29|245477881|Male and Female|Glioma malignant, NOS|2021
20+|0.4|0.4|0.4|Malignant|1033|245477881|Male and Female|Glioma malignant, NOS|2021
20+|0.2|0.2|0.2|Benign/Borderline|461|211050944|Male and Female|Hemangioblastoma|2004
20+|~|~|~|Malignant|~|211050944|Male and Female|Hemangioblastoma|2004
20+|0.2|0.3|0.2|Benign/Borderline|522|213511339|Male and Female|Hemangioblastoma|2005
20+|~|~|~|Malignant|~|213511339|Male and Female|Hemangioblastoma|2005
20+|0.2|0.3|0.2|Benign/Borderline|501|216055494|Male and Female|Hemangioblastoma|2006
20+|~|~|~|Malignant|~|216055494|Male and Female|Hemangioblastoma|2006
20+|0.2|0.2|0.2|Benign/Borderline|473|218481776|Male and Female|Hemangioblastoma|2007
20+|~|~|~|Malignant|~|218481776|Male and Female|Hemangioblastoma|2007
20+|0.2|0.3|0.2|Benign/Borderline|537|220975702|Male and Female|Hemangioblastoma|2008
20+|~|~|~|Malignant|~|220975702|Male and Female|Hemangioblastoma|2008
20+|0.2|0.3|0.2|Benign/Borderline|515|223491138|Male and Female|Hemangioblastoma|2009
20+|~|~|~|Malignant|~|223491138|Male and Female|Hemangioblastoma|2009
20+|0.2|0.3|0.2|Benign/Borderline|544|226163297|Male and Female|Hemangioblastoma|2010
20+|~|~|~|Malignant|~|226163297|Male and Female|Hemangioblastoma|2010
20+|0.2|0.3|0.2|Benign/Borderline|532|228849300|Male and Female|Hemangioblastoma|2011
20+|~|~|~|Malignant|~|228849300|Male and Female|Hemangioblastoma|2011
20+|0.2|0.3|0.2|Benign/Borderline|550|231560392|Male and Female|Hemangioblastoma|2012
20+|~|~|~|Malignant|~|231560392|Male and Female|Hemangioblastoma|2012
20+|0.2|0.2|0.2|Benign/Borderline|513|234048650|Male and Female|Hemangioblastoma|2013
20+|~|~|~|Malignant|~|234048650|Male and Female|Hemangioblastoma|2013
20+|0.2|0.2|0.2|Benign/Borderline|501|236576514|Male and Female|Hemangioblastoma|2014
20+|~|~|~|Malignant|~|236576514|Male and Female|Hemangioblastoma|2014
20+|0.2|0.2|0.2|Benign/Borderline|550|239015354|Male and Female|Hemangioblastoma|2015
20+|~|~|~|Malignant|~|239015354|Male and Female|Hemangioblastoma|2015
20+|0.2|0.2|0.2|Benign/Borderline|569|241359538|Male and Female|Hemangioblastoma|2016
20+|~|~|~|Malignant|~|241359538|Male and Female|Hemangioblastoma|2016
20+|0.2|0.2|0.2|Benign/Borderline|567|243493478|Male and Female|Hemangioblastoma|2017
20+|~|~|~|Malignant|~|243493478|Male and Female|Hemangioblastoma|2017
20+|0.2|0.2|0.2|Benign/Borderline|2657|1210759812|Male and Female|Hemangioblastoma|2017-2021
20+|0.0|0.0|0.0|Malignant|20|1210759812|Male and Female|Hemangioblastoma|2017-2021
20+|0.2|0.2|0.2|Benign/Borderline|526|245414364|Male and Female|Hemangioblastoma|2018
20+|~|~|~|Malignant|~|245414364|Male and Female|Hemangioblastoma|2018
20+|0.2|0.2|0.2|Benign/Borderline|563|247235681|Male and Female|Hemangioblastoma|2019
20+|~|~|~|Malignant|~|247235681|Male and Female|Hemangioblastoma|2019
20+|0.2|0.2|0.2|Benign/Borderline|534|243973474|Male and Female|Hemangioblastoma|2020
20+|~|~|~|Malignant|~|243973474|Male and Female|Hemangioblastoma|2020
20+|0.2|0.2|0.2|Benign/Borderline|510|245477881|Male and Female|Hemangioblastoma|2021
20+|~|~|~|Malignant|~|245477881|Male and Female|Hemangioblastoma|2021
20+|0.2|0.2|0.2|Benign/Borderline|387|211050944|Male and Female|Hemangioma|2004
20+|~|~|~|Malignant|~|211050944|Male and Female|Hemangioma|2004
20+|0.2|0.3|0.2|Benign/Borderline|497|213511339|Male and Female|Hemangioma|2005
20+|~|~|~|Malignant|~|213511339|Male and Female|Hemangioma|2005
20+|0.2|0.3|0.3|Benign/Borderline|561|216055494|Male and Female|Hemangioma|2006
20+|~|~|~|Malignant|~|216055494|Male and Female|Hemangioma|2006
20+|0.3|0.3|0.3|Benign/Borderline|649|218481776|Male and Female|Hemangioma|2007
20+|~|~|~|Malignant|~|218481776|Male and Female|Hemangioma|2007
20+|0.3|0.4|0.4|Benign/Borderline|817|220975702|Male and Female|Hemangioma|2008
20+|~|~|~|Malignant|~|220975702|Male and Female|Hemangioma|2008
20+|0.4|0.5|0.4|Benign/Borderline|982|223491138|Male and Female|Hemangioma|2009
20+|~|~|~|Malignant|~|223491138|Male and Female|Hemangioma|2009
20+|0.5|0.5|0.5|Benign/Borderline|1133|226163297|Male and Female|Hemangioma|2010
20+|~|~|~|Malignant|~|226163297|Male and Female|Hemangioma|2010
20+|0.5|0.6|0.5|Benign/Borderline|1245|228849300|Male and Female|Hemangioma|2011
20+|~|~|~|Malignant|~|228849300|Male and Female|Hemangioma|2011
20+|0.5|0.6|0.5|Benign/Borderline|1253|231560392|Male and Female|Hemangioma|2012
20+|~|~|~|Malignant|~|231560392|Male and Female|Hemangioma|2012
20+|0.5|0.6|0.5|Benign/Borderline|1270|234048650|Male and Female|Hemangioma|2013
20+|~|~|~|Malignant|~|234048650|Male and Female|Hemangioma|2013
20+|0.5|0.5|0.5|Benign/Borderline|1210|236576514|Male and Female|Hemangioma|2014
20+|~|~|~|Malignant|~|236576514|Male and Female|Hemangioma|2014
20+|0.4|0.5|0.4|Benign/Borderline|1083|239015354|Male and Female|Hemangioma|2015
20+|~|~|~|Malignant|~|239015354|Male and Female|Hemangioma|2015
20+|0.4|0.4|0.4|Benign/Borderline|1022|241359538|Male and Female|Hemangioma|2016
20+|~|~|~|Malignant|~|241359538|Male and Female|Hemangioma|2016
20+|0.4|0.4|0.4|Benign/Borderline|1012|243493478|Male and Female|Hemangioma|2017
20+|~|~|~|Malignant|~|243493478|Male and Female|Hemangioma|2017
20+|0.4|0.4|0.4|Benign/Borderline|5036|1210759812|Male and Female|Hemangioma|2017-2021
20+|0.0|0.0|0.0|Malignant|16|1210759812|Male and Female|Hemangioma|2017-2021
20+|0.4|0.4|0.4|Benign/Borderline|1044|245414364|Male and Female|Hemangioma|2018
20+|~|~|~|Malignant|~|245414364|Male and Female|Hemangioma|2018
20+|0.4|0.4|0.4|Benign/Borderline|1032|247235681|Male and Female|Hemangioma|2019
20+|~|~|~|Malignant|~|247235681|Male and Female|Hemangioma|2019
20+|0.4|0.4|0.4|Benign/Borderline|1044|243973474|Male and Female|Hemangioma|2020
20+|~|~|~|Malignant|~|243973474|Male and Female|Hemangioma|2020
20+|0.3|0.4|0.4|Benign/Borderline|939|245477881|Male and Female|Hemangioma|2021
20+|~|~|~|Malignant|~|245477881|Male and Female|Hemangioma|2021
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Local Extensions from Regional Tumors|2004
20+|0.0|0.0|0.0|Malignant|49|211050944|Male and Female|Local Extensions from Regional Tumors|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Local Extensions from Regional Tumors|2005
20+|0.0|0.0|0.0|Malignant|45|213511339|Male and Female|Local Extensions from Regional Tumors|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Local Extensions from Regional Tumors|2006
20+|0.0|0.0|0.0|Malignant|53|216055494|Male and Female|Local Extensions from Regional Tumors|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Local Extensions from Regional Tumors|2007
20+|0.0|0.0|0.0|Malignant|48|218481776|Male and Female|Local Extensions from Regional Tumors|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Local Extensions from Regional Tumors|2008
20+|0.0|0.0|0.0|Malignant|51|220975702|Male and Female|Local Extensions from Regional Tumors|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Local Extensions from Regional Tumors|2009
20+|0.0|0.0|0.0|Malignant|55|223491138|Male and Female|Local Extensions from Regional Tumors|2009
20+|~|~|~|Benign/Borderline|~|226163297|Male and Female|Local Extensions from Regional Tumors|2010
20+|0.0|0.0|0.0|Malignant|52|226163297|Male and Female|Local Extensions from Regional Tumors|2010
20+|~|~|~|Benign/Borderline|~|228849300|Male and Female|Local Extensions from Regional Tumors|2011
20+|0.0|0.0|0.0|Malignant|44|228849300|Male and Female|Local Extensions from Regional Tumors|2011
20+|~|~|~|Benign/Borderline|~|231560392|Male and Female|Local Extensions from Regional Tumors|2012
20+|0.0|0.0|0.0|Malignant|47|231560392|Male and Female|Local Extensions from Regional Tumors|2012
20+|~|~|~|Benign/Borderline|~|234048650|Male and Female|Local Extensions from Regional Tumors|2013
20+|0.0|0.0|0.0|Malignant|46|234048650|Male and Female|Local Extensions from Regional Tumors|2013
20+|~|~|~|Benign/Borderline|~|236576514|Male and Female|Local Extensions from Regional Tumors|2014
20+|0.0|0.0|0.0|Malignant|50|236576514|Male and Female|Local Extensions from Regional Tumors|2014
20+|~|~|~|Benign/Borderline|~|239015354|Male and Female|Local Extensions from Regional Tumors|2015
20+|0.0|0.0|0.0|Malignant|41|239015354|Male and Female|Local Extensions from Regional Tumors|2015
20+|~|~|~|Benign/Borderline|~|241359538|Male and Female|Local Extensions from Regional Tumors|2016
20+|0.0|0.0|0.0|Malignant|41|241359538|Male and Female|Local Extensions from Regional Tumors|2016
20+|~|~|~|Benign/Borderline|~|243493478|Male and Female|Local Extensions from Regional Tumors|2017
20+|0.0|0.0|0.0|Malignant|39|243493478|Male and Female|Local Extensions from Regional Tumors|2017
20+|0.0|0.0|0.0|Benign/Borderline|17|1210759812|Male and Female|Local Extensions from Regional Tumors|2017-2021
20+|0.0|0.0|0.0|Malignant|155|1210759812|Male and Female|Local Extensions from Regional Tumors|2017-2021
20+|~|~|~|Benign/Borderline|~|245414364|Male and Female|Local Extensions from Regional Tumors|2018
20+|0.0|0.0|0.0|Malignant|29|245414364|Male and Female|Local Extensions from Regional Tumors|2018
20+|~|~|~|Benign/Borderline|~|247235681|Male and Female|Local Extensions from Regional Tumors|2019
20+|0.0|0.0|0.0|Malignant|34|247235681|Male and Female|Local Extensions from Regional Tumors|2019
20+|~|~|~|Benign/Borderline|~|243973474|Male and Female|Local Extensions from Regional Tumors|2020
20+|0.0|0.0|0.0|Malignant|23|243973474|Male and Female|Local Extensions from Regional Tumors|2020
20+|~|~|~|Benign/Borderline|~|245477881|Male and Female|Local Extensions from Regional Tumors|2021
20+|0.0|0.0|0.0|Malignant|32|245477881|Male and Female|Local Extensions from Regional Tumors|2021
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004
20+|0.6|0.7|0.6|Malignant|1340|211050944|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005
20+|0.6|0.7|0.7|Malignant|1440|213511339|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006
20+|0.6|0.7|0.7|Malignant|1436|216055494|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007
20+|0.6|0.7|0.6|Malignant|1375|218481776|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008
20+|0.6|0.7|0.7|Malignant|1477|220975702|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009
20+|0.6|0.6|0.6|Malignant|1419|223491138|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009
20+|~|~|~|Benign/Borderline|~|226163297|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010
20+|0.6|0.7|0.6|Malignant|1498|226163297|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010
20+|~|~|~|Benign/Borderline|~|228849300|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011
20+|0.6|0.7|0.6|Malignant|1518|228849300|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011
20+|~|~|~|Benign/Borderline|~|231560392|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012
20+|0.6|0.6|0.6|Malignant|1456|231560392|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012
20+|~|~|~|Benign/Borderline|~|234048650|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013
20+|0.6|0.6|0.6|Malignant|1469|234048650|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013
20+|~|~|~|Benign/Borderline|~|236576514|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014
20+|0.6|0.7|0.6|Malignant|1636|236576514|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014
20+|~|~|~|Benign/Borderline|~|239015354|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015
20+|0.6|0.6|0.6|Malignant|1585|239015354|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015
20+|~|~|~|Benign/Borderline|~|241359538|Male and Female|Lymphomas and Hematopoietic Neoplasms|2016
20+|0.6|0.7|0.6|Malignant|1660|241359538|Male and Female|Lymphomas and Hematopoietic Neoplasms|2016
20+|~|~|~|Benign/Borderline|~|243493478|Male and Female|Lymphomas and Hematopoietic Neoplasms|2017
20+|0.6|0.7|0.6|Malignant|1719|243493478|Male and Female|Lymphomas and Hematopoietic Neoplasms|2017
20+|~|~|~|Benign/Borderline|~|1210759812|Male and Female|Lymphomas and Hematopoietic Neoplasms|2017-2021
20+|0.6|0.6|0.6|Malignant|8182|1210759812|Male and Female|Lymphomas and Hematopoietic Neoplasms|2017-2021
20+|~|~|~|Benign/Borderline|~|245414364|Male and Female|Lymphomas and Hematopoietic Neoplasms|2018
20+|0.6|0.6|0.6|Malignant|1672|245414364|Male and Female|Lymphomas and Hematopoietic Neoplasms|2018
20+|~|~|~|Benign/Borderline|~|247235681|Male and Female|Lymphomas and Hematopoietic Neoplasms|2019
20+|0.5|0.6|0.6|Malignant|1633|247235681|Male and Female|Lymphomas and Hematopoietic Neoplasms|2019
20+|~|~|~|Benign/Borderline|~|243973474|Male and Female|Lymphomas and Hematopoietic Neoplasms|2020
20+|0.5|0.6|0.6|Malignant|1644|243973474|Male and Female|Lymphomas and Hematopoietic Neoplasms|2020
20+|~|~|~|Benign/Borderline|~|245477881|Male and Female|Lymphomas and Hematopoietic Neoplasms|2021
20+|0.5|0.6|0.6|Malignant|1607|245477881|Male and Female|Lymphomas and Hematopoietic Neoplasms|2021
20+|9.0|9.2|9.1|Benign/Borderline|19361|211050944|Male and Female|Meningioma|2004
20+|0.2|0.2|0.2|Malignant|450|211050944|Male and Female|Meningioma|2004
20+|10.0|10.3|10.2|Benign/Borderline|21980|213511339|Male and Female|Meningioma|2005
20+|0.2|0.2|0.2|Malignant|434|213511339|Male and Female|Meningioma|2005
20+|10.5|10.8|10.7|Benign/Borderline|23484|216055494|Male and Female|Meningioma|2006
20+|0.2|0.2|0.2|Malignant|407|216055494|Male and Female|Meningioma|2006
20+|10.9|11.2|11.1|Benign/Borderline|24766|218481776|Male and Female|Meningioma|2007
20+|0.2|0.2|0.2|Malignant|442|218481776|Male and Female|Meningioma|2007
20+|11.6|11.9|11.7|Benign/Borderline|26743|220975702|Male and Female|Meningioma|2008
20+|0.1|0.2|0.2|Malignant|366|220975702|Male and Female|Meningioma|2008
20+|12.3|12.6|12.5|Benign/Borderline|28966|223491138|Male and Female|Meningioma|2009
20+|0.1|0.2|0.2|Malignant|358|223491138|Male and Female|Meningioma|2009
20+|12.0|12.3|12.1|Benign/Borderline|28684|226163297|Male and Female|Meningioma|2010
20+|0.1|0.2|0.1|Malignant|331|226163297|Male and Female|Meningioma|2010
20+|12.1|12.4|12.2|Benign/Borderline|29436|228849300|Male and Female|Meningioma|2011
20+|0.1|0.2|0.1|Malignant|327|228849300|Male and Female|Meningioma|2011
20+|12.3|12.6|12.5|Benign/Borderline|30519|231560392|Male and Female|Meningioma|2012
20+|0.1|0.2|0.1|Malignant|359|231560392|Male and Female|Meningioma|2012
20+|12.6|12.8|12.7|Benign/Borderline|31638|234048650|Male and Female|Meningioma|2013
20+|0.1|0.2|0.2|Malignant|383|234048650|Male and Female|Meningioma|2013
20+|12.8|13.1|12.9|Benign/Borderline|32896|236576514|Male and Female|Meningioma|2014
20+|0.1|0.2|0.1|Malignant|389|236576514|Male and Female|Meningioma|2014
20+|13.3|13.6|13.4|Benign/Borderline|34770|239015354|Male and Female|Meningioma|2015
20+|0.1|0.1|0.1|Malignant|350|239015354|Male and Female|Meningioma|2015
20+|13.6|13.9|13.7|Benign/Borderline|36031|241359538|Male and Female|Meningioma|2016
20+|0.1|0.1|0.1|Malignant|337|241359538|Male and Female|Meningioma|2016
20+|14.0|14.3|14.1|Benign/Borderline|37832|243493478|Male and Female|Meningioma|2017
20+|0.1|0.1|0.1|Malignant|334|243493478|Male and Female|Meningioma|2017
20+|14.1|14.2|14.1|Benign/Borderline|191632|1210759812|Male and Female|Meningioma|2017-2021
20+|0.1|0.1|0.1|Malignant|1591|1210759812|Male and Female|Meningioma|2017-2021
20+|14.0|14.3|14.2|Benign/Borderline|38621|245414364|Male and Female|Meningioma|2018
20+|0.1|0.1|0.1|Malignant|322|245414364|Male and Female|Meningioma|2018
20+|14.6|14.9|14.8|Benign/Borderline|41006|247235681|Male and Female|Meningioma|2019
20+|0.1|0.1|0.1|Malignant|307|247235681|Male and Female|Meningioma|2019
20+|13.2|13.5|13.3|Benign/Borderline|36788|243973474|Male and Female|Meningioma|2020
20+|0.1|0.1|0.1|Malignant|296|243973474|Male and Female|Meningioma|2020
20+|13.9|14.1|14.0|Benign/Borderline|39147|245477881|Male and Female|Meningioma|2021
20+|0.1|0.1|0.1|Malignant|347|245477881|Male and Female|Meningioma|2021
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Mixed glioma|2004
20+|0.2|0.3|0.2|Malignant|493|211050944|Male and Female|Mixed glioma|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Mixed glioma|2005
20+|0.2|0.3|0.3|Malignant|565|213511339|Male and Female|Mixed glioma|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Mixed glioma|2006
20+|0.3|0.3|0.3|Malignant|640|216055494|Male and Female|Mixed glioma|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Mixed glioma|2007
20+|0.3|0.3|0.3|Malignant|591|218481776|Male and Female|Mixed glioma|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Mixed glioma|2008
20+|0.3|0.3|0.3|Malignant|603|220975702|Male and Female|Mixed glioma|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Mixed glioma|2009
20+|0.3|0.3|0.3|Malignant|678|223491138|Male and Female|Mixed glioma|2009
20+|~|~|~|Benign/Borderline|~|226163297|Male and Female|Mixed glioma|2010
20+|0.3|0.3|0.3|Malignant|613|226163297|Male and Female|Mixed glioma|2010
20+|~|~|~|Benign/Borderline|~|228849300|Male and Female|Mixed glioma|2011
20+|0.3|0.3|0.3|Malignant|641|228849300|Male and Female|Mixed glioma|2011
20+|~|~|~|Benign/Borderline|~|231560392|Male and Female|Mixed glioma|2012
20+|0.2|0.3|0.3|Malignant|574|231560392|Male and Female|Mixed glioma|2012
20+|~|~|~|Benign/Borderline|~|234048650|Male and Female|Mixed glioma|2013
20+|0.3|0.3|0.3|Malignant|621|234048650|Male and Female|Mixed glioma|2013
20+|~|~|~|Benign/Borderline|~|236576514|Male and Female|Mixed glioma|2014
20+|0.2|0.2|0.2|Malignant|469|236576514|Male and Female|Mixed glioma|2014
20+|~|~|~|Benign/Borderline|~|239015354|Male and Female|Mixed glioma|2015
20+|0.1|0.1|0.1|Malignant|275|239015354|Male and Female|Mixed glioma|2015
20+|~|~|~|Benign/Borderline|~|241359538|Male and Female|Mixed glioma|2016
20+|0.0|0.1|0.0|Malignant|105|241359538|Male and Female|Mixed glioma|2016
20+|~|~|~|Benign/Borderline|~|243493478|Male and Female|Mixed glioma|2017
20+|0.0|0.0|0.0|Malignant|60|243493478|Male and Female|Mixed glioma|2017
20+|~|~|~|Benign/Borderline|~|1210759812|Male and Female|Mixed glioma|2017-2021
20+|0.0|0.0|0.0|Malignant|124|1210759812|Male and Female|Mixed glioma|2017-2021
20+|~|~|~|Benign/Borderline|~|245414364|Male and Female|Mixed glioma|2018
20+|0.0|0.0|0.0|Malignant|20|245414364|Male and Female|Mixed glioma|2018
20+|~|~|~|Benign/Borderline|~|247235681|Male and Female|Mixed glioma|2019
20+|0.0|0.0|0.0|Malignant|20|247235681|Male and Female|Mixed glioma|2019
20+|~|~|~|Benign/Borderline|~|243973474|Male and Female|Mixed glioma|2020
20+|0.0|0.0|0.0|Malignant|18|243973474|Male and Female|Mixed glioma|2020
20+|~|~|~|Benign/Borderline|~|245477881|Male and Female|Mixed glioma|2021
20+|~|~|~|Malignant|~|245477881|Male and Female|Mixed glioma|2021
20+|0.5|0.6|0.6|Benign/Borderline|1194|211050944|Male and Female|Neoplasm, unspecified|2004
20+|0.6|0.6|0.6|Malignant|1271|211050944|Male and Female|Neoplasm, unspecified|2004
20+|0.7|0.7|0.7|Benign/Borderline|1497|213511339|Male and Female|Neoplasm, unspecified|2005
20+|0.6|0.6|0.6|Malignant|1317|213511339|Male and Female|Neoplasm, unspecified|2005
20+|0.6|0.7|0.7|Benign/Borderline|1429|216055494|Male and Female|Neoplasm, unspecified|2006
20+|0.6|0.6|0.6|Malignant|1285|216055494|Male and Female|Neoplasm, unspecified|2006
20+|0.6|0.7|0.6|Benign/Borderline|1431|218481776|Male and Female|Neoplasm, unspecified|2007
20+|0.5|0.6|0.5|Malignant|1215|218481776|Male and Female|Neoplasm, unspecified|2007
20+|0.6|0.7|0.6|Benign/Borderline|1453|220975702|Male and Female|Neoplasm, unspecified|2008
20+|0.6|0.6|0.6|Malignant|1366|220975702|Male and Female|Neoplasm, unspecified|2008
20+|0.6|0.7|0.7|Benign/Borderline|1545|223491138|Male and Female|Neoplasm, unspecified|2009
20+|0.6|0.6|0.6|Malignant|1414|223491138|Male and Female|Neoplasm, unspecified|2009
20+|0.6|0.7|0.6|Benign/Borderline|1507|226163297|Male and Female|Neoplasm, unspecified|2010
20+|0.5|0.6|0.5|Malignant|1244|226163297|Male and Female|Neoplasm, unspecified|2010
20+|0.6|0.7|0.6|Benign/Borderline|1493|228849300|Male and Female|Neoplasm, unspecified|2011
20+|0.5|0.6|0.5|Malignant|1262|228849300|Male and Female|Neoplasm, unspecified|2011
20+|0.6|0.7|0.7|Benign/Borderline|1593|231560392|Male and Female|Neoplasm, unspecified|2012
20+|0.5|0.5|0.5|Malignant|1275|231560392|Male and Female|Neoplasm, unspecified|2012
20+|0.6|0.6|0.6|Benign/Borderline|1493|234048650|Male and Female|Neoplasm, unspecified|2013
20+|0.5|0.5|0.5|Malignant|1277|234048650|Male and Female|Neoplasm, unspecified|2013
20+|0.6|0.7|0.6|Benign/Borderline|1547|236576514|Male and Female|Neoplasm, unspecified|2014
20+|0.5|0.6|0.6|Malignant|1413|236576514|Male and Female|Neoplasm, unspecified|2014
20+|0.6|0.6|0.6|Benign/Borderline|1526|239015354|Male and Female|Neoplasm, unspecified|2015
20+|0.5|0.6|0.5|Malignant|1373|239015354|Male and Female|Neoplasm, unspecified|2015
20+|0.5|0.6|0.6|Benign/Borderline|1420|241359538|Male and Female|Neoplasm, unspecified|2016
20+|0.5|0.5|0.5|Malignant|1263|241359538|Male and Female|Neoplasm, unspecified|2016
20+|0.5|0.6|0.5|Benign/Borderline|1350|243493478|Male and Female|Neoplasm, unspecified|2017
20+|0.4|0.5|0.5|Malignant|1270|243493478|Male and Female|Neoplasm, unspecified|2017
20+|0.4|0.5|0.5|Benign/Borderline|6001|1210759812|Male and Female|Neoplasm, unspecified|2017-2021
20+|0.5|0.5|0.5|Malignant|6760|1210759812|Male and Female|Neoplasm, unspecified|2017-2021
20+|0.5|0.5|0.5|Benign/Borderline|1292|245414364|Male and Female|Neoplasm, unspecified|2018
20+|0.5|0.5|0.5|Malignant|1354|245414364|Male and Female|Neoplasm, unspecified|2018
20+|0.4|0.4|0.4|Benign/Borderline|1129|247235681|Male and Female|Neoplasm, unspecified|2019
20+|0.5|0.5|0.5|Malignant|1439|247235681|Male and Female|Neoplasm, unspecified|2019
20+|0.4|0.5|0.4|Benign/Borderline|1162|243973474|Male and Female|Neoplasm, unspecified|2020
20+|0.5|0.6|0.5|Malignant|1474|243973474|Male and Female|Neoplasm, unspecified|2020
20+|0.4|0.4|0.4|Benign/Borderline|1118|245477881|Male and Female|Neoplasm, unspecified|2021
20+|0.4|0.5|0.5|Malignant|1294|245477881|Male and Female|Neoplasm, unspecified|2021
20+|2.2|2.4|2.3|Benign/Borderline|4959|211050944|Male and Female|Nerve sheath, benign and malignant|2004
20+|0.0|0.0|0.0|Malignant|46|211050944|Male and Female|Nerve sheath, benign and malignant|2004
20+|2.5|2.6|2.6|Benign/Borderline|5583|213511339|Male and Female|Nerve sheath, benign and malignant|2005
20+|0.0|0.0|0.0|Malignant|53|213511339|Male and Female|Nerve sheath, benign and malignant|2005
20+|2.5|2.6|2.6|Benign/Borderline|5689|216055494|Male and Female|Nerve sheath, benign and malignant|2006
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Nerve sheath, benign and malignant|2006
20+|2.5|2.6|2.6|Benign/Borderline|5799|218481776|Male and Female|Nerve sheath, benign and malignant|2007
20+|0.0|0.0|0.0|Malignant|59|218481776|Male and Female|Nerve sheath, benign and malignant|2007
20+|2.5|2.7|2.6|Benign/Borderline|5919|220975702|Male and Female|Nerve sheath, benign and malignant|2008
20+|0.0|0.0|0.0|Malignant|51|220975702|Male and Female|Nerve sheath, benign and malignant|2008
20+|2.6|2.7|2.7|Benign/Borderline|6220|223491138|Male and Female|Nerve sheath, benign and malignant|2009
20+|0.0|0.0|0.0|Malignant|37|223491138|Male and Female|Nerve sheath, benign and malignant|2009
20+|2.5|2.6|2.6|Benign/Borderline|6093|226163297|Male and Female|Nerve sheath, benign and malignant|2010
20+|0.0|0.0|0.0|Malignant|44|226163297|Male and Female|Nerve sheath, benign and malignant|2010
20+|2.6|2.8|2.7|Benign/Borderline|6452|228849300|Male and Female|Nerve sheath, benign and malignant|2011
20+|0.0|0.0|0.0|Malignant|38|228849300|Male and Female|Nerve sheath, benign and malignant|2011
20+|2.7|2.9|2.8|Benign/Borderline|6856|231560392|Male and Female|Nerve sheath, benign and malignant|2012
20+|0.0|0.0|0.0|Malignant|51|231560392|Male and Female|Nerve sheath, benign and malignant|2012
20+|2.8|3.0|2.9|Benign/Borderline|7169|234048650|Male and Female|Nerve sheath, benign and malignant|2013
20+|0.0|0.0|0.0|Malignant|44|234048650|Male and Female|Nerve sheath, benign and malignant|2013
20+|2.9|3.1|3.0|Benign/Borderline|7573|236576514|Male and Female|Nerve sheath, benign and malignant|2014
20+|0.0|0.0|0.0|Malignant|37|236576514|Male and Female|Nerve sheath, benign and malignant|2014
20+|3.0|3.1|3.0|Benign/Borderline|7714|239015354|Male and Female|Nerve sheath, benign and malignant|2015
20+|0.0|0.0|0.0|Malignant|39|239015354|Male and Female|Nerve sheath, benign and malignant|2015
20+|2.9|3.0|3.0|Benign/Borderline|7658|241359538|Male and Female|Nerve sheath, benign and malignant|2016
20+|0.0|0.0|0.0|Malignant|53|241359538|Male and Female|Nerve sheath, benign and malignant|2016
20+|2.9|3.0|2.9|Benign/Borderline|7704|243493478|Male and Female|Nerve sheath, benign and malignant|2017
20+|0.0|0.0|0.0|Malignant|43|243493478|Male and Female|Nerve sheath, benign and malignant|2017
20+|2.7|2.8|2.8|Benign/Borderline|36314|1210759812|Male and Female|Nerve sheath, benign and malignant|2017-2021
20+|0.0|0.0|0.0|Malignant|191|1210759812|Male and Female|Nerve sheath, benign and malignant|2017-2021
20+|2.8|3.0|2.9|Benign/Borderline|7690|245414364|Male and Female|Nerve sheath, benign and malignant|2018
20+|0.0|0.0|0.0|Malignant|30|245414364|Male and Female|Nerve sheath, benign and malignant|2018
20+|2.8|2.9|2.9|Benign/Borderline|7754|247235681|Male and Female|Nerve sheath, benign and malignant|2019
20+|0.0|0.0|0.0|Malignant|37|247235681|Male and Female|Nerve sheath, benign and malignant|2019
20+|2.4|2.5|2.4|Benign/Borderline|6447|243973474|Male and Female|Nerve sheath, benign and malignant|2020
20+|0.0|0.0|0.0|Malignant|39|243973474|Male and Female|Nerve sheath, benign and malignant|2020
20+|2.6|2.7|2.7|Benign/Borderline|7101|245477881|Male and Female|Nerve sheath, benign and malignant|2021
20+|0.0|0.0|0.0|Malignant|44|245477881|Male and Female|Nerve sheath, benign and malignant|2021
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Neuroepithelial|2004
20+|0.0|0.0|0.0|Malignant|48|211050944|Male and Female|Neuroepithelial|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Neuroepithelial|2005
20+|0.0|0.0|0.0|Malignant|41|213511339|Male and Female|Neuroepithelial|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Neuroepithelial|2006
20+|0.0|0.0|0.0|Malignant|42|216055494|Male and Female|Neuroepithelial|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Neuroepithelial|2007
20+|0.0|0.0|0.0|Malignant|51|218481776|Male and Female|Neuroepithelial|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Neuroepithelial|2008
20+|0.0|0.0|0.0|Malignant|45|220975702|Male and Female|Neuroepithelial|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Neuroepithelial|2009
20+|0.0|0.0|0.0|Malignant|45|223491138|Male and Female|Neuroepithelial|2009
20+|~|~|~|Benign/Borderline|~|226163297|Male and Female|Neuroepithelial|2010
20+|0.0|0.0|0.0|Malignant|52|226163297|Male and Female|Neuroepithelial|2010
20+|~|~|~|Benign/Borderline|~|228849300|Male and Female|Neuroepithelial|2011
20+|0.0|0.0|0.0|Malignant|50|228849300|Male and Female|Neuroepithelial|2011
20+|~|~|~|Benign/Borderline|~|231560392|Male and Female|Neuroepithelial|2012
20+|0.0|0.0|0.0|Malignant|55|231560392|Male and Female|Neuroepithelial|2012
20+|~|~|~|Benign/Borderline|~|234048650|Male and Female|Neuroepithelial|2013
20+|0.0|0.0|0.0|Malignant|48|234048650|Male and Female|Neuroepithelial|2013
20+|~|~|~|Benign/Borderline|~|236576514|Male and Female|Neuroepithelial|2014
20+|0.0|0.0|0.0|Malignant|57|236576514|Male and Female|Neuroepithelial|2014
20+|~|~|~|Benign/Borderline|~|239015354|Male and Female|Neuroepithelial|2015
20+|0.0|0.0|0.0|Malignant|72|239015354|Male and Female|Neuroepithelial|2015
20+|~|~|~|Benign/Borderline|~|241359538|Male and Female|Neuroepithelial|2016
20+|0.0|0.0|0.0|Malignant|47|241359538|Male and Female|Neuroepithelial|2016
20+|~|~|~|Benign/Borderline|~|243493478|Male and Female|Neuroepithelial|2017
20+|0.0|0.0|0.0|Malignant|34|243493478|Male and Female|Neuroepithelial|2017
20+|0.0|0.0|0.0|Benign/Borderline|48|1210759812|Male and Female|Neuroepithelial|2017-2021
20+|0.0|0.0|0.0|Malignant|126|1210759812|Male and Female|Neuroepithelial|2017-2021
20+|~|~|~|Benign/Borderline|~|245414364|Male and Female|Neuroepithelial|2018
20+|0.0|0.0|0.0|Malignant|24|245414364|Male and Female|Neuroepithelial|2018
20+|~|~|~|Benign/Borderline|~|247235681|Male and Female|Neuroepithelial|2019
20+|0.0|0.0|0.0|Malignant|25|247235681|Male and Female|Neuroepithelial|2019
20+|~|~|~|Benign/Borderline|~|243973474|Male and Female|Neuroepithelial|2020
20+|0.0|0.0|0.0|Malignant|22|243973474|Male and Female|Neuroepithelial|2020
20+|~|~|~|Benign/Borderline|~|245477881|Male and Female|Neuroepithelial|2021
20+|0.0|0.0|0.0|Malignant|22|245477881|Male and Female|Neuroepithelial|2021
20+|0.1|0.2|0.1|Benign/Borderline|317|211050944|Male and Female|Neuronal/glial, neuronal|2004
20+|0.0|0.0|0.0|Malignant|37|211050944|Male and Female|Neuronal/glial, neuronal|2004
20+|0.2|0.2|0.2|Benign/Borderline|378|213511339|Male and Female|Neuronal/glial, neuronal|2005
20+|0.0|0.0|0.0|Malignant|53|213511339|Male and Female|Neuronal/glial, neuronal|2005
20+|0.2|0.2|0.2|Benign/Borderline|390|216055494|Male and Female|Neuronal/glial, neuronal|2006
20+|0.0|0.0|0.0|Malignant|43|216055494|Male and Female|Neuronal/glial, neuronal|2006
20+|0.2|0.2|0.2|Benign/Borderline|392|218481776|Male and Female|Neuronal/glial, neuronal|2007
20+|0.0|0.0|0.0|Malignant|46|218481776|Male and Female|Neuronal/glial, neuronal|2007
20+|0.2|0.2|0.2|Benign/Borderline|421|220975702|Male and Female|Neuronal/glial, neuronal|2008
20+|0.0|0.0|0.0|Malignant|47|220975702|Male and Female|Neuronal/glial, neuronal|2008
20+|0.2|0.2|0.2|Benign/Borderline|442|223491138|Male and Female|Neuronal/glial, neuronal|2009
20+|0.0|0.0|0.0|Malignant|42|223491138|Male and Female|Neuronal/glial, neuronal|2009
20+|0.2|0.2|0.2|Benign/Borderline|482|226163297|Male and Female|Neuronal/glial, neuronal|2010
20+|0.0|0.0|0.0|Malignant|32|226163297|Male and Female|Neuronal/glial, neuronal|2010
20+|0.2|0.2|0.2|Benign/Borderline|433|228849300|Male and Female|Neuronal/glial, neuronal|2011
20+|0.0|0.0|0.0|Malignant|40|228849300|Male and Female|Neuronal/glial, neuronal|2011
20+|0.2|0.2|0.2|Benign/Borderline|424|231560392|Male and Female|Neuronal/glial, neuronal|2012
20+|0.0|0.0|0.0|Malignant|44|231560392|Male and Female|Neuronal/glial, neuronal|2012
20+|0.2|0.2|0.2|Benign/Borderline|400|234048650|Male and Female|Neuronal/glial, neuronal|2013
20+|0.0|0.0|0.0|Malignant|33|234048650|Male and Female|Neuronal/glial, neuronal|2013
20+|0.2|0.2|0.2|Benign/Borderline|466|236576514|Male and Female|Neuronal/glial, neuronal|2014
20+|0.0|0.0|0.0|Malignant|34|236576514|Male and Female|Neuronal/glial, neuronal|2014
20+|0.2|0.2|0.2|Benign/Borderline|500|239015354|Male and Female|Neuronal/glial, neuronal|2015
20+|0.0|0.0|0.0|Malignant|32|239015354|Male and Female|Neuronal/glial, neuronal|2015
20+|0.2|0.2|0.2|Benign/Borderline|493|241359538|Male and Female|Neuronal/glial, neuronal|2016
20+|0.0|0.0|0.0|Malignant|48|241359538|Male and Female|Neuronal/glial, neuronal|2016
20+|0.2|0.2|0.2|Benign/Borderline|524|243493478|Male and Female|Neuronal/glial, neuronal|2017
20+|0.0|0.0|0.0|Malignant|35|243493478|Male and Female|Neuronal/glial, neuronal|2017
20+|0.2|0.2|0.2|Benign/Borderline|2356|1210759812|Male and Female|Neuronal/glial, neuronal|2017-2021
20+|0.0|0.0|0.0|Malignant|155|1210759812|Male and Female|Neuronal/glial, neuronal|2017-2021
20+|0.2|0.2|0.2|Benign/Borderline|469|245414364|Male and Female|Neuronal/glial, neuronal|2018
20+|0.0|0.0|0.0|Malignant|23|245414364|Male and Female|Neuronal/glial, neuronal|2018
20+|0.2|0.2|0.2|Benign/Borderline|498|247235681|Male and Female|Neuronal/glial, neuronal|2019
20+|0.0|0.0|0.0|Malignant|34|247235681|Male and Female|Neuronal/glial, neuronal|2019
20+|0.2|0.2|0.2|Benign/Borderline|432|243973474|Male and Female|Neuronal/glial, neuronal|2020
20+|0.0|0.0|0.0|Malignant|23|243973474|Male and Female|Neuronal/glial, neuronal|2020
20+|0.2|0.2|0.2|Benign/Borderline|461|245477881|Male and Female|Neuronal/glial, neuronal|2021
20+|0.0|0.0|0.0|Malignant|41|245477881|Male and Female|Neuronal/glial, neuronal|2021
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Oligodendroglioma|2004
20+|0.4|0.4|0.4|Malignant|832|211050944|Male and Female|Oligodendroglioma|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Oligodendroglioma|2005
20+|0.4|0.4|0.4|Malignant|810|213511339|Male and Female|Oligodendroglioma|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Oligodendroglioma|2006
20+|0.4|0.4|0.4|Malignant|866|216055494|Male and Female|Oligodendroglioma|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Oligodendroglioma|2007
20+|0.4|0.4|0.4|Malignant|817|218481776|Male and Female|Oligodendroglioma|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Oligodendroglioma|2008
20+|0.3|0.4|0.4|Malignant|791|220975702|Male and Female|Oligodendroglioma|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Oligodendroglioma|2009
20+|0.4|0.4|0.4|Malignant|851|223491138|Male and Female|Oligodendroglioma|2009
20+|~|~|~|Benign/Borderline|~|226163297|Male and Female|Oligodendroglioma|2010
20+|0.3|0.4|0.4|Malignant|817|226163297|Male and Female|Oligodendroglioma|2010
20+|~|~|~|Benign/Borderline|~|228849300|Male and Female|Oligodendroglioma|2011
20+|0.3|0.4|0.3|Malignant|769|228849300|Male and Female|Oligodendroglioma|2011
20+|~|~|~|Benign/Borderline|~|231560392|Male and Female|Oligodendroglioma|2012
20+|0.3|0.3|0.3|Malignant|684|231560392|Male and Female|Oligodendroglioma|2012
20+|~|~|~|Benign/Borderline|~|234048650|Male and Female|Oligodendroglioma|2013
20+|0.3|0.3|0.3|Malignant|725|234048650|Male and Female|Oligodendroglioma|2013
20+|~|~|~|Benign/Borderline|~|236576514|Male and Female|Oligodendroglioma|2014
20+|0.3|0.3|0.3|Malignant|728|236576514|Male and Female|Oligodendroglioma|2014
20+|~|~|~|Benign/Borderline|~|239015354|Male and Female|Oligodendroglioma|2015
20+|0.3|0.3|0.3|Malignant|723|239015354|Male and Female|Oligodendroglioma|2015
20+|~|~|~|Benign/Borderline|~|241359538|Male and Female|Oligodendroglioma|2016
20+|0.3|0.4|0.3|Malignant|752|241359538|Male and Female|Oligodendroglioma|2016
20+|~|~|~|Benign/Borderline|~|243493478|Male and Female|Oligodendroglioma|2017
20+|0.3|0.3|0.3|Malignant|732|243493478|Male and Female|Oligodendroglioma|2017
20+|~|~|~|Benign/Borderline|~|1210759812|Male and Female|Oligodendroglioma|2017-2021
20+|0.3|0.3|0.3|Malignant|3412|1210759812|Male and Female|Oligodendroglioma|2017-2021
20+|~|~|~|Benign/Borderline|~|245414364|Male and Female|Oligodendroglioma|2018
20+|0.3|0.3|0.3|Malignant|666|245414364|Male and Female|Oligodendroglioma|2018
20+|~|~|~|Benign/Borderline|~|247235681|Male and Female|Oligodendroglioma|2019
20+|0.3|0.3|0.3|Malignant|740|247235681|Male and Female|Oligodendroglioma|2019
20+|~|~|~|Benign/Borderline|~|243973474|Male and Female|Oligodendroglioma|2020
20+|0.2|0.3|0.3|Malignant|610|243973474|Male and Female|Oligodendroglioma|2020
20+|~|~|~|Benign/Borderline|~|245477881|Male and Female|Oligodendroglioma|2021
20+|0.3|0.3|0.3|Malignant|703|245477881|Male and Female|Oligodendroglioma|2021
20+|0.1|0.1|0.1|Benign/Borderline|152|211050944|Male and Female|Other mesenchymal|2004
20+|0.0|0.0|0.0|Malignant|58|211050944|Male and Female|Other mesenchymal|2004
20+|0.1|0.1|0.1|Benign/Borderline|157|213511339|Male and Female|Other mesenchymal|2005
20+|0.0|0.0|0.0|Malignant|65|213511339|Male and Female|Other mesenchymal|2005
20+|0.1|0.1|0.1|Benign/Borderline|158|216055494|Male and Female|Other mesenchymal|2006
20+|0.0|0.0|0.0|Malignant|57|216055494|Male and Female|Other mesenchymal|2006
20+|0.1|0.1|0.1|Benign/Borderline|166|218481776|Male and Female|Other mesenchymal|2007
20+|0.0|0.0|0.0|Malignant|79|218481776|Male and Female|Other mesenchymal|2007
20+|0.1|0.1|0.1|Benign/Borderline|211|220975702|Male and Female|Other mesenchymal|2008
20+|0.0|0.1|0.0|Malignant|101|220975702|Male and Female|Other mesenchymal|2008
20+|0.1|0.1|0.1|Benign/Borderline|201|223491138|Male and Female|Other mesenchymal|2009
20+|0.0|0.0|0.0|Malignant|79|223491138|Male and Female|Other mesenchymal|2009
20+|0.1|0.1|0.1|Benign/Borderline|178|226163297|Male and Female|Other mesenchymal|2010
20+|0.0|0.0|0.0|Malignant|72|226163297|Male and Female|Other mesenchymal|2010
20+|0.1|0.1|0.1|Benign/Borderline|164|228849300|Male and Female|Other mesenchymal|2011
20+|0.0|0.0|0.0|Malignant|77|228849300|Male and Female|Other mesenchymal|2011
20+|0.1|0.1|0.1|Benign/Borderline|201|231560392|Male and Female|Other mesenchymal|2012
20+|0.0|0.0|0.0|Malignant|71|231560392|Male and Female|Other mesenchymal|2012
20+|0.1|0.1|0.1|Benign/Borderline|183|234048650|Male and Female|Other mesenchymal|2013
20+|0.0|0.0|0.0|Malignant|85|234048650|Male and Female|Other mesenchymal|2013
20+|0.1|0.1|0.1|Benign/Borderline|187|236576514|Male and Female|Other mesenchymal|2014
20+|0.0|0.0|0.0|Malignant|83|236576514|Male and Female|Other mesenchymal|2014
20+|0.1|0.1|0.1|Benign/Borderline|204|239015354|Male and Female|Other mesenchymal|2015
20+|0.0|0.0|0.0|Malignant|91|239015354|Male and Female|Other mesenchymal|2015
20+|0.1|0.1|0.1|Benign/Borderline|165|241359538|Male and Female|Other mesenchymal|2016
20+|0.0|0.0|0.0|Malignant|86|241359538|Male and Female|Other mesenchymal|2016
20+|0.1|0.1|0.1|Benign/Borderline|199|243493478|Male and Female|Other mesenchymal|2017
20+|0.0|0.1|0.0|Malignant|118|243493478|Male and Female|Other mesenchymal|2017
20+|0.1|0.1|0.1|Benign/Borderline|806|1210759812|Male and Female|Other mesenchymal|2017-2021
20+|0.0|0.0|0.0|Malignant|543|1210759812|Male and Female|Other mesenchymal|2017-2021
20+|0.1|0.1|0.1|Benign/Borderline|180|245414364|Male and Female|Other mesenchymal|2018
20+|0.0|0.0|0.0|Malignant|107|245414364|Male and Female|Other mesenchymal|2018
20+|0.1|0.1|0.1|Benign/Borderline|157|247235681|Male and Female|Other mesenchymal|2019
20+|0.0|0.0|0.0|Malignant|97|247235681|Male and Female|Other mesenchymal|2019
20+|0.0|0.1|0.0|Benign/Borderline|119|243973474|Male and Female|Other mesenchymal|2020
20+|0.0|0.1|0.0|Malignant|119|243973474|Male and Female|Other mesenchymal|2020
20+|0.1|0.1|0.1|Benign/Borderline|164|245477881|Male and Female|Other mesenchymal|2021
20+|0.0|0.0|0.0|Malignant|104|245477881|Male and Female|Other mesenchymal|2021
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Pilocytic astrocytoma|2004
20+|0.1|0.1|0.1|Malignant|279|211050944|Male and Female|Pilocytic astrocytoma|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Pilocytic astrocytoma|2005
20+|0.1|0.2|0.1|Malignant|310|213511339|Male and Female|Pilocytic astrocytoma|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Pilocytic astrocytoma|2006
20+|0.1|0.2|0.1|Malignant|307|216055494|Male and Female|Pilocytic astrocytoma|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Pilocytic astrocytoma|2007
20+|0.1|0.2|0.1|Malignant|308|218481776|Male and Female|Pilocytic astrocytoma|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Pilocytic astrocytoma|2008
20+|0.1|0.1|0.1|Malignant|291|220975702|Male and Female|Pilocytic astrocytoma|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Pilocytic astrocytoma|2009
20+|0.1|0.1|0.1|Malignant|273|223491138|Male and Female|Pilocytic astrocytoma|2009
20+|~|~|~|Benign/Borderline|~|226163297|Male and Female|Pilocytic astrocytoma|2010
20+|0.1|0.2|0.2|Malignant|334|226163297|Male and Female|Pilocytic astrocytoma|2010
20+|~|~|~|Benign/Borderline|~|228849300|Male and Female|Pilocytic astrocytoma|2011
20+|0.1|0.2|0.2|Malignant|338|228849300|Male and Female|Pilocytic astrocytoma|2011
20+|~|~|~|Benign/Borderline|~|231560392|Male and Female|Pilocytic astrocytoma|2012
20+|0.1|0.1|0.1|Malignant|274|231560392|Male and Female|Pilocytic astrocytoma|2012
20+|~|~|~|Benign/Borderline|~|234048650|Male and Female|Pilocytic astrocytoma|2013
20+|0.1|0.2|0.1|Malignant|308|234048650|Male and Female|Pilocytic astrocytoma|2013
20+|~|~|~|Benign/Borderline|~|236576514|Male and Female|Pilocytic astrocytoma|2014
20+|0.1|0.1|0.1|Malignant|300|236576514|Male and Female|Pilocytic astrocytoma|2014
20+|~|~|~|Benign/Borderline|~|239015354|Male and Female|Pilocytic astrocytoma|2015
20+|0.1|0.1|0.1|Malignant|300|239015354|Male and Female|Pilocytic astrocytoma|2015
20+|~|~|~|Benign/Borderline|~|241359538|Male and Female|Pilocytic astrocytoma|2016
20+|0.1|0.1|0.1|Malignant|301|241359538|Male and Female|Pilocytic astrocytoma|2016
20+|~|~|~|Benign/Borderline|~|243493478|Male and Female|Pilocytic astrocytoma|2017
20+|0.1|0.1|0.1|Malignant|275|243493478|Male and Female|Pilocytic astrocytoma|2017
20+|0.0|0.0|0.0|Benign/Borderline|72|1210759812|Male and Female|Pilocytic astrocytoma|2017-2021
20+|0.1|0.1|0.1|Malignant|1340|1210759812|Male and Female|Pilocytic astrocytoma|2017-2021
20+|~|~|~|Benign/Borderline|~|245414364|Male and Female|Pilocytic astrocytoma|2018
20+|0.1|0.1|0.1|Malignant|281|245414364|Male and Female|Pilocytic astrocytoma|2018
20+|0.0|0.0|0.0|Benign/Borderline|24|247235681|Male and Female|Pilocytic astrocytoma|2019
20+|0.1|0.1|0.1|Malignant|292|247235681|Male and Female|Pilocytic astrocytoma|2019
20+|0.0|0.0|0.0|Benign/Borderline|16|243973474|Male and Female|Pilocytic astrocytoma|2020
20+|0.1|0.1|0.1|Malignant|257|243973474|Male and Female|Pilocytic astrocytoma|2020
20+|0.0|0.0|0.0|Benign/Borderline|19|245477881|Male and Female|Pilocytic astrocytoma|2021
20+|0.1|0.1|0.1|Malignant|254|245477881|Male and Female|Pilocytic astrocytoma|2021
20+|0.0|0.0|0.0|Benign/Borderline|27|211050944|Male and Female|Pineal parenchymal|2004
20+|0.0|0.0|0.0|Malignant|31|211050944|Male and Female|Pineal parenchymal|2004
20+|0.0|0.0|0.0|Benign/Borderline|50|213511339|Male and Female|Pineal parenchymal|2005
20+|0.0|0.0|0.0|Malignant|31|213511339|Male and Female|Pineal parenchymal|2005
20+|0.0|0.0|0.0|Benign/Borderline|47|216055494|Male and Female|Pineal parenchymal|2006
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Pineal parenchymal|2006
20+|0.0|0.0|0.0|Benign/Borderline|47|218481776|Male and Female|Pineal parenchymal|2007
20+|0.0|0.0|0.0|Malignant|44|218481776|Male and Female|Pineal parenchymal|2007
20+|0.0|0.0|0.0|Benign/Borderline|70|220975702|Male and Female|Pineal parenchymal|2008
20+|0.0|0.0|0.0|Malignant|43|220975702|Male and Female|Pineal parenchymal|2008
20+|0.0|0.0|0.0|Benign/Borderline|44|223491138|Male and Female|Pineal parenchymal|2009
20+|0.0|0.0|0.0|Malignant|47|223491138|Male and Female|Pineal parenchymal|2009
20+|0.0|0.0|0.0|Benign/Borderline|56|226163297|Male and Female|Pineal parenchymal|2010
20+|0.0|0.0|0.0|Malignant|41|226163297|Male and Female|Pineal parenchymal|2010
20+|0.0|0.0|0.0|Benign/Borderline|64|228849300|Male and Female|Pineal parenchymal|2011
20+|0.0|0.0|0.0|Malignant|44|228849300|Male and Female|Pineal parenchymal|2011
20+|0.0|0.0|0.0|Benign/Borderline|63|231560392|Male and Female|Pineal parenchymal|2012
20+|0.0|0.0|0.0|Malignant|41|231560392|Male and Female|Pineal parenchymal|2012
20+|0.0|0.0|0.0|Benign/Borderline|68|234048650|Male and Female|Pineal parenchymal|2013
20+|0.0|0.0|0.0|Malignant|70|234048650|Male and Female|Pineal parenchymal|2013
20+|0.0|0.0|0.0|Benign/Borderline|66|236576514|Male and Female|Pineal parenchymal|2014
20+|0.0|0.0|0.0|Malignant|34|236576514|Male and Female|Pineal parenchymal|2014
20+|0.0|0.0|0.0|Benign/Borderline|64|239015354|Male and Female|Pineal parenchymal|2015
20+|0.0|0.0|0.0|Malignant|59|239015354|Male and Female|Pineal parenchymal|2015
20+|0.0|0.0|0.0|Benign/Borderline|64|241359538|Male and Female|Pineal parenchymal|2016
20+|0.0|0.0|0.0|Malignant|64|241359538|Male and Female|Pineal parenchymal|2016
20+|0.0|0.0|0.0|Benign/Borderline|56|243493478|Male and Female|Pineal parenchymal|2017
20+|0.0|0.0|0.0|Malignant|53|243493478|Male and Female|Pineal parenchymal|2017
20+|0.0|0.0|0.0|Benign/Borderline|242|1210759812|Male and Female|Pineal parenchymal|2017-2021
20+|0.0|0.0|0.0|Malignant|240|1210759812|Male and Female|Pineal parenchymal|2017-2021
20+|0.0|0.0|0.0|Benign/Borderline|60|245414364|Male and Female|Pineal parenchymal|2018
20+|0.0|0.0|0.0|Malignant|42|245414364|Male and Female|Pineal parenchymal|2018
20+|0.0|0.0|0.0|Benign/Borderline|45|247235681|Male and Female|Pineal parenchymal|2019
20+|0.0|0.0|0.0|Malignant|48|247235681|Male and Female|Pineal parenchymal|2019
20+|0.0|0.0|0.0|Benign/Borderline|44|243973474|Male and Female|Pineal parenchymal|2020
20+|0.0|0.0|0.0|Malignant|46|243973474|Male and Female|Pineal parenchymal|2020
20+|0.0|0.0|0.0|Benign/Borderline|37|245477881|Male and Female|Pineal parenchymal|2021
20+|0.0|0.0|0.0|Malignant|51|245477881|Male and Female|Pineal parenchymal|2021
20+|3.6|3.8|3.7|Benign/Borderline|7772|211050944|Male and Female|Pituitary|2004
20+|0.0|0.0|0.0|Malignant|43|211050944|Male and Female|Pituitary|2004
20+|4.0|4.2|4.1|Benign/Borderline|8834|213511339|Male and Female|Pituitary|2005
20+|0.0|0.0|0.0|Malignant|38|213511339|Male and Female|Pituitary|2005
20+|4.4|4.5|4.4|Benign/Borderline|9617|216055494|Male and Female|Pituitary|2006
20+|0.0|0.0|0.0|Malignant|31|216055494|Male and Female|Pituitary|2006
20+|4.6|4.8|4.7|Benign/Borderline|10236|218481776|Male and Female|Pituitary|2007
20+|0.0|0.0|0.0|Malignant|34|218481776|Male and Female|Pituitary|2007
20+|4.9|5.1|5.0|Benign/Borderline|11120|220975702|Male and Female|Pituitary|2008
20+|~|~|~|Malignant|~|220975702|Male and Female|Pituitary|2008
20+|5.3|5.5|5.4|Benign/Borderline|12101|223491138|Male and Female|Pituitary|2009
20+|0.0|0.0|0.0|Malignant|24|223491138|Male and Female|Pituitary|2009
20+|5.3|5.5|5.4|Benign/Borderline|12401|226163297|Male and Female|Pituitary|2010
20+|0.0|0.0|0.0|Malignant|34|226163297|Male and Female|Pituitary|2010
20+|5.5|5.7|5.6|Benign/Borderline|12768|228849300|Male and Female|Pituitary|2011
20+|0.0|0.0|0.0|Malignant|33|228849300|Male and Female|Pituitary|2011
20+|5.9|6.1|6.0|Benign/Borderline|13840|231560392|Male and Female|Pituitary|2012
20+|0.0|0.0|0.0|Malignant|34|231560392|Male and Female|Pituitary|2012
20+|5.8|6.0|5.9|Benign/Borderline|13868|234048650|Male and Female|Pituitary|2013
20+|0.0|0.0|0.0|Malignant|41|234048650|Male and Female|Pituitary|2013
20+|5.9|6.1|6.0|Benign/Borderline|14254|236576514|Male and Female|Pituitary|2014
20+|0.0|0.0|0.0|Malignant|34|236576514|Male and Female|Pituitary|2014
20+|6.1|6.3|6.2|Benign/Borderline|14971|239015354|Male and Female|Pituitary|2015
20+|0.0|0.0|0.0|Malignant|29|239015354|Male and Female|Pituitary|2015
20+|6.2|6.4|6.3|Benign/Borderline|15319|241359538|Male and Female|Pituitary|2016
20+|0.0|0.0|0.0|Malignant|25|241359538|Male and Female|Pituitary|2016
20+|6.4|6.6|6.5|Benign/Borderline|16058|243493478|Male and Female|Pituitary|2017
20+|0.0|0.0|0.0|Malignant|20|243493478|Male and Female|Pituitary|2017
20+|6.1|6.2|6.2|Benign/Borderline|76356|1210759812|Male and Female|Pituitary|2017-2021
20+|0.0|0.0|0.0|Malignant|108|1210759812|Male and Female|Pituitary|2017-2021
20+|6.3|6.6|6.5|Benign/Borderline|16091|245414364|Male and Female|Pituitary|2018
20+|0.0|0.0|0.0|Malignant|23|245414364|Male and Female|Pituitary|2018
20+|6.3|6.5|6.4|Benign/Borderline|16250|247235681|Male and Female|Pituitary|2019
20+|~|~|~|Malignant|~|247235681|Male and Female|Pituitary|2019
20+|5.4|5.6|5.5|Benign/Borderline|13818|243973474|Male and Female|Pituitary|2020
20+|0.0|0.0|0.0|Malignant|23|243973474|Male and Female|Pituitary|2020
20+|5.8|6.0|5.9|Benign/Borderline|14814|245477881|Male and Female|Pituitary|2021
20+|0.0|0.0|0.0|Malignant|31|245477881|Male and Female|Pituitary|2021
20+|16.6|16.9|16.7|Benign/Borderline|35570|211050944|Male and Female|Total|2004
20+|9.0|9.3|9.1|Malignant|19409|211050944|Male and Female|Total|2004
20+|18.6|19.0|18.8|Benign/Borderline|40542|213511339|Male and Female|Total|2005
20+|9.0|9.3|9.2|Malignant|19753|213511339|Male and Female|Total|2005
20+|19.4|19.8|19.6|Benign/Borderline|42971|216055494|Male and Female|Total|2006
20+|8.9|9.2|9.0|Malignant|19831|216055494|Male and Female|Total|2006
20+|20.0|20.4|20.2|Benign/Borderline|45043|218481776|Male and Female|Total|2007
20+|8.9|9.2|9.0|Malignant|20175|218481776|Male and Female|Total|2007
20+|21.2|21.6|21.4|Benign/Borderline|48392|220975702|Male and Female|Total|2008
20+|9.0|9.2|9.1|Malignant|20648|220975702|Male and Female|Total|2008
20+|22.5|22.9|22.7|Benign/Borderline|52167|223491138|Male and Female|Total|2009
20+|8.9|9.1|9.0|Malignant|20847|223491138|Male and Female|Total|2009
20+|22.2|22.6|22.4|Benign/Borderline|52258|226163297|Male and Female|Total|2010
20+|8.7|8.9|8.8|Malignant|20758|226163297|Male and Female|Total|2010
20+|22.5|22.9|22.7|Benign/Borderline|53774|228849300|Male and Female|Total|2011
20+|8.6|8.8|8.7|Malignant|20891|228849300|Male and Female|Total|2011
20+|23.3|23.7|23.5|Benign/Borderline|56523|231560392|Male and Female|Total|2012
20+|8.5|8.8|8.7|Malignant|21167|231560392|Male and Female|Total|2012
20+|23.4|23.8|23.6|Benign/Borderline|57836|234048650|Male and Female|Total|2013
20+|8.6|8.8|8.7|Malignant|21579|234048650|Male and Female|Total|2013
20+|23.9|24.3|24.1|Benign/Borderline|59972|236576514|Male and Female|Total|2014
20+|8.5|8.7|8.6|Malignant|21789|236576514|Male and Female|Total|2014
20+|24.6|25.0|24.8|Benign/Borderline|62697|239015354|Male and Female|Total|2015
20+|8.5|8.7|8.6|Malignant|22074|239015354|Male and Female|Total|2015
20+|24.8|25.2|25.0|Benign/Borderline|64086|241359538|Male and Female|Total|2016
20+|8.4|8.7|8.5|Malignant|22427|241359538|Male and Female|Total|2016
20+|25.4|25.8|25.6|Benign/Borderline|66647|243493478|Male and Female|Total|2017
20+|8.4|8.6|8.5|Malignant|22581|243493478|Male and Female|Total|2017
20+|24.9|25.0|24.9|Benign/Borderline|327810|1210759812|Male and Female|Total|2017-2021
20+|8.1|8.2|8.1|Malignant|109381|1210759812|Male and Female|Total|2017-2021
20+|25.2|25.6|25.4|Benign/Borderline|67274|245414364|Male and Female|Total|2018
20+|8.1|8.4|8.3|Malignant|22383|245414364|Male and Female|Total|2018
20+|25.8|26.2|26.0|Benign/Borderline|69789|247235681|Male and Female|Total|2019
20+|8.0|8.3|8.1|Malignant|22382|247235681|Male and Female|Total|2019
20+|22.9|23.3|23.1|Benign/Borderline|61624|243973474|Male and Female|Total|2020
20+|7.9|8.1|8.0|Malignant|21984|243973474|Male and Female|Total|2020
20+|24.1|24.5|24.3|Benign/Borderline|65526|245477881|Male and Female|Total|2021
20+|7.6|7.8|7.7|Malignant|21422|245477881|Male and Female|Total|2021
20+|2.2|2.4|2.3|Benign/Borderline|4959|211050944|Male and Female|Tumors of Cranial and Spinal Nerves|2004
20+|0.0|0.0|0.0|Malignant|46|211050944|Male and Female|Tumors of Cranial and Spinal Nerves|2004
20+|2.5|2.6|2.6|Benign/Borderline|5586|213511339|Male and Female|Tumors of Cranial and Spinal Nerves|2005
20+|0.0|0.0|0.0|Malignant|53|213511339|Male and Female|Tumors of Cranial and Spinal Nerves|2005
20+|2.5|2.6|2.6|Benign/Borderline|5691|216055494|Male and Female|Tumors of Cranial and Spinal Nerves|2006
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Tumors of Cranial and Spinal Nerves|2006
20+|2.5|2.6|2.6|Benign/Borderline|5801|218481776|Male and Female|Tumors of Cranial and Spinal Nerves|2007
20+|0.0|0.0|0.0|Malignant|59|218481776|Male and Female|Tumors of Cranial and Spinal Nerves|2007
20+|2.5|2.7|2.6|Benign/Borderline|5923|220975702|Male and Female|Tumors of Cranial and Spinal Nerves|2008
20+|0.0|0.0|0.0|Malignant|51|220975702|Male and Female|Tumors of Cranial and Spinal Nerves|2008
20+|2.6|2.7|2.7|Benign/Borderline|6227|223491138|Male and Female|Tumors of Cranial and Spinal Nerves|2009
20+|0.0|0.0|0.0|Malignant|37|223491138|Male and Female|Tumors of Cranial and Spinal Nerves|2009
20+|2.5|2.6|2.6|Benign/Borderline|6097|226163297|Male and Female|Tumors of Cranial and Spinal Nerves|2010
20+|0.0|0.0|0.0|Malignant|44|226163297|Male and Female|Tumors of Cranial and Spinal Nerves|2010
20+|2.6|2.8|2.7|Benign/Borderline|6457|228849300|Male and Female|Tumors of Cranial and Spinal Nerves|2011
20+|0.0|0.0|0.0|Malignant|38|228849300|Male and Female|Tumors of Cranial and Spinal Nerves|2011
20+|2.7|2.9|2.8|Benign/Borderline|6858|231560392|Male and Female|Tumors of Cranial and Spinal Nerves|2012
20+|0.0|0.0|0.0|Malignant|51|231560392|Male and Female|Tumors of Cranial and Spinal Nerves|2012
20+|2.8|3.0|2.9|Benign/Borderline|7174|234048650|Male and Female|Tumors of Cranial and Spinal Nerves|2013
20+|0.0|0.0|0.0|Malignant|44|234048650|Male and Female|Tumors of Cranial and Spinal Nerves|2013
20+|3.0|3.1|3.0|Benign/Borderline|7582|236576514|Male and Female|Tumors of Cranial and Spinal Nerves|2014
20+|0.0|0.0|0.0|Malignant|37|236576514|Male and Female|Tumors of Cranial and Spinal Nerves|2014
20+|3.0|3.1|3.0|Benign/Borderline|7725|239015354|Male and Female|Tumors of Cranial and Spinal Nerves|2015
20+|0.0|0.0|0.0|Malignant|39|239015354|Male and Female|Tumors of Cranial and Spinal Nerves|2015
20+|2.9|3.1|3.0|Benign/Borderline|7668|241359538|Male and Female|Tumors of Cranial and Spinal Nerves|2016
20+|0.0|0.0|0.0|Malignant|53|241359538|Male and Female|Tumors of Cranial and Spinal Nerves|2016
20+|2.9|3.0|2.9|Benign/Borderline|7709|243493478|Male and Female|Tumors of Cranial and Spinal Nerves|2017
20+|0.0|0.0|0.0|Malignant|43|243493478|Male and Female|Tumors of Cranial and Spinal Nerves|2017
20+|2.7|2.8|2.8|Benign/Borderline|36337|1210759812|Male and Female|Tumors of Cranial and Spinal Nerves|2017-2021
20+|0.0|0.0|0.0|Malignant|191|1210759812|Male and Female|Tumors of Cranial and Spinal Nerves|2017-2021
20+|2.8|3.0|2.9|Benign/Borderline|7696|245414364|Male and Female|Tumors of Cranial and Spinal Nerves|2018
20+|0.0|0.0|0.0|Malignant|30|245414364|Male and Female|Tumors of Cranial and Spinal Nerves|2018
20+|2.8|2.9|2.9|Benign/Borderline|7759|247235681|Male and Female|Tumors of Cranial and Spinal Nerves|2019
20+|0.0|0.0|0.0|Malignant|37|247235681|Male and Female|Tumors of Cranial and Spinal Nerves|2019
20+|2.4|2.5|2.4|Benign/Borderline|6450|243973474|Male and Female|Tumors of Cranial and Spinal Nerves|2020
20+|0.0|0.0|0.0|Malignant|39|243973474|Male and Female|Tumors of Cranial and Spinal Nerves|2020
20+|2.6|2.7|2.7|Benign/Borderline|7106|245477881|Male and Female|Tumors of Cranial and Spinal Nerves|2021
20+|0.0|0.0|0.0|Malignant|44|245477881|Male and Female|Tumors of Cranial and Spinal Nerves|2021
20+|0.4|0.4|0.4|Benign/Borderline|839|211050944|Male and Female|Tumors of Neuroepthelial Tissue|2004
20+|7.5|7.7|7.6|Malignant|16084|211050944|Male and Female|Tumors of Neuroepthelial Tissue|2004
20+|0.4|0.5|0.5|Benign/Borderline|973|213511339|Male and Female|Tumors of Neuroepthelial Tissue|2005
20+|7.4|7.7|7.5|Malignant|16278|213511339|Male and Female|Tumors of Neuroepthelial Tissue|2005
20+|0.5|0.5|0.5|Benign/Borderline|1053|216055494|Male and Female|Tumors of Neuroepthelial Tissue|2006
20+|7.4|7.6|7.5|Malignant|16436|216055494|Male and Female|Tumors of Neuroepthelial Tissue|2006
20+|0.4|0.5|0.5|Benign/Borderline|1016|218481776|Male and Female|Tumors of Neuroepthelial Tissue|2007
20+|7.4|7.7|7.5|Malignant|16824|218481776|Male and Female|Tumors of Neuroepthelial Tissue|2007
20+|0.5|0.5|0.5|Benign/Borderline|1084|220975702|Male and Female|Tumors of Neuroepthelial Tissue|2008
20+|7.4|7.6|7.5|Malignant|17124|220975702|Male and Female|Tumors of Neuroepthelial Tissue|2008
20+|0.5|0.5|0.5|Benign/Borderline|1113|223491138|Male and Female|Tumors of Neuroepthelial Tissue|2009
20+|7.4|7.6|7.5|Malignant|17397|223491138|Male and Female|Tumors of Neuroepthelial Tissue|2009
20+|0.5|0.6|0.5|Benign/Borderline|1204|226163297|Male and Female|Tumors of Neuroepthelial Tissue|2010
20+|7.3|7.5|7.4|Malignant|17397|226163297|Male and Female|Tumors of Neuroepthelial Tissue|2010
20+|0.5|0.6|0.5|Benign/Borderline|1190|228849300|Male and Female|Tumors of Neuroepthelial Tissue|2011
20+|7.2|7.4|7.3|Malignant|17499|228849300|Male and Female|Tumors of Neuroepthelial Tissue|2011
20+|0.5|0.5|0.5|Benign/Borderline|1193|231560392|Male and Female|Tumors of Neuroepthelial Tissue|2012
20+|7.2|7.4|7.3|Malignant|17805|231560392|Male and Female|Tumors of Neuroepthelial Tissue|2012
20+|0.5|0.5|0.5|Benign/Borderline|1152|234048650|Male and Female|Tumors of Neuroepthelial Tissue|2013
20+|7.2|7.4|7.3|Malignant|18163|234048650|Male and Female|Tumors of Neuroepthelial Tissue|2013
20+|0.5|0.6|0.6|Benign/Borderline|1293|236576514|Male and Female|Tumors of Neuroepthelial Tissue|2014
20+|7.0|7.3|7.1|Malignant|18047|236576514|Male and Female|Tumors of Neuroepthelial Tissue|2014
20+|0.5|0.6|0.6|Benign/Borderline|1332|239015354|Male and Female|Tumors of Neuroepthelial Tissue|2015
20+|7.1|7.3|7.2|Malignant|18484|239015354|Male and Female|Tumors of Neuroepthelial Tissue|2015
20+|0.5|0.6|0.6|Benign/Borderline|1340|241359538|Male and Female|Tumors of Neuroepthelial Tissue|2016
20+|7.1|7.3|7.2|Malignant|18856|241359538|Male and Female|Tumors of Neuroepthelial Tissue|2016
20+|0.5|0.6|0.6|Benign/Borderline|1359|243493478|Male and Female|Tumors of Neuroepthelial Tissue|2017
20+|7.0|7.2|7.1|Malignant|18949|243493478|Male and Female|Tumors of Neuroepthelial Tissue|2017
20+|0.5|0.5|0.5|Benign/Borderline|6406|1210759812|Male and Female|Tumors of Neuroepthelial Tissue|2017-2021
20+|6.8|6.8|6.8|Malignant|91418|1210759812|Male and Female|Tumors of Neuroepthelial Tissue|2017-2021
20+|0.5|0.6|0.5|Benign/Borderline|1293|245414364|Male and Female|Tumors of Neuroepthelial Tissue|2018
20+|6.8|7.0|6.9|Malignant|18746|245414364|Male and Female|Tumors of Neuroepthelial Tissue|2018
20+|0.5|0.6|0.5|Benign/Borderline|1340|247235681|Male and Female|Tumors of Neuroepthelial Tissue|2019
20+|6.7|6.9|6.8|Malignant|18730|247235681|Male and Female|Tumors of Neuroepthelial Tissue|2019
20+|0.5|0.5|0.5|Benign/Borderline|1222|243973474|Male and Female|Tumors of Neuroepthelial Tissue|2020
20+|6.6|6.8|6.7|Malignant|18296|243973474|Male and Female|Tumors of Neuroepthelial Tissue|2020
20+|0.5|0.6|0.5|Benign/Borderline|1260|245477881|Male and Female|Tumors of Neuroepthelial Tissue|2021
20+|6.4|6.6|6.5|Malignant|17873|245477881|Male and Female|Tumors of Neuroepthelial Tissue|2021
20+|3.8|3.9|3.9|Benign/Borderline|8168|211050944|Male and Female|Tumors of Sellar Region|2004
20+|0.0|0.0|0.0|Malignant|43|211050944|Male and Female|Tumors of Sellar Region|2004
20+|4.2|4.4|4.3|Benign/Borderline|9254|213511339|Male and Female|Tumors of Sellar Region|2005
20+|0.0|0.0|0.0|Malignant|40|213511339|Male and Female|Tumors of Sellar Region|2005
20+|4.5|4.7|4.6|Benign/Borderline|10017|216055494|Male and Female|Tumors of Sellar Region|2006
20+|0.0|0.0|0.0|Malignant|33|216055494|Male and Female|Tumors of Sellar Region|2006
20+|4.8|5.0|4.9|Benign/Borderline|10660|218481776|Male and Female|Tumors of Sellar Region|2007
20+|0.0|0.0|0.0|Malignant|34|218481776|Male and Female|Tumors of Sellar Region|2007
20+|5.1|5.3|5.2|Benign/Borderline|11546|220975702|Male and Female|Tumors of Sellar Region|2008
20+|0.0|0.0|0.0|Malignant|17|220975702|Male and Female|Tumors of Sellar Region|2008
20+|5.5|5.7|5.6|Benign/Borderline|12533|223491138|Male and Female|Tumors of Sellar Region|2009
20+|0.0|0.0|0.0|Malignant|25|223491138|Male and Female|Tumors of Sellar Region|2009
20+|5.5|5.7|5.6|Benign/Borderline|12844|226163297|Male and Female|Tumors of Sellar Region|2010
20+|0.0|0.0|0.0|Malignant|34|226163297|Male and Female|Tumors of Sellar Region|2010
20+|5.6|5.8|5.7|Benign/Borderline|13187|228849300|Male and Female|Tumors of Sellar Region|2011
20+|0.0|0.0|0.0|Malignant|35|228849300|Male and Female|Tumors of Sellar Region|2011
20+|6.0|6.3|6.1|Benign/Borderline|14285|231560392|Male and Female|Tumors of Sellar Region|2012
20+|0.0|0.0|0.0|Malignant|34|231560392|Male and Female|Tumors of Sellar Region|2012
20+|6.0|6.2|6.1|Benign/Borderline|14351|234048650|Male and Female|Tumors of Sellar Region|2013
20+|0.0|0.0|0.0|Malignant|42|234048650|Male and Female|Tumors of Sellar Region|2013
20+|6.1|6.3|6.2|Benign/Borderline|14692|236576514|Male and Female|Tumors of Sellar Region|2014
20+|0.0|0.0|0.0|Malignant|38|236576514|Male and Female|Tumors of Sellar Region|2014
20+|6.3|6.5|6.4|Benign/Borderline|15439|239015354|Male and Female|Tumors of Sellar Region|2015
20+|0.0|0.0|0.0|Malignant|30|239015354|Male and Female|Tumors of Sellar Region|2015
20+|6.4|6.6|6.5|Benign/Borderline|15800|241359538|Male and Female|Tumors of Sellar Region|2016
20+|0.0|0.0|0.0|Malignant|26|241359538|Male and Female|Tumors of Sellar Region|2016
20+|6.6|6.8|6.7|Benign/Borderline|16551|243493478|Male and Female|Tumors of Sellar Region|2017
20+|0.0|0.0|0.0|Malignant|21|243493478|Male and Female|Tumors of Sellar Region|2017
20+|6.3|6.4|6.4|Benign/Borderline|78644|1210759812|Male and Female|Tumors of Sellar Region|2017-2021
20+|0.0|0.0|0.0|Malignant|111|1210759812|Male and Female|Tumors of Sellar Region|2017-2021
20+|6.5|6.7|6.6|Benign/Borderline|16566|245414364|Male and Female|Tumors of Sellar Region|2018
20+|0.0|0.0|0.0|Malignant|23|245414364|Male and Female|Tumors of Sellar Region|2018
20+|6.5|6.7|6.6|Benign/Borderline|16729|247235681|Male and Female|Tumors of Sellar Region|2019
20+|~|~|~|Malignant|~|247235681|Male and Female|Tumors of Sellar Region|2019
20+|5.6|5.8|5.7|Benign/Borderline|14255|243973474|Male and Female|Tumors of Sellar Region|2020
20+|0.0|0.0|0.0|Malignant|24|243973474|Male and Female|Tumors of Sellar Region|2020
20+|6.0|6.2|6.1|Benign/Borderline|15237|245477881|Male and Female|Tumors of Sellar Region|2021
20+|0.0|0.0|0.0|Malignant|32|245477881|Male and Female|Tumors of Sellar Region|2021
20+|9.3|9.5|9.4|Benign/Borderline|19974|211050944|Male and Female|Tumors of the Meninges|2004
20+|0.2|0.3|0.2|Malignant|509|211050944|Male and Female|Tumors of the Meninges|2004
20+|10.3|10.6|10.5|Benign/Borderline|22659|213511339|Male and Female|Tumors of the Meninges|2005
20+|0.2|0.3|0.2|Malignant|502|213511339|Male and Female|Tumors of the Meninges|2005
20+|10.8|11.1|11.0|Benign/Borderline|24143|216055494|Male and Female|Tumors of the Meninges|2006
20+|0.2|0.2|0.2|Malignant|470|216055494|Male and Female|Tumors of the Meninges|2006
20+|11.2|11.5|11.4|Benign/Borderline|25405|218481776|Male and Female|Tumors of the Meninges|2007
20+|0.2|0.3|0.2|Malignant|528|218481776|Male and Female|Tumors of the Meninges|2007
20+|11.9|12.2|12.0|Benign/Borderline|27491|220975702|Male and Female|Tumors of the Meninges|2008
20+|0.2|0.2|0.2|Malignant|473|220975702|Male and Female|Tumors of the Meninges|2008
20+|12.6|12.9|12.8|Benign/Borderline|29682|223491138|Male and Female|Tumors of the Meninges|2009
20+|0.2|0.2|0.2|Malignant|440|223491138|Male and Female|Tumors of the Meninges|2009
20+|12.3|12.6|12.4|Benign/Borderline|29406|226163297|Male and Female|Tumors of the Meninges|2010
20+|0.2|0.2|0.2|Malignant|405|226163297|Male and Female|Tumors of the Meninges|2010
20+|12.4|12.7|12.6|Benign/Borderline|30132|228849300|Male and Female|Tumors of the Meninges|2011
20+|0.2|0.2|0.2|Malignant|405|228849300|Male and Female|Tumors of the Meninges|2011
20+|12.6|12.9|12.8|Benign/Borderline|31270|231560392|Male and Female|Tumors of the Meninges|2012
20+|0.2|0.2|0.2|Malignant|430|231560392|Male and Female|Tumors of the Meninges|2012
20+|12.9|13.1|13.0|Benign/Borderline|32334|234048650|Male and Female|Tumors of the Meninges|2013
20+|0.2|0.2|0.2|Malignant|472|234048650|Male and Female|Tumors of the Meninges|2013
20+|13.1|13.4|13.2|Benign/Borderline|33584|236576514|Male and Female|Tumors of the Meninges|2014
20+|0.2|0.2|0.2|Malignant|479|236576514|Male and Female|Tumors of the Meninges|2014
20+|13.6|13.9|13.7|Benign/Borderline|35524|239015354|Male and Female|Tumors of the Meninges|2015
20+|0.2|0.2|0.2|Malignant|446|239015354|Male and Female|Tumors of the Meninges|2015
20+|13.9|14.2|14.0|Benign/Borderline|36765|241359538|Male and Female|Tumors of the Meninges|2016
20+|0.1|0.2|0.2|Malignant|431|241359538|Male and Female|Tumors of the Meninges|2016
20+|14.3|14.6|14.4|Benign/Borderline|38598|243493478|Male and Female|Tumors of the Meninges|2017
20+|0.2|0.2|0.2|Malignant|458|243493478|Male and Female|Tumors of the Meninges|2017
20+|14.3|14.5|14.4|Benign/Borderline|195095|1210759812|Male and Female|Tumors of the Meninges|2017-2021
20+|0.2|0.2|0.2|Malignant|2154|1210759812|Male and Female|Tumors of the Meninges|2017-2021
20+|14.3|14.6|14.4|Benign/Borderline|39327|245414364|Male and Female|Tumors of the Meninges|2018
20+|0.1|0.2|0.2|Malignant|437|245414364|Male and Female|Tumors of the Meninges|2018
20+|14.9|15.2|15.1|Benign/Borderline|41726|247235681|Male and Female|Tumors of the Meninges|2019
20+|0.1|0.2|0.1|Malignant|406|247235681|Male and Female|Tumors of the Meninges|2019
20+|13.5|13.7|13.6|Benign/Borderline|37441|243973474|Male and Female|Tumors of the Meninges|2020
20+|0.1|0.2|0.2|Malignant|417|243973474|Male and Female|Tumors of the Meninges|2020
20+|14.1|14.4|14.3|Benign/Borderline|39821|245477881|Male and Female|Tumors of the Meninges|2021
20+|0.2|0.2|0.2|Malignant|453|245477881|Male and Female|Tumors of the Meninges|2021
20+|0.7|0.8|0.8|Benign/Borderline|1587|211050944|Male and Female|Unclassified Tumors|2004
20+|0.6|0.6|0.6|Malignant|1284|211050944|Male and Female|Unclassified Tumors|2004
20+|0.9|1.0|0.9|Benign/Borderline|1999|213511339|Male and Female|Unclassified Tumors|2005
20+|0.6|0.7|0.6|Malignant|1330|213511339|Male and Female|Unclassified Tumors|2005
20+|0.9|1.0|0.9|Benign/Borderline|2000|216055494|Male and Female|Unclassified Tumors|2006
20+|0.6|0.6|0.6|Malignant|1301|216055494|Male and Female|Unclassified Tumors|2006
20+|0.9|1.0|0.9|Benign/Borderline|2086|218481776|Male and Female|Unclassified Tumors|2007
20+|0.5|0.6|0.6|Malignant|1226|218481776|Male and Female|Unclassified Tumors|2007
20+|1.0|1.1|1.0|Benign/Borderline|2279|220975702|Male and Female|Unclassified Tumors|2008
20+|0.6|0.6|0.6|Malignant|1391|220975702|Male and Female|Unclassified Tumors|2008
20+|1.1|1.2|1.1|Benign/Borderline|2530|223491138|Male and Female|Unclassified Tumors|2009
20+|0.6|0.6|0.6|Malignant|1430|223491138|Male and Female|Unclassified Tumors|2009
20+|1.1|1.2|1.1|Benign/Borderline|2645|226163297|Male and Female|Unclassified Tumors|2010
20+|0.5|0.6|0.5|Malignant|1264|226163297|Male and Female|Unclassified Tumors|2010
20+|1.1|1.2|1.2|Benign/Borderline|2743|228849300|Male and Female|Unclassified Tumors|2011
20+|0.5|0.6|0.5|Malignant|1283|228849300|Male and Female|Unclassified Tumors|2011
20+|1.2|1.2|1.2|Benign/Borderline|2847|231560392|Male and Female|Unclassified Tumors|2012
20+|0.5|0.6|0.5|Malignant|1292|231560392|Male and Female|Unclassified Tumors|2012
20+|1.1|1.2|1.1|Benign/Borderline|2770|234048650|Male and Female|Unclassified Tumors|2013
20+|0.5|0.5|0.5|Malignant|1291|234048650|Male and Female|Unclassified Tumors|2013
20+|1.1|1.2|1.1|Benign/Borderline|2760|236576514|Male and Female|Unclassified Tumors|2014
20+|0.5|0.6|0.6|Malignant|1433|236576514|Male and Female|Unclassified Tumors|2014
20+|1.0|1.1|1.1|Benign/Borderline|2613|239015354|Male and Female|Unclassified Tumors|2015
20+|0.5|0.6|0.5|Malignant|1389|239015354|Male and Female|Unclassified Tumors|2015
20+|0.9|1.0|1.0|Benign/Borderline|2445|241359538|Male and Female|Unclassified Tumors|2016
20+|0.5|0.5|0.5|Malignant|1282|241359538|Male and Female|Unclassified Tumors|2016
20+|0.9|1.0|0.9|Benign/Borderline|2368|243493478|Male and Female|Unclassified Tumors|2017
20+|0.4|0.5|0.5|Malignant|1286|243493478|Male and Female|Unclassified Tumors|2017
20+|0.8|0.9|0.9|Benign/Borderline|11057|1210759812|Male and Female|Unclassified Tumors|2017-2021
20+|0.5|0.5|0.5|Malignant|6851|1210759812|Male and Female|Unclassified Tumors|2017-2021
20+|0.9|0.9|0.9|Benign/Borderline|2344|245414364|Male and Female|Unclassified Tumors|2018
20+|0.5|0.5|0.5|Malignant|1381|245414364|Male and Female|Unclassified Tumors|2018
20+|0.8|0.9|0.8|Benign/Borderline|2164|247235681|Male and Female|Unclassified Tumors|2019
20+|0.5|0.5|0.5|Malignant|1456|247235681|Male and Female|Unclassified Tumors|2019
20+|0.8|0.9|0.9|Benign/Borderline|2208|243973474|Male and Female|Unclassified Tumors|2020
20+|0.5|0.6|0.5|Malignant|1490|243973474|Male and Female|Unclassified Tumors|2020
20+|0.7|0.8|0.8|Benign/Borderline|2058|245477881|Male and Female|Unclassified Tumors|2021
20+|0.4|0.5|0.5|Malignant|1313|245477881|Male and Female|Unclassified Tumors|2021
20+|0.1|0.1|0.1|Benign/Borderline|154|211050944|Male and Female|Unique astrocytoma variants|2004
20+|0.0|0.0|0.0|Malignant|36|211050944|Male and Female|Unique astrocytoma variants|2004
20+|0.1|0.1|0.1|Benign/Borderline|159|213511339|Male and Female|Unique astrocytoma variants|2005
20+|0.0|0.0|0.0|Malignant|40|213511339|Male and Female|Unique astrocytoma variants|2005
20+|0.1|0.1|0.1|Benign/Borderline|190|216055494|Male and Female|Unique astrocytoma variants|2006
20+|0.0|0.0|0.0|Malignant|49|216055494|Male and Female|Unique astrocytoma variants|2006
20+|0.1|0.1|0.1|Benign/Borderline|188|218481776|Male and Female|Unique astrocytoma variants|2007
20+|0.0|0.0|0.0|Malignant|50|218481776|Male and Female|Unique astrocytoma variants|2007
20+|0.1|0.1|0.1|Benign/Borderline|214|220975702|Male and Female|Unique astrocytoma variants|2008
20+|0.0|0.0|0.0|Malignant|58|220975702|Male and Female|Unique astrocytoma variants|2008
20+|0.1|0.1|0.1|Benign/Borderline|239|223491138|Male and Female|Unique astrocytoma variants|2009
20+|0.0|0.0|0.0|Malignant|66|223491138|Male and Female|Unique astrocytoma variants|2009
20+|0.1|0.1|0.1|Benign/Borderline|258|226163297|Male and Female|Unique astrocytoma variants|2010
20+|0.0|0.0|0.0|Malignant|46|226163297|Male and Female|Unique astrocytoma variants|2010
20+|0.1|0.1|0.1|Benign/Borderline|275|228849300|Male and Female|Unique astrocytoma variants|2011
20+|0.0|0.0|0.0|Malignant|63|228849300|Male and Female|Unique astrocytoma variants|2011
20+|0.1|0.1|0.1|Benign/Borderline|285|231560392|Male and Female|Unique astrocytoma variants|2012
20+|0.0|0.0|0.0|Malignant|59|231560392|Male and Female|Unique astrocytoma variants|2012
20+|0.1|0.1|0.1|Benign/Borderline|274|234048650|Male and Female|Unique astrocytoma variants|2013
20+|0.0|0.0|0.0|Malignant|69|234048650|Male and Female|Unique astrocytoma variants|2013
20+|0.1|0.1|0.1|Benign/Borderline|285|236576514|Male and Female|Unique astrocytoma variants|2014
20+|0.0|0.0|0.0|Malignant|79|236576514|Male and Female|Unique astrocytoma variants|2014
20+|0.1|0.1|0.1|Benign/Borderline|292|239015354|Male and Female|Unique astrocytoma variants|2015
20+|0.0|0.0|0.0|Malignant|52|239015354|Male and Female|Unique astrocytoma variants|2015
20+|0.1|0.1|0.1|Benign/Borderline|324|241359538|Male and Female|Unique astrocytoma variants|2016
20+|0.0|0.0|0.0|Malignant|68|241359538|Male and Female|Unique astrocytoma variants|2016
20+|0.1|0.1|0.1|Benign/Borderline|314|243493478|Male and Female|Unique astrocytoma variants|2017
20+|0.0|0.0|0.0|Malignant|73|243493478|Male and Female|Unique astrocytoma variants|2017
20+|0.1|0.1|0.1|Benign/Borderline|1676|1210759812|Male and Female|Unique astrocytoma variants|2017-2021
20+|0.0|0.0|0.0|Malignant|298|1210759812|Male and Female|Unique astrocytoma variants|2017-2021
20+|0.1|0.1|0.1|Benign/Borderline|341|245414364|Male and Female|Unique astrocytoma variants|2018
20+|0.0|0.0|0.0|Malignant|65|245414364|Male and Female|Unique astrocytoma variants|2018
20+|0.1|0.2|0.1|Benign/Borderline|367|247235681|Male and Female|Unique astrocytoma variants|2019
20+|0.0|0.0|0.0|Malignant|57|247235681|Male and Female|Unique astrocytoma variants|2019
20+|0.1|0.1|0.1|Benign/Borderline|328|243973474|Male and Female|Unique astrocytoma variants|2020
20+|0.0|0.0|0.0|Malignant|59|243973474|Male and Female|Unique astrocytoma variants|2020
20+|0.1|0.2|0.1|Benign/Borderline|340|245477881|Male and Female|Unique astrocytoma variants|2021
20+|0.0|0.0|0.0|Malignant|47|245477881|Male and Female|Unique astrocytoma variants|2021
